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Abstract
Tissue engineering and regenerative medicine strategies have the potential to treat numerous chronic 
degenerative conditions that are a significant burden on health services worldwide. At present, many 
groups are attempting to regenerate damaged organs and tissues using phenotypically diverse cell 
types with intricately designed biomaterials. Given the restricted proliferative capacity of terminally 
differentiated cells, stem and progenitor cells, capable of high levels of proliferation and guided 
lineage differentiation, have become of significant interest.
In order to assess populations heterogeneously from four diverse niches, adherent cells from human 
bone marrow, dental pulp, peripheral blood and umbilical cord were isolated using various isolation 
methods: Bone marrow-derived populations, termed Mesenchymal Stem Cells (MSCs), were 
purchased from Lonza; Peripheral blood cells were isolated using Histopaque and RosetteSep 
commercial isolation strategies; Umbilical cord-derived populations were isolated either by the plating 
of Wharton’s jelly on tissue culture plastic or, alternatively, the mechanical and enzymatic digestion 
of the entire cord; finally, Dental pulp-derived populations were isolated via mechanical and 
enzymatic digestion of the pulp tissue.
Following isolation, adherent populations were maintained in basal culture conditions until required. 
Bone marrow-derived populations demonstrated an inability to maintain phenotype and proliferation 
following progressive in vitro culture, in particular following a sixth passage. This is most likely 
attributable to the rapid in vitro aging of the population, as demonstrated by the quickly reducing 
length of telomeres.
Peripheral blood cells isolated using both Histopaque and RosetteSep methods demonstrated little 
cross-phenotypic variance. Adherent cells displayed an ability to form CFU-Fs and CFU-GMs upon 
semi-solid culture and, furthermore, a capacity to undertake adipogenic, chondrogenic and osteogenic 
differentiation following appropriate stimulation. However, they could not be cultured beyond an 
initial passage, a severe limitation from a tissue engineering perspective.
Umbilical cord cells isolated by plating Wharton’s jelly or whole cord digestion exhibited 
morphologically dissimilar but phenotypically similar profiles. However, whilst demonstrating an 
ability to undertake neuronal lineage differentiation, populations showed a similar proliferative and 
phenotypic demise following increasing in vitro culture as that of bone marrow-derived MSCs.
Dental pulp-derived populations demonstrated stable phenotype and proliferation rates regardless of in 
vitro culture time, likely due to the lengths of their telomeres being maintained or reducing at a rate 
similar to that of those observed in vivo. Cells cultured in semi-solid media demonstrated the ability to 
generate CFU-Fs and CFU-GMs, and therefore an ability to undertake diverse differentiation 
including adipogenic, chondrogenic, osteogenic, neuronal and hepatic lineages. However, given their 
heterogeneous expression of plasticity maintaining proteins Sox2 and Oct4, whilst furthermore 
expressing proteins associated with early embryonic development and those of the neuronal and 
retinal pigmental epithelium lineage, such differentiation may represent just a part of their lineage 
potential. Purification of populations based upon Hoechst33342 produced cells capable of forming 
microvascular-like structures following appropriate semi-solid culture. However, comparable to 
purification based upon surface antigens, the sorted population re-established a heterogeneous 
phenotype following allowance of proliferation, therefore suggesting either the incorporation of 
impurities when utilising such selection criteria or, alternatively, an innate ability of cells to re­
establish the heterogeneous niche post-purification. Assuming the former, novel cell purification 
strategies based upon Stem Cell Conserved Domains (SCCD) were devised, potentially allowing for 
the homogeneous selection of stem and progenitor subsets.
In conclusion, whilst populations isolated from each niche demonstrated multilineage potential, the 
limitations of bone marrow-, peripheral blood- and umbilical cord-derived populations must be 
addressed if these cells are to be utilised clinically. However, the homogeneous selection of dental 
pulp subpopulations using SCCD purification strategies may provide a population on which to base 
future regenerative strategies.
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1. Introduction
1.1 Overview of Tissue Engineering
1.1.1 Fundamentals of Tissue Engineering
Neurodegenerative disorders, cardiovascular disease, musculoskeletal abnormalities, 
macular degeneration, diabetes and cancer are diseases typically caused by aging or 
trauma, which subsequently prevent cells from undertaking reparative maintenance. 
Obstruction of these pathways can result in cellular malfunction or cellular 
senescence, consequentially causing erroneous protein production or tissue necrosis 
respectively. These diseases place excessive burden upon health services worldwide. 
With operations a time consuming process and donated organs and tissues in 
significant shortage, treatment of an ever-ageing population is becoming 
problematic. Given these facts, cell and molecular biologists, biochemists, engineers, 
pharmacologists and physicians have undertaken collaboration in an attempt to 
devise tissue-engineering strategies capable of providing ready supplies of organs 
and tissues1'28.
The concept of a tissue-engineered approach evolves from the ability of adult 
humans to undertake limited regeneration throughout their lifespan. For example, 
blood and skin are continually restored, and liver, bone, muscle, and blood vessels 
maintain a limited capacity for self-repair. However, it is important to emphasise 
that, whilst tissues are repaired following injury, the replacement tissue is often a 
non-functional scar tissue29'31. Tissue engineering thereby endeavours to induce 
regeneration in situations where naturally-occurring regeneration will no longer take 
place3’32'35.
1.1.2 Strategic Approaches to Tissue Engineering
Approaches that attempt to invoke tissue regeneration have been devised along three 
strategies: (i) acellular matrices to invoke in situ tissue regeneration; (ii) implantation 
of primary isolated or cultured cells; (iii) implantation of tissues assembled in vitro 
via a combination of cells and scaffolds36"38.
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Acellular matrices, where unseeded polymers are implanted within a patient, are 
dependent on the natural ability of the body to undertake regenerative processes 
when exposed to precise temporal and spatial signals. Acellular tissue matrices are 
generally prepared via the removal of cellular components from tissues using 
mechanical and chemical manipulation, thereby producing collagen-rich matrices. 
These matrices undergo deliberate degradation upon implantation and are generally 
substituted with ECM proteins secreted by cells growing inwardly4,39'42.
Autologous and allogeneic implantation of cells has thus far yielded promising yet 
inconclusive results. Clinical benefit has been observed following the intravenous 
(IV) administration of heterogeneous populations of mesenchymal stem cells (MSCs) 
in patients exhibiting a range of clinical abnormalities including osteogenesis 
imperfecta, myocardial infarction and acute graft-versus-host disease43*50. However, 
despite the encouraging results achieved, significant questions remain. 
Fundamentally we must consider methods of cell delivery, understand the intricate 
networks of adhesion molecules and chemokines and the guidance of cells to sites of 
injury, and finally the mechanisms that improve clinical prognosis51. Combining 
various cell types with biomaterials has the potential to overcome many of these 
problems, although such strategies possess a host of other problems. The engineering 
of semi-artificial and transplantable tissue requires research into the biocompatibility 
of materials seeded with various cell types. Furthermore, the issues of adhesion, 
nutrition, proliferation and differentiation in vivo must be rigorously studied. 
However, combining a given cell type with the correct biomaterial would 
undoubtedly give rise to numerous products with key applications in tissue 
engineering52'57.
Undoubtedly each of these tissue-engineering strategies exhibits individual benefits 
relevant to multiple therapeutic applications. However, this thesis will largely focus 
upon cellular-mediated approaches to tissue engineering, for which reproducible 
isolation and comprehensive characterisation are required. Given that terminally- 
differentiated somatic cell types have severe proliferation and trans-differentiation 
limitations, stem cells have attracted considerable interest as a potential cell source 
for tissue-engineering strategies.
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1.2 The Potential of Stem Cells for Tissue Engineering Strategies
1.2.1 The Stem Cell: Concepts of Plasticity
Stem cells are unspecialised precursors with a unique ability to self-renew whilst 
maintaining the capacity to differentiate along multiple lineages when exposed to 
appropriate cytokines and growth factors. The stem cell population self-maintains by, 
on average, each stem cell division generating one replacement stem cell (i.e. a 
clone) and one transit-amplifying cell (i.e. a lineage-committed cell). This is known 
as asymmetric division. Alternatively, consistency within the population can be 
achieved through symmetrical divisions, provided that each time a given stem cell 
generates two transit-amplifying cells, one other produces two daughter stem cells 
(Figure 7.i)9’58'59.
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Plasticity implies the ability of a stem cell to differentiate along multiple lineages 
when exposed to defined environmental cues, although the degree of plasticity 
appears to vary between stem cell populations. Elementary developmental theories 
depict distinct lineages emerging from pluripotent cells throughout early 
embryogenesis, with progressively more restricted, less plastic cells generating 
specialised precursors that make up preparatory material for organs and tissues. It 
was therefore assumed that cells rigidly follow the theory of the central dogma, 
progressing in a unidirectional manner along defined differentiation pathways with 
an inability to modify fates60"61. Consequently the concept of plasticity was given 
solely to cells associated with early stages of development. However, numerous 
studies in recent years have challenged this pre-conception, suggesting that many 
tissue-specific stem cells in embryos and adults may in fact possess a plastic 
potential, allowing them to differentiate towards cell types of an unrelated lineage if 
transferred to an appropriate environment62"83. These alternative environments, many 
of which have been created in vitro through the utilisation of growth factors, 
reprogram the cell to generate daughter cells consistent with this new environment.
1.2.2 Identification of Underlying Mechanisms Governing Stem Cell Plasticity
Following the discovery of more plasticity than initially anticipated, exhaustive 
investigations attempting to understand pluripotency in stem cells at the molecular 
level have been pursued to elucidate their fundamental properties and processes of 
cellular reprogramming. It seems that plasticity is a property conveyed to cells during 
the early stages of embryogenesis, a cocktail of as yet unidentified factors present 
within the blastocyst pre-programming the genome to invoke a capacity for self­
renewal and pluripotent differentiation. Validation of these factors have been 
demonstrated through several elaborate studies, initially when somatic cells were 
reprogrammed by transferring their nuclear contents into oocytes or by fusion with 
embryonic stem cells84"89. Identification of factors responsible for this transferral of 
pluripotency have been partially established through an investigation demonstrating 
nuclear reprogramming of permeabilised human cells using extracts from Xenopus 
laevis eggs and early embryos. Digitonin and non-digitonin permeabilised 293T 
kidney cells and primary isolated leukocytes have been cultured in the presence of 
Xenopus egg extracts. Permeabilised cells exhibited an upregulation of pluripotency-
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associated genes, though surprisingly, non-permeabilised cells also demonstrated an 
upregulation, albeit at a reduced level. However, reprogrammed leukocytes had a 
limited lifespan and did not express surface antigens associated with pluripotent 
cells, suggesting that reprogramming was incomplete. Interestingly, the ability of egg 
extract to infer plasticity varied with different stages of Xenopus embryogenesis. 
Upregulation of pluripotency-associated genes was detected with extracts prepared 
from eggs and fertilised embryos at stage 4 (8 cell) and stage 5 (16 cell) but lost at 
blastula stage 9, thereby suggesting that reprogramming activity is lost at midblastula 
transition (MET) and the initiation of zygotic transcription in Xenopus embryos. 
Furthermore, late blastula-stage extracts were not only inactive but also inhibited 
reprogramming. Immunodepletion screening of egg extracts identified the chromatin 
remodelling protein ATPase BRG1 as a key regulator inferring pluripotent 
competence in cells90. It is surmised that BRG1 works in alliance with other 
chromatin-remodelling ATPases, including ISWI-191, to achieve nuclear 
reprogramming. ISWI-I is a member of the ISWI remodelling complex, which is 
distinct from the SWI-SNF complex. ISWI-D is mandatory for the specific release of 
TATA binding factor from adult nuclei incubated with Xenopus oocyte extracts, 
which accompanies chromatin decondensation and protein exchange. It is therefore 
likely that ATPase-dependent remodelling occurs in conjunction with transcriptional 
regulators such as Oct4, Sox2 and Nanog to achieve pluripotency.
Recent identification of Oct4 transcriptional targets has revealed an interaction 
between Oct4, Sox2 and Nanog which provide a framework for core transcriptional 
circuitry that maintains pluripotency through a series of feedback and feedforward 
loops92. Sox2 seemingly represents the foundation of this regulatory pathway, 
synergistic ally functioning with Oct4 to activate Oct-Sox enhancers that in turn 
regulate the expression of Nanog, Oct4 and Sox2 itself93. Concomitant expression of 
these regulatory genes represents the apex of a hierarchical pathway of plasticity, 
seemingly regulating numerous pathways involved in the maintenance of 
plasticity92,94"102 and multilineage differentiation. Predictably, null mutations of Sox2, 
Oct4 or Nanog result in early embryonic lethality due to an inability to maintain 
pluripotency and subsequent guided differentiation within cells100,103"104.
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Understanding pathways involved in maintaining plasticity is required if stem cells 
are to become therapeutically viable, allowing controlled differentiation towards 
desired lineages to address numerous debilitating illnesses. Thus far, embryonic stem 
(ES) cells have provided an ideal model for investigating such intricate networks, 
allowing rapid identification of pathways involved in maintaining and suppressing 
plasticity. However, whilst representing ideal candidates with respect to studying 
developmental pathways, their therapeutic value remains fundamentally 
questionable, although ongoing investigations utilising induced pluripotent stem 
(iPS) cell technologies are attempting to overcome such ethical and technical issues 
(see 1.3.3)
1.3 Embryonic Stem Cells
1.3.1 The History of Embryonic Stem Cell Research
ES cell research and its accompanying ethical and legal dilemmas are vehemently 
debated amongst the media, general public, politicians and academics of numerous 
disciplines. Whilst this is predictable considering their potential therapeutic benefits 
but difficult moral issues, it is perhaps surprising that the vast majority of discussions 
perceive ES cells as an innovatively discovered cell source, whilst in actual fact 
recent developments are based on previous research efforts. Indeed, research on 
teratocarcinomas and embryonic stem cells undertaken throughout the previous half 
century have passed through several distinct phases {Figure 1.2), inevitably 
influenced by available technologies, contemporary scientific interest and social 
demands. Comparatively reticent interest during the 1950s and 1960s increased 
significantly in the 1970s, corresponding to curiosity in mammalian developmental 
biology and cell differentiation. The identification of mouse ES cells in the early 
1980s prompted supposition for their utilisation as a vehicle for introducing targeted 
genetic modifications into the germ line, thereby highlighting embryonic stem cells 
as a potential tool for gene function analysis. Ultimately the isolation of human ES 
cells and their potential application in regenerative medicine cumulatively resulted in 
both the scientific community and general public envisaging ideal regeneration 
strategies, effectively supplying off-the shelf replacements for irreparable organs and 
tissues
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Although investigations probing mouse and human ES cells proceeded along 
corresponding experimental pathways, advances using mouse cells generally 
superseded their human counterparts by approximately a decade. In recent years, 
however, human and mouse models have been used simultaneously in comparative 
experiments, though it is apparent that research undertaking human ES cell 
experiments profited substantially from the underpinning advances achieved using 
mouse cells. Furthermore, concurrent experiments using mouse and human cells 
quickly demonstrated that, despite numerous similarities, results obtained with 
mouse cells are not necessarily directly applicable to human cells105.
Investigation detailing a mouse strain of which 
testicular teratomas occur in approximately 1% 
of males.
Commencement of systematic experimental 
work investigating teratomas and 
teratocarcinomas.
Teratomas develop with high incidence in testes 
that are derived from grafted genital ridges.
(1974-1975) Mouse chimaeras are produced by 
injection of embryonic carcinoma cells into the 
blastocyst cavity.
(1978-1987) Derivation of several monoclonal 
antibodies that recognize unique antigens on 
mouse and human embryonic carcinoma cells. 
Retinoic acid induces differentiation of mouse 
embryonic stem cells (ES cells) in culture.
Mouse ES cells give rise to germline chimaeras.
The first genetically modified mouse is 
generated using homologous recombination in 
ES cells.
Derivation of the first human ES and embryonic 
Germ (EG) cell lines.
Derivation of human ES cell lines by somatic 
cell nuclear transfer?
First successful large-scale clinical trials using 
differentiated cells that are derived from human 
ES cells?
2001
Future
Differentiation of teratocarcinomas in vitro.
Retransplantable teratocarcinomas derived from 
early mouse embryos grafted to extra-uterine 
sites confirm the essentially embryonic nature 
of the stem cells in teratocarcinomas. 
(1970-1974) Numerous isolations of cell lines 
that are derived from teratocarcinomas. 
Embryonal carcinoma (EC) cells are 
established.
(1977-1980) Isolation of human embryonic 
carcinoma cell lines.
Mouse ES cells are derived directly from the 
mouse blastocyst in culture.
(1986-1987) Transgenesis using ES cells. 
Gene targeting using ES cells and homologous 
recombination.
Derivation from primordial germ cells of 
mouse embryonic germ cell lines.
Derivation of mouse ES cells from blastocysts 
that are produced by transfer of somatic nuclei 
into enucleated oocytes (somatic cell nuclear 
transfer).
Figure 1.2 - ES cell timeline - The history of embryonic stem cell research105.
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1.3.2 The Embryonic Stem Cell Niche
ES cells are derived from the inner cell mass (ICM) of the early embryo (blastocyst) 
and demonstrate a pluripotent capacity allowing them to differentiate into any cell 
type present within the three germ layers (endoderm, mesoderm and ectoderm) in 
addition to germ cells107"112. However, ES cells cannot differentiate to form 
extraembryonic tissues and therefore are considered pluripotent as opposed to 
totipotent.
The potential plasticity of neonatal-derived stem cells can largely be hypothesised by 
considering the early stages of embryogenesis. Shortly after fertilisation, the haploid 
nuclei of the oocyte and sperm amalgamate to generate a single nucleus containing 
the diploid number of chromosomes. Following zygotic division, the resulting 
progeny undertake several rounds of further division to form a compact ball of cells 
called the morula. Each of the 32-128 cells in the morula is totipotent and can 
therefore generate all cell types of the embryo in addition to all extraembryonic 
tissues necessary for implantation in the uterine wall. This remarkable totipotent 
ability allows the sacrifice of one or more cells of the morula without impairment, a 
phenomenon on which the foundations of genetic testing are based. Preimplantation 
genetic diagnosis, used in fertilisation treatments, is a technique in which a totipotent 
morula cell is drawn into a micropipette and subjected to a sensitive PCR assay using 
cDNA primers, and is now available for an increasing number of genetic disorders in 
order to screen for potential disease-associated mutations. This technology allows 
physicians to inform parents of the health of the embryo prior to implantation of the 
still-viable morula into the uterus.
Whilst travelling along the oviduct, cells of the morula continue to proliferate to 
form a hollow sphere called the blastocyst (or blastula). During concluding days in 
the oviduct and primary days in the utems, a small number of cells delaminate from 
the surface layer of the blastula to generate an ICM within the cavity {Figure 1.3). 
This cluster of cells represents the source of ES cells which can be dissociated from 
the ICM and cultured in vitro using techniques first developed more than 20 years 
ago for the manipulation of mouse embryos. However, it is imperative to emphasise 
that the ICM forms prior to implantation, with blastocysts generated in vitro
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containing an ICM despite the fact that the embryo was created and maintained in a 
test tube113.
Figure 1.3 - From zygote to blastula: early stages of human development113.
The time from fertilisation to implantation in the uterine wall is approximately 14 
days in humans. Shortly after implantation, the blastocyst invaginates, initiating a 
crucial succession of cell motilities known as gastrulation. This key event results in 
the formation of the three genu layers of the developing embryo: ectoderm, 
endodenu, and mesodenu. Fonuation of the three genu layers begins the rudimentary 
outline of the human body as numerous cellular fates are detenuined: the endodenu 
gives rise to vasculature and blood-forming organs; the mesoderm produces muscle; 
and the ectodenu generates the skin and nervous system {Figure 1.4, Figure 1.5).
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1.3.3 Isolation of Embryonic Stem Cells
The derivation of the first human ES cell lines and human embryonic germ (EG) cell 
lines lagged significantly behind their murine counterparts. Considering that isolation 
techniques were comparable and the necessary markers to identify human ES and EC 
cells were readily available, it is probable that such delays were attributable to 
difficulties involved in obtaining suitable human embryonic material and the 
understandable reluctance of many investigators to work in a field fraught with 
potential legal problems, combined with political and moral dilemmas'13,115'126. 
However, despite such obstacles, detailed reports of isolated human ES and EG cells 
were published in 1998. The first publication described the successful isolation of ES 
cell lines from human blastocysts108. In this study, fresh or frozen cleavage stage
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human embryos, generated by in vitro fertilisation (IVF) for clinical puiposes, were 
obtained. Embryos were cultured to the blastocyst stage and the trophoectoderm 
removed by immunosurgery127 using a rabbit anti-human spleen cell antiserum 
followed by exposure to guinea pig complement. Fourteen intact inner cell masses 
were isolated from lysed trophoectoderm and plated on mouse embryonic fibroblasts. 
Following culture, a central mass of cells was removed from epithelial outgrowths 
and, following gentle dissociation with a micropipette, replated on mouse embryonic 
fibroblasts. Following further culture, colonies with a morphology resembling ES 
cells were selected and expanded. Individual cells were selected by micropipette, 
establishing the isolation of five ES cell lines originating from five separate embryos, 
and cultured on mouse embryonic fibroblasts. The resulting cells demonstrated a 
high ratio of nucleus to cytoplasm, prominent nucleoli, and colony morphology 
similar to that observed previously with rhesus monkey ES cells. Three cell lines had 
a normal XY karyotype, two displayed a normal XX karyotype, and four of the cell 
lines were successfully cryopreserved and thawed following 5 to 6 months of 
continuous undifferentiated proliferation. The other cell line was reported to have 
retained a normal XX karyotype following 6 months of culture. However, whilst this 
study failed to identify any karyotypic abnormalities following prolonged in vitro 
culture, studies examining mouse ES cells have reported karyotype modifications128’ 
129 which may be translatable to human ES cells. Thus, before human ES cells are 
considered for therapeutic application, investigations must comprehensively 
demonstrate that such abnormalities do not arise.
Cells isolated from human blastocysts expressed high levels of telomerase activity. 
Telomerase is a ribonucleoprotein responsible for the addition of telomere repeats to 
ends of chromosomes, a mechanism responsible for the maintenance of replicative 
life-span and hypothesised to regulate aging in all species130. Furthermore, the 
blastocyst-derived ES cells expressed cell surface markers associated with 
undifferentiated non-human primate ES and human EC cells, including SSEA3, 
SSEA4, Tra-1-60, Tra-1-81 and alkaline phosphatase. The pluripotency regulator 
Oct4 was highly expressed in undifferentiated ES cells, and thus unsurprisingly 
human ES cell lines demonstrated the potential to form derivatives of all three 
embryonic germ layers, with all five aforementioned cell lines producing teratomas 
following injection into severe combined immunodeficient (SCID) beige mice. Each
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teratoma contained epithelium (endoderm); cartilage, bone, smooth muscle and 
skeletal muscle (mesodenn); and neural epithelium, embryonic ganglia and skeletal 
squamous epithelium (ectoderm). In vitro, tire ES cells differentiated when cultured 
in the absence of a mouse embryonic feeder layer, both in the presence and absence 
of human leukaemia inhibitory factor (LIE). Additionally, when grown to confluence 
and allowed to form multiple layers, ES cells spontaneously differentiated despite the 
presence of the feeder cells108.
Concurrent with the isolation of ES cells from the human blastocyst, in 1998 
Shamblott et al. detailed the isolation of EG cells from primordial germ cells (PGCs) 
via the mechanical and enzymatic digestion of gonadal ridges and mesenteries from 
5 to 9 week post-fertilisation human embryos. Following isolation and culture on 
mouse embryonic fibroblasts, human EG cells demonstrated many of the features 
observed with ES cells including high levels of alkaline phosphatase and a 
pluripotent capacity for differentiation131. However, whilst EG cells again 
demonstrated potential clinical value, they are plagued with the same ethical and 
technical dilemmas tarnishing ES cell research.
Whilst ES and EG cells derived from both the blastocyst and fetal gondal tissues 
respectively demonstrate differentiation capacities with enormous clinical promise, a 
major drawback of using such cells is the issue of histocompatibility, a principle 
lying at the heart of many failed clinical attempts. Somatic cell nuclear transfer 
(SCNT) techniques have attempted to overcome such problems, with the underlying 
principles extrapolating from studies demonstrating that in amphibians, nuclei 
transferred from human keratinocytes established in culture support development to 
the juvenile tadpole stage ' . However, it is important to stress that whilst this re­
programming involves differentiation of cells into complex tissues and organs, no 
development to the adult stage was reported, leaving open to question whether 
complete re-programming of somatic cell nuclei was possible. Nevertheless, further 
investigations demonstrated the birth of live lambs following nuclear transfer from 
cultured ES cells, although it was required to induce cellular quiescence within the 
donor cells, essentially inducing the cell to exit the growth phase, a period which 
causes modifications to chromatin structure that facilitate re-programming of gene 
expression. This breakthrough was followed by the demonstration that cells derived
15
from fetal or adult-derived tissue were also capable of generating full-term lambs 
when induced to exit the growth cycle and enter the G0 phase of the cell cycle 
{Figure 1.6) prior to nuclear transfer.
Removal of nuclei from 
fertilised oocyte
Generation of egg 
containing donor nuclei 
via micropipette insertion 
and electronic pulses
Generation of blastocyst 
and ICM
Implantation via IVF to allow / \ Isolation and culturing ot cells
Figure 1.6- Diagrammatic representation of SCNT.
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Three populations of cells were synthesised for the experiment: those derived from: 
(i) a day-9 embryo; (ii) a day 26 fetus; and (iii) mammary gland of a 6 year old ewe 
in the last trimester of pregnancy. Whilst ultrasound scamring detected 21 single 
fetuses 50-60 days post oestrus, 62% of the fetuses aborted, a significantly greater 
number than the 6% that had been predicted following results obtained from natural 
mating studies134. Following approximately 110 days of pregnancy, 4 fetuses were 
dead, all from embryo-derived cells, with post-mortems indicating liver failure as the 
cause of two of the abortions, although no reason could be attributed to the remaining 
two. Following full-term, eight ewes gave birth to live lambs representing all three 
cell cloned populations. One weak lamb, derived from fetal fibroblasts, died shortly 
after birth, although a post-mortem failed to identify any abnormality or infection. 
However, at 12.5%, perinatal loss was not dissimilar to that occurring in a large 
study of commercial sheep, when 8% of lambs died within 24 hours of birth135, hi all 
cases lambs exhibited morphological characteristics attributable to the breed used to 
derive the nucleus donors and not that of the oocyte donor. Furthermore 
microsatellite analysis confirmed that each lamb was derived from the cell 
population used as the nuclear donor. Thus the lamb born from the somatic-derived 
nucleus demonstrated that terminally differentiated cells can be reprogrammed to 
generate all three germ layers, subsequently leading to much controversial interest136.
Understandably progression towards human based SCNT was undertaken, and in 
2001 Cibelli et al. published findings detailing the first transfer of a human somatic 
cell and subsequent progression to pronuclear and early embryonic development. 
However, claims of early embryonic growth following SCNT seem premature given 
that the most advanced embryo reached only the 6-cell stage. Moreover, such was the 
consternation generated by these preliminary data that three members of the editorial 
board of the publishing journal felt the need to resign137. Thus, whilst SCNT may in 
future lead to promising regenerative technologies via the generation of autologous 
organs and tissues, at present methods for acquiring them are primitive and raise 
many ethical questions. Furthermore almost all previously cloned animals exhibit 
one or more abnormalities138'139. Unsurprisingly therefore human reproductive 
cloning, in which embryos generated by SCNT are allowed to develop to full term, is 
illegal in most countries.
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Fllowing results obtained using SCNT techniques, investigators attempted to re­
induce such plasticity in a synthetic manner, essentially recreating the genetic 
reprogramming conditions found within the developing egg. An elegant study 
hypothesised that enforced expression of a limited number of genes associated with 
maintenance of plasticity may allow direct reprogramming of somatic cells . To 
evaluate this hypothesis, investigators introduced a mini-library of 24 candidate 
reprogramming factors into mouse embryonic fibroblasts containing a fusion of the 
(3-galactosidase and neomycin-resistance genes expressed from the Fbxl5 locus, 
which is expressed in mouse ES cells and early embryos, although it is non-essential 
for the maintenance of plasticity. Fundamental principles of this system encompass 
the ability of the activated Fbxl5 gene to generate resistance to the antibiotic G418. 
Mouse embryonic fibroblasts infected with all 24 candidate genes, cultured on feeder 
cells in G418 containing-ES cell media, generated drug resistant colonies with a 
proportion exhibiting an ES-like morphology, including a round shape, large 
nucleoli, and negligible cytoplasm. Following an intricate elimination process, the 
transcription factors Oct4, Sox2, Klf4 and c-Myc were acknowledged as capable of 
inducing pluripotency, though curiously Nanog was evidently dispensable.
However, despite reports detailing similarities between the iPS cells and primary 
isolated murine ES cells, key differences were noted, including the inability of iPS 
cells to achieve germline transmission in blastocyst complementation assays. 
Furthermore, iPS cells exhibited a gene expression profile similar but not identical to 
that of murine ES cells. Subsequently, several groups have attempted to progress 
direct reprogramming techniques with a view to generating cells identical to primary 
isolated ES cells from a given species. Interestingly, direct reprogramming was 
achieved using the same quartet of factors in rhesus macaque and human cells140"141, 
indicating that fundamental transcriptional machinery governing plasticity is 
conserved across species {Table 1.1). Further investigations have demonstrated a 
redundancy for c-Myc during reprogramming142"143, a result of significant clinical 
benefit considering that c-Myc reactivation can predispose cells to malignant 
transformation of iPS derivatives144.
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Factor combination Overview of achievements
Mouse
KLF4, c-Myc, Oct4, Sox2 Initial report generating iPS cells from mouse embryonic and 
adult fibroblasts. IPS cells exhibited morphological and growth 
characteristics associated with ES cells, furthermore expressing
ES associated markers. Subcutaneous transplantation into nude 
mice resulted in tumour formation containing tissues composing 
all three germ layers. Following injection into blastocysts, iPS 
cells contributed towards mouse embryonic development. No 
germline transmission was achieved in chimeric mice84.
PCLF4, c-Myc, Oct4, Sox2 Following iPS induction and Nanog-based purification, germline 
competent cells exhibiting increased ES-cell-like gene expression 
and DNA methylation patterns compared with Fbxl5 iPS cells 
were obtained. The four transgenes were strongly silenced in 
Nanog iPS cells. Adult chimeras were obtained from several 
Nanog iPS cell clones, with one clone transmitting through the 
germline to the next generation. Approximately 20% of the 
offspring developed tumours attributable to the reactivation of the 
c—Myc transgene141.
KLF4, Oct4, Sox2 Generation of murine and human iPS cells in the absence of the c- 
Myc retrovirus. Generated from adult dermal fibroblasts, iPS cells 
exhibited many ES cell characteristics. Mice derived from 
generated iPS cells did not develop tumours145.
KLF4, c-Myc, Oct4, Sox2 Synthesis of mouse iPS cells exclusive of viral vectors. Repeated 
transfection of two expression plasmids, one containing Oct4, 
Sox2 and KLF4 cDNAs, the other incorporating c-Myc cDNA, 
into mouse embryonic fibroblasts resulted in iPS cells without 
evidence of plasmid integration146.
KLF4, c-Myc, Oct4, Sox2 Reprogramming of mouse fibroblasts and liver cells using a non­
integrating adenovirus transiently expressing Oct4, Sox2, KLF4, 
and c-Myc. Adenoviral iPS cells exhibited DNA methylation 
patterns associated with reprogrammed cells, expressed 
endogenous pluripotency genes, formed teratomas, and 
contributed to multiple tissues, including the germline, in chimeric 
mice147.
KLF4, Oct4, Sox2 Reprogramming efficiency increased via the utilisation of 
methyltransferase and Histone deacetylase (HDAC) inhibitors. In 
particular, valproic acid (VPA), an HDAC inhibitor, improved 
reprogramming efficiency more than 100 fold without the 
introduction of the oncogene c-Myc148.
Oct4 Reprogramming of murine adult neuronal stem cells with Oct4 
(one factor iPS) generated cells resembling ES cells in vitro and 
vivo, efficiently differentiating into neurons, cardiomyocytes, and 
germ cells in vitro, whilst capable of teratoma development and 
germ line transmission in vivo .
Rhesus macaque
KLF4, c-Myc, Oct4, Sox2 Generation of iPS cells via retrovirus-mediated introduction of 
specified transcription factors142.
Human
KLF4, c-Myc, Oct4, Sox2 
hTERT, SY40 large T
Derivation of iPS cells from fetal, neonatal and adult human 
primary cells, including dermal fibroblasts. IPS cells resembled
ES cells with regards morphology and gene expression and in
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Oct4, Sox2, Nanog, Liii28
KLF4, c-Myc, Oct4, Sox2
KLF4, Oct4, Sox2 
Oct4, Sox2
their ability to generate teratomas witliin immune-deficient 
mice150.
Reprogramming of human somatic cells generated pluripotent 
human cells exhibiting a normal karyotype, expressing telomerase 
and ES cell-associated surface markers and genes, and 
maintaining a developmental capacity capable of generating 
advanced derivatives of all three primary germ layers143.
iPS cells generated from human adult dermal fibroblasts exhibited 
similar morphological, proliferative, phenotypic, gene expression 
and epigenetic parameters as human ES cells, and could 
furthermore differentiate into cell types of the three germ layers in 
vitro and in teratomas151.
See murine desciption145.
See murine desciption148.
Table 1.1 - Investigations detailing reprogramming of cells from numerous species using 
combinatorial arrays of transcription factors144.
Whilst the ability to reprogramme cells has generated much excitement with regards 
potential clinical and technical outcomes, much concern has been voiced with 
regards the oncogenicity of factors utilised in reprogramming and the potential for 
insertional mutagenesis consequential to integrating retroviral or lentiviral vectors. 
Primary reports detailing generation of germline competent iPS cells further noted 
that approximately 20% of chimeric mice succumbed to tumours that were 
attributable to the reactivation of the c-Myc proviral transgene that had 
spontaneously integrated into the host genome141. Whilst many groups have achieved 
successful reprogramming in the absence of c-Myc, the percentage of cells 
undertaking an iPS cell phenotype was greatly reduced in comparison with 
reprogramming in the presence of c-Myc. Thus, whilst c-Myc does not appear to be 
critical to the reprogramming of cells, results would suggest that c-Myc instead acts 
as a reprogramming catalyst, increasing the speed of the stochastic events reinstating 
pluripotency. Given the low reprogramming efficiency in the absence of c-Myc and 
the residual risk inherent to integrating gene transfer vectors, alternative approaches 
to reprogramming have been undertaken, including the use of small molecule 
chemicals in conjunction with genetic factors148, the use of adult stem cells as a 
starting population for reprogramming and non-integrating gene transfer systems to 
deliver required reprogramming genes146. Should these alternative approaches prove 
a stable and efficient method of reprogramming following intensive studies, a 
clinical use for iPS cells must surely await.
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1.4 Human Adult Stem Cells
1.4.1 Human Adult Stem Cell Niches
Whilst developmentally primitive cells such as ES and EG cells have demonstrated 
impressive capacities for lineage induced differentiation, ethical and technical issues 
have and will continue to inhibit clinical advances. It is therefore hoped that 
understandings of plasticity and mechanisms of differentiation gained via the study 
of these controversial cells can accelerate research concerning cells derived from 
adult tissues. Throughout recent years numerous publications have challenged the 
dogma that organ specific, somatic stem cells do not integrate into unrelated organs 
and consequently adopt phenotypic or functional characteristics ’ ’ ‘ . This
ability to undertake transdifferentiation could yield immense promise for clinical 
applications incorporating adipose164, bone165, cartilage166, neural167, tooth16S and 
numerous other regenerative approaches. Thus cells isolated from numerous adult 
tissues {Figure 1.7) are currently being assessed for their ability to undertake such 
multilineage differentiation.
Hair follicles 
Comea/Retina 
Dental pulp
Skin
Adipose
Skeletal muscle
-Brain
- Peripheral blood 
-Heart
- Intestines 
Bone marrow
Figure 1.7 - Regions of known stem cell residence facilitating potential isolation.
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1.4.2 Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) are a well-characterised population of self- 
renewing cells that produce progenitors capable of differentiating into every type of 
mature blood cell in a comprehensively defined hierarchy {Figure 1.8). 
Developmentally, HSCs are derived from the mesoderm, with morphological studies 
hypothesising the hemangioblast as the common mesodermal precursor for both the 
endothelial and hematopoietic lineages. In non-mammalian vertebrate embryos, 
several distinct tissues independently specify hematopoietic fate, for example the 
yolk sac generates a transient ephemeral embryonic hematopoietic system, whilst the 
region of the dorsal aorta generates the adult hematopoietic system169"171. Within the 
mammalian embryo, original theories depicted adult HSCs acquiring their 
phenotypic fate within the blood islands of the yolk sac during midgestational stages 
and subsequently migrating and colonising the fetal liver and progressively the adult 
bone marrow, their eventual niche of residence172. However, recent investigations 
have suggested that the aorta-gonad-mesonephros (AGM) regions, and more 
specifically the midgestation dorsal aorta, as the initial area in which adult­
repopulating HSCs are generated173"175. However, like many areas of developmental 
biology, alternative theories appear plausible and consequently studies investigating 
the origin of adult HSCs in mammals are continually being undertaken. Furthermore, 
several recent studies concentrating on the mouse embryo have implicated numerous 
other tissues as reservoirs for, and perhaps even producers of, adult HSCs176. 
Unfortunately however, due to the in utero development of mammalian embryos and 
subsequent lack of optimal assay systems, identification and characterisation of 
human HSCs and procuring lineage mapping has proved somewhat difficult.
In vitro assays investigating both murine and human hematopoiesis are sufficient to 
demonstrate clonal myelo-erythroid, B-, NK- (Natural Killer) and dendritic cell but 
not T cell, proliferation and differentiation. However, whilst competitive in vivo 
repopulating studies in mice have demonstrated a sustained self-renewal and 
multipotent differentiation capacity of murine HSCs, in addition to T cell 
development from HSCs and committed progenitors, such assays cannot be 
performed in humans due to obvious ethical considerations. Thus throughout 
previous years studies have attempted to generate surrogate assays. Long-term
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culture initiating cell assays (LTC-IC) are useful for the identification of primitive or 
primarily quiescent progenitors in vitro, demonstrating a capacity for self renewal or 
multilineage differentiation. However, to investigate human HSCs in vivo two 
essential prerequisites need to be met: Primarily the host should not eliminate the 
xenografts via an immune response, and secondly provide a permissive 
microenvironment for engraftment and multilineage differentiation of donor cells. 
Spontaneously occurring immunodeficient mouse strains partially meet these criteria 
and have been manipulated in order to enhance their model function, generating 
mouse models such as NOD-SCID (NonObese Diabetic Severe Combined 
Immunodeficient), (32 microglobulin knockout, NOD-RAG1 knockout, 
NOD/SCID/yc triple-mutant, and RAG2/common cytokine receptor y chain double 
mutant. In contrast to murine xenotransplantation models, a large animal 
transplantation allowing the introduction of human HSCs intraperitoneally into 
unconditioned, early gestational sheep fetuses can be undertaken. In this model low 
numbers of selected progenitors can engraft, allowing myelo-erythroid as well as T 
and B lymphoid numbers to be monitored over several years " . Thus through
numerous replicate models understanding of hematopoiesis has steadily progressed, 
with results from respective studies enhancing perception of hierarchal hematopoietic 
pathways. Current theories depict the HSC residing as a pluripotent stem cell, giving 
rise to: myeloid stem cells capable of generating erythrocytes, platelets, neutrophils, 
monocytes and subsequently macrophages, eosinophils, basophils, and mast cells; B 
stem cells differentiating to form B cells and subsequently plasma cells; and T stem 
cells committed towards the T cell lineage {Figure 7.5)179. In addition to B- and T- 
lymphoid stem cells, an additional myeloid precursor cell (not shown in Figure 1.8) 
generates NK cells. Furthermore, recent studies have suggested that both lymphoid 
and myeloid precursors are implicated in the generation of dendritic cells in vivo180' 
182. Perhaps most striking with regards to this current model of hematopoiesis is the 
association of HSCs with pluripotency. Whilst demonstrating an ability to 
differentiate towards all blood lineages, such abilities do not strictly fulfil the 
terminology of pluripotency. However, recent investigations examining HSC 
plasticity have reported expression of pluripotent-associated markers183 and non­
blood related differentiation, thereby indicating a potential pluripotent aspect184’186.
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Figure 1.8 - Differentiation cascade of HSCs. NK lineage pathway is not shown179. CFU-GEMM 
- Colony Forming Unit-Granulocyte-Erythrocyte-Monocyte-Megakaryocyte; BFU-E - Burst 
Forming Unit-Erythroid; CFU-E - Colony Forming Unit-Erythroid ; BFU-Meg - Burst 
Forming Unit-Megakaryocyte; CFU-Meg - Colony Forming Unit-Megakaryocyte; CFU-GM - 
Colony Forming Unit-Granulocyte-Monocyte; CFU-G - Colony Forming Unit-Granulocyte; 
CFU-M - Colony Forming Unit-Monocyte; CFU-Eo - Colony Forming Unit-Eosinophil; CFU- 
Bas - Colony Forming Unit - Basophile; CFU-Mast - Colony Forming Unit-Mast Cell.
Given their blood regenerative capacity and potential further lineage commitment, 
the isolation of HSCs for therapeutic application could obviously yield immense 
therapeutic results. In addition to bone marrow, HSCs have been found in numerous 
other adult tissues including peripheral187 and umbilical cord blood183, and following 
successful heterogeneous cell isolation, the homogeneous isolation of HSCs is 
imperative for therapeutic progression. Unlike purification of numerous cell types, 
the generation of monoclonal antibodies against CD34 almost two decades ago has 
enabled high purification of HSC and progenitor populations, though fails to 
comprehensively distinguish between the two. Furthennore, among non- 
hematopoietic tissues, CD34 is expressed on endothelial cells (ECs). Therefore a
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surface profile comprising combinatorial antigen expression is utilised to purify the 
desired stem, progenitor and functional hematopoietic populations from various 
tissues in both mice {Figure 1.9) and humans {Table 1.2). However, whilst numerous 
results achieved via the study of hematopoiesis in mice are translatable to humans, 
many of the surface marker profiles of HSCs and progenitor cells differ {Figure 
1.10). Furthermore, it is still acknowledged that, despite purification using a 
combinatorial array of surface markers, murine and human HSC populations remain 
heterogeneous with regards multipotentiality.
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Figure 1.9 - Conceptual hematopoietic hierarchies in adult mice. Long-term hematopoietic stem 
cells (LT-HSC) self-renew for life, whereas their downstream short-term (ST)-HSC self-renew 
for six to eight weeks. Further downstream progenitors have been prospectively isolated to 
phenotypic, functional, and for the more mature cells, gene expression profile homogeneity. 
MPP - multipotent progenitor; CLP - common lymphoid progenitor; CMP - common myeloid 
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Tissue Surface marker profile Read out Assay
Candidate HSC
FBM Lin CD34' Th-T T/B/myeloid SCID-hu
FBM CD34+ CD38' HLA-DR+ Clonal B/myeloid CFU
CB CD34+ CD3810 CD10‘ CD 19' Clonal B/myeloid Liquid culture
CB CD34+ CD38" CD33' CD10' Clonal B/myeloid CFU
CB/BM Lin CD34+ CD38’ Clonal B/NK/myeloid NOD-SCID
CB Lin CD34' CD38‘ B/T/myeloid NOD-SCID
BM Lin CD34' T/myeloid Fetal sheep
CB Lin CD34+ CD38' CD33+ B/myeloid NOD-SCID
Candidate lymphoid progenitors
FBM/BM Lin CD34+ CD38+ CD10+ Clonal B/NK/DC Stroma culture
FBM/BM CD45RA+ Thy-F HLA-DR+ T cells SCID-hu
CB CD34+ CD38' CD7+ IL-7Ra Clonal B/NK/DC Stroma culture
Candidate myeloid progenitors
BM CD34+ CD45RO' CFU-GM enriched Methylcellulose
BM CD34+ CD45RO+ BFU-E enriched Methylcellulose
CB/BM/PB CD34+ CD45RA+ CFU-GM enriched Methylcellulose
CB/BM/PB CD34+ CD45RA' BFU-E enriched Methylcellulose
Fetal BM/BM CD34+ CD64' M-CSFRhl CFU-G/M/GM enriched Methylcellulose
Fetal BM/BM CD34+ CD64+ M-CSFR111 CFU-M enriched Methylcellulose
Fetal BM/BM CD34+ CD64‘ M-CSFR10 CFU-G enriched Methylcellulose
FL/CB/MPB CD34+IL-3R10 All myeloid colonies Methylcellulose
FL/CB/MPB CD34+IL-3R+ CFU-GM enriched Methylcellulose
FL/CB/MPB CD34+IL3R- BFU-E enriched Methylcellulose
CB/BM CD34+/Flt-3+ CFU-GEMM/GM enriched Methylcellulose
CB/BM CD34+/Flt-3' BFU-E enriched Methylcellulose
CB CD34+/CCR1 + CFU-GM em-iched Methylcellulose
CB CD34+/CCR1+ BFU-E enriched Methylcellulose
Table 1.2 - Surface marker expression on candidate human hematopoietic stem and progenitor 
ceils. FL — Fetal liver; FBM — Fetal bone marrow; CB — Cord blood; BM — Bone marrow; PB - 
Peripheral blood; MPB — Mobilised peripheral blood.
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c-Kit+ c-Kit+
Y
Negative for: B220, CD3, CD4, 
CDS, Mac-1, Gr-1, Terl 19
Negative for: CD 10, CD 14, 
CD15, CD16, CD19, CD20
Figure 1.10 - Candidate HSC surface markers in murine and human cell populations.
Despite fundamental purification issues of HSCs and progenitors of varying 
differentiation capacity, the selection of populations based upon surface marker 
profiles has sufficed in allowing translation towards clinical applications. At present, 
the common clinical application of hematopoietic cell transplantation (HCT) treats 
patients with malignancies, bone marrow failure states, and immunodeficiencies via 
autologous or allogeneic means. Patients receiving autologous grafts receive such 
treatments due to an underlying malignancy comprising either a high risk of relapse 
or a pre-failure post standard chemotherapy. Thus, the therapeutic principle 
underpinning autologous transplantation denotes an ability to administer significantly 
increased doses of radiation and/or chemotherapy in order to maximise tumour 
eradication, with the dose-limiting toxicity, detrimental to the hematopoietic organ, 
rescued by the HCT. Conversely, allogeneic transplantation differs in that HSCs are 
obtained from an appropriately matched HLA-donor. Such allogeneic HCTs not only 
infer an ability to rescue patients who undergo myeloablative radiation combined 
with or without chemotherapy, but the allogeneic graft can also confer an effect that 
has been termed graft-versus-tumour189. However, a significant complication of 
allogeneic transplantation using an unmodified graft is the consequential graft- 
versus-host disease (GVHD)190, in which mature T cells that develop following 
implantation identify host antigens as foreign bodies and subsequently mount an 
immune attack against the host organs. Whilst numerous efforts are underway in an
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attempt to reduce the morbidity and mortality of GVHD, the current method of 
repression requires that patients undertake systemic post-transplant 
immunosuppressive therapy for the remainder of their lives. Studies have 
demonstrated that T cell depletion of bone marrow results in significantly increased 
incidences of graft failure, whilst further studies observed an increased loss or 
reduction of graft-versus-tumour activity following T cell diminution178. Purification 
of HSCs destined for T cell lineage and comprehensive study may therefore generate 
methods for modification or removal of T cells alleviating immunogenic responses 
against the host.
Considering HSCs within the whole, remarkable advances throughout the previous 
decade have allowed their utilisation within a clinical setting. However, issues 
regarding regulation of self-renewal and capacity for differentiation of varying HSC 
stem and progenitor subpopulations require further clarification. Should fundamental 
knowledge addressing these issues be attained, HSCs and their progenitor 
counterparts may be able to be used in numerous clinical treatments.
1.4.3 Bone Marrow-derived Mesenchymal Stem Cells
In addition to HSCs residing within the bone marrow, MSCs represent a co­
inhabiting in vitro adherent population capable of proliferative expansion with a 
finite lifespan of 15-50 cell population doublings. The first successful isolation of 
fibroblast-like colonies from bone marrow were detailed almost four decades ago, 
with the isolation protocol based upon the adherence of fibroblast-like cells to the 
plastic substrate of the cell culture plate and a concomitant lack of adherence of co­
isolated HSCs191. To date, this procedure is considered a standard protocol to isolate 
bone marrow MSCs192'194, with isolation and characterisation of MSCs from 
numerous vertebrate species, including human75,83,195, murine192’194’196, lapine197, 
canine198, ovine199, avian, porcine200, equine201 and bovine202, founded on this 
pioneering isolation technique. However, MSCs isolated in this manner are 
exceedingly heterogeneous, likely incorporating osteoblasts and their precursors, 
adipocytes, fibroblasts, reticular cells, macrophages, endothelial cells, and a fraction 
of blood cells and HSCs203'204. Thus numerous approaches have been, and continue 
to be, investigated in an attempt to prepare bone marrow-derived MSCs
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encapsulating increased homogeneity75’83’195’203’205'211, predominantly via selection 
based upon surface antigen expression profiles. MSCs can be defined in their 
undifferentiated state via the extracellular antigen expression pattern CD13+, CD29+, 
CD44+, CD54+, CD73+, CD90+, CD105+, CD106+, CD166+, CD271+, SSEA-4+, 
SH2+, SH3+, SH4+, frizzled-9+, CD3', CD 11 a", CD14', CD19‘, CD31', CD34', CD38', 
CD45" and CD66b'205,212. Tliis phenotypic profile does however modify with 
prolonged in vitro culture, perhaps signifying a reduction or cessation of 
multipotentiality. Alternatively, modified surface expression may indicate lineage 
commitment or differentiation of cells within the population, with spontaneous 
differentiation of MSCs in culture being demonstrated in studies of bone marrow- 
derived MSCs in rat213. Perhaps more accurate assessment of the global cellular 
phenotype can therefore be ascertained by the assessment of intracellular proteins 
associated with maintenance of plasticity or guided differentiation. At present, 
antigens such as STRO-1 represent the most widely used markers for MSC 
identification214'215, and whilst some antigens are undoubtedly capable of yielding a 
population of greater homogeneity following sorting, they fail to distinguish between 
stem cells and committed progenitors of lesser plasticity. The stem cell proliferation 
marker nucleostemin is a protein found in the nucleoli of ES cells, adult CNS stem 
cells, primitive cells in the bone marrow and cancer cells, and is hypothesised to 
regulate cell cycle progression in stem and cancer cells216'217. However, nucleostemin 
once again encompasses the problems associated with STRO-1 with regards to 
progenitor impurity. Investigations are therefore ongoing in an attempt to identify a 
marker specific to MSCs which is lost immediately following lineage commitment. 
However, due to the innate ability of stem cells to undertake multilineage 
differentiation, if antigen-based selection is to be used for homogeneous cell 
isolation, it is likely that no sole antigen will identify non-committed MSCs, and that 
subsequently an array of surface markers will be required to identify such 
populations.
The ability of bone marrow-derived cells to differentiate designate them a stem cell 
containing population, however their mechanisms of plasticity remain fervently 
debated. The expression of Oct4, a crucial mediator of plasticity in ES cells, has been 
reported to be both positively and negatively expressed within bone marrow-derived 
MSCs218'220. A study investigating Oct4 function within murine-derived somatic
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stem cells revealed that Oct4 is dispensable for both cellular self-renewal and 
maintenance221, suggesting that somatic stem cells mediate plasticity by alternative 
mechanisms. However, numerous studies have documented Oct4 expression within 
bone marrow-derived MSCs, also noting its interaction with other ES-associated 
proteins. In addition to similar gene targeting, studies have suggested that Oct4 
expression in MSCs promotes expression of MSC-specific genes and regulates cell 
cycle progression222. Investigations have also suggested expression of other 
hypothesised co-regulators of plasticity including Sox2 and Nanog ‘ , although
the expression and location of all of these proteins appears to vary dependent on the 
antibodies utilised within the study220. It is therefore imperative that, if 
comprehensive characterisation of given cells is to be achieved, a known standard 
antibody must be utilised in all studies in order to allow comparative expression.
MSCs demonstrate the ability to undertake numerous lineage commitments in vitro, 
capable of generating adipocytes, chondrocytes, osteoblasts, astrocytes, 
oligodendrocytes, neurons, tenocytes and myocytes following exposure to 
appropriate chemical stimuli75,225. This innate differentiation ability does however, 
along with their proliferative capabilities, decrease with increasing in vitro passage. 
This rapid aging of MSCs following in vitro culture is thought be the result of 
quickly decreasing telomere lengths226'233, a mechanism which may have significant 
clinical impacts.
Whilst homogeneous in vitro characterisation of bone marrow-derived MSCs and 
residing subpopulations remains elusive, many in vivo applications using these cells 
have, perhaps in many cases prematurely, been undertaken. Progression of MSC 
research to in vivo trials is further scrutinised when we consider that very little is 
known with regards the extent to which MSCs are responsible for normal growth and 
maintenance throughout development and adulthood. Nevertheless, non-manipulated 
bone marrow-derived MSCs have been applied to numerous clinical models with 
varying success, including attempted regeneration of skeletal muscle, cardiac muscle, 
liver, skin, GI tract, lung, pancreas, kidney, and central nervous system156.
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1.4.4 Isolation of MSC-like Cells from Numerous Other Adult tissues
Evolving from the understanding that bone marrow-derived MSCs possess a capacity 
to elicit multilineage differentiation surpassing previously held concepts, 
investigations attempting to isolate cells of such potentiality from alternative adult 
tissue sources have been undertaken. Utilising an array of continually evolving 
isolation methods, cells exhibiting varying levels of plasticity have been isolated 
from numerous tissues including hair follicles234, brain tissue235"236, cornea237"240 and 
retina241"244, dental pulp245"246, lung247, peripheral blood248"251, heart252, intestines253' 
256, adipose155’257"264, skeletal muscle74,265"268 and skin162,269'273 from many species 
including humans. Furthermore, in addition to cells isolated from adult tissues, 
populations derived from embryo/adult adjoining tissues such as placenta and 
umbilical cord cells have also demonstrated multipotentiality {Table 1.3), although 
the origin of the populations, disputably embryo or adult generated, remains 
unconflnned.
The isolation of cells exhibiting plasticity from numerous adult tissues has raised 
hopes of developing tissue engineered devices incorporating adult- derived cells, 
potentially overcoming the ethical dilemmas and intensive technical issues 
encountered with ES cells. However, many studies fail to identify the fundamental 
properties of isolated cells, characterising the heterogeneous phenotype rather than 
comprising subpopulations. Whilst surface markers have allowed partial purification 
of subpopulations to enable studies of increased homogeneity, partitioning of cells 
encapsulating varying plasticity and lineage commitment remains elusive. Thus, 
whilst numerous reports have documented phenotypic profiles, differentiation 
capacities and in vitro proliferation of cells isolated from numerous tissues, it is 
important to emphasise that such analysis incorporates globally isolated cell 
populations, failing to attribute a given phenotype, differentiation induction or 
proliferative ability to individual cells. Whilst many perceive this as trivial with 
regards their utilisation clinically, the presence of lineage committed progenitors has 
the potential to generate undesirable tissues following implantation. However, when 
using such therapies as a last resort, many patients may decide that the potential gain 
far outways this risk.
31
•-C
P<u
oeu
CU
W)a<u
P• IM
'Pv
CS
V3
Po
fi<u
Q
Pu<us
apo
<D
&
CU
Xio
3
CSS
oi
«4-lo
0)p
s
bO
O
CL>
S(U
bOI
Oxi
O
p<D
bD
O
+O
o\
8-u
+m 6
P-H
U &o 
^ toS S
U Q 
V u
Q ^ 
3s UrO
Q cn 
O ^
C—l cn r)
Q+r 
o §
+ON OCN H 
Q u
o-u
o R u u
o
<
&o
o
Kl
PI
+ (N 
X o 
00 
+ ^
<D
ta
Q
+
O
P
Ph
p• r-H
e
PQ
(D
Ph4_i
w
ca.
.s
kb
<L>
■P +P m^—i
q4 .S 
Q g
< I
i—l o 
ffi U
+C^
O § 
w 13 + >
Q + 
o 2i +"st'm +
+x>
1x5
Q
U
o
U
o
• 0P "o <d «bo £ o £ u ^ 
to
° Sto 
P 00 
bo 'P 
P s■as
p ’S2 ° ti.c*( o
u £
cT^
‘3 73 <d a bX) 9 
o S
S+-
H °o
GO ■*—h 
+ cd^-i
H
Q +
DO 
, NO ■
3: ^ Q £ 
U H
^ tj’
P < 
u w 
u- 00
M co
wm oo P c/0
ON o 
<N O
p +u bo
+ a
C3
z
+
ro
P
o
3
S
p
3>
o
&
W
r-
NO
+
NO
T^
P
O
m
m
!—I
P
u
'-O
,=t
P
U
+
m
P
O
r-3
ffi
CDbo
&
B
.2
'O
e3
U
cb
ooo
p4
CO
U
+
r-
P
O
i
o
.3
i i
<D
t3
H
+
‘C
bo
P
<
U
P
fX
S
►3
tu
'Sh 'Shm w u
+
p
o
oo
+
P-(00
U
U
4*
U
I
ooo
+
CN
H
<
in
•p*
P
O
V
m
P
U
m
P
U
bDI
_o
P p
g> pW) O o fa (L> £4-> rt> GO h-jro ^
cT.2'
| S| ^ 
2 >N
p ^
So"
S
2
S '§>
<
■p-
0
+ +o r^rt-Q 5 
4 P
P- cn cn cn
P ’—lB p 
r u
T—< C ^
cn ^
p x
^6
as
O P 
+ L> ^ , 
^ wn P p- U Q
+2U
3
u
paoo
p
(Dpa
•&to
Ph
O P P o« fa <D P bD QJ 
O £
o
O pr. H)
o bD•a 9<d j.n*
SPSOV-HT3 p O
jl \ 1
o ^ 
bD £ 
O rS 
ft O
7 a<; jg
o
I
% . < o
W °o 
00 !—(
+ !h
3: Ho
o
in
cn
P H 
U+a
P*cn
P
O
bo
P
O
p-
P
u
>
3‘pIS
Re
tin
a2
41
'24
4,
28
6'2
87
 
D
CX
+ F
lk
-1
+ H
es
l+ 
M
us
as
hi
+ 
N
es
tin
+ 
N
eu
ro
na
l - 
Ph
ot
or
ec
ep
to
rs
, a
m
ac
rin
e a
nd
ho
riz
on
ta
l c
el
ls,
 R
PE
, r
od
 b
ip
ol
ar
, M
ul
le
r 
gl
ia
, r
et
in
al
 g
an
gl
io
n 
ce
lls
Sk
el
et
al
 m
us
cl
e7
4,
26
5'2
68
 
CD
 10
+ C
D
 1
3+
 C
D
34
+/
' C
D
45
' C
D
56
+ B
cl
-2
+ S
ea
-1
+ 
A
di
po
ge
ni
c,
 C
ho
nd
ro
ge
ni
c,
 O
ste
og
en
ic
,
H
em
at
op
oi
et
ic
, N
eu
ro
na
l, S
ke
le
ta
l m
us
cl
e
co
cdrtoi-i
d
(U
OJQO
<
+
On
cd
u
Vm
Q
U
.a
GO
O
1boo
<D
o
a o
<d 'd
^ © P bo
-6 .2 
S -d O H 
^Cj C3
U U
d<u
bJOodi
•
+m
ffico
+(N
ffi
GO
+ino
U
10 4-
Q “cs 
U x , o V) co
qV“ -i->oou•3*d-
Q
U
rn
Q
a
+a\(N
u
oo
o
'i
ID
8bOO<u
a
V*J
(D
oo d o S 
2Td H
o
i-d ^
u
o'
"ddbOa
rj-pc
3t*4_>o
O
U
p
x
+
CO
CO
3
U
+
CO
CO
Q
O
+
Ti­ro
Q
U
Tdoo
oa
Ido
‘S « * * -2 © !_ -d
3 £ *3 s
ITS H C 3-s 2 ©
CA o ^. JD§ -I «
Jd « 5S wj ■g ^3 3m ® y
T3 h: ©Sage 
« e s e fee S o gWl g w a 
W) q> <U 
‘d X3 ‘3 
JS 3 «i 
.g « 2 Ta
^ g g£ 
g .S ^ S
bxi -m g 
w b®
« ot a» ^ !<3
S O g ra 
a - H 2Aj S3ZI O • QJ S ,1s CA >35CA pQCQ ca d>■a « *5 cass a «
S x g- g
S3 =
■5 C/3 —« ^ ^<u S . *ss© S .2 T3 °^ a a Id© w S S ©
at u.
+s a g « g
8 a ! -g iflj C3 H ai
1 !I^
_ S ^ a ©
^ g g g >C m u
<u■“ w
G X) 
O —
Sha.
B S u4J Q, 
2 cn
■“ .a ,u 
.a g 3
© a ^ -O "5 « a o ^ .2 5 £ ^ ”© .© a a, c ^ -n 
^ .2 F S 
+j s a a S» g ■ « X a crj j- a: 94 dj +4ST tfl
0 -C9u a ■!-» g "s i- a g •g a b® a 
c58 g © 2fS w a ^
xg
u
g
a
2
U
l
aco<JU
O'
B
2a
u
fik
V)
aaOJb®o
!■
g
g94
g
94
g
g94
g
<
I
s
og<
ao
CL
X
94
a
gaa
94
_>
"w
O
OxJ5 ,2
o *«S >0 
y>a£ g 
a ^3•g I g S
(A tw>
t; £o _Cl a 
94 a PC §
1 ©, PC
coco
1.5 Aims
1.5.1 Aims of the study
Investigations demonstrating the innate plasticity of cells residing in numerous adult 
tissues have raised hopes for rapid generation of numerous tissue engineered devices 
addressing a range of debilitating illnesses. However, whilst isolation of populations 
exhibiting multilineage potential has been documented for numerous adult tissues, 
detailed characterisation of homogeneous subpopulations have yet to be refined. 
Whilst adult-derived stem cells have, to some extent, distanced themselves from the 
ethical and technical dilemmas associated with embryonic-derived stem cells or 
synthetically modified iPS cells, they encompass many technical issues of their own, 
not least their inability to maintain phenotype following in vitro culture. It is 
therefore imperative that, prior to clinical commencement, complete understandings 
of individual subpopulations are ascertained, detailing their potential to maintain 
phenotype, differentiation ability, proliferation capacity, karyotype, and a capability 
to contribute to teratoma formation in vivo. This study, therefore, endeavours to 
assess the characteristics of cells derived from human bone marrow, peripheral 
blood, umbilical cord, and dental pulp in vitro, detailing fundamental aspects of the 
populations incorporating heterogeneous and increasingly homogeneous assessment. 
However, since it is likely that isolated cells will be heterogeneous, likely 
incorporating stem and progenitor cells of varying plasticity and developmental 
commitment, it is difficult to hypothesise with any great purpose the type of 
subpopulations we expect to obtain from each respective tissue. This issue is 
complicated further by findings detailing the potential plasticity of HSCs , thus 
questioning, if attained, which cells (MSC-like cells, HSCs, progenitor cells, etc.) are 
responsible for observed differentiation. And whilst it is plausible that increased 
homogeneity may be facilitated via optimisation of isolation techniques, it is likely 
that isolated cells will require purification post culture. However, it is largely 
accepted that purification via positive or negative antibody exclusion fails to 
adequately isolate homogeneous populations, novel strategies of purification may 
need to be developed. In the first instance, however, isolated populations will be 
assessed in a heterogeneous manner in an attempt to identify the subpopulations 
present, the phenotypic and proliferative stability of the population following in vitro
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culture, and finally the capacity of the population to undertake lineage 
differentiation. Following this heterogeneous assessment, attempts will be made to 
homogeneously isolate subpopulations hypothesised to be present following 
heterogeneous characterisation.
It is foreseen that by comprehensively characterising the stability and potential of 
cells isolated from numerous sources, informative decisions can be made allowing 
the selection of an optimal cell type for a given therapeutic application. Thus it is 
hoped that the study will provide comprehensive characterisations on which to 
advance the utilisation of these cells for therapeutic applications, whilst also 
providing a template detailing characterisation requirements on which future cell 
assessment can be based. Investigations will therefore attempt to:
1. Optimise methods for the isolation of adherent cells from human peripheral 
blood, dental pulp and umbilical cord. Each varying isolation procedure will 
be scored for its ability to isolate populations exhibiting homogeneous 
characteristics whilst being able to maintain a stable undifferentiated 
phenotype when cultured in basal conditions in vitro and when subjected to 
freeze-thaw cycles.
2. Phenotypically characterise each isolated cell population using an array of 
antibodies to compose a surface antigen profile of the heterogeneous 
populations, potentially indicating the phenotypes of subpopulations present 
within the culture. Cell populations will be subjected to such analysis at each 
passage and following freeze-thaw cycling to assess the effects of in vitro 
culture and cryopreservation on the cells, whilst bone marrow-derived cells 
purchased from Lonza will also be characterised at each passage. With 
respect to cells isolated from peripheral blood and dental pulp, for which 
information regarding the donor will be available, the phenotype of 
populations from each donor will be compared.
3. Investigate expression of plasticity regulatory proteins within each 
respectively isolated population throughout increasing in vitro basal culture 
and following cryopreservation. Expression of proteins such as Oct4 and
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Sox2 would indicate a population capable of undertaking multilineage 
differentiation, and thus the effects of prolonged in vitro culture and 
cryopreservation upon each respective cell type and subsequently their ability 
to maintain an undifferentiated phenotype can be addressed via monitoring 
the expression of such proteins.
4. Assess the proliferation capacities of each isolated cell type throughout in 
vitro culture and following cryopreservation. Should the given cell type be 
utilised within a clinical setting, it is likely that large numbers, and hence 
prolonged in vitro passage and possible cryopreservation, will be required, 
and thus it is imperative that the population can reproducibly generate mass 
numbers of daughter cells.
5. Establish numbers of hematopoietic and non-hematopoietic progenitor 
subpopulations within each passage of respective culture using colony 
forming unit (CPU) assays. Such CPU assays will enable quantification of the 
number of hematopoietic and non-hematopoietic progenitor cells within each 
heterogeneously isolated population. The number of CPUs can therefore be 
monitored and compared across passage number and donor.
6. Assess impacts of in vitro culture upon the aging of cells through the 
monitoring of telomere lengths within each population. Furthermore, in the 
case of peripheral blood and dental pulp cells, for which donor information is 
available, compare telomere lengths and respective regulation in donors of 
varying age and sex. Telomere degradation within cells is known to be a key 
regulator of the aging process and thus comparing telomere lengths within 
each population will enable the effects of in vitro culture to be assessed.
7. Investigate lineage potential of each isolated population at varying passages 
and following cryopreservation when induced using commercially available 
and chemically-defined differentiation media. The ability of isolated 
populations to reproducibly undertake differentiation towards desired 
lineages represents the underpinning of many tissue engineering and 
regenerative medicine approaches, and thus it is imperative that cultures are 
assessed for their lineage potential.
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8. Homogeneously isolate subpopulations exhibiting varying phenotypic surface 
antigen expression and, following purification, characterise cells as detailed 
above for heterogeneous populations. However, should antibody- based 
purification strategies prove to be ineffective for the homogeneous isolation 
of desired subpopulations, novel approaches to cell sorting will be 
considered.
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2. Materials and Methods
2.1 Isolation of Adherent Cell Populations
2.1.1 Mesenchymal Stem Cells Derived from Human Bone Marrow
Cryopreserved passage 2 human mesenchymal stem cells (MSCs) were purchased 
from Lonza (Cat#PT-2501). When required, 750,000 (1 vial) of these cells were 
thawed and seeded into 2 x T-75 tissue culture plastic flasks in MSCGM™ 
Mesenchymal Stem Cell Growth Media (Lonza; Cat#PT-3001), thereby changing 
into passage 3 cells. Cells were obtained from the posterior iliac crest of healthy 
males and non-pregnant females aged between 18 and 45 years. Harvested cells were 
tested for purity using flow cytometry and for their ability to undertake adipogenic, 
chondrogenic and osteogenic lineages. They were positive for surface antigens 
CD29, CD44, CD105 and CD166, and exhibited negative expression of CD14, CD34 
and CD45. In this thesis, the MSCs were maintained in MSCGM™ Mesenchymal 
Stem Cell Growth Media (Lonza; Cat#PT-3001).
2.1.2 Isolation of Mononuclear Cells from Human Peripheral Blood using
Histopaque Density Centrifugation
Human peripheral blood was isolated from the median cubital vein of donors using a 
21-gauge SURFLO® winged needle infusion set (Terumo®; Cat#SV-21BL). 
Heparin (Sigma-Aldrich; Cat#H4784) was added to 20ml of isolated blood at a final 
concentration of 0.5pg/ml to prevent coagulation. To isolate mononuclear cells, 5ml 
of blood were layered onto 3ml of Histopaque® -1077 (Sigma-Aldrich; Cat#H8889) 
in 4 x 15ml Falcon tubes (BD Biosciences; Cat#352096). Samples were spun at 2700 
x g for 20 minutes at 20°C with the absence of brakes. Following centrifugation the 
lymphocyte/monocyte layer was harvested, initially through scraping cells from the 
side of the tubes using the tip of a pipette prior to harvesting the entire contents. The 
resulting isolates of two harvested lymphocyte/monocyte layers were combined in 
one 30ml universal. 20ml of PBS/lmM EDTA (4°C) were added and solutions 
centrifuged at 2300 x g for 10 minutes at 4°C. Following discarding of the 
supernatant, pelleted cells were resuspended in PBS/lmM EDTA (4°C) and spun at
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2000 x g for 10 minutes at 4°C. Centrifuged cells were resuspended in PBS/lmM 
EDTA (4°C) and spun for at 1300 x g for 15 minutes at 4°C. Finally, pelleted cells 
were resuspended in 10ml of DMEM (Low glucose) (GIBCO; Cat#10567014) 
containing 10% (v/v) PCS and 1% (v/v) 10,000U/ml of penicillin and lOmg/ml of 
streptomycin in 0.9% (w/v) sodium chloride (Sigma-Aldrich; Cat#S7653), prior to 
plating into 2 wells of a 6 well pre-coated fibronectin (20pg/ml) plate. Media was 
replaced after 72 hours, thereby removing the non-adherent lymphocytes.
2.1.3 Isolation of Mononuclear Cells from Human Peripheral Blood using
RosetteSep® Human Monocyte Enrichment Cocktail
Peripheral blood from donors was withdrawn as described in 2.1.2. To isolate 
mononuclear cells, EDTA was added to 10ml whole blood at a final concentration of 
ImM in 2 x 15ml Falcon tube (BD Biosciences; Cat#352096). 500pl of RosetteSep® 
Human Monocyte Enrichment Cocktail (StemCell Technologies; Cat#15028) were 
added to 10ml of whole blood and vortexed. Following 20 minutes incubation at 
room temperature, samples were diluted with 10ml of PBS with 2% (v/v) FCS and 
ImM EDTA and agitated gently. Diluted samples were layered on top of 15ml 
Ficoll-Paque® (StemCell Technologies; Cat#07907) and centrifuged for 20 minutes 
at 2600 x g at room temperature with the absence of brakes. Cells were harvested 
from the Ficoll-Paque® plasma interface and washed twice with PBS containing 2% 
(v/v) FCS. Cells were resuspended in 10ml of DMEM (Low glucose) (GIBCO; 
Cat#l0567014) containing 10% (v/v) FCS and 1% (v/v) 10,000U/ml of penicillin 
and lOmg/ml of streptomycin in 0.9% (w/v) sodium chloride (Sigma-Aldrich; 
Cat#S7653), prior to plating into 2 wells of a 6 well pre-coated fibronectin (20pg/ml) 
plate. Media was replaced after 72 hours, removing the non-adherent lymphocyte 
layer.
The underlying principle of the RosetteSep® protocol is founded on the ability of the 
antibody cocktail to crosslink unwanted human cells in human whole blood to 
multiple RBCs, fonning immunorosettes {Figure 2.1). This increases the density of 
the unwanted (rosette) cells, such that they are pelleted along with the free RBCs 
when centrifuged over a buoyant density media such as Ficoll-Paque®. Crucially, 
mononuclear cells cease to be labelled with antibody and are therefore readily
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identified and harvested as a highly enriched population at the interface between the 
plasma and the buoyant density media.
40
Add RosetteSep® 
antibody cocktail
Unwanted cells are cross- 
linked to red blood cells 
(rosetted) with Tetrameric 
Antibody Complexes
Label
Layer over 
Ficoll-Paque®
Incubate for 20 
minutes at room 
temperature
Ficoll-Paque®
Figure 2.1 - Isolation of 
Mononuclear Cells from 
Human Peripheral Blood 
using RosetteSep® Human 
Monocyte Enrichment 
Cocktail.
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Plasma 
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Ficoll-Paque®
Red cells and 
unwanted cells (rosetted)
■■■
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(unrosetted)
41
2.1.4 Isolation of Cells from Human Umbilical Cord Following Blood Vessel
Removal and Plating of Wharton’s Jelly on Tissue Culture Plastic
Fresh human umbilical cords were obtained with informed consent following birth 
and stored in Hanks’ balanced salt solution for 1-24 hours prior to tissue processing. 
To obtain multipotent cells from Wharton’s jelly, cords were washed in PBS/1 mM 
EDTA (4°C) prior to the removal of blood vessels. Following blood vessel removal, 
Wharton's jelly was plated directly onto untreated tissue culture plastic of a 6 well 
plate. Plated Wharton’s jelly dissections were soaked in DMEM (Low glucose) 
(GIBCO; Cat#10567014) containing 15% (v/v) FCS and 1% (v/v) 10,000U/ml of 
penicillin and lOmg/ml of streptomycin in 0.9% (w/v) sodium chloride (Sigma- 
Aldrich; Cat#S7653). Following cell adherence and proliferation, dissected 
Wharton's jelly was removed from the culture and cells maintained in fresh basal 
media.
Wharton’s
Jelly
Wharton’s
Jelly
Arteries
Figure 2.2 - Isolation of cells from Wharton’s jelly following blood vessel removal.
2.1.5 Isolation of Cells from Human Umbilical Cord by Whole Cord Digestion
Fresh cords stored in Hanks’ balanced salt solution for 1-24 hours were washed in 
PBS/1 mM EDTA (4°C). Whole cords were mechanically disassembled into fractions 
approximately 50mm2 in size. Dissected cords were enzymatically digested by 
incubation in a solution containing 2% (w/v) Dispase I (Sigma-Aldrich; Cat#4818) 
and 2% (w/v) Collagenase type II (Invitrogen; Cat# 17101015) overnight at 37°C 
with gentle agitation. Digested cords were centrifuged at 2000 x g for 5 minutes at 
20°C. Pelleted substrates were resuspended in DMEM (Low glucose) (GIBCO; 
Cat# 10567014) containing 10% (v/v) FCS and 1% (v/v) 10,000U/ml of penicillin 
and lOmg/ml of streptomycin in 0.9% (w/v) sodium chloride (Sigma-Aldrich;
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Cat#S7653), prior to filtration using a 0.2jiM filter to remove debris. Following 
filtration, cells were seeded into wells of a 6 well plate at a concentration of 50,000 
cells per well.
Wharton's
Jelly
Arteries
Enzymatic digestion of whole 
cord overnight at 37°C with 
gentle agitation
Pelleted cells resuspended in 
DMEM (Low glucose) with 
15% ECS and 1 % antibiotic
Figure 2.3 - Isolation of cells from umbilical cord following w hole cord digestion.
2.1.6 Isolation of Cells from Human Dental Pulp
Teeth were acquired following infonned consent after dental procedures or loss of 
deciduous teeth. Received teeth were stored in 199 Media (GIBCO; Cat# 12350039) 
containing 5% (v/v) FCS and 1% (v/v) 10,000U/ml of penicillin and lOmg/ml of 
streptomycin in 0.9% (w/v) sodium chloride (Sigma-Aldrich; Cat#S7653) until 
delivered to the laboratory for pulp isolation. Upon arrival, teeth were treated in a 
gentamicin solution (Invitrogen; Cat# 15710-049) (20pg/ml) for 5 minutes at room 
temperature to eradicate any residing infection. To isolate pulp, teeth were sheered at 
the dentine interface {Figure 2.4) and pulp removed. Following mechanical 
dissection using forceps and scalpel, pulp was enzymatically digested in a solution 
composing 2% (w/v) Dispase I (Sigma-Aldrich; Cat#4818) and 2% (w/v) 
Collagenase type II (Invitrogen; Cat# 17101015) for 8 hours at 37°C with gentle 
agitation. Digested pulp was centrifuged at 2000 x g for 5 minutes at 4°C and 
pelleted cells resuspended in 199 Media containing 5% (v/v) FCS and 1% (v/v) 
10,000U/ml of penicillin and lOmg/ml of streptomycin in 0.9% (w/v) sodium 
chloride (Sigma-Aldrich; Cat#S7653). The resuspended solution was filtered through 
a 0.2|iM filter to remove debris and cells seeded in 1 well of an uncoated 6 well 
plate.
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Wafering blade
II
Mechanical and
enzymatic digestion of 
pulp
Pelleted cells resuspended in 
Media 199 with 5% PCS and 
1 % antibiotic
Figure 2.4 - Isolation of multipotent progenitor cells from human dental pulp.
2.1.7 Cell Culture Techniques
Cells were maintained on conventional tissue culture polystyrene plastic unless 
otherwise stated (Scientific Laboratory Supplies, UK). Cells requiring passage were 
initially washed in PBS following removal of redundant media and enzymatically 
dissociated using a solution comprising 5g porcine Trypsin, 2g EDTA in lOOmL of 
0.9% (w/v) sodium chloride (Sigma-Aldrich; Cat#6567) diluted to a working 
concentration of 10% (v/v) using PBS. Cells were trypsinised at 37°C for 15 minutes 
and the enzymatic reaction subsequently neutralised via the addition of an equal 
volume of serum-containing basal media. Detached cells were pelleted by 
centrifugation at 2000 x g for 5 minutes at 4°C and resuspended in an appropriate 
volume of corresponding basal media. Resuspended cells were seeded in a given 
culture vector and incubated at 37°C with 5% CO2. Cell culture media was 
replenished every 4 days. The basal media used for culture was dependent on the 
isolated cell type. Cells were subcultured at a ratio of 1:3, although dental pulp could 
be subcultured up to 1:10.
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2.1.8 Freezing and Thawing of Cells
Cultured cells were enzymatically dissociated using Trypsin as detailed in 2.1.7. 
Pelleted cells were resuspended in 1ml of a solution consisting of 90% (v/v) FCS and 
10% (v/v) DMSO (Sigma-Aldrich; Cat#C6164). Suspended cells were transferred to 
a cryo-vial and placed into a commercially available freezing box containing 
isopropanol, which cools at 1°C per minute, and stored at -80°C for 24 hours, after 
which vials were transferred to liquid nitrogen storage. To thaw, frozen vials were 
heated at 37°C and resuspended in 1ml of pre-warmed basal media. Resuspended 
cells were transferred to relevant tissue culture plasticware.
2.2 Flow Cvtometrv-based Phenotyping
2.2.1 Phenotypic Analysis of Cells using Flow Cytometry
Cultured cells were enzymatically dissociated using Trypsin and pelleted by 
centrifugation at 2000 x g for 5 minutes at 4°C. Pelleted cells were resuspended in 
PBS and 100pi containing approximately 1 x 105 cells added to each of the required 
number of flow cytometry sample tubes. lOpl of antibody (1:10 working dilution) 
{Table 2A) or their appropriate isotype (1:10 working dilution) {Table 2.2) were 
added to the cell suspension and samples incubated for 15 minutes at 4°C in the 
absence of light. Cells incubated in the absence of antibodies were used as an 
additional control. Following incubation, 180pl of BD FACSFlow™ (BD 
Biosciences; Cat#342003) were added to each sample. Cells were processed to a 
count of 3 x 104 per sample using a Becton Dickinson FACSort with Cell Quest 
software.
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Isotype control Working
Dilution
Supplier Catalogue
Number
Goat IgM (PE) 1:10 Santa-Cruz sc-2082
Mouse IgGl (FITC) 1:10 Serotec MCA928F
Mouse IgGl (PE) 1:10 Miltenyi Biotech 130-092-212
Mouse IgGl, k (FITC) 1:10 BD Biosciences 555748
Mouse IgGl, k (FITC) 1:10 Cedarlane CLCMG101
Mouse IgGl, k (PE) 1:10 BD Biosciences 340761
Mouse IgGl, k (PE-Cy5) 1:10 BD Biosciences 555750
Mouse IgG2a (FITC) 1:10 Serotec MCA929F
Mouse IgG2b (FITC) 1:10 Serotec MCA1423F
Mouse IgG2b, k (PE) 1:10 BD Biosciences 555743
Mouse IgM (FITC) 1:10 Serotec MCA692F
Polyclonal IgG (FITC) 1:10 Serotec AAC10F
Rat IgG2a (FITC) 1:10 Serotec MCA1125F
Table 2,2 - Flow cytometry isotype controls.
2.2.2 Phenotypic Association of Surface Antigens
Ready availability of purified antibodies and simultaneous advances in flow 
cytometric techniques have allowed numerous surface antigens to be attributed to a 
given cell type (Table 2.3), thereby hypothetically allowing homogeneous 
characterisation of subpopulations following cell isolation. Surface antigens listed in 
Table 2.1 were selected to generate surface marker profiles of cells isolated from 
bone marrow, peripheral blood, umbilical cord and dental pulp over increasing 
passage in vitro. Assembling such detailed phenotypic characteristics allowed the 
effects of prolonged in vitro culture to be assessed and furthermore suggested 
potential classification of the numerous subpopulations within the culture.
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2.2.3 Processing of Raw Flow Cytometry Data usinu WinMDI Version 2.8
Following cell processing, acquired data was analysed using WinMDI Version 2.8. 
To calculate the percentage of cells demonstrating positive expression of a given 
antigen within the population, raw fluorescence binding values for the given 
antibody were compared with the corresponding isotype for that particular antibody 
within a histogram (Figure 2.5). Positive expression was calculated as fluorescence 
shifted to the right of the isotype control and quantified by assigning a marker to 
subtract fluorescence attributable to the isotype control and thereby homogeneously 
gate cells exhibiting positive expression. The number of events demonstrating 
positive expression was plotted.
£ 12 c cI >Z ui
Isotype control Antibody Number of events: 3 x 104 
Percentage of cells gated: 86.4%
Logarithmic fluorescence
Figure 2.5 - Calculation of positive expression of a given antigen within a cell population using 
WinMDI following analysis by flow cytometry.
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2,3 Cell Proliferation
2.3.1 Assessment of Proliferation using CvOUANT® Cell Proliferation Assay
Cells were assessed for their proliferation capacity over a defined culture period 
using CyQUANT® Cell Proliferation Assay Kit (Invitrogen; Cat#C7027). The 
underlying principle for the CyQUANT® kit is the utilisation of a proprietary green 
fluorescent dye, CyQUANT® GR, which exhibits strong fluorescence enhancement 
when bound to cellular nucleic acids. To carry out proliferative studies, cells were 
cultured as described in 2.1.7. Then, at the relevant time points, culture media was 
removed and cells washed with PBS prior to freezing at -80°C within the plastic 
culture vial until required, hi order to generate controls for the proliferation study, 
cells identical to those required for analysis were enzymatically dissociated using 
Trypsin and pelleted as described in 2.1.7. Cells were resuspended in PBS and 
counted using a haemocytometer. Defined cell numbers were aliquoted into 
eppendorfs and centrifuged at 2000 x g for 5 minutes. The resultant supernatant was 
carefully discarded and pelleted cells frozen at -80°C until required.
On the day of the experiment, the concentrated cell-lysis buffer stock solution 
provided (Component B) was diluted 20-fold with distilled water to generate a lx 
solution. Shortly before carrying out the experiment, the CyQUANT® GR stock 
solution (Component A) was diluted 80-fold in 1 x cell-lysis buffer to create a 5x 
solution.
To analyse frozen samples and controls, cells previously counted and subsequently 
frozen were thawed at room temperature. Counted cells were resuspended in 200pi 
of CyQUANT® GR/cell-lysis buffer solution via brief vortexing and transferred to 
an RNase-free 96 well microplate (Bio-Rad; Cat#223-9441). Cells were incubated 
for 5 minutes at room temperature in the absence of light and analysed using an 
FLX800 microplate fluorescence reader in conjunction with a KC Junior operating 
platform (BIO-TEK Instruments). In order to generate a standard cuive, fluorescent 
values for control samples of known cell number were plotted, generating a baseline 
on which to calculate cells present in given samples based on fluorescence.
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2.4 Antibody-based Cell Purification
2.4.1 Mo-Flow High-speed Cell Sorting for the Purification of Cell Populations
based on Surface Marker Expression or Emission of Hoechst 33342 Dye
Following phenotypic evaluation described in 2.2, cells were sorted based on their 
surface marker expression. Cells were removed from culture and labelled as 
described in 2.2.1. In addition, Hoechst 33342 (Invitrogen, Cat#H3570) was also 
used as a marker for the isolation of a residing side population (SP). In this case, 
cells were pelleted and resuspended as in 2.2.1. Hoechst 33342 was added to a final 
concentration of 5|ig/ml and vortexed. Samples were incubated at 37°C for 90 
minutes and agitated every 15 minutes, after which cells were centrifuged at 2000 x g 
for 5 minutes at 4°C and the pellet resuspended in a fresh lOOpl volume of PBS. 
Cells stained with Hoechst or antibodies detailed in Table 2.1 were analysed using a 
Mo-Flow high speed cell sorter {Figure 2.6). Selected populations were retained in 
pre-warmed basal media and transferred to a T-25 TC plastic flask containing basal 
media. Sorted cells were cultured at 37°C until required for further analysis.
Analyzer controls charge 
on plates to vary deflection
Mixed population 
of cells labeled with 
fluorescent antibodies 
1 (Hi) and 2 (>€))
Figure 2.6 - Diagrammatic representation of High-speed cell sorting using Mo-Flow. Image 
courtesy of Dr N. M. Ponzio, UMDNJ.
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2.5 Colony-Forming Unit Assays
2.5.1 Introduction
Within the adult human, hematopoietic and non-hematopoietic progenitor cells reside 
within numerous tissues. Such cells represent highly proliferative subpopulations 
capable of differentiation towards numerous lineages. With regards to hematopoietic 
progenitors, such cells differentiate into all mature blood cells. Non-hematopoietic 
progenitors have been demonstrated to form numerous functional cell types 
including adipocytes, chondrocytes, osteoblasts and tenocytes. In vitro assay systems 
have been developed to quantify hematopoietic and non-hematopoietic multi­
potential progenitors and lineage restricted progenitors. Colony Forming Unit - 
Granulocyte Monocyte (CFU-GM) assays identify progenitors of the erythrocyte, 
granulocyte, monocyte-macrophage and megakaryocyte myeloid cell lineages, and 
Colony Forming Unit - Fibroblast (CFU-F) assays those of non-hematopoietic 
potential. Such assays represent semi-solid media with appropriate stimuli capable of 
inducing individual progenitors known as CPUs to proliferate and subsequently form 
discrete cell clusters or colonies. CFU assays were therefore undertaken using the 
methylcellulose-based Complete MethoCult media range, utilising CFU-GM (Stem 
Cell Technologies; Cat#28404) and CFU-F (Stem Cell Technologies; Cat#28374) 
assays accordingly.
2.5.2 Human Colony-Forming Cell Assays Using MethoCult®
When required, volumes of aliquoted CFU-GM or CFU-F MethoCult® media were 
thawed overnight under refrigeration (2-8°C). Culture dishes were prepared by 
placing two 35mm Petri dishes with lids inside a 100mm Petri dish with a lid. A third 
35mm Petri dish without a lid was added containing distilled water in order to 
maintain humidity. This set of dishes represented one duplicate assay. Cultured cells 
were enzymatically dissociated using Trypsin and pelleted by centrifugation at 2000 
x g for 5 minutes at 4°C. Pelleted cells were counted using a Haemocytometer and 
resuspended in IMDM media (GIBCO; Cat#21980065) with 2% (v/v) FCS and 1% 
(v/v) 10,000U/ml of penicillin and lOmg/ml of streptomycin in 0.9% (w/v) sodium 
chloride (Sigma-Aldrich; Cat#S7653) at lOx the concentration required for plating.
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0.3ml of cell suspension was added to 3ml of pre-thawed MethoCult® media and the 
contents vortexed vigorously. Following a 5 minute incubation to allow dissipation 
of bubbles, 1.1ml of the cell containing methylcellulose solution was dispensed into 
each 35mm Petri dish. Media was distributed uniformly across each plate by gently 
tilting and rotating the dish to allow the meniscus to attach to the wall of the dish on 
all sides. 35mm Petri dishes were placed into the 100mm Petri dish and incubated at 
37°C with 5% CO2 and greater than 95% humidity for 14 days.
To establish CFU formation, cultures were monitored on a daily basis and imaged 
using transmitted light microscopy, with the number of colonies in 50 random image 
frames counted. The average number of colonies within an area of 250pM x 680|.tM 
were then ascertained and recorded.
2.6 Telomere Length Analysis
2.6.1 Assessment of Telomere Length by Flow Cytometry using Fluorescent In
Situ Hybridisation and a Fluorescein-conjugated Peptide Nucleic Acid
(PNA) Probe
The Telomere PNA Kit/FITC for Flow Cytometry (DAKO; Cat#K5327) provides an 
expedient method for detection of the telomeric sequences present in nucleated cells 
from vertebrates. The probes of this kit cease to recognise subtelomeric sequences, 
and in contrast to traditional telomere restriction fragment (TRF) measurements, the 
DAKO kit, therefore, allows an estimation of the telomere length without inclusion 
of subtelomeres. The kit is deliberately designed to ensure that post-hybridisation 
treatments are kept to a minimum and formaldehyde washes are avoided. The probe 
of the kit recognises telomeric repeats, although intrachromosomal TTAGGG repeats 
are also measured within the fluorescent signal. However, examination of the 
literature demonstrates that whilst prevalence of non-telomeric TTAGGG sequences 
varies, they were found to be few and short using the sensitive Q-FISH method with 
a PNA probe. These data, in conjunction with closely correlated Southern blotting, 
support the idea that intrachromosomal telomere sequences are of minimal 
significance for the total hybridisation signal detected by flow cytometry.
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In order to assess telomere lengths, cultured cell populations were washed with PBS 
and enzymatically dissociated via incubation with Trypsin for 15 minutes at 37°C. 
Following centrifugation at 2000 x g for 5 minutes at 4°C, cells were counted using a 
Haemocytometer. For each sample, 2 x 106 test cells and 2 x 106 control cells were 
aliquoted into two 30ml universal tubes. 6ml of PBS were added to each tube and 
resuspended cells divided into 4 x 1.5ml aliquots (1 x 106 cells) and placed into 
1.7ml microcentrifuge tubes. Cells were centrifuged at 500 x g for 5 minutes and the 
supernatant discarded. To the control cells, 300pl of Hybridisation solution were 
added, whilst 300pl of Telomere PNA Probe/FITC solution were added to the test 
cells and vortexed. The four solutions were placed in a pre-wanned heating block at 
82°C for 10 minutes. Cells were vortexed and incubated at room temperature 
overnight in the absence of light. Post-incubation, 1ml of Wash Solution (1:10 
dilution) was added to each of the four tubes and vortexed. Tubes were placed in a 
pre-warmed heating block at 40°C for 10 minutes and vortexed. Following 
centrifugation at 500 x g for 5 minutes and decanting of the supernatant, 1ml of 
Wash Solution (1:10 dilution) was added to each tube and vortexed. Tubes were 
again incubated in a pre-warmed heating block at 40°C for 10 minutes and vortexed 
prior to centrifugation at 500 x g for 5 minutes. Following discarding of the 
supernatant, samples were treated in a 2mg/ml Propidium iodide solution for 15 
minutes at 4°C. Samples were then spun at 500 x g for 5 minutes at 4°C and 
resuspended in lOOpl of PBS. Samples were transferred to flow cytometry analysis 
tubes and vortexed prior to incubation for 5 hours at 4°C in the absence of light. Post­
incubation, samples were analysed using a Becton Dickinson FACSort with Cell 
Quest software. Quantum FITC MESF beads (Bangs Laboratories; Cat#824), which 
allowed for the direct quantification of FITC content within a sample in terms of 
number of molecules or equivalent soluble fluorochrome (MESF), were used as 
quantitative controls.
2.6.2 Analysis of DNA Labelled using Fluorescent In Situ Hybridisation and a
Fluorescein-conjugated PNA Probe
Following cell processing, acquired data was analysed using WinMDI Version 2.8. 
Generation of a standard curve by plotting the MESF (y-axis) against the peak 
channel (x-axis) for each of the four fluorescence intensity populations provided in
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the Quantum FITC MESF beads kit allowed a baseline on which to quantify telomere 
lengths. To analyse results obtained using the PNA/FITC probes, all cells not cycling 
within the G0/rphase of the cell cycle were excluded as to ensure analysis assessed 
single copy DNA possessing cells only. Fluorescence projecting above that detected 
in the sample containing hybridisation solution without the PNA probe, a solution 
which essentially provided an isotype, was noted. Positive fluorescence and MESF 
values were noted and Bangs QuickCal software (Bangs Laboratories) used to 
calculate telomere lengths.
2.7 Lineage Induction of Cell Populations
2.7.1 Differentiation of Cells towards Committed Lineages using
Commercially Available Media
For differentiation of liMSCs, umbilical cord and dental pulp-derived cells, cultured 
cells were enzymatically dissociated from the tissue culture polystyrene and 
centrifuged at 2000 x g for 5 minutes at 4°C. Pelleted cells were resuspended in a 
lineage induction media at a seeding density dependent on cell type for 28 days. For 
liMSCs and umbilical cord-derived cells, a density of 5 x 104 cells per well of a 24 
well plate TC plastic plate were seeded. For dental pulp, a seeding density of 3 x 103 
cells was used within the same substrate. For differentiation of peripheral blood- 
derived cells, populations isolated as described in 2.1.2/2.1.3 were cultured in basal 
media for approximately 7 days. Upon attaining 70-80% confluence, induction media 
was added to the culture and maintained for 28 days.
To induce adipogenic differentiation, cells were cultured for 10 days in pre-adipocyte 
growth media (Promocell; Cat#C-27410) with supplement (Promocell; Cat#C- 
39425) comprising 0.4% (v/v) ECGS/H, 5% (v/v) FCS, lOng/ml Epidermal growth 
factor and lpg/ml hydrocortisone. After 10 days, cells were transferred to pre­
adipocyte differentiation media (Promocell; Cat#C-27436) with supplement 
(Promocell; Cat#C-39436) containing 8pg/ml d-Biotin, 0.5pg/ml bovine Insulin, 
400ng/ml dexamethasone, 44fj,g/ml IBMX, 9pg/ml L-Thyroxine and 3pg/ml 
ciglitazone. Following 72 hours in pre-adipocyte differentiation media, cells were 
maintained for 15 days in adipocyte nutrition media (Promocell; Cat#C-27438)
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containing 0.003% (v/v) FCS, 8jig/ml d-Biotin, 0.5|ig/ml recombinant human Insulin 
and 400ng/ml dexamethasone.
For chondrogenic lineage induction, cells were resuspended in DMEM (High 
glucose) (GIBCO; Cat# 10313039) supplemented with 1% (v/v) ITS premix (contains 
0.5mg/ml Insulin from bovine pancreas, 0.5mg/ml human transferrin and 0.5pg/ml 
sodium selenite) (Biotrace; Cat#354351), lOOmM Ascorbate-2-Phosphate, lOOnM 
dexamethasone, 1% (v/v) FCS and lOmg/ml TGF-pl (R&D Systems; Cat#240-B- 
002/CF).
For osteogenic differentiation, cells were cultured in DMEM (Low glucose) 
(GIBCO; Cat# 10567014) supplemented with 10% (v/v) FCS, lOOmM Ascorbate-2- 
Phosphate, lOOnM dexamethasone and lOmM p-glycerophosphate.
To induce neural differentiation, cells were resuspended in basal media 
supplemented with 1% (v/v) retinoic acid (Sigma-Aldrich; Cat# R2625).
2.7.2 Differentiation of Cells towards Committed Lineages using Chemically
Defined Media
Cultured cells were dissociated from culture and pelleted as described in 2.7.1. On 
this occasion, however, cells were cultured in serum-free, chemically-defined media 
synthesised specifically to generate conditions for the maintained proliferation of 
cells in an undifferentiated state (basal media) or differentiation towards adipogenic, 
chondrogenic, osteogenic, neuronal and hepatic phenotypes.
2.7.3 Differentiation of Hoechst SP Sorted cells Towards an Endothelial
Lineage using Human Plasma-based Gels
Cells isolated based on Hoechst 33342 (Invitrogen; Cat#H3570) expression, as 
described in section 2.4.1, were seeded on a human plasma based gel. Gels were 
synthesised following the isolation of human peripheral blood from the median 
cubital vein of donors and subsequent prevention of coagulation using 10% (v/v) 
lOmM sodium citrate, which inhibited clotting by chelation of Ca2+. Anticoagulated
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blood samples were incubated at room temperature for 2 hours prior to a further 
incubation overnight at 4°C. This overnight incubation caused separation of the 
blood cells and blood plasma to generate two distinct fractions. Blood fractionation 
was further enhanced by centrifugation at 700 x g for 10 minutes at 4°C. Following 
collection of the supernatant, the blood pellet was discarded and the retained 
supernatant subjected to a further centrifugation at 700 x g for 5 minutes at 4°C in 
order to ensure complete removal of residual red blood cells, white blood cells and 
platelets. Purified plasma was frozen at -20°C until required.
When required, frozen plasma was thawed at room temperature and subsequently 
pre-warmed to 37°C. At the same time culture media, which would replenish the 
chelated Ca2+ content and therefore re-establish conversion of prothrombin (factor II) 
to thrombin (factor I) and subsequently production of fibrin, was prepared and pre­
warmed to 37°C. In this case, DMEM (High glucose) (GIBCO; Cat#10313039) was 
combined with 1% (v/v) 10,000 U/ml penicillin and lOmg/ml streptomycin in 0.9% 
(w/v) sodium chloride (Sigma-Aldrich; Cat#S7653). DMEM was used as a basal 
media for the routine culture and maintenance of human cells using the hydrogel 
system. The blood plasma fraction was added to the basal media at a concentration of 
10% (v/v) and returned to 37°C, in a humidified atmosphere, containing 5% CO2. 
After approximately 3-5 minutes of incubation a stable hydrogel formed as a result of 
combination of the two solutions. Gels were generally cast 3mm in thickness unless 
gels of a greater thickness were required for a particular investigation.
Cultured Hoechst 33342 side populations were trypsinised and pelleted as described 
in section 2.1.7. Cells were then introduced to the plasma in one of two ways: (i) 
Trypsinised cells were transferred to the fluid plasma and vortexed. The cell seeded 
plasma was distributed among the desired culture vials and incubated at 37°C until 
solidified; (ii) Plasma was distributed directly into culture vessels and allowed to 
solidify at 37°C. Cells were resuspended in a culture media and administered to the 
surface of the gel. In this case, cells were cultured in 199 Media (GIBCO; 
Cat#12350039). Cells were cultured at 37°C for 28 days.
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2.8 Immunohistochemistrv
2.8.1 Controls for Immunofluorescent Staining
In order to establish a positive control for immunofluorescent investigations and 
furthermore optimise staining, cells known to express a given protein were stained 
with serial dilutions of the primary and secondary antibody {Figure 2.7). Cells 
known not to express the given protein were also stained in order to establish a 
negative control. Controls to assess the extent of non-specific binding and hence 
fluorescence of secondary antibodies were carried out by replacing primary 
antibodies with PBS.
1:250 (P) 1:100 (P)1:1000 (P) 1:750 (P) 1:500 (P)
1:1000 (S) 1:1000 (S)1:1000 (S) 1:1000 (S) 1:1000 (S) 1:1000 (S)
1:100 (P)1:250 (P)1:1000 (P)1:2000 (P) 1:750 (P) 1:500 (P)
1:750 (S) 1:750 (S)1:750 (S)1:750 (S) 1:750 (S) 1:750 (S)
1:1000 (P) 1:750 (P) 1:500 (P) 1:250 (P) 1:100 (P)1:2000 (P)
1:500 (S)1:500 (S) 1:500 (S) 1:500 (S) 1:500 (S)1:500 (S)
1:100 (P)1:1000 (P) 1:500 (P) 1:250 (P)1:750 (P)1:2000 (P)
1:100 (S) 1:100 (S) 1:100 (S) 1:100 (S) 1:100 (S)1:100 (S)
Figure 2.7 — Serial dilution assay of primary/secondary antibody with cells known to express 
(positive control) or not to express (negative control) a given protein. P - Primary antibody; S - 
Secondary antibody.
2.8.2 Immunofluorescent Staining of Differentiated and Undifferentiated Cells
Samples cultured on 13mm TC polystyrene coverslips (Sarstedt; Cat#83.1840.002) 
were fixed through incubation with a solution containing 4% (v/v) formaldehyde and 
2% (w/v) sucrose for 15 minutes at 37°C. Post-fixation, samples were washed in PBS 
and seeded cells permeabilised by exposure to a 0.005% (v/v) solution of Triton- 
X100 (Sigma-Aldrich; Cat#X-100) for 5 minutes at 4°C. Following a rinse in PBS at 
room temperature, the primary antibody {Table 2.4, Table 2.5), diluted accordingly 
with 1% (w/v) BSA, was added to the sample and incubated for 1 hour at 37°C. Post-
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incubation samples were rinsed with a 0.1% (v/v) Tween-20 (Sigma-Aldrich; 
Cat#P9416) solution for 5 minutes at room temperature and incubated with a 
corresponding secondary antibody (diluted accordingly with 1% (w/v) BSA) {Table 
2.6) for 1 hour at 37°C. Stained samples were washed with a 0.1% (v/v) Tween-20 
solution and incubated with Oregon Green® 488 Phalloidin (Invitrogen; Cat#07466) 
(diluted to appropriate working concentration with distilled water) for 30 minutes at 
4°C, after which samples were washed in PBS for 5 minutes and mounted using 
Vector Shield with DAPI (Vector Laboratories; Cat#H-1200) or Vector Shield 
(Vector Laboratories; Cat#H-1000) with TO-PRO-3 (Invitrogen; Cat#T3605) added 
at a concentration of 0.001% (v/v). Mounted samples were imaged using laser­
scanning confocal microscopy.
For particular applications, a second primary antibody raised within a different 
species to the first was added to illustrate combined expression of two distinct 
proteins in a given cell. In such instances, the incubation of samples with Oregon 
Green® 488 Phalloidin was discarded and samples were instead washed with 0.1% 
(v/v) Tween-20 solution and subjected to 1 hour incubation at 37°C with the second 
primary antibody diluted accordingly with 1% (w/v) BSA. Following a rinse with 
0.1% (v/v) Tween-20 solution, samples were incubated with a corresponding 
secondary antibody presenting an alternative fluorochrome than the initial stain 
(diluted accordingly with 1% (w/v) BSA) and incubated for 1 hour at 37°C.
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Antigen Host Reactivity Conjugate Working
Dilution
Supplier Catalogue
Number
IgG Chicken Rabbit Alexa Fluor 488 1:100 Invitrogen A21441
IgG Chicken Rabbit Alexa Fluor 594 1:100 Invitrogen A21442
IgG Chicken Mouse Alexa Fluor 488 1:100 Invitrogen A21200
IgG Donkey Sheep Alexa Fluor 594 1:100 Invitrogen A11016
IgG Goat Rabbit Alexa Fluor 568 1:100 Invitrogen A11011
IgG Goat Mouse Alexa Fluor 488 1:100 Invitrogen A21042
IgG Goat Rabbit Texas Red 1:100 Invitrogen T2767
IgG Goat Mouse Rhodamine 1:500 MP Biochemicals 55527
IgG Rabbit Goat Alexa Fluor 594 1:100 Invitrogen A11080
Table 2.6 - Secondary antibodies used for immunofluorescence.
2.9 Histological staining
2.9.1 Identification of Lipids using Oil Red O Staining
Prior to staining, a 0.5% (w/v) Oil red O solution was prepared. To generate this, 
0.5g of Oil Red O (Sigma-Aldrich; Cat#O0625) were dissolved in 100ml of 
concentrated 1, 2-Propanediol (Sigma-Aldrich; Cat#398039) and heated to 95°C with 
gentle agitation. Whilst still warm, 0.5% (w/v) Oil Red O solution was filtered 
through coarse filter paper and incubated overnight at room temperature. Following 
incubation, the solution was passed through a media fritted glass filter and stored at 
room temperature until required.
To stain cells with Oil Red O, cultured cells were air dried for 30 minutes prior to 
fixation in a formaldehyde-sucrose solution for 15 minutes at 37°C. Samples were 
rinsed in three changes of distilled water, hi order to avoid transfer of water into the 
Oil Red O, samples were incubated for 5 minutes in absolute 1, 2-Propanediol. Pre­
prepared 0.5% (w/v) Oil Red O solution was added and samples incubated at 60°C 
for 8 minutes. Samples were rinsed in 85% (v/v) 1, 2-Propanediol solution and 
washed in distilled water prior to staining with Gill’s number 1 Hematoxylin solution 
(Sigma-Aldrich; Cat#GHS-l) for 30 seconds at room temperature. Stained samples 
were washed in miming water for 3 minutes and rinsed in two changes of distilled 
water prior to mounting with aqueous mounting media. Samples were imaged using 
transmitted light microscopy.
73
2.9.2 Identification of Glvcosaminoglvcans using Alcian Blue Staining
Prior to staining, two solutions were prepared. To produce a 1% (w/v) Alcian blue 
solution, Ig of Alcian blue 8GX (Sigma-Aldrich; Cat#A5268) was dissolved in 
100ml of 3% (v/v) glacial acetic acid. Nuclear Fast Red solution was produced by 
dissolving O.lg of Nuclear Fast Red (Sigma-Aldrich; Cat#N3020) in 100ml of 5% 
(w/v) aluminium sulphate solution and adding O.lg of thymol.
Following fixation of cells with a formaldehyde-sucrose solution for 15 minutes at 
37°C, samples were washed in 3% (v/v) glacial acetic acid solution for 3 minutes at 
room temperature. Samples were transferred to a 1% (v/v) Alcian blue solution and 
incubated for 30 minutes. Stained samples were washed in running water for 2 
minutes and further rinsed in distilled water prior to counterstaining with Nuclear 
Fast Red solution for 5 minutes. Following 3 washes with distilled water, samples 
were dehydrated by successive incubations in 70% (v/v), 80% (v/v), 90% (v/v) and 
100% (v/v) ethanol for 5 minutes periods. Samples were mounted using DPX and 
imaged using transmitted light microscopy.
2.9.3 Identification of Collagen using Van Geison Staining
Samples were fixed using a formaldehyde-sucrose solution and washed in distilled 
water prior to treatment with Celestine blue (Sigma-Aldrich; Cat#206342) for 30 
minutes at room temperature. Samples were rinsed in distilled water and cells 
differentiated by brief exposure to 1% (v/v) acid alcohol. Following a wash in 
distilled water, samples were stained with Van Geison solution (Sigma-Aldrich; 
Cat#HT254) for 5 minutes and blotted using filter paper. Dried samples were 
dehydrated by successive incubations in 70% (v/v), 80% (v/v), 90% (v/v) and 100% 
(v/v) ethanol for 5 minutes periods. Samples were mounted using DPX and imaged 
using transmitted light microscopy.
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2.9.4 Identification of Extracellular Matrix Calcification using Von Kossa
Staining
Samples fixed using formaldehyde-sucrose were washed in 3 changes of distilled 
water for 5 minutes and incubated in 1 % (w/v) silver nitrate solution for 60 minutes 
under the presence of ultraviolet light. Following 3x5 minute rinses in distilled 
water, samples were treated with a 2.5% (w/v) sodium thiosulphate solution for 5 
minutes at room temperature. Samples were washed in 3 changes of distilled water 
for 5 minutes and counterstained in Harris’ Hematoxylin solution (Sigma-Aldrich; 
Cat#HHS16) for 10 minutes at room temperature. Following washing in alkaline 
water for 5 minutes, samples were differentiated with brief exposure to 1 % (v/v) acid 
alcohol and dehydrated by successive incubations in 70% (v/v), 80% (v/v), 90% 
(v/v) and 100% (v/v) ethanol for 5 minutes periods. Dehydrated samples were 
mounted using DPX and imaged using transmitted light microscopy.
2.10 SEM imaging
2.10.1 Critical Point Drying Preparation of Samples for Imaging using
Scanning Electron Microscopy
Cells required for imaging using scanning electron microscopy were cultured on 
sterile glass coverslips. To process cells for imaging, cells were subjected to critical 
point drying. Samples were initially fixed with a solution containing 4% (v/v) 
formaldehyde and 2% (w/v) sucrose for 15 minutes at 37°C prior to undertaking 
critical point drying. Anhydrous samples were imaged using Scanning Electron 
Microscopy.
2.11 RT-PCR analysis
2.11.1 Isolation of RNA for RT-PCR analysis
Before isolating RNA, the following solutions were prepared in addition to those 
provided within the Qiagen RNeasy Mini Kit (Qiagen; Cat#74104): (i) lOpl of 1M P-
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Mercaptoethanol (Sigma Aldrich; Cat#M3148) were added to 1ml of buffer RLT. (ii) 
44ml of 100% ethanol were added to 6ml of buffer RPE.
To isolate RNA, adherent cells in a 24 well plate were subjected to three 5 minute 
washes in PBS followed by treatment with 350pl of buffer RJLT. Following 5 
minutes incubation at room temperature, cell lysate was transferred to a QIAshredder 
column and centrifuged at 13500 x g for 2 minutes. Eluted supernatant was diluted 
with 250pl of 100% ethanol and transferred to an RNeasy mini column prior to 
centrifugation at 13500 x g for 15 seconds, after which 500(j.l of buffer RW1 were 
added to the column and incubated for 5 minutes at room temperature. Following a 
further 15 second centrifugation at 13500 x g, 500pl of buffer RPE were added to the 
column followed by centrifugation for 15 seconds at 13500 x g. Finally, a further 
500j.il of buffer RPE were added and columns centrifuged at 13500 x g for 2 minutes. 
To elute the RNA, the column was placed into a fresh 1.5ml RNase free eppendorf 
tube to which 30pl of RNase-free dEEO were added. Following 10 minutes 
incubation at room temperature, columns were centrifuged at 13500 x g for 1 minute. 
Suspended RNA was collected and frozen at “80°C until required.
2.11.2 Reverse Transcription of RNA to Generate cDNA
Prior to reverse transcription, the following solutions were prepared: (i) Stock 
solution 1 comprising lj.il 50uM 01igo(dT)2o, Ij-il lOmM dNTP cocktail and 9j.il 
RNase-free dHiO. (ii) Stock solution 2 was generated via combining 4ja,i 5X first- 
strand buffers, lj.il 0.1M DTT, Ipl RNaseOUT recombinant RNase inhibitor (40 
U/jul) and lj.il Superscript III RT (200U/j.il). These stock solutions were sufficient for 
reverse transcription of one sample (2ju,l) of RNA generated from 2.11.1 (15- 
200(.ig/ml total RNA) and were scaled up accordingly to accommodate larger sample 
volumes. 2jal of RNA solution were added to stock solution 1 and incubated at 65°C 
for 5 minutes to initiate denaturation and then immediately transferred to a -20°C 
environment for 1 minute. Samples were subsequently treated with stock solution 2 
and incubated for 40 minutes at 50°C, after which they were heated for a further 15 
minutes at 70°C. Resultant cDNA was stored at 4°C until required for analysis. 
Unless otherwise stated, solutions were components of the Superscript™ III 
CellsDirect cDNA Synthesis System (Invitrogen; Cat#l8080-200).
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2.H.3 RT-PCR Analysis of Isolated cDNA
Generation of RT-PCR reactions comprised 2pl of cDNA synthesised in 2.11.2 
diluted 100 fold using molecular biology grade dHaO (Invitrogen; Cat# 10977015), 
0.5pl of sense primer (lOOpM) (Sigma Aldrich), 0.5pl antisense primer (lOOpM) 
(Sigma Aldrich), 7.5pl SYBR green single tube real time PCR master mix (Bio-Rad; 
Cat#172-5100) and 4.5pl of molecular grade df^O. Stated volumes were adjusted 
accordingly when required.
Reactions were synthesised in RNase-free 96 well plates (Bio-Rad; Cat#223-9441) 
with a total reaction volume of 15pl. Pipetting was undertaken using RNase-free 
pipette tips. Controls were generated by replacing template cDNA with an equal 
volume of dHaO in order to identify potential DNA contaminants. PCR reactions 
{Table 2.7) were earned out using a Bio-Rad i-cycler (Bio-Rad).
Step Temperature Time Number of cycles
Initial denaturation 95°C 3 minutes 1
Denaturation 95°C 1 minute 40
Annealing Variable 30 seconds 40
Amplification 95°C 30 seconds 40
Final amplification 95°C 30 seconds 1
Soak 4°C Indefinite 1
Table 2.7 - RT-PCR reaction conditions. Annealing temperature was dependent upon optimised 
conditions for each primer detailed in Table 2.8.
Ct values were calculated at the point at which fluorescence generated as a result the 
SYBR green molecule binding double stranded DNA during amplification passed a 
threshold value (Excitation 497nm, Emission 520nm when bound to dsDNA). Post­
amplification, melt curve analysis of the product was performed via subjecting plates 
to an increase in temperature at an increment of 1°C per second commencing at 55°C 
and terminating at 95°C, allowing quantification of the decrease in fluorescence as a 
result of the dsDNA becoming denatured, the two strands dissociating and thus the 
SYBR green emission decreasing. The variation in dsDNA melting temperature was
77
an indicator of the similarity of the amplification product base composition compared 
to the target product for a given primer.
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2.12 Enzyme-Linked Immunosorbent Assay (ELISA)
2.12.1 Isolation of Protein for ELISA
Cells differentiated towards a hepatic lineage as detailed in section 2.7.2 were 
washed 3 times in PBS following removal of the culture media. Cells were treated 
with 1% (w/v) sodium-dodecyl sulphate for 5 minutes at room temperature and the 
subsequent lysate transferred to an eppendorf. Lysate samples were denatured via 
treatment at 95°C for 5 minutes and stored at -20°C until required.
2.12.2 Assessment of Human Serum Albumin Production using ELISA
Human serum albumin production was detected using a Human serum ELISA 
quantitation assay kit (Bethyl Laboratories; Cat#E80-129). Prior to undertaking the 
assay, the following solutions were prepared: (i) Coating buffer containing 0.05M 
sodium bicarbonate, pH9.6. (ii) Wash solution comprising 50mM Tris, 0.14M NaCl, 
0.05% (v/v) Tween 20, pH8.0. (iii) Blocking solution containing 50mM Tris, 0.14M 
NaCl and 1% (w/v) bovine serum albumin, pH8.0. (iv) Sample diluent, prepared by 
combining 50mM Tris, 0.14M NaCl, 1% (w/v) bovine serum albumin and 0.05% 
(v/v) Tween 20, pH8.0.
On the day of the experiment, the required numbers of 96 well plates were coated 
with lOOpl of coating solution supplemented with lOpg/ml of goat anti-human 
albumin antibody. Samples were incubated at room temperature for 1 hour after 
which samples were washed 3 times in 200pl of wash solution. Following washing, 
the antibody associated substrata was blocked via the addition of 200(4.1 of blocking 
solution and incubation at room temperature for 5 minutes, after which cells were 
subjected to 3 further washes with wash solution. In order to generate a calibration 
curve from which unknown serum albumin concentrations could be extrapolated, 
defined standard concentrations of human serum albumin were produced using 
human serum with a previously elucidated concentration of semm albumin. Human 
serum albumin was serially diluted with sample diluent such that the final 
concentrations of serum albumin used as standards were l.OxlO4, 400, 200, 100, 50, 
25, 12.5, 6.25, 3.12 and 1.6ng/mL. Experimental samples comprising cell lysates and
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media aspirates were diluted based upon predicted serum albumin concentrations 
using sample diluent (1:10). lOOpl of calibration controls and associated samples 
were added to appropriately pre-coated wells and incubated for 1 hour at room 
temperature. Post-incubation, samples were washed 5 times with 200pl of wash 
buffer. Controls were included in which samples were replaced with identical 
volumes of dfhO to identify non-specific binding. Horseradish peroxidise conjugate 
was diluted l:7.5xl04 using sample diluent and lOOpl transferred to each well. 
Following 1 hour incubation at room temperature, samples were washed 5 times in 
200pl of wash buffer. Immediately prior to use, enzyme substrate 3, 3’, 5, 5’- 
tetramethylbenzidine (TMB) was prepared by combining equal volumes of the two 
provided substrate reagents, and lOOpl added to each sample. Following 30 minutes 
incubation at room temperature, the reaction was terminated by exposure to lOOpl of 
2M H2SO4. Samples were analysed using a pQuant microwell plate reader with 
associated KC Junior operating platform (BIO-TEK Instruments). Final 
concentrations of target protein in the experimental samples were calculated by 
reference to an equation based on the curvature of the calibration cuive: y = 
0.3279Ln(x) + 0.0602, re-expressed as x = eA[(y-0.0602)70.039] where y is the 
absorbance and x is the target protein concentration.
2.12.3 Assessment of Human Transferrin Production using ELISA
Human transferrin production was detected using a Human transferrin ELISA 
quantitation assay kit (Assaypro; Cat#ET3105). Prior to undertaking the experiment, 
the following solutions were prepared: (i) Sample diluent was produced by diluting 
the provided 10X diluent concentrate 10 fold using dHzO. (ii) Wash buffer was 
prepared by diluting the provided 10X concentrate 10 fold using dH20. Control 
standards were generated by serial dilution of a provided 1 mg/ml standard solution 
of human apo-transferrin providing final concentrations for standard curve 
generation of 750, 375, 118, 59, 29, 15, 7.5, 3.8, 1.9, 1.0, 0.5 and 0.25ng/mL. 
Experimental samples comprising cell lysates and media aspirates were diluted based 
upon predicted serum albumin concentrations using sample diluent (1:10). 50pl of 
standards and samples were aliquoted into a 96 well plate pre-coated with polyclonal 
goat anti-human apo-transferrin antibody and incubated at room temperature for 2 
hours. Controls were included in which samples were replaced by an identical
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volume of dthO to identify non-specific binding. Post-incubation, samples were 
washed 5 times with 200pl of wash buffer and subjected to 1 hour incubation at room 
temperature in the presence of 50pl of an SOX solution of biotinylated polyclonal 
goat anti-human transferrin antibody diluted accordingly with diluent. Following 
incubation, samples were washed 5 times with 200j.il of wash buffer and subjected to 
a 30 minute incubation at room temperature in the presence of 50pl of 100X 
Streptavidin-Peroxidase conjugate diluted accordingly using diluent solution. 
Samples were subjected to 5 further washes using 200|.il of wash buffer and treated 
with 50pi of 3, 3’, 5, 5’-tetramethylbenzidine for 10 minutes at room temperature. 
Reacting vessels were terminated using 0.5M HC1 and analysed using a pQuant 
microwell plate reader with associated KC Junior operating platform (BIO-TEK 
Instruments). Final concentrations of target protein in the experimental samples were 
calculated by reference to an equation based on the curvature of the calibration 
curve: y = 0.1521Ln(x) + 0.0716 and transposed such that x becomes the subject: 
x = eA[(y-0.0716)70.1521] where y is the absorbance and x is the target protein 
concentration. The absorbance for unknown samples was then used to calculate the 
resultant concentration of human apo-transferrin.
2.13 Construction of Stem Cell Conserved Domain (SCCD) Reporter
Constructs
2.13.1 Synthesis of Primers for Amplification of Selected SCCDs
Genes known to exhibit a functional aspect within a desired cell phenotype were 
examined using the Evolutionary Conserved Region (ECR) browser 
nittp:/-;ecrbrowscr.dcodc.or»), an on-line program allowing comparative 
bioinfonnatics detailing evolutionary conservation of genomes across numerous 
species. Regions upstream of the selected genes were assessed for the presence of 
highly conserved intronic DNA sequences conserved throughout numerous species, 
thereby signifying an important functional aspect. Transcription factor binding sites 
present within conserved intronic regions were examined and the potential 
functionality of the sequence noted. These regions were termed Stem Cell Conserved 
Domains (SCCDs) {Figures 2.8-2.10) and primers were designed {Table 2.9) in order 
to amplify selected SCCD regions {Table 2.10) for eventual cloning.
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Sox2 gene
Sox2a (Short sequence)
Sox2b (Long sequence)
Transposons and simple repeats 
Coding exons 
Intronic regions 
Intergenic regions 
Untranslated regions (UTRs) 
ECRs
Figure 2.8 - SCCDs residing upstream of the Sox2 gene - potential for identification and 
purification of cells exhibiting varying levels of plasticity.
NRSFla (Short sequence) 
NRSFlb (Long sequence)
NRSF2a (Short sequence)
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Figure 2.9 - SCCDs residing upstream of the REST (NRSF) gene - potential for the 
identification and purification of neuronal progenitor cells.
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DLK-1 gene
DLK-1
Figure 2.10 - SCCDs residing upstream of the DLK-1 gene - potential for the identification and 
purification of adipogenic progenitor (Pre-adipocyte) cells.
2.13.2 PCR Amplification of Identified SCCD Regions
PCR was utilised in order to amplify selected SCCD regions identified in 2.13.1. To 
generate PCR reactions, a 50|il reaction comprising 5pi PFU polymerase lOx buffer 
(Promega; Cat#M776A), Ipl dNTP mixture (Promega; Cat#U1511), 5pl sense 
primer (lOOpM) (MWG), 5pl antisense primer (100pM) (MWG) {Table 2.9), Ipl 
human genomic DNA (Promega; Cat#G3041), 0.4pl PFU polymerase (Promega; 
Cat#M7741) and 32.6pl nuclease free water, was prepared. Reactions were 
perfonned {Table 2.10) using a PxE 0.2 thermal cycler (Thenno Electron 
Corporation).
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2.13.3 Purification of Synthesised PCR Product
PCR products generated in 2.13.2 were purified using QIAquick PCR Purification kit 
(Qiagen; Cat#28106). To purify, 5 volumes of Buffer PB were added to 1 volume of 
the PCR sample, applied into the QIAquick column and centrifuged for 1 minute at 
13500 x g. The flow-through was discarded and the column washed by adding 750jil 
of PE buffer prior to centrifugation for 1 minute at 13500 x g. Following discarding 
of flow-through, the column was re-centrifuged for an additional 1 minute at 13500 x 
g to completely remove residual ethanol present within buffer PE. The column was 
placed into a fresh 1.5ml eppendorf tube, and the DNA eluted by adding 30ql of 
nuclease-free water to the centre of the column, incubated for 5 minutes at room 
temperature, and finally centrifuged for 2 minutes at 13500 x g.
2.13.4 Enzymatic Digestion of Purified PCR Product and pGL3p Reporter
Construct
In order to generate restriction sites to allow cloning of SC CD sequences into the 
pGL3P luciferase reporter construct (Promega; Cat#E1761), purified PCR products 
generated in 2.13.2/2.13.3 and the pGL3P reporter construct were subjected to 
enzymatic digestion. Products and construct were initially digested with Mlul 
restriction enzyme (Promega; Cat#R6381) {Table 2.11), then, following purification 
using QIAquick PCR Purification Kit (Qiagen; Cat#28106), digested with Xhol 
restriction enzyme (Promega; Cat#R6165) {Table 2.12).
Component PCR product digestion pGL3P Digestion
Product/Construct 15ftl 2|rt
1 Ox buffer D
(Promega; Cat#R9921) 2jal 2pl
lOxBSA 2pl 2jil
Mlul enzyme lj.il 0.5pl
Nuclease free water Opl 13.5pl
Total 20jil 20 pi
^Incubated for 4 hours at 37°C
Table 2.11 - Mlul restriction digests of SCCD PCR product and pGL3P construct.
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Component PCR product digestion pGL3P Digestion
Product/Construct 
lOx buffer D
15 pi 2pl
(Promega; Cat#R9921) 2pl 2pl
lOx BSA 2pl 2pl
Xhol enzyme Ipl 0.5pl
Nuclease free water Opl 13.5pl
Total 20pl 20pl
:i:Incubated for 4 hours at 37°C
Table 2.12 - Xhol restriction digests of SCCD PCR product and pGL3P construct. 
2.13.5 Analysis of Digested Products using Agarose Gel Electrophoresis
Digested products and constracts generated in 2.13.4 were analysed using agarose 
gel electrophoresis. 1-2% (w/v) multi-purpose agarose (Bioline; Cat#BIO-41025) 
was combined with 0.5 x TBE buffer and heated until fully dissolved, at which point 
5pi of ethidium bromide were added (lOmg/ml aqueous solution) (Sigma Aldrich; 
Cat#E-5134). The resulting solution was poured into 12 x 14cm or 20.5 x 10cm 
casting trays and, following insertion of appropriate combs, allowed to solidify at 
room temperature. The cast gels were submerged in horizontal gel electrophoresis 
tanks containing 0.5 x TBE buffer. lOpl of samples generated in 2.13.4 were 
combined with 2pl of 6 x loading buffer (Promega; Cat#G1881) and subsequently 
loaded into the wells. The size of the PCR or construct digest was determined by 
loading either a lOObp DNA ladder (Promega; Cat#G2891), Ikb ladder (Promega; 
Cat#G7541), or Mass ruler (Fermentas; Cat#SM0403). In general, gels were run for 
3 hours at 60V. The electrophoretically separated DNA was visualised using an 
Evenscan broadband dual wavelength transluminator (Alpha Innotech Corporation), 
encapsulated within a Multilmagell Light Cabinet (Alpha Innotech Corporation), at a 
wavelength of 302mn.
2.13.6 Recovery of Digested DNA from Agarose Gels
Digested products separated by electrophoresis in 2.13.5 were assessed and DNA 
corresponding to the desired fragment sizes excised from the gel using a scalpel
87
blade following visualisation with long wave UV translumination. DNA was 
recovered from the excised gel using QIAquick Gel Extraction Kit (Qiagen; 
Cat#28706) following the manufacturers instructions. Briefly, 3 volumes of buffer 
QG were added to 1 volume of pre-weighed gel extract and incubated for 10 minutes 
at 50°C to allow the gel fragment to dissolve. One gel volume of 100% isopropanol 
was added and the sample vortexed prior to transfer to a QIAquick spin column, 
which was subsequently placed into a 2ml collection tube and centrifuged at 13500 x 
g for 1 minute. Following discarding of the flow-through, the column was washed 
via the addition of 750jil of PE buffer and centrifuged for 1 minute at 13500 x g. 
Initial flow-through was discarded and the column subjected to a second 
centrifugation to ensure complete removal of residual ethanol present within buffer 
PE. The column was placed into a fresh 1.5ml eppendorf tube and the DNA eluted 
via the addition of 30p.l of nuclease free water to the centre of the column, incubation 
for 5 minutes at room temperature, and finally centrifugation at 13500 x g for 2 
minutes.
2.13.7 Ligation of Digested PCR Products and Reporter Construct
Ligation of purified digests was undertaken using LigaFast™ Rapid DNA Ligation 
System (Promega; Cat#M8225). For each ligation, insert: vector molar ratios were 
varied, ranging from 1:1 to 3:1 ratios of molar ends. To calculate the required 
volumes of digested products and construct required for each ligation, the following 
calculation was performed:
Ng Vector x kb size of insert x insert: vector ratio = ng of insert required
Kb size of vector
A ligation reaction was performed with lOOng of digested vector DNA (pGL3P), 
calculated amount of digested insert, 5 pi of 2 x Rapid ligation buffer, 3 units (Weiss 
units) of T4 DNA Ligase, and nuclease free water to a final volume of lOpl, 
Synthesised ligation reactions were incubated for 5 minutes at room temperature.
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2.13.8 Transformation of Ligated Reporter Plasmids into Chemically
Competent E. coli Cells
Reporter plasmids generated in 2.13.7 were transformed into strains of competent E. 
coli (DH5-a) (Invitrogen; Cat#l 8265-017). To initiate transformations, a 50pl aliquot 
of competent cells was defrosted on ice, and the lOpl ligation reaction generated in 
2.13.7 added to the thawed cells. Following 30 minutes incubation on ice, samples 
were subjected to a heat-shock at 42°C for 45 seconds prior to re-transferral to ice for 
2 minutes. 950|ul of pre-warmed LB broth were added to the transformations, and the 
cultures incubated at 37°C for 1 hour with agitation at 225rpm. 50-200pl of cultured 
transfonnations was spread onto LB agar plates supplemented with lOOpg/ml 
ampicillin, and cultured overnight at 37°C. Following overnight incubation, formed 
colonies were selected using a sterile pipette tip, and transferred to a universal tube 
containing 5ml of LB broth culture media supplemented with l OOpg/ml ampicillin. 
Isolated colonies were cultured overnight at 37°C with agitation at 225rpm. Post­
culture, glycerol stocks containing 750pl of culture and 750pl of 80% (v/v) glycerol 
were mixed and frozen at -80°C until required. 1ml of culture was taken and 
subjected to mini-preparation for subsequent analysis to confinn uptake of the 
correct insert.
2.13.9 Mini-Preparation of Plasmid DNA
A small scale preparation of up to 20pg of plasmid DNA was purified for screening 
using QIAprep Spin Miniprep Kit (Qiagen; Cat#27106). 1ml of transformed cells 
taken from overnight cultures was centrifuged at 2600 x g for 5 minutes at 4°C. 
Following discarding of the supernatant, cells were resuspended in 250pl of buffer 
PI and transferred to a 1.5ml eppendorf tube. To the suspension, 250pl of buffer P2 
were added and mixed thoroughly via inverting the tubes 4-6 times. 350|.il of buffer 
N3 were added to the solution and mixed by a repeat inversion. Following 
centrifugation for 10 minutes at 13500 x g, the resultant supernatants were applied to 
a QIAprep spin column and centrifuged for 60 seconds at 13500 x g. Following 
discarding of flow-through, columns were washed with 0.5ml of buffer PB and 
centrifuged for 60 seconds at 13500 x g. Flow-through was discarded and columns 
subjected to a second wash with 0.75ml of buffer PE followed by centrifugation for
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60 seconds at 13500 x g. Following discarding of the supernatant, columns were re­
centrifuged to remove residual wash buffer, after which the QIAprep column was 
placed into a clean 1.5ml eppendorf tube. To elute DNA, 50pl of buffer EB were 
added to the centre of each column then, post 5 minutes incubation at room 
temperature, centrifuged at 13500 x g for 5 minutes.
2.13.10 Test Digest of Plasmid DNA
Purified plasmid DNA generated in 2.13.9 was subjected to restriction enzyme 
digestion to confirm the presence and correct location of the insert. Plasmid DNA 
was initially digested with ACC65I (Promega; Cat#R6921) restriction enzyme {Table
2.13) , then, following purification using QIAquick PCR Purification Kit (Qiagen; 
Cat#28106), digested with BGLII restriction enzyme (Promega; Cat#R6807) (Table
2.13) .
Component ACC65I Digestion BGLII Digestion
Product/Construct
1 Ox buffer D
15jil 15 pi
(Promega; Cat#R9921) 2pl 2pl
lOx BSA 2pl 2pl
Restriction enzyme Ipl Ipl
Nuclease free water Opl Ojil
Total 20pl 20j.il
Incubated for 4 hours at 37°C
Table 2.13 - ACC65I and BGLII restriction digests of Plasmid DNA construct.
Purified fragments generated following restriction digest were analysed using two 
methods. Firstly, fragments were subjected to agarose gel electrophoresis as detailed 
in 2.13.5 and fragment sizes assessed. Following identification of correct fragment 
sizes, purified fragments were sent for sequencing to The Sequencing Service 
(School of Life Sciences, University of Dundee) using Applied Biosystems Big-Dye 
Version 3.1 chemistry on an Applied Biosystems model 3730 automated capillary 
sequencer.
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2.13.11 Maxi-Preparation of Plasmid DNA
Following demonstration of the correct sequence insertion into the construct, 
QIAfilter Plasmid Maxi Kit (Qiagen; Cat#12263) was utilised for the isolation of up 
to 500pg of plasmid DNA, 200pl of glycerol stocks of plasmid generated in 2.13.8 
were added to 100ml of LB broth media supplemented with lOOpg/ml ampicillin and 
cultured for 12 hours at 37°C with agitation at 225rpm. Following incubation, cells 
were harvested by centrifugation at 2600 x g for 15 minutes at 4°C and the pellet 
resuspended in 10ml of buffer PL To this suspension, 10ml of buffer P2 were added 
and, following mixing by 4-6 inversions of the tube, was incubated at 20°C for 5 
minutes. Post-incubation, 10ml of chilled buffer P3 were added to the lysate and, 
following mixing by inversion, the solution transferred to a QIAfilter cartridge and 
incubated for 10 minutes at room temperature. During this incubation, a Qiagen-tip 
500 was equilibrated via the addition of 10ml of buffer QBT, which was 
subsequently allowed to empty from the column via gravity flow. Following 
incubation, the cap of the QIAfilter cartridge outlet nozzle was removed and a 
plunger inserted, allowing the cell lysate to enter the previously equilibrated Qiagen- 
tip by gravity flow, which was washed twice with 30ml buffer QC. DNA was eluted 
by washing with 15ml of buffer QF, and precipitated by adding 10.5ml of 
isopropanol, mixing, and centrifuging at 13500 x g for 30 minutes at 4°C. Post- 
centrifugation, the supernatant was carefully decanted and the pellet washed with 
5ml of 70% (v/v) ethanol. Following centrifugation at 13500 x g for 10 minutes, the 
supernatant was again carefully discarded and the pellet air-dried for 10 minutes. 
DNA was dissolved in a suitable volume of TE buffer (pH 8.0).
2.13.12 Quantification of DNA Concentration bv Spectrophotometry
DNA concentration of purified plasmids was detennined using a UV 
spectrophotometer (Jenway Genova Life Science Analyser). Calibration of the 
spectrophotometer was achieved using lOOpl of dH20. Following calibration, DNA 
diluted 100 fold was analysed, with the DNA concentration detennined using the 
following formula: Original concentration = O.D. value (wavelength 260mn) x 
50ng/ml x dilution factor, where 1 O.D. at 260mn for double stranded (ds) DNA
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equals 50ng/ml of dsDNA386. Quantified plasmids were stored at ~20°C until required 
for transfection.
2.14 Transfection of SCCD Reporter Constructs
2.14.1 Transfection of Cells using Amaxa Human MSC Nucleofector® Kit
Human MSC Amaxa Nucleofector® technology (Amaxa; Cat#VPE-1001) was used 
to transfect synthesised constructs into cultured cells. When approximately 85% 
confluent, cells were harvested as described in 2.1.7. Pelleted cells were resuspended 
in PBS and counted using a haemocytometer. The desired number of cells (105 cells 
per nucleofection sample) was transferred to an eppendorf and centrifuged at 200 x g 
for 10 minutes in a microcenhifuge. Following discarding of the supernatant, the 
pellet was resuspended in Human MSC Nucleofector Solution at a final 
concentration of 4 x 105 cells/1 OOpl. 2pg of construct DNA synthesised in section 
2.13 or associated pGL3P (Promega; Cat# E1761) or pGL3C (Promega; Cat#E1741) 
control were added to the lOOpl cell suspension. 0.1 pg of Renillin internal control 
were also added to non-control samples, and solutions transferred to an Amaxa 
certified cuvette, taking care to avoid air bubbles whilst pipetting. The cuvettes were 
transferred to an Amaxa Nucleofector and subjected to the U-23 program, which 
initiates high Transfection efficiency. To the treated cells, 5 OOpl of pre-warmed 
culture media were added and the entire contents transferred to pre-prepared culture 
plates containing media at 37°C using the pipettes provided. Cells were incubated at 
37°C and assessed for post-nucleofection viability after 2 hours by assessment of the 
GFP control (below). Cells were cultured for a further 22 hours and analysed as 
described in 2.14.3.
To establish a positive control additional to the pGLP3P and pGLP3C constructs and 
Renillin, pmaxGFP from Potellina sp. was transfected into one cell-containing well 
and observed using laser scanning confocal microscopy to assess transfection 
efficiency.
To generate a negative control, cells were treated with DNA and transfection 
solutions without induction using the U-23 program. As a second control, cells
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without DNA were treated with these solutions and induced with the Amaxa 
Nucleofector.
2.14.2 Transfection of Cells using Oiageii Effectene® Transfection Reagent
Cells seeded within a 24 well plate and cultured in basal and defined differentiation 
media as described in 2.7.2 were transfected using a Qiagen Effectene Transfection 
Kit (Qiagen; Cat#301427). On the day of transfection, Ipg of DNA synthesised in 
2.12 or appropriate pGLP3P or pGLP3C control was diluted to a concentration of 
0.2)ug/ul with DNA-condensation buffer (Buffer EC) to a total volume of 60pi for 
each proposed transfection. 0.1 pg of Renillin were added to non-control containing 
samples. To this solution, 1.6pl of Enhancer were added and the resulting product 
vortexed for 1 second. Following incubation at room temperature for 5 minutes, 
samples were briefly centrifuged to remove solution from the top of the eppendorf. 
To this solution, 5pi of Effectene Transfection Reagent were added and mixed via 
gentle pipetting. Samples were incubated for 10 minutes at room temperature to 
allow formation of the transfection complex. Whilst complex formation was 
ongoing, culture media was aspirated from each well and the cells washed with PBS. 
350pl of desired media were added to the cells. Following formation of the 
transfection complex, 350pl of the same media were added to the solution. Mixing 
was achieved by gentle pipetting and the solution was immediately added drop-wise 
onto the cells culturing within the 24 well plates. Plates were smoothly rotated to 
ensure uniform distribution of the transfection complexes. Cells were incubated at 
37°C and assessed for post-nucleofection viability after 2 hours by the assessment of 
the GFP positive control as described 2.14.1. Cells were cultured for a further 22 
hours and analysed as described in 2.14.3. pGLP3P, pGLP3C and Renillin were used 
as positive controls. To generate a negative control, cells were transfected in the 
absence of synthesised DNA constructs.
2.14.3 Analysis of Cells Transfected with Synthesised Constructs
Quantification of luciferase protein production conveyed from transfected plasmids 
was estimated using the Dual Luciferase Assay kit (Promega; Cat#E1500). Briefly, 
transfected cells were washed twice with PBS prior to the addition of 70pl of 1 x
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passive lysis buffer to each well and incubation for 15 minutes at room temperature 
with gentle agitation. 20pi of the acquired lysate were added to wells of a 96 well 
plate (Bio-Rad; Cat# Cat#223-9441) and the plate transferred to a Glomax 96 
microplate luminometer Quantificat. lOOpl of Firefly luciferase and lOOpl of sea 
Renilla luciferase substrate were injected into each well to calculate luminescence 
intensity. Renilla luciferase substrate solution determined production of the internal 
control Renillin, and thereby allowed normalisation for transfection efficiency.
2.IS Statistics
2.15.1 Statistical Analysis of Quantitative Results
Flow cytometry, CyQuant Proliferation, Telomere Length, and ELISA experiments 
were each performed in duplicate and repeated 4 times (n = 4). For SCCD 
transfection studies, each experiment was carried out in triplicate (n = 4). Following 
data collection, Microsoft Excel was used to calculate the mean average and standard 
deviation of results. To assess the statistical significance of results, a two tail student 
t-test was employed where necessary.
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3. Human Bone Marrow as a Potential Source of Multipotent Adult
Stem/Progenitor Cells
3.1. Introduction
3.1.1 Bone Marrow-derived MSCs
Following the discovery that the bone marrow niche harbours multipotent cells in 
addition to the well characterised HSC population, investigators have striven to 
characterise these cells both in vitro and in vivo. Isolated MSCs have been combined 
with numerous chemical and topographical stimuli attempting to maintain cells in an 
undifferentiated state or induce lineage specific differentiation44,154,387’390. At present 
however, subpopulations capable of maintaining plasticity or undertaking directed 
lineage differentiation have yet to be homogeneously isolated. Furthermore, whilst 
expression of plasticity-associated markers such as Oct4 have been demonstrated 
within bone marrow-derived MSCs, expression profiles vary between laboratories, 
perhaps attributable to differing culture conditions or antibodies used for 
characterisation220. Conversely, reports describing the absence of Oct4 expression 
may be correct given findings suggesting that Oct4 is not required for self-renewal of 
mouse somatic stem cells221. An alternative theory regarding this absence of Oct4 
expression is that bone marrow-derived cells, thought to be exhibiting multipotential 
abilities, in fact do not. Instead, the bone marrow niche may represent a residence 
accommodating numerous committed progenitor subpopulations, capable of 
unipotent differentiation subsequent to appropriate stimuli, thereby not requiring 
expression of Oct4. This hypothesis is further substantiated when we consider their 
limited capacity for proliferation in vitro3,91, thought to be attributable to rapidly 
decreasing telomeres233, a demise not usually associated with stem cells, in particular 
ES cells, which express telomerase and can be cultured for prolonged periods in 
vitro. However, it must be noted that characteristics observed in vitro do not 
necessarily correlate with functional capabilities in vivo, and the phenotypic 
degeneration may be attributable to a lack of knowledge with regards current ex vivo 
culture protocols. Regardless of whether isolated bone marrow cells possess a 
multipotent stem cell population, it is almost certain that the heterogeneously isolated 
population will contain numerous progenitor subpopulations. It is therefore
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imperative that each subpopulation and, if present, stem cell population is 
homogeneously isolated and assessed for their differentiation capacity both in vitro 
and in vivo. Furthermore, homogenous isolation of individual subpopulations may 
facilitate the optimisation of culture conditions to maintain phenotypes of each 
subpopulation in vitro, allowing prolonged ex vivo expansion generating large 
numbers of cells, a substantial benefit if bone marrow-derived cells are to be utilised 
clinically.
Whilst it is likely that bone marrow contains numerous lineage progenitors, each of 
which could excel when applied homogeneously within a given restorative 
application, many investigators insist that adult cell-based regenerative approaches 
require a multipotent stem cell based foundation. At present, STRO-1 is widely used 
for the purification of hypothesised multipotent cells from bone man'ow203, although 
in addition to the obvious diverse potential of STRO-1+ selected populations, which 
exhibit an ability to generate cells including adipocytes, chondrocytes, osteoblasts 
and neuronal cells, STRO-T cell populations have demonstrated capacities for 
potential therapeutic application, exhibiting an innate ability to support 
hematopoietic engraftment in vivo392. This potential of STRO-1' populations to be 
used for therapeutic applications highlights the heterogeneity of the bone marrow 
niche, and encourages purification methods generating greater homogeneity to be 
tailored. However, given that significant advancements in purification are required in 
order to homogeneously isolate subpopulations of varying plasticity, it is essential in 
the first instance to establish the potential of bone marrow-derived cells, in addition 
to cells isolated from alternative tissues (Chapters 4 to 6), in a heterogeneous 
maimer. Lonza purchased MSCs have demonstrated an ability to undertake 
adipogenic, chondrogenic and osteogenic differentiation following exposure to 
appropriate stimuli and, whether such observed lineage commitment is undertaken by 
a stem (mesenchymal or hematopoietic) or progenitor subpopulation, the population 
as a whole clearly demonstrates a potential for clinical use. It is therefore imperative 
that Lonza MSCs are assessed for their ability to heterogeneously maintain 
phenotype and proliferative capacities throughout in vitro culture, issues addressed 
within this chapter.
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3.1.2 Aims of this Chapter
This investigation into bone marrow-derived cells therefore aims to use flow 
cytometry to assess potential subpopulations present at each respective passage 
whilst furthermore assessing the phenotypic stability of the population. In addition, 
the ability of the population to maintain proliferation throughout in vitro culture will 
be addressed. Previous studies have described phenotypic and proliferation 
instability of bone marrow-derived cells and have attributed this to rapidly reducing 
telomere lengths in vitro233, seemingly causing the population to age more rapidly 
than in vivo. The telomere lengths of these bone marrow cells will also therefore be 
assessed. Overall, this chapter aims to confirm previously obtained data for bone 
marrow-derived cells and establish a base on which to compare cells isolated from 
other tissues.
3.2 Phenotyping of Bone Marrow Cells using Flow Cytometry
3.2.1 Phenotypic Analysis of Bone Marrow Cells throughout Prolonged In
Vitro Culture using Flow Cytometry
Adherent fibroblast-like cells {Figure 3.1) isolated from bone marrow and 
demonstrating in vitro differentiation capacities are termed MSCs, although this 
collective description fails to emphasise the heterogeneity of the population. 
Nevertheless, this population forms the basis of much stem cell related research, 
predominantly using cells of low passage number due to their stability with regards 
proliferation and differentiation. However, whilst this is acceptable for small scale in 
vitro experiments, clinical utilisation of any cell type is likely to require abundant 
numbers of cells, and thus cells of greatly increased passage are likely to be required. 
It is therefore surprising that comprehensive characterisation of MSC phenotypes 
throughout prolonged in vitro culture have failed to be comprehensively studied, 
with only a handful of studies examining modifications of cell phenotype, 
proliferation and differentiation capacities at varying passage393. It is therefore 
uncertain the extent to which the MSC phenotype modifies in vitro. Furthermore, it is 
imperative that observed modifications in surface phenotype can be directly
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correlated to differing regulation of transcription factors controlling plasticity, 
differentiation and proliferation.
Figure 3.1 - Adherent Lonza-purchased bone marrow-derived cells cultured in basal media 
(Passage 4).
In an attempt to ascertain the effects of prolonged in vitro culture on cellular 
phenotype, bone marrow-derived MSCs were cultured in commercial basal media 
and their surface phenotype at passages 4-9 assessed using flow cytometry. 
Antibodies were selected to probe an array of surface antigens associated with 
MSCs, HSCs and endothelial cells, and ES and progenitor cells.
Throughout passages 4 and 5 the bone marrow-derived population maintained 
consistently high expression of MSC-associated markers {Figure 3.2). CD29 was 
expressed by approximately 95.2% of the population at passage 4, reducing to 89.5% 
and 88.7% at passages 5 and 6 respectively. However, expression reduced to 59.0%, 
54.0% and 34.6% at passages 7, 8 and 9 respectively {Figure J.3). This fate was 
mirrored by other MSC-associated markers including CD44 which, following 
expression of 76% - 88% throughout passages 4-6 decreased to 40% at passage 7
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and 23.0% and 13.5% at passages 8 and 9 respectively. The population expressed 
CD117 in a similar manner, with 91.7%, 84.0% and 81.0% expression at passages 4, 
5 and 6 reducing to 12.8%, 2.3% and 1.9% at passages 7-9.
Whilst CD29, CD44 and CD117 exhibited stable expression within the population 
throughout passages 4-6, alternative MSC markers displayed instability following 
passage 5. CD73 was expressed by 78.2% and 73.7% of cells at passages 4 and 5, but 
only 59.8%, 23.4%, 17.6% and 11.5% at passages 6, 7, 8 and 9 respectively. CD90 
incorporated similar phenotypic modifications following in vitro culture, with 94.2% 
and 86.3% expression at passages 4 and 5 reducing to 55.5%, 12.4%, 6.3% and 2.6% 
at passages 6-9. TGF-[3 receptor CD 105 was expressed by 87.0% and 83.8% of the 
population at passages 4 and 5, reducing to 55.8%, 7.4%, 1.4% and 0.8% at passages 
6-9 respectively. CD 146 is hypothesised to represent a marker of MSCs, and was 
expressed within 81.7% and 73.6% of the population at passages 4 and 5. However, 
at passages 6-9 only 11.6%, 9.0%, 1.4% and 1.3% of cells respectively expressed 
CD 146. Passages 6 - 9 also resulted in downregulation of CD 166, with expression 
levels of 74.9% and 69.3% at passages 4 and 5 reducing to 20.1%, 13.9%, 1.3% and 
1.1 % at passages 6-9 respectively.
HLA-ABC, also known as MHC class I, was expressed by 29.8% and 26.7% of cells 
during passages 4 and 5 but only 7.4%, 2.5%, 0.9% and 0.9% at passages 6-9. 
HLA-DR, the second class of MHC antigen, was expressed by 4.9% and 4.8% of 
cells at passages 4 and 5 but reduced to 1.4%, 0.9%, 0.6% and 0.4% at passages 6-9 
respectively.
CD 106 has been proposed to act as key regulator of MSC migration in vivo and 
2.5%, 2,9% and 7.5% of cells respectively expressed CD106 at passages 4, 5 and 6. 
However, at passages 7, 8 and 9 only 0.4%, 0.4% and 1.0% expressions were 
observed. STRO-1 was expressed by 2.2% of the population at passage 4, reducing 
to 1.3%, 0.6%, 0.3% and 0.6% at passages 5-9 respectively. Interestingly however, 
no passage 9 cells expressed STRO-1, suggesting that hypothesised stem cell 
subpopulations are lost following prolonged culture should STRO-1 represent its 
proposed function.
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Phenotyping of the bone marrow-derived population demonstrated disconcerting 
downregulation of hypothesised MSC markers following 5-6 passages of culture. 
Whilst the functional aspect of many of these markers remains questionable, the 
absence of markers such as CD 105, which acts as a receptor for the chondrogenesis- 
inducing growth factor TGF-p, would suggest that the population demonstrates a 
reduced capacity to undertake differentiation following prolonged in vitro culture. It 
is therefore suggested that studies investigating the differentiation potential of bone 
marrow-derived MSCs utilise early passage cells, and thereby ascertain accurate 
results with regards the differentiation capacity of the population. However, whilst 
this may facilitate gaining further understanding of the population, the lack of scope 
for phenotypically stable proliferation limits their potential with regards clinical 
application, for which large numbers of cells are likely to be required. It is possible 
that results describing downregulation of MSC-associated markers can provide a 
platform on which to tailor culture conditions in order to maintain phenotypic 
characteristics of the population. Conversely, the downregulation of MSC-associated 
antigens may be a reflection of their ability to differentiate into different tissue 
phenotypes.
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In addition to probing the bone marrow-derived population for the expression of 
MSC-associated markers, cells were further examined for their expression of surface 
antigens associated with HSCs and endothelial cells {Figures 3.4 and 3.5). CD9 is 
predominantly expressed by endothelial cells, platelets and megakaryocytes394, 
although expression has also been reported in undifferentiated ES cells. CD9 was 
expressed by 18.7%, 19.1% and 15.7% of cells at passages 4, 5 and 6 respectively, 
but reduced to 1.8%, 0.3% and 0.03% passages 7-9. ESC and endothelial cell- 
associated marker CD31 was expressed by 0.9%, 0.9%, 0.04% and 0.6% of cells at 
passages 4-7, though interestingly increased to 20.0% and 23.8% at passages 8 and 
9 respectively. CD34 class II was expressed by 0.75% of the population at passage 4 
and gradually increased to 2.7% at passage 9. Alternative splice variant CD34 class 
III was expressed by 2.8% - 5.9% of the population throughout passages 4-9.
Von Willebrand factor receptor CD41a was expressed by 0.09% of cells at passage 4, 
increasing to 1.8% at passage 9. CD45 exhibited similar expression, with 0.3% 
expression at passage 4 increasing to 2.8% at passage 9. CD50 was expressed by 
0.3%, 0.6% and 0.9% of the population at passages 4, 5 and 6 respectively, 
increasing to 3.1%, 2.4% and 3.4% at passages 7-9. CD62E maintained minimal 
expression throughout in vitro culture, with between 0.2% and 0.9% expression at 
passages 4 - 9. Finally, CD 133 exhibited progressively increasing expression, with 
0.1% at passage 4 increasing to 2.9% at passage 9.
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Bone marrow-derived populations were further probed for surface antigens 
associated with ES cells and progenitors of varying commitment {Figures S.6 and 
3,7), Whilst CD 15 is highly expressed in mouse MSCs, only 0.03% - 0.6% of human 
MSCs demonstrated expression. CD30 is highly expressed in embryonal carcinoma 
cells and, interestingly, the bone marrow population exhibited 20.1% - 31.7% 
expression throughout passages 4-9. CD56 was expressed by 0.4%, 1.1% and 
0.01% of cells throughout passages 4-6, increasing to 2.6%, 3.5% and 5.1% at 
passages 7, 8 and 9 respectively. CD135 was expressed by 3.4%, 2.6% and 2.5% at 
passages 4, 5 and 6 respectively, reducing to 0.9% at passages 7-9.
Phenotypic profiling of bone marrow-derived cells demonstrated significant 
modifications following in vitro culture. Surface antigens hypothesised to be 
associated with MSCs, HSCs and endothelial cells, and ES and progenitor cells were 
up- and down- regulation at varying passage, indicating variability within 
subpopulations comprising the heterogeneous population. However, in order to 
understand the effects of in vitro on isolated cells, it will be necessary to correlate 
transcriptional profiling, proliferation and differentiation capacities with a surface 
expression phenotype.
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3.3 Proliferation Capacity of Bone Marrow Cells
3.3.1 Proliferation Capacities of Bone Marrow Cells throughout Prolonged In
Vitro Culture using CvQUANT Analysis
In order to further demonstrate phenotypic transformation following prolonged in 
vitro culture, the proliferative capacity of MSCs was assessed at passages 4-9 
(Figure 3.5). 1 x 104 bone marrow-derived cells were seeded per well of a 24 well 
culture plate and maintained in basal media for 7 days, with the total cell number per 
well counted at days 1, 3 and 7. Following 24 hours of culture, passage 4 cells had 
proliferated to generate 1.7 x 104 cells. Passage 5 cells generated a slightly reduced 
number of cells following 24 hours of culture, with approximately 1.5 x 104 cells. 
Prolonged in vitro culture resulted in further reduced proliferation rates, with 1.3-, 
1.1-, 1.0- and 1.0- x 104 cells observed following 24 hours of culture at passages 6, 7, 
8 and 9 respectively.
Whilst reduced proliferation was observed following 24 hours of basal culture, 
increased quiescence within the population was further pronounced when examining 
cells cultured for 72 hours. Whilst passage 4 and 5 cultures generated 3.1- and 2.8- x 
104 cells respectively at day 3, succeeding passages demonstrated reduced levels of 
proliferation, with passage 6-9 cultures generating approximately 1.4-, 1.7-, 1.2- 
and 1.2- x 104 respectively.
Following 7 days of culture, passages 4 and 5 indicated further proliferation within 
the population, attaining cell numbers of approximately 4.4 x 104 in both passages. 
Cells cultured for prolonged in vitro periods continued to demonstrate a reduced 
capacity for proliferation, with 2.4-, 2.0-, 1.4- and 1.2 x 104 cells at passages 5, 6, 7 
and 9 respectively post 7 days of basal culture.
Assessment of MSC proliferation in vitro demonstrated their progressively reduced 
ability to undertake cell division, in particular post passage 5. This reduction 
coincides with the downregulation of MSC-associated surface antigens observed in 
3.2.1, and poses significant problems if these cells are to be used clinically. It is
109
therefore required that culture conditions are optimised to ensure that cells are able to 
proliferate to Hayflicks limit of 70 cell passages395.
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3.4 Telomere Length Assessment of Bone Marrow Cells
3.4.1 Telomere Length Regulation of Bone Marrow Cells throughout
Prolonged In Vitro Culture using DAKO Telomere Length Analysis
Telomeres represent specialised structures present at the ends of eukaryotic 
chromosomes and are proposed to control the underlying mechanistic pathways 
governing cell replicative lifespan and possibly the aging process. Such structures 
may therefore represent attractive markers for assessing the impact of cell culture on 
the population, potentially allowing modification of culture media to reduce 
degradation of or even retain telomere length. However, in order to maintain 
telomere length, the base generating enzyme telomerase must be activated, and 
whilst this can conceivably overcome reducing telomere length, its activation can 
often be associated with cancer. In vivo, humans demonstrate an average telomere 
loss of approximately 17 bases per annum233, although cells have been demonstrated 
to age more rapidly in vitro.
Bone marrow-derived MSCs were cultured in commercially available basal media on 
tissue culture polystyrene and assessed for their respective X chromosome telomere 
length following varying periods of culture {Figure 3.9). Passage 4 cells globally 
exhibited a mean X chromosome telomere length of 10721 bases, which reduced 
subsequent to further culture. Passage 5 cells exhibited an average telomere length of 
10655 bases, reducing to 10549, 10431, 10330 and 10188 base lengths at passages 6, 
7, 8 and 9 respectively. The results demonstrated a reduced telomere length of 
approximately 100 - 150 bases per passage, significantly greater than the proposed 
17 base loss per annum observed in vivo. It is likely therefore that this rapid 
reduction in telomere lengths impact significantly on cellular phenotype, causing the 
modifications of phenotype and reduced proliferation observed in MSC cultures. 
Culture conditions should therefore be tailored to reduce this rapid aging of cells in 
vitro, with maintenance of telomeres inducing a more stable phenotype, proliferation 
rate and differentiation capacity, all of which are key parameters if these cells are to 
be utilised clinically.
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3.5 Conclusion
3.5.1 Bone marrow as a Niche for the Isolation of Clinically Desirable Cells
Bone marrow-derived cells represent the most comprehensively studied cell type to 
date and have already been utilised in numerous in vivo applications. However, flow 
cytometry data presented within this chapter suggests significant heterogeneity 
within the population, expressing antigens associated with MSCs, HSCs and 
endothelial cells, and ES and alternative progenitor subsets. However, the 
heterogeneic phenotype varied significantly during prolonged in vitro culture and 
this raises concerns with regards their potential clinical utilisation, especially given 
that maintained passage of adherent cells is likely to be required in order to generate 
the cell numbers needed for regenerative applications. Furthermore, the modification 
of surface phenotype with increasing in vitro culture coincided with a reduced 
capacity to undertake proliferation, both of which are likely attributable to the rapid 
aging of the population as demonstrated by telomere length regulation studies.
Following observation of this apparent aging of the population in vitro, modification 
of ex vivo culture conditions may provide an enviromnent capable of maintaining the 
natural in vivo phenotype. It is therefore hoped that results obtained in this study can 
infer a baseline on which to compare alternative culture conditions, in particular the 
telomere length study which, given the apparent rapid aging the population in vitro, 
can represent an attractive marker with which to compare in vitro with in vivo 
conditions. Furthennore, upon attaining a consistent in vitro phenotype following 
prolonged culture, homogeneous isolation of individual subpopulations present 
within adherent bone marrow cultures may allow the application of bone marrow- 
derived cells within numerous clinical applications, given that the population is 
likely to contain cells of varying plasticity and lineage commitment in addition to 
terminally differentiated, essentially clinically redundant cells. This homogeneous 
isolation is reuired if bone marrow-derived populations are to be utilised in any 
clinical setting, given that progenitor subsets of undesirable lineage commitment are 
likely to hinder, or potentially prove detrimental, to a regenerative strategy.
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In conclusion the bone marrow can be regarded as a niche of significant interest, 
potentially allowing for the isolation of cells of varying potential. Further studies 
must now concentrate upon developing optimised culture conditions and isolation 
strategies to facilitate the prolonged ex vivo culture of clinically useful cells without 
modifications of phenotype or reduction of proliferations rates which are likely 
attributable to rapid aging of cells. Furthermore, in order to facilitate their 
purification and assess the differentiation potential of cells isolated from varying 
donors, functional characteristics must be associated with their surface antigen 
profiles, allowing rapid assessment and homogeneous isolation of desired 
subpopulations post initial isolation from each donor.
3.5.2 Response to Chapter Aims
Results gained within this chapter address the aims set out in 3.1.1 by hypothesising 
potential subpopulations following analysis by flow cytometry, although it was noted 
that this phenotype, along with proliferation rate, modified following in vitro culture. 
Rapidly reducing telomere lengths have previously been hypothesised to be 
responsible for this, and such rapid aging was undertaken by Lonza bone marrow 
cells. Given the data obtained, this chapter has provided a base on which to compare 
cells isolated from other adult tissues.
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4. Human Peripheral Blood as a Potential Source of Multipotent Adult
Stem/Progenitor Cells
4.1 Human Peripheral Blood Cells
4.1.1 Introduction
Human peripheral blood represents an attractive niche for the isolation of cells, being 
a renewable source with straightforward and relatively non-invasive methods of 
isolation. However, whilst methods for the isolation of cells from peripheral blood 
are well documented, the populations of adherent cells present remains open to 
discussion.
Initial theories of the central dogmaa refuted the presence of endothelial progenitor 
cells (EPCs) and the corresponding vasculogenesis within the adult human, insisting 
that such cells are limited to presence within the early embryo in order to induce 
development of the circulatory system. However, following the discovery of EPCs in 
1997396, policies of the central dogma have been repeatedly challenged, with 
researchers hypothesising that transplantation of EPCs may augment vasculogenesis, 
potentially allowing therapeutic strategies for the treatment of ischemic diseases to 
be developed, with many preliminary studies already exhibiting palpable clinical 
benefit ' . EPCs demonstrate an impressive capacity to undertake proliferation
and furthermore can develop into mature endothelial cells (ECs), principles 
fundamental to their clinical potential. However, at present their origin within 
peripheral blood populations remains unclear, with numerous groups articulating 
differing opinions with regards EPC derivation. CD14+ cells, which are typically 
CD34", have been suggested as the source of EPCs399, with this monocyte enriched 
population displaying an ability to undertake an EC-like phenotype in vitro. 
Interestingly, however, this population also expresses dendritic cell antigens, 
suggesting that monocytes can differentiate into macrophages, dendritic cells, or ECs 
depending on environmental cues. Furthermore, data obtained from this study 
demonstrated that the EPCs, also known as angioblasts, are of increased abundance 
within peripheral blood than previously hypothesised. And whilst this study 
adequately assessed capabilities of a purified CD14+/CD34' subpopulation, it was
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interesting to note the results obtained from the transplantation of CD34' and 
CD14+/CD34' into ischemic mice. Whilst both subpopulations grafted within the 
endothelium of murine blood vessels, this was only observed following the co- 
injection of CD34+ cells, suggesting that leukocyte-leukocyte interactions perform a 
critical role governing angioblast behaviour in vivo. Conversely, other groups have 
demonstrated that CD34+ cells, of which a subset represent EPCs according to one 
study396, differentiate along the monocyte/macrophage lineage in v//ro400, casting 
further doubt on the origin of EPCs. This uncertainty has resulted in a theory 
depicting two distinct populations of EPCs, the first co-expressing 
monocyte/macrophage and EC markers, with the second expressing EC-associated 
markers only and subsequently demonstrating an impressive capacity for 
proliferation401’402. At present, however, no methodologies exist to homogeneously 
purify populations based upon their functional capacities, and thus the origin of EPCs 
remains illusive403.
To further complicate matters regarding adherent subpopulations present within 
human peripheral blood, a recent study has suggested the presence of a multipotent 
cell population exhibiting many characteristics associated with ES cells404. Proposed 
Multipotent Progenitor Cells (MFCs) were isolated from healthy donors following 
the administration of granulocyte colony stimulating factor. Small clusters of 
adherent proliferating cells demonstrated expression of ES cell-associated 
transcription factors Nanog, Oct4, c-Myc and KLF-4, and furthermore established 
lineage progression towards neurons, glial cells, hepatocytes, cardiomyocytes, 
endothelial cells and osteoblasts following exposure to appropriate chemical stimuli. 
However, whilst this innate differentiation capacity potentially offers a potent source 
of functional cell types, it is fundamental that this MFC population is homogeneously 
assessed. Considering chemotactic summoning of cells post trauma, it is likely that 
the blood contains numerous stem and progenitor subsets in addition to EPCs, 
trafficking towards sites of injury in order to provide functional repair. This 
hypothesised MFC population could in fact therefore represent an array of stem and 
progenitor cells, each with a differing lineage potential. The aim of this chapter is 
therefore to identify potential adherent subpopulations present within human 
peripheral blood isolated from four donors using Histopaque and RosetteSep 
methodologies through antigen-based phenotypic profiling. Furthermore,
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alternatively isolated populations will be assessed for their ability to generate CFU- 
Fs and CFU-GMs to hypothesise residing numbers of multipotent and hematopoietic 
progenitor subsets respectively. Finally, peripheral blood cells will be induced using 
adipogenic, chondrogenic and osteogenic differentiation conditions in order to assess 
the capability of the population to undertake such lineage commitment.
4.1.2 Aims of this Chapter
This investigation aims to assess human peripheral blood as a niche for the isolation 
of clinically desirable cells, comparing those isolated using Histopaque and 
RosetteSep methods from four donors. Respectively isolated populations will be 
analysed using flow cytometry to hypothesise residing subpopulations present and 
this phenotype, along with their proliferation rate, monitored throughout in vitro 
culture. Should similar phenotype and proliferation modifications as those seen in 
bone marrow-derived cells be observed, telomere length analysis will be undertaken. 
CFU assays will be undertaken to quantify the number of CFU-Fs and CFU-GMs 
present in each population, and their ability to undertake adipogenic, chondrogenic 
and osteogenic differentiation assessed. Following these investigations, it is hoped 
that an optimal method for the isolation of cell from human peripheral blood can be 
identified, yielding populations of multipotent cells maintaining a stable phenotype 
and proliferation rate following in vitro culture.
4.2 Isolation of Cells from Human Peripheral Blood
4.2.1 Isolation of Cells from Human Peripheral Blood using Histopaque and 
RosetteSep Purification
Human peripheral blood was isolated from the median cubital vein of both male and 
female donors representing varying ages {Table 4.1). Cells were isolated either by 
Histopaque density centrifugation or RosetteSep purification so as to assess the 
phenotypic capacities of cells isolated by these two techniques. Pelleted 
lymphocyte/monocyte layers isolated using the respective isolation strategies were 
resuspended in DMEM (Low glucose) supplemented with 10% (v/v) FCS and 1% 
(v/v) 10,000U/ml of penicillin and lOmg/ml of streptomycin in 0.9% (w/v) sodium
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chloride (Sigma-Aldrich; Cat#S7653) and seeded onto fibronectin-coated tissue 
culture polystyrene plates.
Peripheral blood donor Donor age (Years) Donor sex
1 23 Male
2 41 Male
3 31 Female
4 39 Female
Table 4.1 - Peripheral blood donors.
Cells isolated using both Histopaque and RosetteSep methodologies isolated 
adherent cells with a small, rounded morphology from all donors 24 hours post 
isolation {Figures 4.1 and 4.2). Following 72 hours of culture, the media was 
replaced in order to remove non-adherent cells. Interestingly, RosetteSep cultures 
demonstrated a reduced number of non-adherent cells compared with Histopaque 
isolation independent of donor. However, following 7-10 days of further basal 
culture, both populations yielded adherent cells displaying a fibroblastic-like 
phenotype {Figures 4.3 and 4.4). Regardless of donor, adherent cells isolated using 
each methodology displayed limited capacity for cell division, failing to proliferate 
following passage post initial confluence.
Figure 4.1 - Blood donor 2 cells isolated using 
Histopaque density centrifugation and 
cultured on fibronectin coated plates for 24 
hours in basal media.
Figure 4.2 - Blood donor 3 cells isolated using 
RosetteSep and cultured on fibronectin coated 
plates for 24 hours in basal media.
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4Figure 4.3 - Blood donor 2 cells isolated using 
Histopaque density centrifugation and 
cultured on fibronectin coated plates for 7 
days in basal media.
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Figure 4.4 - Blood donor 3 cells isolated using 
RosetteSep and cultured on fibronectin coated 
plates for 7 days in basal media.
4.3 Phenotyping of Peripheral Blood Cells using Flow Cytometry
4.3.1 Phenotypic Analysis of Peripheral Blood Cells throughout Prolonged In
Vitro Culture using Flow Cytometry
Whilst Histopaque and RosetteSep isolation of cells from each donor generated no 
observable variations with regards morphology and proliferation capacity, 
comprehensive assessment of adherent cells was facilitated by surface antigen 
profiling using flow cytometry. Adherent cells cultured for 7 days in commercial 
basal media were enzymatically dissociated from the surface prior to analyysis using 
an array of MSC-associated markers revealed comparable expression in cells from all 
donors isolated using Histopaque and RosetteSep methodologies {Figures 4.5 and 
4.6).
CD29 is expressed by leukocytes and proposed MSCs, and cells isolated from all 
donors using both Histopaque and RosetteSep purification methods demonstrated 
high levels of expression. Histopaque-isolated cells demonstrated 82.1%, 78.2%, 
74.4% and 86.5% expression following 7 days of basal culture from the blood of 
donors 1, 2, 3 and 4 respectively. Equivalent expression was observed within cells 
isolated using RosetteSep, exhibiting 76.8%, 90.5%, 85.7% and 81.9% from blood 
donors 1-4.
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CD44 is also expressed by leukocytes whilst furthermore demonstrating high levels 
of expression in bone marrow-derived cells detailed in 3.2.1. Histopaque-isolated 
cells exhibited 82.7%, 78.3%, 77.8% and 77.9% expression from blood donors 1-4 
respectively, whilst RosetteSep-isolated equivalents exhibited similar expression 
levels, generating 78.5%, 84.7%, 85.6% and 87.1%.
CD73 exhibits a broad expression profile including high expression on endothelial 
cells and MSCs. Both Histopaque and RosetteSep-isolated cells from all blood 
donors exhibited positive CD73 population expression of approximately 73% - 84%, 
indicating potential residence of endothelial and/or MSC-like cells within the 
adherent population.
Both HSCs and MSCs are hypothesised to express the CD90 surface antigen, and 
blood-derived cells from donors 1-4 demonstrated high levels of expression within 
the adherent population. Histopaque-isolated cells from donors 1-4 exhibited 
76.1%, 83.5%, 72.8% and 78.9% expression respectively, with RosetteSep-isolated 
cells demonstrating similar expression of 83.8%, 90.5%, 89.3% and 90.0%.
CD 105 is presented on the surface of numerous cell types including endothelial cells, 
MSCs and activated monocytes, and populations derived from human peripheral 
blood therefore predictably demonstrated high levels of expression. Histopaque- 
isolated cells exhibited 80.8%, 83.4%, 84.4% and 80.0% expression in donor cells 1 
to 4 respectively with RosetteSep-isolated cells exhibiting positive expression in 
91.5%, 86.5%, 87.7% and 86.7% of cells.
Also known as VCAM-1, CD 106 has been proposed as a chemotactic regulator of 
MSCs post trauma. Within peripheral blood populations isolated using Histopaque 
density centrifugation, donors 1 through 4 demonstrated consistent levels of CD 106 
expression, with 65.6%, 69.8%, 63.5% and 62.8% of cells respectively. RosetteSep- 
isolated cells demonstrated fractionally lower expression within the population, 
exhibiting 59.7%, 54.8%, 54.8% and 49.2% expression in donor cells 1-4.
Histopaque-isolated cells exhibited 69.9%, 70.9%, 72.1% and 72.4% expression of 
the primitive HSC-associated marker CD117 in blood donors 1 - 4 respectively
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following 7 days of basal culture. RosetteSep-isolated cells demonstrated slightly 
increased expression at 76.7%, 77.0%, 74.0% and 84.3%.
CD 146 currently represents a marker for isolating populations of cells capable of 
undertaking multilineage differentiation, and the Histopaque populations from 
donors 1 through 4 demonstrated 76.1%, 74.8%, 67.6% and 74.3% expressions 
respectively. RosetteSep-isolated cells exhibited marginally increased levels of 
CD146, with 74.2%, 79.5%, 87.4% and 85.2%. CD166 functions as a transmembrane 
glycoprotein and is expressed on MSCs and activated monocytes. Within peripheral 
blood cells, populations isolated using Histopaque exhibited surprisingly low levels, 
with only 16.3%, 14.5%, 18.7% and 20.2%. RosetteSep isolations gave similar 
results, with 13.7%, 18.7%, 21.0% and 16.6%.
HLA-ABC is a key antagonist within the immune response and is highly expressed 
on MSCs. Peripheral blood cells derived using Histopaque demonstrated 53.1%, 
49.4%, 42.8% and 50.6% expressions, with RosetteSep-derived populations 
exhibiting a similar phenotype, demonstrating 59.5%, 52.4%, 48.5% and 50.5%. 
Interestingly the MHC class II marker HLA-DR, which is expressed at low levels in 
bone marrow-derived cells, was highly expressed in peripheral blood-derived 
populations. Histopaque-isolated cells demonstrated 59.1%, 54.9%, 42.6% and 
31.5% expression, whilst RosetteSep-isolated populations produced similar 
expression, with 55.7%, 63.0%, 54.7% and 51.6%.
STRO-1 expression within the peripheral blood populations was comparable to 
levels observed within bone marrow-derived cells, with cells isolated from blood 
donors 1-4 using Histopaque exhibiting 0.6%, 0.3%, 0.4% and 0.4% expression 
respectively. RosetteSep-isolated cells also demonstrated STRO-1 expression similar 
to bone marrow-derived populations, with 0.3%, 0.7%, 0.4% and 0.3%.
Considering MSC-associated surface antigen expression of peripheral blood-derived 
cells isolated using both Histopaque and RosetteSep, it is apparent that, whilst not 
exhibiting morphological or proliferative similarities, the population contains 
subpopulations of cells phenotypically similar to those present within bone marrow- 
derived populations at low passage, displaying comparable if slightly decreased
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levels of CD29, CD44, CD90, CD117, CD146 and STRO-1. These cells may 
therefore incorporate the hypothesised MPC population. Furthermore, CD73 and 
CD 105 were comparably expressed within the two populations, although peripheral 
blood cells demonstrated marginally higher expression. MSC chemotaxic regulator 
CD 106 exhibited significantly increased expression within peripheral blood 
populations, probably attributable to its function of guiding MSCs to sites of injury, a 
capacity not required whilst residing within the bone marrow niche. Surprisingly 
CD 166, which is highly expressed within early passage bone marrow populations, 
demonstrated much lower expression within peripheral blood cells. However, most 
significant was the increased expression of MHC classes I and II, which 
demonstrated considerably higher expression within peripheral blood populations 
compared with bone marrow-derived counterparts, an expression which could impact 
significantly with regards allogeneic transplantations of such cells.
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Furthering MSC-associated surface antigen profiling, peripheral blood cells were 
investigated for their expression of hematopoietic and endothelial cell-associated 
antigens {Figures 4.7 and 4.8). The monocyte, endothelial and platelet-associated 
antigen CD9 exhibited expression within 17.2%, 13.7%, 17.4% and 16.9% of cells 
isolated from donors 1-4 respectively using Histopaque and 18.8%, 15.1%, 20.9% 
and 14.4% with RosetteSep isolation.
CD 14 has been proposed as a key marker of EPCs, and cells isolated using 
Histopaque from donors 1-4 demonstrated 69.5%, 66.5%, 75.7% and 60.1% 
positive expression respectively. RosetteSep isolation produced similar CD 14 
expression, with 65.9%, 59.7%, 58.6% and 57.2%. The endothelial-associated 
marker CD31 was similarly expressed by cells isolated using both Histopaque and 
RosetteSep methodologies, with 56% - 68% having expression in blood donors 1 - 4.
Following previous studies attempting to identify EPCs within peripheral blood, 
numerous hypotheses have been generated with regards to their surface expression 
patterns. Whilst almost all perceive that EPCs express CD14, the expression of CD34 
on EPCs remains questionable. Histopaque-isolated cells from donors 1-4 
demonstrated 11% - 18% expression of the CD34 class II variant, with RosetteSep- 
isolated cells exhibiting similar expression. However, CD34 class III demonstrated 
considerably greater expression within both the Histopaque and RosetteSep purified 
cells of 51% - 65%.
CD41a is predominantly expressed on platelets and megakaryocytes and was 
therefore predictably expressed by low numbers of the population, indicating that the 
majority of such cells were removed during Histopaque and RosetteSep isolations. 
CD45 is expressed by numerous blood cells including monocytes and was highly 
expressed by cells isolated using Histopaque, with 84.1%, 85.6%, 87.0% and 88.1% 
from donors 1-4. RosetteSep-isolated cells exhibited similar expression with 89.4%, 
86.8%, 82.0% and 92.1% respectively. CD50 represents a leukocyte-associated 
antigen and is highly expressed within donor populations isolated using Histopaque 
and RosetteSep, with 83% - 91% of the population demonstrating positive 
expression. Interestingly, leukocyte adhesion molecule CD62E demonstrated 
expression using Histopaque and RosetteSep of 11% - 25% positive expression,
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suggesting the presence of cytokine-stimulated endothelial cells within the 
population. Finally, hematopoietic and non-hematopoietic progenitor subset- 
associated marker CD133 demonstrated 29% - 51% positive expression in both 
isolation techniques, indicating the presence of progenitor subsets exhibiting 
endothelial and alternative lineage potentials.
Hematopoietic and endothelial-associated antigen expression within all peripheral 
blood donors isolated demonstrated similar expression profiles. The expression of 
CD 14, respective classes of CD34 and CD 133 suggests the presence of endothelial 
progenitor subsets within the population, with their isolation and homogeneous 
characterisation offering significant clinical potential. However, purification using 
each individual surface antigen is unlikely to allow homogeneous isolation of EPCs 
since CD 14 and CD 133 are likely to be expressed on progenitors of alternative 
lineage and CD34 of alternative hematopoietic progenitors. Furthermore, whilst 
purification based upon combined expression of these three markers may result in 
greater homogeneity, it is likely that alternative progenitor impurities would persist 
and thus alternative sorting methods should be developed.
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Peripheral blood-derived populations were finally investigated for their expression of 
ES and alternative lineage progenitor-associated surface antigens {Figures 4.9 and 
4.10). CD 15 is a marker associated with monocytes and murine ES and MSCs, 
although it was not expressed by bone marrow-derived populations. Since peripheral 
blood-derived cells exhibit significant comparability with bone marrow-derived 
populations when probed with MSC-associated antigens, high levels of expression 
observed in peripheral blood-derived populations are likely to be attributable to 
monocytes. Histopaque-isolated cells exhibited 54.4%, 48.6%, 46.9% and 62.4% 
positive expression in donors 1-4 respectively, whilst RosetteSep isolation 
demonstrated 52.5%, 53.5%, 43.5% and 42.4% respectively.
CD30 is expressed in early embryonic cells in addition to immune-associated cells, 
and both Histopaque and RosetteSep peripheral blood-derived populations exhibited 
0.5% - 1.7% cell specific expression within donor populations 1-4. Whilst this 
population may represent a subset of undesired immunogenic cells, they may in fact 
represent an immature cell population exhibiting high proliferation and 
differentiation capacity, and thus their isolation and homogeneous characterisation 
would be of significant interest.
CD56 is known to be expressed on approximately 10% - 25% of peripheral blood 
leukocytes although it is also thought to be expressed by more primitive progenitor 
subsets, and thus its 1% - 3% expression within isolated populations is of interest, 
with homogeneous isolation of subsets of cells expressing CDS6 perhaps producing 
cells with multidifferentiation potential.
CD81 represents a surface antigen associated with neural progenitor subsets and is 
expressed by 0.5%, 0.2, 0.1% and 0.1% of cells isolated using Histopaque from 
donors 1-4 respectively. RosetteSep isolations generated 0.1% positive expression 
within donor 1 cells, although donor 2, 3 and 4 populations failed to demonstrate 
CD81 expression, and it may be that the proposed increased monocyte purification of 
RosetteSep isolation discriminates against this cell type. NGFR represents a surface 
antigen expressed by more committed neuronal phenotypes, and Histopaque 
isolations from donors 1 - 4 exhibited 0.5%, 0.2%, 0.1% and 0.1% expression 
respectively. Interestingly, RosetteSep isolations demonstrated 0.1% upregulation in
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donor 1 cells only, furthering the hypothesis that RosetteSep may discriminate 
against these cells.
CD135 represents a primitive marker of ES cells and HSCs, and was expressed 
within 9.0%, 6.9%, 3.3% and 2.1% of cells isolated from donors 1-4 respectively 
using Histopaque. RosetteSep isolations, however, produced higher levels with 9.6%, 
18.4%, 4.6% and 7.1% expression.
Surface antigen profiling of peripheral blood-derived populations has determined that 
variations in donor age or sex yields insignificant differences with regards phenotype 
of adherent populations, with cells displaying consistent levels of MSC, HSC, EPC, 
monocyte and alternative lineage progenitor markers. Furthermore, varying methods 
of isolation produce little difference with regards population surface expression, with 
differences probably attributable to environmental volatility of blood donors, 
unavoidable parameters such as time of isolation (morning or afternoon), diet and 
recent activity of the donor undoubtedly resulting in varying numbers of each cell 
population being present within the peripheral blood circulation. However, regardless 
of accompanying parameters, peripheral blood undoubtedly contains cells of varying 
lineage potential and, considering its relatively non-invasive isolation, could 
represent a readily available and renewable source for autologous clinical 
applications, although allogeneic utilisation must first overcome the high levels of 
MHC class expression. It is therefore suggested that each individual subpopulation is 
homogeneously isolated and assessed for differentiation capacity, potentially 
providing a source of clinically useful cells on tap.
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4.4 CFU Analysis of Peripheral Blood Cells
4.4.1 CFU-Fibroblast Analysis of Peripheral Blood-derived Cells
Given the expression of surface antigens associated with MSCs and lineage 
progenitors observed by flow cytometry, CFU-F assays were perfonned on 
peripheral blood-derived cells to establish the number of non-hematopoietic 
multipotent progenitors present. Following initial confluence, 1 x 106 isolated cells 
were seeded for CFU-F analysis and the number of colonies {Figures 4.11 and 4.12) 
counted following 12 days of culture. Blood donor 1 cells isolated using Histopaque 
generated an average of 74.5 colonies per 35mm2 culture dish, similar to the 78.5 
colonies achieved with RosetteSep. Blood donors 2, 3 and 4 isolated using 
Histopaque generated similar numbers of colonies following 12 days of culture, with 
respective populations generating 66.8, 69.8 and 68.3 colonies per 35mm2 culture 
dish. RosetteSep-isolated cells for these respective donors generated 82.3, 70.8 and 
53.3 {Figure 4.13). Interestingly, these data suggest that, despite 75% - 90% of cells 
expressing the hypothesised MSC-associated marker CD 146, the actual number of 
cells within the population exhibiting CFU-F capacities, and therefore associated 
stem/progenitor characteristics, is much smaaller. In fact, less than 0.007% of cells 
exhibited the capacity to generate CFU-Fs, suggesting that the remainder of cells 
may represent more terminally committed progenitor subsets. STRO-1 was 
expressed on 0.2% - 0.8% of the population, and whilst this number correlates more 
accurately with the number of cells exhibiting CFU-F capacity compared with 
alternative MSC markers such as CD90 and CD 146, the number of STRO-l+ cells 
within the population are too plentiful for each to represent a CFU-F forming cell. 
Therefore, it may be that STRO-1 allows partial purification of progenitor subsets, 
though still incorporating cells demonstrating increased commitment.
Regarding donor variation, results obtained suggest minimal differences in the 
number of CFU-Fs present within each donor population, with differences again 
likely to be attributable to environmental factors discussed previously. Furthermore, 
Histopaque and RosetteSep isolations resulted in cells capable of generating similar 
numbers of CFU-Fs, supplementing the phenotype data achieved in 4.3.
134
N
um
be
r o
f C
FU
s/
10
6 c
el
ls
Figure 4.11 - CFU-F formation by adherent 
blood donor 1 cells isolated using Histopaque 
and cultured for 12 days in MethoCult media.
Figure 4.12 - CFU-F formation by adherent 
blood donor 1 cells isolated using RosetteSep 
and cultured for 12 days in MethoCult media.
□ Histopaue 
E RosetteSep
Figure 4.13 - CFU-F formation per 1 x 106 cells isolated from human peripheral blood donors 1 
- 4 using Histopaque and RosetteSep isolation methods following 12 days of MethoCult culture. 
Values represent mean number of cells observed per 35mm: culture dish for each donor and 
isolation technique (n = 4). Error bars correspond to Standard Deviations. Student /-test 
indicated that there were no significant differences in the number of CFU-Fs generated in 
donors 1-4 isolated using RosetteSep compared with corresponding Histopaque isolations 
(+p>0.05).
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4.4.2 CFU-Granulocvte/Monocvte Analysis of Peripheral Blood-derived Cells
Peripheral blood-derived cells demonstrated positive expression of surface markers 
associated with hematopoietic progenitors and subsequently were assessed for their 
capacity to generate CFU-GMs. CFU-GM assays allow the quantification of 
hematopoietic progenitors within cell populations. Peripheral blood cells isolated 
from donors 1-4 using Histopaque and RosetteSep were cultured to confluency and 
1 x 106 cells seeded in MethoCult stimulation media. Following 12 days of culture, 
seeded populations had generated visible colonies (Figures 4.14 and 4.15). 
Histopaque-isolated cells generated an average of 69.3, 60.1, 55.3 and 57.5 colonies 
per 35mm2 culture dishes, compared to 62.3, 61.0, 64.5 and 49.3 colonies generated 
following RosetteSep isolation (Figure 4.16). However, these results once again cast 
doubt on the exact phenotype of cells exhibiting HSC and EPC surface antigens. 
CD 14 represents a hypothesised EPC marker, and was expressed by 57% - 76% of 
donor cells. However, the number of colonies generated by 1 x 106 cells suggests that 
again less than 0.007% of cells within the population are capable of generating CFU- 
GMs. Thus it is likely that the majority of cells expressing FISC and EPC markers 
such as CD14, CD34 classes II and III, CD45 and CD133 are progenitors incapable 
of generating CFU-GM, suggesting a more committed phenotype.
Considering comparative cell profiling of the peripheral blood populations, variation 
in blood donor age or sex revealed no significant variation regarding the number of 
CFU-GM forming cells within the populations, with differences likely to be due to 
environmental variance. This echoes variation due to method of isolation: no 
significant differences were observed in number of CFU-GM forming cells isolated 
using the two methods. Considering the minimal variation observed with regards 
surface phenotype and number of CFU-Fs/CFU-GMs generated following 
Histopaque and RosetteSep isolations, Histopaque may represent a more attractive 
technology for isolation of cells for clinical application given its reduced cost. 
Therefore the remainder of this chapter will concentrate upon assessing cells isolated 
using Histopaque density centrifugation.
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Figure 4.14 - CFU-GM formation by adherent 
blood donor 1 cells isolated using Histopaque 
and cultured for 12 days in MethoCult media.
Figure 4.15 - CFU-GM formation by adherent 
blood donor 1 cells isolated using RosetteSep 
and cultured for 12 days in MethoCult media.
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Blood donor 1 Blood donor 2 Blood donor 3 Blood donor 4
□ Histopaue 
tB RosetteSep
Figure 4.16 - CFU-GM formation per 1 x 106 cells isolated from human peripheral blood donors 
1 - 4 using Histopaque and RosetteSep isolation methods following 12 days of MethoCult 
culture. Values represent mean number of cells observed per 35mm2 culture dish for each donor 
and isolation technique (n = 4). Error bars correspond to Standard Deviations. Student Mest 
indicated that there were no significant differences in the number of CFU-GMs generated in 
donors 1-4 isolated using RosetteSep compared with corresponding Histopaque isolations 
(+p>0.05).
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4.5 Differentiation of Peripheral Blood Cells
4.5.1 Adipogenic Differentiation of Peripheral Blood-derived Cells using
Commercial Differentiation Media
Peripheral blood-derived cells demonstrated expression of multipotent-associated 
markers and furthermore a small number were able to generate CFU-Fs following 
appropriate stimulation, an intrinsic property associated with highly proliferative and 
plastic cells. To assess differentiation potential within peripheral blood populations, 
cells isolated from donors 1-4 using Histopaque were subjected to differentiation 
stimuli. To ascertain capabilities of the population to undertake adipogenic 
differentiation, adherent cells were cultured in basal media for 7 days, at which point 
media was replaced with commercial pre-adipocyte growth media. Following 10 
days of culture, pre-adipocyte differentiation media was added to the cells for 72 
hours, after which cultures were maintained for 15 days in adipocyte nutrition media. 
Following 21 days of culture, populations from donors 1-4 heterogeneously 
expressed the adipocyte-specific circulatory protein adiponectin (Figure 4.17), and 
the key adipogenesis regulator PPARy (Figure 4.18) within approximately 50% of 
cells. Furthermore, following 21 days of adipogenic induction, approximately 20% of 
the population demonstrated lipid production as observed by positive staining with 
Oil Red O (Figures 4.19 and 4.20).
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Figure 4.17 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque 
cultured in commercial adipogenic 
differentiation media for 21 days stained with 
Hoechst 33258 (blue) and adiponectin 
antibody (red). Approximately 50% of 
adherent blood cells exhibited positive 
adiponectin expression.
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Figure 4.18 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque 
cultured in commercial adipogenic 
differentiation media for 21 days stained with 
Hoechst 33258 (blue) and PPARy antibody 
(red). Approximately 50% of adherent blood 
cells exhibited positive PPARy expression.
Figure 4.19 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque 
cultured in commercial adipogenic 
differentiation media for 21 days stained Oil 
Red O (red). Approximately 20% of adherent 
blood cells exhibited positive Oil Red O 
expression.
Figure 4.20 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque 
cultured in commercial adipogenic 
differentiation media for 21 days stained Oil 
Red O (red) (Magnified version of Figure 
4.19). Approximately 20% of adherent blood 
cells exhibited positive Oil Red O expression.
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4.5.2 Chondrogenic Differentiation of Peripheral Blood-derived Cells using
Commercial Differentiation Media
Furthering demonstration of adipogenic differentiation, isolated peripheral blood 
cells cultured for 7 days in basal media post Histopaque isolation were induced with 
chondrogenic stimulation media, which was replenished every 3 days throughout the 
28 day culture period. Peripheral blood cells isolated from donors 1 - 4 demonstrated 
chondrogenic lineage progression following 21 days of culture, expressing the 
chondrogenic-associated protein Collagen II {Figure 4.21) and the hypertrophic 
cartilage protein Collagen X {Figure 4.22) in approximately 70% of the population.
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Figure 4.21 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque 
cultured in commercial chondrogenic 
differentiation media for 21 days stained with 
Hoechst 33258 (blue) and collagen II antibody 
(red). Approximately 70% of adherent blood 
cells exhibited positive collagen II expression.
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Figure 4.22 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque cultured 
in commercial chondrogenic differentiation 
media for 21 days stained with Hoechst 33258 
(blue) and collagen X antibody (red). 
Approximately 70% of adherent blood cells 
exhibited positive collagen X expression.
4.5.3 Osteogenic differentiation of Peripheral Blood-derived Cells using
Commercial Differentiation Media
Histopaque-isolated cells from peripheral blood donors 1 - 4 were further assessed 
for their ability to undergo non-associated lineage differentiation by assessing their 
capability to generate osteoblasts. Adherent cells cultured for 7 days post isolation 
were induced with commercial osteogenic differentiation media which was 
subsequently replenished every 3 days throughout the culture. Following 21 days of
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stimulated culture, cells exhibited expression of the osteogenesis master regulator 
CBFA-1 {Figure 4.23) and the mineralisation co-ordinator osteocalcin {Figure 4.24) 
within approximately 70% of the population, demonstrating the capacity of 
subpopulations within peripheral blood-derived cells to undertake osteogenic 
differentiation.
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Figure 4.23 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque 
cultured in commercial osteogenic 
differentiation media for 21 days stained with 
Hoechst 33258 (blue) and CBFA-1 antibody 
(red). Approximately 70% of adherent blood 
cells exhibited positive CBFA-1 expression.
Figure 4.24 - Peripheral blood donor 2 cells 
(Passage 1) isolated using Histopaque 
cultured in commercial osteogenic 
differentiation media for 21 days stained with 
Hoechst 33258 (blue) and osteocalcin antibody 
(red). Approximately 70% of adherent blood 
cells exhibited positive osteocalcin expression.
4.6 Conclusion
4.6.1 Peripheral Blood as a Niche for the Isolation of Clinically Desirable Cells
Cells isolated from peripheral blood of donors comprising varying sex and age 
demonstrated little morphological or phenotypic differences regardless of isolation 
methodology. Adherent populations demonstrated heterogeneous surface antigen 
expression associated with a diverse range of cell types; CD 14, hypothesised to be 
expressed by EPCs, was expressed by approximately 65% of cells and, following 
results obtained in previous studies hypothesising that there may in fact be two 
distinct EPC populations, comprising a CD147CD34' and CD14+/CD344 phenotype, 
the expression of CD34 class II and CD34 class III antigens within approximately 
15% - 60% of cells respectively, further substantiated this hypothesis. Furthermore,
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the expression of CD9 and CD 105 within subsets of the population suggested the 
presence of EPCs within peripheral blood populations.
In addition to expressing both classes of CD34 antigen, which are expressed by both 
HSCs and EPCs, hematopoietic antigens CD90, CD105 and CD135 were also 
expressed, indicating the presence of a HSC subpopulation within peripheral blood- 
derived cells. The presence of HSC-like cells was also signified by the ability of 
0.007% of cells to generate CFU-GMs, although this confirmed that not all HSC 
antigen expressing cells are of hematopoietic lineage.
A comparable number of peripheral blood-derived cells also demonstrated the ability 
to undertake stimulated CFU-F formation, and the presence of potential MFCs was 
further suggested by the heterogeneous expression of CD29, CD44, CD73, CD90, 
CD 105, CD 146, CD 166 and STRO-1. However, given the expression of ES and 
progenitor-associated antigens CD15, CD30, CD56 and CD135, it could be that 
progenitor subsets were responsible for the formation of these observed CFU-Fs.
Given the heterogeneous nature of adherent peripheral blood cells, and furthermore 
the hypothesised capability of HSCs to undertake non-hematopoietic multilineage 
differentiation, it is difficult to hypothesise which cell type is responsible for the 
observed adipogenic, chondrogenic and osteogenic differentiation. However, at 
present methods to purify cells exhibiting MPC, ES cell-like or progenitor, HSC and 
EPC phenotypes are unavailable, thus restricting investigations attempting to identify 
the responsible cell type.
Whilst peripheral blood appears to contain a heterogeneous array of cells exhibiting 
MPC, ES cell-like and committed progenitor, HSC and EPC-asscoiated 
characteristics, the inability of cells to proliferate following initial passage infers 
significant clinical boundaries which must be addressed via tailoring of culture 
conditions. Perhaps therefore homogeneous isolation of individual subpopulations 
would allow both the identification of cells exhibiting varying capabilities and 
subsequent tailoring of in vitro culture conditions to allow prolonged proliferation of 
such cell types, highlighting peripheral blood as a self-renewing source of MPC, 
progenitor, HSC and EPC subsets with numerous clinical applications.
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4.6.2 Response to Chapter Aims
Results presented within this chapter largely address aims detailed in 4.1.1, with cells 
isolated from four different donors using Histopaque and RosetteSep methods 
characterised by surface phenotype expression, CFU-F and GM capabilities, and an 
ability to undertake multilineage differentiation. However, given the limited self- 
renew capacity of adherent cells, no quantifiable data could be gained with regards 
phenotypic and proliferative stability or telomere length regiulation. Nevertheless, it 
was apparent that cells isolated from the four donors using Histopaque and 
RosetteSep methods yielded phenotypically similar cells, and studies should now 
attempt to optimise culture conditions to prolong their in vitro lifespan.
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5. Human Umbilical Cord as a Potential Source of Multipotent Adult
Stem/Progenitor Cells
5.1 Introduction
5.1.1 Umbilical Cord Cells
The umbilical cord is a connecting structure allowing passage of key nutrients from 
the mother to the residing embryo or fetus, developing from the yolk sac in the 5th 
week of development. Interestingly, the cord is not directly connected to a mother’s 
circulatory system, and instead interacts with the placenta which permits transfer of 
materials to and from the mother’s blood without concomitant interaction. 
Structurally the cord consists of two umbilical arteries and one umbilical vein 
encapsulated within a layer of Wharton’s jelly, a glutinous material predominantly 
composed of mucopolysaccharides. The umbilical vein functions as a passage for the 
transportation of oxygenated, nutrient rich blood to the fetus, with the two arteries 
facilitating the removal of deoxygenated, nutrient depleted blood from the embryo.
Interaction of the developing embryo with the umbilical cord is undertaken within 
three weeks post-fertilisation, facilitated by a comiecting stalk. Following 28 days of 
development the fully formed yolk sac, present at the levels of the anterior wall of 
the embryo, is restrained to a vitelline duct which is surrounded by a primitive 
umbilical cord ring. Post 5 weeks of development this ring contains numerous 
fundamental structures. Firstly, in addition to containing the established umbilical 
vein and two arteries, the ring houses an internal connecting stalk which bypasses the 
allantois or primitive excretory duct. Additionally, the ring structure contains the 
vitelline duct or yolk sac stalk, and furthermore a canal which connects the intra- and 
extra- embryonic coelomic cavities. Following a further 5 weeks of development, the 
gastrointestinal tract has fully developed and subsequently protrudes through the 
umbilical cord ring to generate a physiologically normal herniation within the 
umbilical cord, concurrently replacing the yolk sac duct. Following 3 months of 
development these loops of bowel regress into the peritoneal cavity and become the 
cord as is observed post-natally.
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Within the developing fetus the generated umbilical cord interacts via the abdomen, 
an area which post-natally becomes the umbilicus or naval. Within the fetus, the 
umbilical cord vein projects towards the transverse fissure of the liver at which point 
it splits into two individual branches: the left progression adjoins with the hepatic 
portal vein, with the right branch, known as the ductus venosus, functioning to 
permit approximately 80% of incoming blood to bypass the liver and flow via the left 
hepatic vein into the inferior vena cava, which subsequently transports blood towards 
the heart. The two umbilical arteries bypass each side of the urinary bladder and 
interact with the internal iliac arteries405.
The developmental immaturity and functional interaction with embryonic tissues 
identifies umbilical cords as a potential niche for the isolation of both primitive and 
adult cells of various lineage committment. At present the hyaluronic acid preserved 
network of glycoprotein microfibrils and collagen fibres present within Wharton’s 
jelly has been used for the isolation of fibroblastic-like cells. These adherent cells 
display many of the characteristics associated with bone marrow-derived cells, 
including the expression of MSC-associated markers CD29, CD44 and CD 105, 
although do not express hematopoietic markers such as CD34 and CD45. 
Furthermore, the population demonstrates the capacity to undertake adipogenic, 
chondrogenic and osteogenic differentiation290. However, like bone marrow-derived 
populations, these adherent cells represent a heterogeneous population, highlighted 
by the identification of myofibroblasts via ultrastructural characterisation406.
The umbilical cord therefore represents an attractive tissue for the isolation of both 
adult and embryonic-like cells, with both potentially offering significant clinical 
potential. However, at present, Wharton’s jelly remains the most studied component 
of the cord, with investigations neglecting many other regions. This is surprising 
since it is likely that the cord contains primitive cell types derived from the 
developing fetus, given it is known that nutrient and cell exchange between mother 
and fetus is a two way transferral, with fetal derived cells being present within the 
peripheral blood of pregnant women407. Thus it is perplexing that populations have 
not been probed for ES and primitive progenitor- associated markers, with the 
homogeneous assessment of individual ES and adult-derived subpopulations residing 
within the cord potentially allowing for the isolation and banking of mother and child
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cells from this redundant organ, providing autologous cells with potential for use in 
later life.
5.1.2 Aims of this Chapter
The aim of this chapter is therefore to phenotypically hypothesise subpopulations 
present within alternatively isolated cord populations, with cells being isolated either 
by plating of Wharton’s jelly or digestion of the whole cord. Given the interactive 
purpose of the tissue, it is likely that the cord will contain both adult and ES-like 
cells. Furthermore, the proliferative and phenotypic stability of both populations will 
be assessed following prolonged in vitro culture and also following freeze-thawing, 
an important issue if cord cells are to be successfully banked for future regenerative 
strategies. Finally, given that Wharton’s jelly-derived cord cells have previously 
demonstrated an ability to undertake adipogenic, chondrogenic and osteogenic 
lineages following exposure to appropriate stimuli, cells isolated via both 
methodologies will be assessed for their capacity to undertake neuronal 
differentiation, thereby further assessing the plasticity of the populations.
5.2 Isolation of Cells from Human Umblical Cord
5.2.1 Isolation of Cells from Human Umbilical Cord by Plating of Wharton’s
Jelly or Whole Cord Digestion
Fresh whole umbilical cords were obtained following the birth of four separate 
children and stored in Hanks’ balanced salt solution for up to 24 hours. No 
information was obtained with regards the age of the mother, sex of the unborn infant 
or duration of the pregnancy, restricting comparative studies of isolated cells. 
Umbilical cords were approximately 50cm in length and 2cm in diameter, allowing 
the isolation of high numbers of cells. Furthermore, the length of the cord facilitated 
an attempt at varying isolation methods in order to compare adherent cells obtained. 
Cells were isolated from cords using two different methods: (i) Umbilical cords were 
mechanically dissected and the two umbilical arteries and one umbilical vein 
removed. Wharton’s jelly was then carefully removed and plated onto tissue culture 
plastic in the presence of basal media and cultured at 37°C; (ii) Whole umbilical
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cords were mechanically dissembled to generate small fractions approximately 
50mm2. Subsequently these cuttings were enzymatically digested via incubation in a 
solution containing 2% (w/v) Dispase I and 2% (w/v) Collagenase type II overnight 
at 37°C with gentle agitation. Following centrifugation, pelleted cells were 
resuspended in basal media and, following filtration to remove non-cellular debris, 
seeded onto tissue culture substrate and cultured at 37°C.
Regardless of donor or isolation technique, cells adhered following 24 hours of 
culture, though initially whole cord digestion cultures produced a greater number of 
adherent cells. Nevertheless, cells isolated from different donors using both 
techniques became confluent within the 10 days following isolation, although the 
morphology of Wharton’s jelly and whole cord cultures varied considerably, with 
cells isolated from Wharton’s jelly exhibiting a fibroblastic morphology and 
generating obvious colonies (Figures 5.1 and 5.2), compared with the smooth 
muscle-like morphology observed in whole cord cultures (Figures 5.3 and 5.4). 
Interestingly, despite their apparent morphological differences, both populations 
expressed the stem cell proliferation marker nucleostemin within approximately 30% 
of the population (Figure 5.5) throughout passages 3-5, although no expression was 
observed in any cells following this passage (Figure 5.6).
Figure 5.1 - Umbilical cord donor 1 cells Figure 5.2 - Umbilical cord donor 2 cells
isolated from Wharton’s jelly and cultured in isolated from Wharton’s jelly and cultured in
basal media for 10 days. basal media for 8 days.
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Figure 5.3 - Umbilical cord donor 1 cells Figure 5.4 - Umbilical cord donor 2 cells 
isolated via whole cord digestion and cultured isolated via whole cord digestion and cultured
in basal media for 10 days. in basal media for 9 days.
20nm
Figure 5.5 - Umbilical cord donor 1 cells 
isolated from Wharton's jelly and cultured in 
basal media (Passage 4; 0 x Freeze-thaw 
cycles) stained with Hoechst 33342 (blue), 
Oregon green (green) and nucleostemin 
antibody (red). Approximately 30% expressed 
nucleostemin at passages 3 to 5.
20nm
Figure 5.6 - Umbilical cord donor 1 cells 
isolated from Wharton’s jelly and cultured 
in basal media (Passage 7; 0 x Freeze-thaw 
cycles) stained with Hoechst 33342 (blue), 
Oregon green (green) and nucleostemin 
antibody (red). No cells expressed 
nucleostemin post a sixth passage of in vitro 
culture.
5.3 Phenotyping of Umbilical Cord Cells using Flow Cytometry
5.3.1 Phenotypic Analysis of Umbilical Cord-derived Cells. Isolated by Plating
Wharton’s Jelly or Whole cord Digestions, Throughout Prolonged In
Vitro Culture using Flow Cytometry
Adherent cells isolated from four separate cords demonstrated obvious 
morphological differences. However, in order to identify potential subpopulations 
residing within the cultures, passage 3 and further cultures were phenotypically
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assessed using flow cytometry. However, due to the anonymity of cord donors 
regarding age of the mother, sex of the baby and term of the pregnancy, phenotyping 
and subsequent experiments were undertaken using only cord donor 1 cells isolated 
by each methodology.
Interestingly, despite their apparent morphological differences, umbilical cord 1 cells 
derived either by plating of Wharton’s jelly or whole cord digestion displayed similar 
phenotypic profiles. Concerning a subset of MSC-associated surface antigens, both 
Wharton’s jelly and whole cord digest-derived populations displayed consistently 
high levels of expression throughout passages 3-5 {Figures 5.7 and 5.8). CD29 
demonstrated high expression within Wharton’s jelly-derived cells, exhibiting 
88.4%, 87.1% and 83.0% at passages 3, 4 and 5 respectively. This expression was 
comparable with cells isolated by whole cord digestion, which expressed 90.5%, 
92.0% and 85.3%. Alternative MSC-associated markers demonstrated similar 
expression within each isolated population, with CD44, CD73, CD90 and CD117 
expressed by 82% - 93% of cells in each population at passages 3-5. Furthermore, 
the cells demonstrated similar levels of STRO-1 expression with those observed in 
bone marrow, exhibiting 0.4% - 0.8% expressions at passages 3-5. CD 106 also 
exhibited comparable expression levels for each isolation method and with bone 
marrow-derived cells.
However, whilst numerous MSC-associated markers within alternatively isolated 
cord populations demonstrated expression levels comparable with those obseived in 
bone marrow-derived cells, other markers had reduced expression. CD 105 was 
expressed by approximately 87% of passage 4 bone marrow cells, but 56% - 70% 
expression in cord cells throughout passages 3-5. CD 146 and CD 166 displayed 
lower expression in comparison with bone marrow-derived cells. Wharton’s jelly- 
derived cells displayed 33.6%, 45.4% and 47.4% CD146 expression at passages 3, 4 
and 5 respectively, slightly higher than the 35.2%, 37.2% and 39.0% observed within 
whole cord digests. CD 166 demonstrated reduced expression in cord cells compared 
with bone marrow-derived equivalents, with Wharton’s jelly-derived populations 
demonstrating 37.3%, 39.4% and 33.7% expression at passages 3 - 5 respectively, 
and whole cord digests 14.8%, 16.3% and 18.3%.
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Wharton’s jelly- derived populations exhibited 47.0%, 40.9% and 33.7% expression 
of HLA-ABC at passages 3, 4 and 5 respectively, whilst furthermore demonstrating 
42.2%, 32.4% and 25.9% expression of HLA-DR. However, HLA-ABC was 
expressed by 13% - 16% of whole cord digestion-isolated cells, which also exhibited 
11% - 28% HLA-DR expression, a downregulation which could have significant 
impact with regards implant rejection should umbilical cord cells be required for 
allogeneic transplantation.
However, whilst umbilical cord-derived cells demonstrated alternative regulation of 
MSC-associated surface antigens compared with bone marrow-derived cells, cord 
populations isolated by respective methods demonstrated a similar inability to 
maintain phenotype, with passages 6-8 demonstrating progressively reduced 
downregulation of MSC-associated surface antigens (Figures 5.9 and 5.10).
CD29 demonstrated downregulation within the population following a sixth passage, 
with Wharton’s jelly isolated cells demonstrating 42.0%, 30.2% and 16,4% 
expression at passages 6, 7 and 8 respectively. Whole cord isolates mirrored this 
CD29 downregulation, with 46.0%, 25.0% and 8.7% expression.
MSC-associated antigen CD44 exhibited downregulation at passage 6 onwards in 
both isolated cord populations. Wharton’s jelly-isolated cells demonstrated 
progressive downregulation at passages 6-8, the population demonstrating 59.9%, 
30.5% and 6.0% CD44 expression. Adherent cells isolated by whole cord digestion 
also exhibited progressive CD44 downregulation, with populations exhibiting 37.1%, 
15.6% and 3.4% expression at passages 6-8. CD73 was also downregulated, with 
Wharton’s jelly-derived cells demonstrating 39.1%, 27.1% and 13.4% expression at 
passages 6-8 and whole cord digests 37.1%, 11.4% and 12.8%.
CD90 demonstrated reduced upregulation within both isolated cord populations at 
passage 6 onwards, with 52.0%, 28.3% and 6.3% expression at passages 6 - 8 of 
Wharton’s jelly-derived cells, whilst whole cord digests demonstrated 41.5%, 24.3% 
and 5.8%. CD 105 mirrored CD90 expression within both populations, with 34.3%, 
23.0% and 2.5% of Wharton’s jelly derivatives demonstrating expression at passages 
6 to 8 respectively. Whole cord digests also demonstrated reduced expression of
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CD 105, with passage 6-8 cultures demonstrating 29.0%, 15.6% and 1.7% 
expression respectively. Stem cell factor cytokine receptor CD117 demonstrated 
reduced global upregulation within both isolated populations. Wharton’s jelly- 
derived cells progressively downregulated CD117 within the population, exhibiting 
68.5%, 18.1% and 3.5% expression at passages 6-8 respectively. Adherent cells 
isolated by whole cord digestions displayed similar regulatory expression, with 
passages 6 - 8 respectively demonstrating 52.4%, 8.6% and 5.0% expression.
CD 166 demonstrated differential expression between isolated cord populations and 
when compared with bone marrow-derived cells. Wharton’s jelly-derived cultures 
displayed progressive global downregulation of CD 166, with passages 6, 7 and 8 
populations exhibiting 22.0%, 16.6% and 0.9% expressions. Interestingly, whole 
cord digestion isolation maintained expression at passage 6, with 21.0% of cells 
exhibiting positive expression. However, passages 7 and 8 resulted in 
downregulation of CD 166, with 12.4% and 1.1% positive expression.
HLA-ABC and HLA-DR demonstrated contrasting expression within differently 
isolated populations during passages 3-5, although both populations exhibited 
progressive downregulation of these MHC antigens throughout passages 6-8, 
resulting in less than 1% of cells expressing either antigen at passage 8, regardless of 
isolation methodology. STRO-1 was also downregulated at increasing passage in 
each isolated culture, with passage 8 populations failing to demonstrate positive 
expression.
Interestingly CD 146, whilst expressed at lower levels within each cord population 
than bone marrow-derived cells, maintained expression until passage 7, at which 
point each population demonstrated reduced expression. This expression was further 
downregulated at passage 8, at which point approximately 1% of the population 
expressed CD 146.
In conclusion, adherent cord cells derived by different methodologies displayed 
similar MSC-associated phenotypic characteristics, with the notable exceptions of 
CD 166 and both MHC antigens. However, as with bone marrow-derived 
populations, each cord-derived population demonstrated an inability to maintain
151
expression of MSC-associated markers following a sixth passage of in vitro culture, 
an issue which must be addressed if these cells are to be utilised clinically.
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Following assessment of the populations for expression of MSC-associated surface 
antigens, isolated cord populations were assessed for their global expression of HSC 
and endothelial-associated surface antigens at passages 3-5 {Figures 5.11 and 5.12) 
and 6-8 {Figures 5.13 and 5.14). Endothelial-associated antigens CD31 and CD133 
maintained low levels of expression throughout passages 3-5 of Wharton’s jelly and 
whole cord-derived cultures, with less than 1.0% of cells demonstrating expression. 
However, following passage 6, each isolated population exhibited progressive 
upregulation of CD31 and CD133, perhaps indicating, given the simultaneous 
downregulation of MSC-associated markers, endothelial differentiation of cells 
previously exhibiting a plastic phenotype. Interestingly, endothelial and ES- 
associated antigen CD9 was expressed by 28% - 43% of cells isolated by the 
different methodologies at passages 3-5. However, CD9 demonstrated progressively 
reduced global expression at passages 6-8, culminating in approximately 1% of 
Wharton’s jelly and whole cord-derived cells exhibiting expression at passage 8. 
Perhaps, therefore, CD9 is expressed predominantly by EPCs, and subsequently 
downregulates due to spontaneous differentiation of these cells a consequence of in 
vitro culture. Alternatively, given that CD9 is proposed to be expressed by ES cells, 
perhaps a subset of CD9 cells may represent a population derived from the 
developing fetus. It would therefore be interesting to purify CD9+ cells in a 
combinatorial manner, co-staining and sorting using additional ES/endothelial 
antigens, thereby potentially isolating populations of ES or endothelial specificity.
HSC-associated surface antigen CD34 class II was expressed by 10.2% and 10.6% of 
Wharton’s jelly-derived cells at passages 3 and 4 respectively. However, following a 
fifth passage, CD34 class II was downregulated, demonstrating 3.8%, 2.8%, 2.1% 
and 0.9% expression at passages 5-8. CD34 class III demonstrated increased 
expression within the Wharton’s jelly-derived population, with 20.1%, 20.3%, 21.2% 
and 19.2% expression at passages 3, 4, 5 and 6 respectively. However, following a 
seventh passage Wharton’s jelly-derived cells demonstrated reduced CD34 class III 
expression, with passages 7 and 8 exhibiting 7% and 3% expression respectively. 
Interestingly, whole cord digestions yielded populations exhibiting reduced levels of 
CD34 class II expression, with 1.6%, 1.5%, 2.2%, 5.0% and 2.3% of cells 
demonstrating expression at passages 3-7 respectively. Following an eighth 
passage, however, CD34 class II demonstrated 0.5% expression. CD34 class III was
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also expressed by reduced numbers of whole cord digest cells compared with their 
Wharton’s jelly counterparts, with 18.2%, 16.6%, 16.7% and 14.5% expression at 
passages 3-6 respectively. However, subsequent passages demonstrated reduced 
upregulation, with 3.7% and 1.6% expression at passages 7 and 8 respectively.
CD50 was expressed by both Wharton’s jelly and whole cord digest populations, 
demonstrating maintained expression of 10% - 22% throughout passages 3-6. 
However, following a seventh passage Wharton’s jelly and whole cord-derived cells 
demonstrated reduced CD50 expression of less than 3%. Further suggesting of 
spontaneous differentiation within each population was the progressive upregulation 
of CD41a, CD45 and CD62E upon increasing passage, suggesting non-induced 
endothelial differentiation within subsets of the population.
Following assessment of cord cells using HSC and endothelial-associated antigens, it 
appears that the umbilical cord contains subpopulations phenotypically similar to 
HSCs and EPCs, both of which could represent therapeutically useful tools. 
Furthermore CD9, which is hypothesised to be expressed by both EPCs and primitive 
ES cells, could represent a marker which, if used along side additional ES or HSC- 
associated antigens, could facilitate the purification of populations exhibiting 
differing lineage potential. However, the persistent inability of culture conditions to 
maintain the phenotype of either cord population represents the initial challenge 
which must be addressed.
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Umbilical cord-derived populations were finally assessed for their expression of ES 
and progenitor-associated surface antigens at passages 3-5 {Figures 5.15 and 5.16) 
and 6 - 8 {Figures 5.17 and 5.18). ES cell-associated antigen CD30 was expressed by 
68.1%, 62.5% and 49.4% of Wharton’s jelly-derived cells at passages 3 - 5 
respectively, marginally higher than the expression observed in whole cord digest 
isolated cells, which demonstrated 41.4%, 42.3% and 33.2% expression. However, 
cord cells isolated by each method exhibited progressively reduced expression at 
passages 6-8, with Wharton’s jelly-derived cells exhibiting 15.3%, 12.5% and 5.8% 
expression respectively, and whole cord digests 8.9%, 12.2% and 4.5%. CD56 and 
CD135 were expressed similarly to CD30, although whilst GDI35 demonstrated 
reduced expression following a sixth passage, CD56 global downregulation was less 
extreme, with expression maintained by 19.5% and 17.5% of passage 8 populations 
isolated from Wharton’s jelly and whole cord digests respectively. Interestingly 
CD 15, which is expressed by murine ES cells, displayed little or no expression 
within passages 3 - 5 of Wharton’s jelly or whole cord-derived cells, though was 
progressively upregulated at higher passages.
CD81 and NGFR are surface antigens related to neuronal lineages, and displayed 
differing levels of expression within contrastingly isolated populations. Whilst 
Wharton’s jelly-derived cultures exhibited little or no expression, whole cord digests 
displayed 0.2% - 0.3% positive expression throughout passages 3-5, although no 
expression was observed at passages beyond this, suggesting that cultures failed to 
maintain this immature neuronal phenotype. However, the purification of this 
subpopulation could yield cells with a capacity for neuronal differentiation. In fact, 
the cord appears to contain ES and progenitor-like subpopulations which, whether 
mother or fetus derived, could offer a source of clinically useful cells isolated non- 
invasively.
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If umbilical cord-derived populations are to be utilised clinically, it is imperative that 
isolated cells can be freeze-stored for prolonged periods without modification to their 
phenotype, proliferation or differentiation capacity. Cord cells isolated by varying 
methodologies were therefore frozen at -80°c at passage 4. Following 30 days at - 
80°c, cells were thawed and resuspended in basal media. Freeze-thawed and non- 
freeze-thawed passage 5 cells from each isolation were assessed for their expression 
of MSC- (Figure 5.19), HSC- and endothelial- (Figure 5.20), and ES- and 
progenitor- (Figure 5.21) associated surface antigens.
MSC-associated surface antigens displayed downregulation within populations 
subjected to a freeze-thaw cycle compared with those which remained in culture, 
regardless of isolation method. CD29 was expressed by 83.0% of passage 5 
Wharton’s jelly-derived populations, though following a freeze-thaw cycle, 
equivalent passage cells exhibited 57.5% expression. Whole cord digestion cells, 
which demonstrated 85.3% expression at passage 5, also exhibited severely reduced 
upregulations following a freeze-thaw cycle, with only 46.0% expression. CD44, 
CD73, CD90, CD105, CD106, GDI 17, CD146, HLA-ABC and HLA-DR also 
demonstrated similarly reduced expression following freeze-thawing, although 
perhaps most signficant was the reduction in STRO-1 expression post freeze­
thawing. CD 166 expression was reduced following freezing of Wharton’s jelly- 
derived populations, from 33.7% expression in passage 5 cells not subjected to 
freezing to 14.6% post-freeze-thawing. Interestingly whole cord digest isolates 
demonstrated no downregulation of CD 166, exhibiting 18.3% and 18.4% in non- 
freeze-thaw and freeze-thaw cultures respectively.
HSC and endothelial-associated surface antigens displayed, with the exception of 
CD9, little or no downregulation within either isolated population following a freeze- 
thaw cycle. CD9 however demonstrated reduced expression in both populations, 
from 32.6% expression in passage 5 Wharton’s jelly-derived cells reducing post­
freezing to 11.4%. Whole cord digest isolated cells, of which 28.8% exhibited 
expression following passage 5, demonstrated reduced expression of CD9 post 
freezing, with only 8.7% expression.
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Concerning ES- and progenitor-associated surface antigen expression following 
freeze-thawing of cells, numerous markers exhibited reduced expression compared 
with their continually cultured counterparts. Passage 5 Wharton’s jelly-derived cells 
exhibited 49.4% expression of CD30, though following a freeze-thaw cycle only 
17.5% of the population demonstrated expression. Whole cord digest populations 
demonstrated similar expression of CD30, with the 33.5% expression observed 
within non-freeze-thaw populations decreasing post freeze-thaw cycling, with the 
population demonstrating 13.1% expression. CD56 and CD135 expression within 
both respectively isolated populations demonstrated similar downregulation post 
freeze-thawing, whilst CD 15, CD81 and NGFR were not expressed by any passage 5 
populations.
Following phenotyping with an array of surface antigens, it is hypothesised that 
Wharton’s jelly and whole cord-derived cord populations contain MSC-like stem and 
progenitor cells, HSCs and EPCs, and more primitive ES-like cells. However, it is 
apparant that freeze-thaw cycling results in modified expression of many of these 
surface antigens, and it would therefore be of significant interest to investigate 
telomere lengths within cells subjected to freeze-thaw cycling and compare them 
with those in non-freeze-thawed populations in order to ascertain whether cells 
rapidly age following cryopreservation. Telomere length studies could therefore 
again represent a key analytical tool to determine effects of optimised freeze-thaw 
protocols, since it is imperative that isolated cells can be frozen until required for 
therapeutic utilisation without phenotypic modifications.
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5.4 Proliferation Capacity of Umbilical Cord Cells
5.4.1 Proliferation Capacities of Differently Isolated Umbilical Cord Cells
throughout Prolonged In Vitro Culture using CvOUANT Analysis
Further to the demonstration that isolated umbilical cord populations fail to maintain 
a stable phenotype following prolonged in vitro culture, adherent cells were assessed 
for their proliferative capacity over time {Figures 5.22 and 5.23). Following the 
seeding of 1 x 104 cells, passage 3 - 5 cultures of varyingly isolated populations 
displayed similar proliferative capacities, with total cell numbers of approximately 2 
xlO4, 3.2 x 104 and 4.7 x 104 at days 1, 3 and 7 respectively. However, following a 
sixth passage each Wharton’s jelly and whole cord-derived cells displayed reduced 
capacities to undertake proliferation, with passage 6 cells generating 1.5 x 104, 2.5 x 
104 and 3.2 x 104 at days 1, 3 and 7 respectively. Whilst passage 7 cells derived from 
Wharton’s jelly displayed a similar proliferative capacity to passage 6 cells, passage 
7 whole cord digest cells exhibited reduced proliferation compared with passage 6 
cells, generating 1 x 104 fewer cells following 7 days of basal culture. However, 
following an eighth passage both isolated cell populations displayed severe 
limitations to undertake proliferation compared with early passage cells, generating 
approximately 1.5 x 104 cells following 7 days of culture.
Proliferation assays examining Wharton’s jelly and whole cord-derived cells 
revealed reduced capacities of the population to undertake cell divisions following 
prolonged in vitro culture. In fact, as with their phenotypic profiles, each isolated 
cord population undertakes this reduced capacity following a sixth passage, 
simultaneous to the global downregulation of perceived MSC antigens. Whilst no 
telomere studies were performed with umbilical cord-derived cells, given their 
similarity to bone marrow-derived populations, it is likely that these cells undertake 
rapid aging in vitro, and it is therefore imperative that culture conditions are 
optimised to prevent this rapid telomere demise and subsequent reduction in 
proliferation and modification of phenotype.
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5,5 Neural Differentiation of Umbilical Cord Cells
5.5,1 Neuronal Differentiation of Umbilical Cord-derived Cells Isolated from
Wharton’s jelly and Cultured in Commercial Differentiation Media
Following phenotypic profiling using surface antigens, it was apparent that 
Wharton’s jelly and whole cord-derived cell populations exhibited a heterogeneic 
phenotype potentially containing MSC- and progenitor-like cells, HSCs and EPCs, 
and more primitive ES-like cells. Given that Wharton’s jelly-derived cells reporting a 
similar phenotype to that observed within this investigation have previously 
demonstrated an ability to differentiate towards adipogenic, chondrgenic and 
osteogenic lineages290’408’411, isolated populations were assessed for their ability to 
progress along a neuronal lineage. To achieve this, passage 4 cells derived from 
Wharton’s jelly and whole cord digestions were cultured in conditions known to 
induce neuronal differentiation. Following 28 days of induction, adherent cells 
displayed morphological {Figures 5.24 and 5.25) and phenotypic characteristics 
associated with terminally differentiated neuronal cells. Whilst neural progenitor- 
associated protein nestin was expressed by approximately 40% of induced cells at 
day 21 {Figure 5.26), expression had ceased at day 28 {Figure 5.27) and was 
replaced by proteins associated with terminally differentiated neuronal cell types. 
The expression of nestin within 40% of the population was, however, particularly 
interesting given that less than 0.5% of cells expressed neuronal progenitor- 
associated antigens CD81 and NGFR, thereby indicating that a non-committed stem 
cell population had undergone differentiation to a neuronal progenitor cell expressing 
nestin. These subpopulations appeared to further commit towards a mature neuronal 
phenotype following further induction, with the neuronal-associated proteins Beta- 
Ill-tubulin {Figure 5.28), neurofilament {Figure 5.29), SI00 {Figure 5.30) and 
synaptophysin {Figure 5.31) expressed by approximately 40% of induced cord cells 
following 28 days, although interestingly the population also expressed Schwann- 
cell-associated proteins GFAP {Figure 5.32) and p?5 {Figure 5.33) by approximately 
5% of cells. This ability of umbilical cord-derived cells to undertake neuronal 
differentiation upon exposure to differentiation stimuli could offer immense clinical 
benefit. Interesting to note, however, is the heterogeneous differentiation of the 
population, with varying subpopulations from both cord niches exhibiting phenotypic
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characteristics associated with Schwann and neuronal lineages. However the stem or 
progenitor subsets from which each terminally differentiated cell originates is 
unclear, with CD81+, NGFR+, MSC-like, ES-like or even HSC associated antigen 
expressing cells perhaps responsible for the differentiation.
Figure 5.24 - Umbilical cord donor 1 cells 
isolated from Wharton’s jelly (Passage 4; 0 x 
freeze-thaw) and cultured in neuronal 
differentiation media for 28 days.
Figure 5.25 - Umbilical cord donor 1 cells 
isolated via whole cord digestion (Passage 4; 
0 x freeze-thaw) and cultured in neuronal 
differentiation media for 28 days.
Figure 5.26 - Umbilical cord donor 1 cells 
isolated from Wharton's jelly (Passage 4; 0 x 
freeze-thaw) and cultured in neuronal 
differentiation media for 21 days stained with 
Hoechst 33342 (blue), Oregon green (green) 
and nestin antibody (red). Approximately 
40% of umbilical cord cells exhibited positive 
nestin expression following 21 days of 
induction.
Figure 5.27 - Umbilical cord donor 1 cells 
isolated from Wharton’s jelly (Passage 4; 0 x 
freeze-thaw) and cultured in neuronal 
differentiation media for 28 days stained 
with Hoechst 33342 (blue), Oregon green 
(green) and nestin antibody (red). No 
umbilical cord cells exhibited positive nestin 
expression following 28 days of induction.
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Figure 5.28 - Umbilical cord donor 1 cells 
isolated via whole cord digestion (Passage 4; 0 
x freeze-thaw) and cultured in neuronal 
differentiation media for 28 days stained with 
Hoechst 33342 (blue), Oregon green (green) 
and beta-IU-tubulin antibody (red). 
Approximately 40% of umbilical cord cells 
exhibited positive beta-ill-tubulin expression.
Figure 5.29 - Umbilical cord donor 1 cells 
isolated from Wharton’s jelly (Passage 4; 0 x 
freeze-thaw) and cultured in neuronal 
differentiation media for 28 days stained with 
Hoechst 33342 (blue), Oregon green (green) 
and neurofilament antibody (red). 
Approximately 40% of umbilical cord cells 
exhibited positive neurofilament expression.
Figure 5.30 - Umbilical cord donor 1 cells 
isolated via whole cord digestion (Passage 4; 0 
x freeze-thaw) and cultured in neuronal 
differentiation media for 28 days stained with 
Hoechst 33342 (blue), Oregon green (green) 
and S100 antibody (red). Approximately 40% 
of umbilical cord cells exhibited positive S100 
expression.
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Figure 5.31 - Umbilical cord donor 1 cells 
isolated from Wharton’s jelly (Passage 4; 0 x 
freeze-thaw) and cultured in neuronal 
differentiation media for 28 days stained with 
Hoechst 33342 (blue), Oregon green (green) 
and synaptophysin antibody (red). 
Approximately 40% of umbilical cord cells 
exhibited positive synaptophysin expression.
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Figure 5.32 - Umbilical cord donor 1 cells 
isolated from Wharton's jelly (Passage 4; 0 x 
freeze-thaw) and cultured in neuronal 
differentiation media for 28 days stained with 
Hoechst 33342 (blue), Oregon green (green) 
and GFAP antibody (red). Approximately 5% 
of umbilical cord cells exhibited positive 
GFAP expression.
Figure 5.33 - Umbilical cord donor 1 cells 
isolated from Wharton's jelly (Passage 4; 0 x 
freeze-thaw) and cultured in neuronal 
differentiation media for 28 days stained 
with Hoechst 33342 (blue), Oregon green 
(green) and p75 antibody (red). 
Approximately 5% of umbilical cord cells 
exhibited positive p75 expression.
5.6 Conclusion
5.6.1 Umbilical Cord as a Niche for the Isolation of Clinically Desirable Cells
Umbilical cords represent an attractive organ for the isolation of cells originating 
from both the mother and the unborn fetus, potentially allowing isolation of cells 
exhibiting innate capacities for multilineage differentiation. Wharton's jelly or whole 
cord digestion isolations yielded morphologically dissimilar yet phenotypically 
comparable cells, displaying similar phenotypic surface expression composed of 
markers associated with bone marrow-derived MSCs, alternative non-hematopoietic 
progenitor lineages, HSCs and EPCs, and ES cells. However, this heterogeneic 
phenotype, like that observed in bone marrow-derived populations, failed to be 
maintained following in vitro culture. In fact, numerous cells appeared spontaneously 
differentiate following a sixth passage, as observed by a decrease in plasticity- 
associated antigens and an increase in those associated with terminally differentiated 
phenotypes, in particular CD31 and CD 133, which are largely associated with 
functional endothelial cells. Such terminal differentiation could be the result of 
MSC-like cells, primitive fetal-derived cells or EPCs undertaking such spontaneous
lineage induction. Furthennore, Wharton’s jelly and whole cord-derived cells 
displayed surface phenotype modifications following freeze-thaw cycling, another 
issue which must be addressed if this cell source is to be utilised within a clinical 
setting. In addition to this phenotypic instability, proliferative capacities of the 
populations were reduced upon increasing passage.
Given that previous reports have detailed the isolation of phenotypically comparable 
cells from Wharton’s jelly capable of differentiating towards adipogenic, 
chodrogenic and osteogenic lineages, isolated cord cells were differentiated towards 
a neuronal lineage to demonstrate a further capacity of differentiation. However, 
whilst neuronal differentiation was obseived within approximately 40% of the 
population, and furthermore Schwann cell lineage induction within 5% of cells, it is 
difficult to associate this differentiation with one specific cell phenotype given the 
heterogeneity of the population. However, given that less that 0.5% of cells 
expressed the neuronal progenitor-associated proteins CD81 and NGFR, it is likely 
that MSCs or a more primitive cell undertook differentiation given that 
approximately 40% of cells expressed nestin following 21 days of neuronal induction 
and further differentiated towards a mature neuronal lineage after 28 days.
In conclusion, if umbilical cord-derived populations are to be used as a cell source 
for clinical application, several issues must be addressed. Primarily, homogeneous 
subpopulations present within the heterogeneously isolated adherent population 
should be purified in order to facilitate banking of fetal and mother-derived cells of 
varying potential. And whilst Wharton’s jelly and whole cord-derived populations 
exhibited similar phenotypic profiles, given the expression, albeit minimal, of 
neuronal progenitor antigens, and furthermore the slightly reduced expression of 
MHC class antigens, it may be that whole cord digests represent a more suitable base 
material for undertaking purification strategies. Achieving purification of such 
subpopulations may resolve the second issue, potentially allowing tailoring of culture 
and freeze-thaw cycling conditions to maintain the mother and fetal subpopulations 
in a desired phenotypic state. Should these issues be addressed, the umbilical cord 
will undoubtedly provide a therapeutically useful reservoir for the isolation of cells 
for autologous utilisation within mother and fetus in later life.
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5.6.2 Response to Chapter Aims
Results obtained within this chapter address the aims set out in 5.1.1 by 
phenotypically characterising Wharton’s jelly and whole cord-derived cells using 
flow cytometry. Furthermore, the ability of isolated populations to maintain 
phenotype and proliferation following in vitro culture and freeze-thaw cycling was 
investigated, results of significant interest from a clinical viewpoint. Finally, results 
describing the ability of these cord cells to differentiate towards a neuronal 
phenotype not only addressed the aims set out 5.1.1, but complemented previously 
published results describing adipogenic, chondrogenic and osteogenic differentiation 
of phenotypically similar cells.
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6. Human Dental Pulp as a Potential Source of Pluripotent Adult
Stem/Progenitor Cells
6.1. Introduction 
6.1.1 Dental pulp cells
The vertebrate neural crest is a pluripotent cell population derived from the lateral 
ridges of the neural plate during early stages of embryogenesis. Neural crest cells 
disperse from the dorsal surface of the neural tube and migrate extensively 
throughout the embryo, subsequently generating an array of differentiated cell types. 
Throughout recent years, understanding of neural crest cell establishment within the 
early embryo and subsequent lineage segregation, differentiation and functional 
contribution to a given cell type, mediated by genetic and epigenetic mechanisms, 
have been elucidated.
During craniofacial development, neural crest cells migrate ventrolaterally due to 
populating of the branchial arches. The proliferative activity of these cells generates 
the discrete swellings that demarcate each branchial arch. The subsequent migration 
of these ectodermally-derived cells makes an extensive contribution to the formation 
of mesenchymal structures within the head and neck. Studies monitoring cell 
migration have further demonstrated that neuroectodenn cells of rhombomeres 1-4 
(rl - 4), located in the forming posterior midbrain and anterior hindbrain, transform 
into cranial neural crest (CNC) cells, which migrate into the first branchial arch and 
thereafter reside within the maxillary and mandibular prominences. Residing CNC 
cells contribute significantly to tooth morphogenesis, migrating, proliferating and 
differentiating into odontoblasts, cementoblasts, fibroblasts, osteoblasts and 
chondroblasts or their precursor representatives.
In addition to CNC cells, non-CNC cells have also been demonstrated to reside 
within the developing tooth, although their tissue of origin remains unaccounted for. 
Transplantation of wild-type tooth germ into the kidney of /acZ-transgenic mice 
demonstrated localisation of host lacZ expressing cells and RBCs within the 
transplanted tooth. LacZ expressing cells were located near or inside blood vessels,
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demonstrating that circulating cells are capable of invading the dental pulp via blood 
vessel angiogenic mechanisms and consequentially circulating cells could be the 
origin of non-CNC cells within the dental pulp. However, whilst this study 
hypothesises a potential migratory pathway for the presence of non-CNC cells, it 
fails to identify the tissue from which the circulating cells originated412414.
Subsequent to the demonstration that dental pulp could yield numerous stem and 
progenitor cells of CNC and non-CNC association, numerous studies were 
undertaken attempting to isolate pluripotent cells hypothesised to reside within the 
tissue. Thus far studies have isolated cells reserving an MSC-like morphology and 
phenotype, similarly possessing a multipotent ability to differentiate along 
adipogenic, chondrogenic, osteogenic and neural phenotypes, although maintaining 
negative aspects such as reduced proliferative and differentiation capacities 
following prolonged in vitro culture245"246. Studies isolating cells from deciduous 
teeth from children aged 5-7 years noted the expression of Oct4, Nanog, SSEA-3, 
SSEA-4, Tra-1-60 and Tra-1-81 throughout the 25 passage culture277. However, no 
investigation has yet reported that this expression of embryonic associated markers 
and ability to undertake lineage differentiation extends to cells isolated from adult 
teeth. Furthermore, and perhaps more importantly from a clinical perspective, no 
studies have yet identified cells responsible for these observed results, failing to 
attribute expression firstly to CNC or non-CNC cells, and subsequently to which 
stem or progenitor subsets within the given cell family. Considering developmental 
studies which have noted that CNC cells partially and terminally differentiate to form 
odontoblasts, cementoblasts, fibroblasts, osteoblasts and chondroblasts or their 
precursor representatives, it is fundamental that sustained proliferation and 
differentiation potential, surface phenotype and karyotype stability and consequently 
clinical applicability, be assessed. Whist this may seem cumbersome to many 
clinically associated representatives, the ability of numerous committed progenitor 
subsets within heterogeneous cell populations to spontaneously generate life 
threatening tissues must not be underestimated. Therefore dental pulp cells derived 
from deciduous and adult teeth should be homogeneously segregated in order to 
generate individual subpopulations of differing potential which can be rigorously 
characterised. Initially however, this chapter will investigate the types of cells 
present within heterogeneously isolated populations using flow cytometry to probe
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surface antigen expression and immunofluorescent staining to investigate intrinsic 
proteins. The stability of this heterogeneic phenotype and also the proliferative 
capacity of the population will be assessed throughout increasing in vitro culture and 
also following freeze-thaw cycling, whilst CFU-F and CFU-GM assays will be 
undertaken to establish the number of non-hematopoietic and hematopoietic 
progenitors present respectively. Assuming the hypothesised presence of stem or 
progenitor subsets following aforementioned analysis, populations will be 
differentiated along varying lineages in order to establish multipotentiality of dental 
pulp populations. If subsequent to this analysis we hypothesise the presence of 
varying stem and progenitor subpopulations of interest, the cells will be isolated 
using surface antigen purification methodologies and characterised upon a basis of 
greater homogeneity.
6.1.2 Aims of this Chapter
This investigation aims to characterise adherent cell populations from the dental pulp 
of donors of varying age, sex and tooth condition. Isolated cells will be characterised 
using flow cytometry to identify CNC and non-CNC subpopulations, and this 
phenotype, as well as proliferation, assessed for stability throughout in vitro culture 
and following freeze-thaw cycling. Given their potentially immature phenotype, 
pulp-derived cells will be investigated for the presence of proteins associated with 
maintenance of plasticity and early lineage commitment, particularly towards that of 
the neuronal progenitor. CFU assays will be undertaken to quantify the number of 
CFU-Fs and CFU-GMs present in each population and cells will be induced towards 
adipogenic, chondrogenic, osteogenic, neuronal and hepatic lineages in order to 
assess their multipotentiality. Each of these characterisation steps will be carried out 
at increasing in vitro passage and following freeze-thaw cycling, and telomere length 
assays will be undertaken to identify the aging rate of the population. In the 
assumption that adherent cells will be heterogeneous, populations will be purified 
based on surface antigen expression and these cells characterised as detailed above.
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6.2 Isolation of Cells from Human Dental Pulp
6.2.1 Isolation of Cells from Human Dental Pulp by Enzymatic Digestion
Teeth were attained following consented dental extractions or loss of milk teeth and 
stored in 199 Media with 5% (v/v) PCS and 1% (v/v) 10,000U/ml of penicillin and 
lOmg/ml of streptomycin in 0.9% (w/v) sodium chloride until pulp isolation. Pulp 
was extracted from teeth and enzymatically digested prior to plating in one well of a 
6-well plate. Adult and deciduous incisors, canines, pre-molars and molars {Figure
6.1) of differing conditions were received from donors of varying age and sex {Table
6.1) . Table 6.1 identifies tooth position using a tooth numbering system detailed in 
Figure 6.1, and attributes a score of 1-10 (1 — Poor; 10 — Excellent) qualitatively 
dependent on condition of tooth. Cells adhered to the uncoated tissue culture plastic 
following 4 to 10 days of incubation and began rapid proliferation, attaining a state 
of confluence approximately 7 days after initial adherence.
T TT>1 T TT 1
LR1 LL1
Figure 6.1 - Diagrammatic representation of tooth numbering system; UL - Upper Left; UR - 
Upper right; LL - Lower left; LR - Lower right.
Dental pulp cells were isolated from 23 of the 31 donors, adhering following a 
minimum of 4 days of culture and a maximum of 10. No correlation could be devised 
to associate number of days for cell adherence with age, sex, tooth position or 
condition of tooth, although none of the received teeth attaining a condition score of 
1 allowed for the isolation of adherent cells. In such teeth, pulp was no longer a 
morphologically soft tissue, and instead portrayed a hard, black appearance which
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could not be mechanically or enzymatically digested. No explanation could be 
devised to suggest possible reasons why cells could not be isolated from teeth of 
good condition, with no observable correlation to donor age, sex or tooth position.
Adherent cells from all donors exhibited a heterogeneous fibroblastic-like 
morphology, although numerous other morphologically dissimilar cells were 
observed in all populations {Figures 6.2 to 6.10). Adherent cells proliferated rapidly, 
attaining confluence within one well of a 6 well plate after a minimum of 5 days 
post-adherence and a maximum of 18 days. Due to their variance in donor age, sex, 
condition of tooth and the position from which it was extracted, donors 1-4 were 
subjected to further analysis as detailed below. The remaining adherent cells were 
subcultured up to 3 passages to attain a greater cell number and subsequently frozen 
until required.
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Figure 6.2 - Cells isolated from pulp donor 1 following 9 days of primary culture.
Figure 6.3 - SEM image of pulp donor 1 cells Figure 6.4 - SEM image of pulp donor 1 cells 
(Passage 5, 1 x freeze-thaw cycles) cultured in (Passage 5, 1 x freeze-thaw cycles) cultured in 
commercial basal media. commercial basal media.
S>9*A-SC; Dflt* SOJulTOM 
PNAdUd ■ 9092 Tmm U0«00
Figure 6.5 - SEM image of pulp donor 2 cells 
(Passage 5,1 x freeze-thaw cycles) cultured in 
commercial basal media.
Figure 6.6 - SEM image of pulp donor 2 cells 
(Passage 5, 1 x freeze-thaw cycles) cultured in 
commercial basal media.
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Figure 6.7 - SEM image of pulp donor 3 cells Figure 6.8 - SEM image of pulp donor 3 cells 
(Passage 5, 1 x freeze-thaw cycles) cultured in (Passage 5, 1 x freeze-thaw cycles) cultured in 
commercial basal media. commercial basal media.
Figure 6.9 - SEM image of pulp donor 4 cells Figure 6.10 - SEM image of pulp donor 4 cells 
(Passage 5, 1 x freeze-thaw cycles) cultured in (Passage 5, 1 x freeze-thaw cycles) cultured in 
commercial basal media. commercial basal media.
6.3 Phenotyping of Dental Pulp Cells
6.3.1 Phenotypic Analysis of Dental Pulp Cells throughout Prolonged In Vitro
Culture using Flow Cytometry
Phenotypic analysis of cell populations derived from bone marrow and umbilical 
cord demonstrated the inability of such populations to maintain a stable phenotype 
following maintained periods of in vitro culture. This spontaneous modification of 
phenotype is both concerning and limiting with regards their potential utilisation 
within a clinical setting, given that the reduced expression of stem cell-associated 
antigens is accompanied by a reduced, and ultimately deceased, capacity to 
undertake proliferation and differentiation in vitro. Thus it is probable that 
therapeutic strategies utilising such cells will largely focus upon early passage cells
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given their increased proliferative and differentiation capacities. However, it is likely 
that many clinical applications will require significantly large numbers of cells, and 
thus the ability of the selected cell type to be readily cultured in vitro without 
variation of phenotype will be preferable in order to generate large cell numbers 
without taking large biopsies from donors. Therefore, in order to assess the 
capabilities of dental pulp-derived cells to maintain a constant phenotype over 
increasing passage in vitro, cells derived from donors 1 - 4 were subjected to 
phenotypic analysis during each passage. Furthermore, cells were assessed for 
phenotypic variance following freeze-thaw cycling, a key feature if the cells are to be 
used clinically, in particular for cells which are being isolated and ‘banked’. At 
present, cells derived from umbilical cord and umbilical cord blood are popular 
tissues for the isolation and freezing of cells which maybe used autologously should 
the newly born child or, given the likely presence of adult cells the mother, require 
any medical treatment in their later years. Dental pulp, and in particular that derived 
from spontaneously extracting deciduous teeth, may offer an alternative cell source 
from which autologous cells can be isolated, particularly if they can maintain a stable 
phenotype following long-term freeze storage.
Isolated cells were cultured up to 3 passages at which point a suitable cell number 
had been attained in order to assess the population by flow cytometry. Adherent cells 
from each donor were assessed for their expression of MSC-, HSC- and endothelial-, 
and ES- and progenitor- associated surface antigens at passages 3 to 9 and passage 
30. Cells were also assessed for their ability to sustain phenotype following freeze­
thawing. Finally, cells were cultured for prolonged periods in chemically-defined 
basal media which could potentially overcome many of the ethical and technical 
dilemmas associated with serum-containing commercial media.
Whilst little phenotypic difference was observed between varying donors within 
blood and cord derived populations, the inability of blood-derived cells to maintain 
proliferation and that of cord cells to maintain a stable phenotype or proliferation rate 
following prolonged in vitro culture or freeze-thaw cycling presents significant 
hurdles from a therapeutic viewpoint. Therefore, of significant interest with regards 
dental pulp-derived populations is that, whilst displaying little or no variability 
between differing donors, they are capable of maintaining a phenotype throughout
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prolonged in vitro culture and post freeze-thaw cycling at passage 5/6 {Figures 6.11 
to 6.40).
Concerning MSC-associated surface antigen expression {Figures 6.11, 6.14, 6.17, 
6.20, 6.23, 6.26, 6.29, 6.32, 6.35 and 6.38), dental pulp donors displayed similar 
expression of all antigens and maintained this phenotype throughout prolonged in 
vitro culture. Cells from each donor were cryopreserved at passage 5 and, following 
30 days at -80°C, were resuspended in commercial or chemically-defmed basal 
media. Following two further passages in commercial or chemically-defined culture 
conditions, passage 8 cells were assessed for their MSC-associated profile. Cells 
subjected to freeze-thaw and cultured in commercial or chemically-defined culture 
conditions demonstrated no phenotypic difference between each other or continually 
cultured cells {Figures 6.35 and 6.38), highlighting dental pulp-derived cells as a cell 
source capable of being cryopreserved until required for therapeutic application.
Phenotypically, cell populations demonstrated approximately 90% expression of 
CD29 and CD117 at each passage, though interestingly alternative MSC-associated 
antigens exhibited lower expression. Hyaluronic acid plasticity regulator CD44 was 
expressed by approximately 20% of cells, whilst CD90 and CD 105 exhibited 25% - 
35% expression. MSC-associated antigen CD73 demonstrated approximately 30% - 
50% expression. Multipotent- and endothelial-associated antigen CD 146 was 
consistently expressed by 20% - 30% of donor cells, though interestingly CD 166 
demonstrated little or no expression within the populations. MHC class I antigen 
HLA-ABC consistently demonstrated 20% - 30% expression within the population, 
whilst MHC class II antigen HLA-DR exhibited approximately 5%. Whilst CD 106 
exhibited little or no expression within the populations, STRO-1 expression within 
the populations was maintained at approximately 0.5% - 1.5%.
HSC- and endothelial- associated antigens {Figures 6.12, 6.15, 6.18, 6.21, 6.24, 6.27, 
6.30, 6.33, 6.36 and 6.39) were also maintained on cells from varying donor and 
passage. Furthermore, cells subjected to freeze-thaw cycling and cultured in 
chemically-defined basal media also demonstrated conserved expression of HSC and 
endothelial antigens. ES- and monocyte- associated surface antigen CD9 
demonstrated approximately 10% - 20% expression, although since it is unlikely that
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monocytes would be present within the dental pulp, it is hypothesised that CD9+ cells 
may represent primitive subpopulations of endothelial or ES-like cells. Endothelial- 
associated antigens CD31 and CD 133 were expressed by few or no cells within the 
populations, although conversely cytokine-stimulated endothelial antigen CD62E 
was consistently expressed by approximately 5% - 20%. Whilst CD41a and CD45 
were expressed by minimal or no cells, approximately 10% - 20% demonstrated 
expression of the leukocyte antigen CD50, although given the niche, it is perhaps 
more feasible that this antigen is expressed by alternative cell types. Concerning 
HSC-associated markers, populations demonstrated approximately 5% - 10% 
expression of CD34 class II antigen, whilst CD34 class III was expressed by 20% - 
30% of cells.
Dental pulp-derived populations furthermore maintained antigens associated with 
ES- and progenitor- cell types throughout prolonged passage and following freeze- 
thaw cycling {Figures 6.IS, 6.16, 6.19, 6.22, 6.25, 6.28, 6.31, 6.34, 6.37 and 6.40). 
Whilst cells exhibited little or no expression of murine ES marker CD 15, a number 
of other ES-associated antigens were consistently expressed within the populations. 
CD30 was expressed by approximately 25% - 40%, whilst progenitor antigens CD56 
and CD 135 demonstmted maintained expression of approximately 20% - 40%. 
Unsurprisingly given its developmental derivation from the neural crest, populations 
exhibited approximately 5% CD81 and NGFR expression, a potential subpopulation 
of neuronal progenitor cells.
In conclusion, dental pulp-derived populations displayed an array of MSC-, HSC-, 
ES- and progenitor- associated antigens which could represent attractive 
subpopulations of cells for a diverse range of therapeutic utilisations. Furthermore, 
the ability of heterogeneously isolated populations to maintain this phenotype 
following prolonged passage, freeze-thaw cycling and culture in semm-free media, 
highlights this cell source as an attractive proposition for future regenerative 
strategies, allowing for the culture of large numbers of cells which can be 
cryopreserved until required. It is of extreme interest, therefore, to homogeneously 
isolate and characterise each individual subpopulation, assessing its capacity to 
undertake lineage specific differentiation, with phenotype assaying suggesting the 
presence of cells capable of attaining a number of terminal lineages following
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appropriate stimulation, thereby providing a potent clinical cell source for numerous 
applications.
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6.3.2 Protein Expression Profiling of Dental Pulp Cells throughout Prolonged
In Vitro Culture using Immunofluoresence
Unlike bone marrow-, peripheral blood- and umbilical cord-derived cells, isolated 
dental pulp populations maintained a stable phenotype throughout prolonged in vitro 
culture. However, stable phenotypic expression profiling does not necessarily 
translate to a conservation of molecular pathways governing plasticity or lineage 
commitment. Thus it is imperative to establish the ability of the population to 
maintain a capacity to undertake multilineage differentiation when cultured for 
prolonged periods in vitro. Dental pulp populations were therefore investigated for 
protein expression over increasing passage, cultured within commercial and 
chemically-defined basal media, using antibodies complimentary to proteins 
associated with plasticity or partial lineage commitment.
Fundamental to the maintenance of plasticity is Oct4, a POU-homeodomain 
transcription factor which is initially expressed as a maternal transcript and is 
required for the formation of a pluripotent inner cell mass. Moreover, stringent 
regulation of Oct4 expression is necessary to maintain ES cell identity, with 
modifications of Oct4 expression generating specified differentiation of ectodermal, 
endodermal or mesodermal primitive progenitors92. Following immunofluorescent 
staining for Oct4 in isolated dental pulp cells, populations from donors 1-4 
heterogeneously expressed this protein in approximately 30% of the population. Both 
nuclear and cytoplasmic expression was observed and, interestingly, cells maintained 
expression after prolonged in vitro culture {Figures 6.41 and 6.42).
Oct4 regulates plasticity through a co-operative mechanism with Sox2, forming Oct- 
Sox heterodimers which bind the Nanog promoter94,373. Dental pulp donors 1-4 
heterogeneously expressed Sox2 in approximately 40% of cells, again maintaining 
this expression after increasing passage in vitro. Expression was both nuclear {Figure 
6.43) and cytoplasmic {Figure 6.44) associated, although expression localisation was 
heterogeneous within a population and was in no sense attributable to passage 
number or donor.
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Figure 6.41 - Dental pulp donor 3 (Passage 3) 
cultured in commercial basal media stained 
with Hoechst 33342 (blue), Oregon green 
(green) and Oct4 antibody (red). 
Approximately 30% of dental pulp cells 
exhibited positive Oct4 expression.
Figure 6.42 - Dental pulp donor 3 (Passage 
30) cultured in commercial basal media 
stained with Hoechst 33342 (blue), Oregon 
green (green) and Oct4 antibody (red). 
Approximately 30% of dental pulp cells 
exhibited positive Oct4 expression.
Figure 6.43 - Dental pulp donor 3 (Passage 3) 
cultured in commercial basal media stained 
with Hoechst 33342 (blue), Oregon green 
(green) and Sox2 antibody (red). 
Approximately 40% of dental pulp cells 
exhibited positive Sox2 expression.
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Figure 6.44 - Dental pulp donor 3 (Passage 
30) cultured in commercial basal media 
stained with Hoechst 33342 (blue), Oregon 
green (green) and Sox2 antibody (red). 
Approximately 40% of dental pulp cells 
exhibited positive Sox2 expression.
A further proposed regulator of plasticity, Cripto-1, which is hypothesised to 
function within the Wnt/p-catenin/Tcf signalling pathways and subsequently in stem 
cell renewal, pluripotency and guided differentiation, was also heterogeneously 
expressed within approximately 10% of the population throughout increasing 
passage (Figures 6.45 and 6.46), displaying largely cytoplasmic localised expression.
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Figure 6.45 - Dental pulp donor 1 (Passage 3) 
cultured in commercial basal media stained 
with Hoechst 33342 (blue), Oregon green 
(green) and Cripto-1 antibody (red). 
Approximately 10% of dental pulp cells 
exhibited positive Cripto-1 expression.
■
Figure 6.46 - Dental pulp donor 1 (Passage 3) 
cultured in commercial basal media stained 
with Hoechst 33342 (blue), Oregon green 
(green) and Cripto-1 antibody (red). 
Approximately 10% of dental pulp cells 
exhibited positive Cripto-1 expression.
Tra-1-81 is expressed by human ES, EG and EC cells and, whilst it is generally 
perceived as a marker of pluripotency, its exact functional role is unknown. Dental 
pulp-derived populations heterogeneously expressed Tra-1-81 cytoplasmically in 
approximately 10% of the population in in vitro culture (Figures 6.47 and 6.48), and 
furthermore maintained expression following freeze-thaw cycling.
Figure 6.47 - Dental pulp donor 2 (Passage 3) 
cultured in commercial basal media stained 
with Hoechst 33342 (blue), Oregon green 
(green) and Tra-1-81 antibody (red). 
Approximately 10% of dental pulp cells 
exhibited positive Tra-1-81 expression.
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Figure 6.48 - Dental pulp donor 2 (Passage 
30) cultured in commercial basal media 
stained with Hoechst 33342 (blue), Oregon 
green (green) and Tra-1-81 antibody (red). 
Approximately 10% of dental pulp cells 
exhibited positive Tra-1-81 expression.
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STRO-1 and nucleostemin are currently perceived as markers of cells exhibiting 
multipotent ability, and cells from all donors demonstrated expression of both 
markers over time in culture. Nucleostemin was expressed within the nucleus of 
approximately 60% of the population {Figure 6.49), and furthermore cells exhibiting 
positive nucleostemin expression demonstrated co-expression with STRO-1 {Figure 
6.50), indicating the presence of proliferative cells with multipotent capacity.
Figure 6.49 - Dental pulp donor 4 (Passage 5) 
cultured in commercial basal media stained 
with Hoechst 33342 (blue), Oregon green 
(green) and nucleostemin antibody (red). 
Approximately 60% of dental pulp cells 
exhibited positive nucleostemin expression.
20(im
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Figure 6.50 - Dental pulp donor 4 (Passage 
14) cultured in commercial basal media 
stained with Hoechst 33342 (blue), STRO-1 
antibody (green) and nucleostemin antibody 
(red). Approximately 60% of dental pulp 
cells exhibited positive dual nucleostemin 
and STRO-1 expression.
The expression of neuronal-associated antigens CD81 and NGFR within the 
population suggests the presence of a neuronal progenitor subset, which is 
unsurprising given the developmental origin of the dental pulp niche. REST 
represents a protein responsible for the silencing of neuronal specific genes in non­
neuronal tissues, and is downregulated upon appropriate neuronal stimuli by a 
truncated version of the protein, REST4, which is hypothesised to silence REST 
expression via binding of the BDNF promoter. It is interesting, therefore, that dental 
pulp-derived populations demonstrated approximately 15% positive REST4 
expression in basal conditions within subsets of the population {Figures 6.51 and 
6.52), perhaps suggesting that REST4 is transcribed as to allow basal levels of 
proteins associated with neuronal progenitors such as nestin {Figure 6.53) and TBR2 
{Figure 6.54), which were expressed by approximately 10% of the populations.
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Figure 6.51 - Dental pulp donor 1 (Passage 10) 
cultured in commercial basal media stained 
with Hoechst 33342 (blue), Oregon green 
(green) and REST4 antibody (red). 
Approximately 15% of dental pulp cells 
exhibited positive REST4 expression.
Figure 6.52 - Dental pulp donor 1 (Passage 
15) cultured in commercial basal media 
stained with Hoechst 33342 (blue), Oregon 
green (green) and REST4 antibody (red). 
Approximately 15% of dental pulp cells 
exhibited positive REST4 expression.
2<lum
Figure 6.53 - Dental pulp donor 1 (Passage 
10) cultured in commercial basal media 
stained with Hoechst 33342 (blue), Oregon 
green (green) and nestin antibody (red). 
Approximately 10% of dental pulp cells 
exhibited positive nestin expression.
Figure 6.54 - Dental pulp donor 1 (Passage 
10) cultured in commercial basal media 
stained with Hoechst 33342 (blue), Oregon 
green (green) and TBR2 antibody (red). 
Approximately 10% of dental pulp cells 
exhibited positive TBR2 expression.
To further the identification of neuronal progenitors within the population and the 
developmental origin of the dental pulp, isolated populations were assessed for their 
expression of proteins associated with the retinal pigment epithelium (RPE) lineage 
{Figure 6.55). The generation of terminally differentiated RPE results from lineage 
commitment of undifferentiated ES cells towards progressively more committed 
retinal precursors, finally producing a functional RPE cell type. Progression towards
228
the RPE phenotype requires a downregulation of Oct4, allowing expression of 
proteins required for differentiation. Following downregulation of Oct4, cells 
destined for an RPE lineage express Pax6, a Six3 activated transcription factor 
essential for normal development of the mammalian lens. Pax6+ cells further commit 
to RPE precursors which express MiTF, a protein involved in RPE differentiation via 
modulation of the expression of major melanogenic proteins such as tyrosinase and 
tyrosinase-related proteins TRP1 and TRP2.
f \ Undifferentiated human ES cells( ESC )
MiTF MiTF+
Retinal Pigment Epithelium
Pigment' PigmenC
Figure 6.55 - Progressive RPE lineage commitment.
Dental pulp-derived populations exhibited maintained expression of both Pax6 
{Figure 6.56) and MiTF {Figure 6.57) within approximately 30% of cells, indicating 
the presence of a neuronal progenitor subset of RPE lineage commitment. However, 
it has yet to be established whether Pax6f cells are in fact co-expressing MiTF, for 
which a dual stain using these two proteins must be carried out. Nevertheless, the 
presence of cells transcribing factors associated with retinal and/or RPE precursor 
cells offers immense therapeutic value for diseases such as macular degeneration,
229
potentially facilitating the isolation of progenitor subsets capable of regenerating the 
RPE layer. Further investigations must now concentrate upon the homogeneous 
isolation of these cells and identify which chemical stimuli enable guided 
differentiation.
Figure 6.56 - Dental pulp donor 3 (Passage 
15) cultured in commercial basal media 
stained with Hoechst 33342 (blue), Oregon 
green (green) and pa\6 antibody (red). 
Approximately 30% of dental pulp cells 
exhibited positive pax6 expression.
20um
Figure 6.57 - Dental pulp donor 3 (Passage 
15) cultured in commercial basal media 
stained with MiTF antibody (red). 
Approximately 30% of dental pulp cells 
exhibited positive MiTF expression.
Intracellular protein expression profiling of dental pulp-derived populations further 
confirmed flow cytometric observations that the population contains an array of stem 
and progenitor subpopulations. The maintained expression of Oct4, Sox2, Cripto-1, 
nucleostemin and STRO-1 suggests the presence of highly plastic stem cell 
populations capable of undertaking differentiation towards numerous lineages; whilst 
alternative staining with REST, TBR2, pax6 and MiTF suggests the presence of 
neuronal progenitors, with these proteins likely to represent cells capable of 
undertaking neuronal and RPE lineage differentiation. As a whole the population 
represents an attractive source of stem and progenitor subsets, although it is required 
that each subpopulation is homogeneously isolated and assessed for their 
differentiation capacity, potentially allowing their precise application within neuronal 
and alternative regenerative strategies.
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6.4 Proliferation Capacity of Dental Pulp Cells
6.4.1 Proliferation Capacities of Dental Pulp Cells throughout Prolonged In
Vitro Culture and Freeze-thaw Cycling using CvQUANT Analysis
In order to assess the effects of in vitro culture upon dental pulp proliferation 
capacity, 0.5 x 104 cells were cultured in commercial basal conditions throughout 7 
day culture and cell numbers assessed at days 1, 3 and 7. Given the maintained 
phenotypic expression between varying donors over increasing passage demonstrated 
in 6.3.1, only dental pulp donor 1 cells were assessed.
Continuously cultured dental pulp donor 1 cells {Figure 6.58) and equivalent freeze- 
thawed populations {Figure 6.59), frozen following a third passage and thawed 
following 30 days cryopreservation at -80°C, were assessed for their proliferation 
rates at passages 4/5 through to 9. Passage 4 cells not subjected to freeze-thawing 
generated approximately 0.7 x 104, 2.7 x 104 and 3.9 x 104 cells at days 1, 3 and 7 
respectively. Interestingly, increasingly cultured populations, whether cryopreserved 
or continually cultured, maintained this rate of proliferation. Passage 5 to 9 cultures 
not exposed to cryopreservation demonstrated approximately 0.7 x 104, 2.7 x 104 and 
3.9 x 104 cells at days 1, 3 and 7 respectively, whilst freeze-thaw cultures in fact 
demonstrated slightly greater proliferation rates, with passage 5 to 9 cells generating 
approximately 0.9 x 104, 3.0 x 104 and 4.4 x 104 cells at days 1, 3 and 7 respectively. 
However, this increase is likely to be attributable to minimal differences in seeding 
density or slight modifications to culture conditions.
The ability of dental pulp-derived populations to maintain proliferation following 
prolonged in vitro culture is a significant progression towards their therapeutic 
utilisation, enabling cryopreservation of isolated cells until required for clinical 
application. Whilst no quantifiable data was acquired for late passage cultures, no 
qualitative reduction was observed in proliferative capacity within cells cultured up 
to 40 passages, and it is likely that such populations will continue to proliferate to the 
Hayflicks limit of 70 passages395. Furthermore, whilst CyQUANT analysis was not 
utilised to assess cells isolated from different donors, since these cells displayed a 
comparable ability to maintain phenotype, and similar proliferation rates from a
231
qualitative perspective, it is hypothesised that they also displayed this capacity to 
maintain proliferation post prolonged in vitro culture and freeze-thawing.
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6.5 Telomere Length Assessment of Dental Pulp Cells
6.5.1 Telomere Length Regulation of Dental Pulp-derived Cells throughout
Prolonged In Vitro Culture using DAKO Telomere Length Analysis
Reduced proliferation rates observed in bone marrow-derived populations are likely 
to be attributable to rapid aging of the population when cultured in vitro, a hypothesis 
substantiated by the hastily degrading telomeres observed in 3.4.1. However, given 
the sustained phenotypic and proliferative capacities of dental pulp populations 
following prolonged in vitro culture, it was hypothesised that the population did not 
age in the same manner as their bone marrow counterparts when cultured ex vivo, 
with cells instead displaying in vivo TTAGG base reductions. Alternatively, it was 
considered, given the observed expression of telomerase and subsequent telomere 
maintenance within ES cells, that these phenotypically immature dental pulp cells 
may in fact sustain telomere lengths in vitro via telomerase activity.
Dental pulp donor 1 cells cultured in commercially available basal media were 
therefore assessed for their telomere lengths at passages 4 through to 9 {Figure 6.60), 
and unlike bone marrow-derived cells, did not exhibit rapid reductions in telomere 
length. Instead, cells displayed a stable X chromosome telomere length, with an 
average base length of 13190, 13234, 13189, 13155, 13154 and 13208 at passages 4 
to 9 accordingly. However, given the limitations of the assay, it is difficult to confirm 
with certainty whether cells are in fact maintaining telomere lengths or aging at a 
comparable in vivo rate. However, results do confirm that in vitro culture infers 
minimal impact upon telomere lengths and subsequent aging of these cells, although 
it must be noted that the assay incorporates a heterogeneous population and 
subsequently generates an average X chromosome telomere length for the global 
population. Thus whilst many cells, presumably of a more committed phenotype, 
may in fact be demonstrating reducing telomere lengths, alternative telomerase- 
expressing members of the population, presumably more primitive cells, may be 
maintaining telomere lengths. Thus further studies must ascertain whether telomerase 
is expressed within the population.
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6.6 CFU Analysis of Dental Pulp Cells
6.6.1 CFU-Fibroblast Analysis of Dental Pulp-derived Cells
Given the surface and intracellular protein expression profiling of dental pulp 
populations derived from varying donors, it was hypothesised that the population 
contained progenitors capable of multilineage differentiation and subsequently CFU- 
F formation. Therefore 0.5 x 104 passage 4, 6 and 9 cells derived from donors 1-4 
were cultured in conditions known to accommodate CFU-F formation within a 
35mm2 culture dish. Following 7 days of culture, distinct colonies were apparent 
{Figures 6.61 and 6.62); seeded cells from each donor at varying passage generated 
similar average numbers of CFU-Fs {Figure 6.63). Passage 4 populations generated 
24.8, 21.3, 23.5 and 19.5 average CFU-F formations for donors 1, 2, 3 and 4 
respectively. Passage 6 populations from donors 1-4 generated similar average 
CFU-F numbers, producing 18.5, 20.0, 24.0 and 22.3 colonies per 35mm2 culture 
dish following 7 days of culture. Passage 9-derived populations from donors 1-4 
produced CFU-Fs following 7 days of culture, with an average of 28.9, 17.5, 22.0 
and 25.5 colonies generated for each respectively.
Results obtained from CFU-F investigations of pulp donor 1-4 populations revealed 
a comparable number of CFU-F fonnations per 0.5 x 104 cells seeded, whilst 
furthermore maintaining this capacity despite prolonged passage. Interestingly, 
whilst dental pulp-derived populations displayed relatively low expression of MSC- 
associated antigens compared with bone marrow-derived cells, they exhibited an 
innate ability to generate large numbers CFU-Fs, suggesting that CD90 and 
alternative MSC-associated antigen expressing cells are not necessarily stem or 
progenitor subsets. In conclusion, dental pulp populations, as surface and 
intracellular expression profiles would suggest, contain a concentrated number of 
subpopulations demonstrating CFU-F capacity associated with stem and progenitor 
subsets, and thereby represent a cell source with significant clinical potential. Should 
homogeneous isolation of each subpopulation eventually be achieved, the CFU-F 
assay may represent an attractive technique for assessing multipotent prospects of 
each respectively isolated population.
237
N
um
be
r o
f C
FU
s/
0.
5 
x 1
04
 c
el
ls
Figure 6.61 - CFU-F formation from dental Figure 6.62 - CFU-F formation from dental
pulp donor 1 (Passage 4; 0 x Freeze-thaw) pulp donor 1 (Passage 9; 0 x Freeze-thaw)
cultured for 7 days in MethoCult media. cultured for 7 days in MethoCult media.
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Figure 6.63 - CFU-F formation per 0.5 x 104 cells isolated from human dental pulp donors 1 - 4 
(0 x Freeze-thaw) at passages 4, 6 and 9 and cultured for 7 days in MethoCult media. Values 
represent mean number of cells observed per 35mm2 culture dish for each donor (n = 4). Error 
bars correspond to Standard Deviations.
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6.6.2 CFU-Graiiulocvte/Monocvte Analysis of Dental Pulp-derived Cells
Given expression of HSC-associated antigens CD34 class II and III within all dental 
pulp populations, 0.5 x 104 cells from donors 1-4 were cultured in conditions known 
to induce CFU-GM formation within 35mm2 culture plates. Following 7 days of 
culture, distinct colonies were observed {Figures 6.64 and 6.65). Passage 4 seeded 
populations exhibited 5.0, 6.5, 6.8 and 5.5 average CFU-GM formations respectively, 
passage 6 cells 5.3, 7.8, 5.3 and 7.0 and passage 9 cells 8.8, 4.3, 5.5 and 7.5 {Figure 
6.66). The capacity of maintained cells to generate CFU-GMs following stimulation 
would indicate a subpopulation of cells representing hematopoietic progenitors. 
Given their respective properties, this population is likely to possess a capability to 
generate mature blood cells, thereby offering immense clinical benefit. Whilst it is 
unknown which cell type within the population is capable of generating such 
colonies, CD34+ populations are the most likely given the expression of this antigen 
in HSC populations. However, given the hypothesised plasticity of the population 
and the demonstratable expression of plasticity regulators such as Oct4 and Sox2, it 
could be that these cells, following to appropriate stimulation, differentiate towards 
hematopoietic progenitor cells and subsequently generate a proportion of observed 
colonies. Thus the homogeneous isolation and CFU-GM assessment of each 
subpopulation within human dental pulp must be undertaken.
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Figure 6.64 - CFU-GM formation from dental Figure 6.65 - CFU-GM formation from dental 
pulp donor 1 (Passage 4; 0 x Freeze-thaw) pulp donor 1 (Passage 9; 0 x Freeze-thaw) 
cultured for 7 days in MethoCult media. cultured for 7 days in MethoCult media.
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Figure 6.66 - CFU-GM formation per 0.5 x 104 cells isolated from human dental pulp donors 1 - 
4 (0 x Freeze-thaw) at passages 4, 6 and 9 and cultured for 7 days in MethoCult media. Values 
represent mean number of cells observed per 35mm2 culture dish for each donor (n = 4). Error 
bars correspond to Standard Deviations.
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6.7 Differentiation of Dental Pulp Cells
6.7.1 Assessment of Pluripotential Ability of Dental Pulp-derived Cells
throughout Increasing Passage In Vitro
Following the demonstration of maintained expression of factors attributable to the 
regulation of plasticity, whilst furthermore signifying an ability to generate CFU-Fs 
and CFU-GMs, dental pulp cells were investigated for their ability to differente 
towards numerous lineages. Cells of varying passage from donors 1-4 were 
therefore induced with commercially available media and chemically-defined, 
serum-free alternatives to assess their ability to differentiate.
6.7.2 Adipogenic Differentiation of Pulp-derived Cells using Commercially
Available Media
Dental pulp cells were cultured in pre-adipocyte growth media at a seeding density of 
3 x 103 cells per well of a 24 well plate for the initial 10 days of culture, followed by 
exposure to pre-adipocyte differentiation media for 3 days and maintained in 
adipocyte nutrition media for a further 15 days. Following 7 days of culture, 
approximately 60% of cells expressed the in vivo circulating protein adiponectin. 
Expression was localised to the cytoplasm {Figure 6.67), although following culture 
in pre-adipocyte differentiation media followed by nutrition media, expression was 
also detected within the nucleus after 21 days {Figure 6.68). It is particularly 
interesting that adiponectin was expressed after 7 days, since previous reports have 
attributed adiponectin expression exclusively to mature adipocytes317, although Oil 
Red O staining failed to identify lipid formation within the population at this stage of 
induction. It may therefore be interesting to examine the levels of 
phosphatidylinositol-3-kinase within adipogenically induced dental pulp cells, since 
adiponectin secretion is blocked by pharmacological inhibitors of this kinase.
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Figure 6.67 - Dental pulp donor 3 cells 
(Passage 10) cultured in commercial pre­
adipocyte growth media for 7 days stained 
with Hoechst 33258 (blue), Oregon green 
(green) and adiponectin antibody (red). 
Approximately 60% of dental pulp cells 
exhibited positive adiponectin expression.
Figure 6.68 - Dental pulp donor 3 cells 
(Passage 10) cultured in commercial pre­
adipocyte growth media for 10 days, 3 days in 
pre-adipocyte differentiation media and 8 
days in adipocyte nutrition media stained 
with Hoechst 33258 (blue), Oregon green 
(green) and adiponectin antibody (red). 
Approximately 60% of dental pulp cells 
exhibited positive adiponectin expression.
Leptin functions as a key regulator of overall body weight via the inhibition of food 
intake and stimulation of energy expenditure. Following 14 days of adipogenic 
culture, approximately 60% of cells demonstrated cytoplasmic expression of Leptin 
{Figure 6.69) and maintained this expression throughout the remainder of the 28 day 
culture. CHOP is a stress induction protein responsible for inhibition of adipogenesis, 
and was observed within approximately 70% of the population during the initial 7 
days of adipogenic culture {Figure 6.70), after which the distinct nuclear expression 
was no longer detected. Down-regulation of CHOP allows the expression of 
adipocyte specific proteins such as adiponectin and leptin, and other proteins such as 
PPAR gamma 2 and perilipin, which exhibited cytoplasmic expression within 
approximately 60% of dental pulp cells following 14 days of adipogenic culture. 
Regulation of these proteins allow phenotypic and morphological modifications 
towards a mature adipocyte, with lipid droplets being readily observable within 
approximately 60% of differentiated dental pulp cells following 28 days culture 
{Figures 6.71 and 6.72). However, it must be noted that dental pulp cells do not 
homogeneously differentiate into mature adipocytes, with many cells failing to adopt 
lipid vacuoles typical of the adipogenic phenotype. Whilst conceivably these cells
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could still be undertaking differentiation, and with further adipogenic induction 
would develop such morphological features, it is hypothesised that the non-lipid 
producing cells may be progenitors of alternative lineages, and are therefore unable 
to undertake adipogenic differentiation. Nevertheless, the ability of dental pulp cells 
from donors 1 - 4 to undertake adipogenic differentiation highlights these cells as a 
potential cell source for clinical treatment following trauma or invasive surgery. 
Furthermore, their ability to differentiate despite prolonged in vitro culture or freeze- 
thaw cycling increases their potential within the field of fat regeneration.
Figure 6.69 - Dental pulp donor 2 cells 
(Passage 30) cultured in commercial pre­
adipocyte growth media for 10 days, 3 days in 
pre-adipocyte differentiation media and 1 
day in adipocyte nutrition media stained with 
Hoechst 33258 (blue), Oregon green (green) 
and leptin antibody (red). Approximately 
60% of dental pulp cells exhibited positive 
leptin expression.
Figure 6.70 - Dental pulp donor 1 cells 
(Passage 5) cultured in commercial pre­
adipocyte growth media for 7 days stained 
with Hoechst 33258 (blue), Oregon green 
(green) and CHOP antibody (red). 
Approximately 70% of dental pulp cells 
exhibited positive CHOP expression during 
the initial 7 days of culture within adipogenic 
inducting medium, after which no expression 
was observed.
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Figure 6.71 - Dental pulp donor 4 cells 
(Passage 30) cultured in commercial pre­
adipocyte growth media for 10 days, 3 days in 
pre-adipocyte differentiation media and 15 
days in adipocyte nutrition media stained 
with Oil Red O (Red) and counterstained 
with Gill's number 1 Hematoxylin (Blue). 
Approximately 60% of dental pulp cells 
exhibited positive Oil Red O staining.
Figure 6.72 - Dental pulp donor 2 cells 
(Passage 15) cultured in commercial pre­
adipocyte growth media for 10 days, 3 days 
in pre-adipocyte differentiation media and 
15 days in adipocyte nutrition media stained 
with Oil Red O (Red) and counterstained 
with Gill's number 1 Hematoxylin (Blue). 
Approximately 60% of dental pulp cells 
exhibited positive Oil Red O staining.
6.7.3 Adipogenic Differentiation of Pulp-derived Cells using Chemically-
defined Media
Whilst dental pulp-derived cells demonstrated the ability to differentiate towards an 
adipogenic lineage when stimulated with commercially available media, the use of 
serum-containing media may generate concern when used to a clinical setting. 
Therefore dental pulp cells were differentiated using chemically-defined adipogenic 
induction media. 3 x 103 dental pulp cells per well of a 24 well plate were cultured in 
chemically-defined media and assessed for their adipogenic associated phenotype as 
above. As with cells cultured in commercial media, adiponectin expression was 
detected following 7 days of culture. However, protein expression was both 
cytoplasmic and nuclear localised, perhaps suggesting an increased commitment 
towards an adipogenic phenotype. Leptin {Figure 6.73), PPAR gamma 2 {Figure 
6.74) and perilipin were expressed in approximately 60% of the population after 14 
days of culture, following the down-regulation of CHOP, which exhibited nuclear 
localised expression within approximately 70% of cells for the initial 7 days of 
adipogenic culture {Figure 6.75). Whilst upregulation of these adipogenic proteins 
coincided with those observed following differentiation in adipogenic commercial
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media, lipid droplets were fonned within approximately 60% of cells after 21 days 
{Figure 6.76), as opposed to commercial induction in which they were observed after 
28 days.
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Figure 6.73 - Dental pulp donor 1 cells 
(Passage 4) cultured in chemically-defined 
adipogenic differentiation media for 14 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and leptin antibody (red). 
Approximately 60% of dental pulp cells 
exhibited positive leptin expression.
Figure 6.75 - Dental pulp donor 1 cells 
(Passage 5) cultured in chemically-defined 
adipogenic differentiation media for 7 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and CHOP antibody (red). 
Approximately 70% of dental pulp cells 
exhibited positive CHOP expression during 
the initial 7 days of culture within adipogenic 
inducting medium, after which no expression 
was observed.
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Figure 6.74 - Dental pulp donor 1 cells 
(Passage 4) cultured in chemically-defined 
adipogenic differentiation media for 14 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and PPAR gamma 2 antibody 
(red). Approximately 60% of dental pulp 
cells exhibited positive PPAR gamma 2 
expression.
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Figure 6.76 - Dental pulp donor 4 cells 
(Passage 30) cultured in chemically-defined 
adipogenic differentiation media for 21 days 
stained with Oil Red O (Red) and 
counterstained with Gill’s number 1 
Hematoxylin (Blue). Approximately 60% of 
dental pulp cells exhibited positive Oil Red 
O staining.
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6.7.4 Chondrogenic Differentiation of Pulp-derived Cells using Commercially
Available Media
Dental pulp cells were seeded at a concentration of 3 x 10 ’ cells per well of a 24 well 
plate and induced with the TGF-pi containing chondrogenic differentiation media. 
Approximately 90% of induced cells expressed collagen I throughout the initial 5 
days of culture after which point it no longer transcribed {Figure 6.77). Aggrecan, a 
proteoglycan whose cleavage has been associated with numerous diseases including 
rheumatoid arthritis and osteoarthritis, was expressed in approximately 70% of cells 
following 14 days of chondrogenic culture {Figure 6.78). Previous investigations 
mechanistically examining the events during chondrogenic differentiation noted that 
synthesis of aggrecan and versican core protein signalled an intermediate stage of 
chondrogenesis, which also involved the small leucine-rich proteoglycans decorin 
and biglycan. The study also detailed that following aggrecan synthesis, collagen II 
was synthesised, an event mirrored in approximately 90% of the differentiating 
dental pulp cells {Figure 6.79). Furthermore, Collagen X was also detected within 
approximately 30% of cells following 21 days of differentiation, a protein largely 
associated with hypertrophic cartilage326 {Figure 6.80). Differentiating 
subpopulations of cells exhibited morphological features associated with 
chondrocytes after 28 days {Figures 6.81 and 6.82), and chondrogenic differentiation 
was further confirmed using Alcian blue to identify the presence of 
glycosaminoglycans within approximately 60% of the population {Figure 6.83). Van 
Geison staining further confinned the presence of collagens in approximately 90% of 
cells following 28 days of differentiation {Figure 6.84).
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Figure 6.77 - Dental pulp donor 1 cells 
(Passage 10) cultured in commercial 
chondrogenic media for 28 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and collagen I antibody (red). Approximately 
90% of dental pulp cells exhibited positive 
collagen I expression during the initial 5 days 
of chondrogenic culture, after which no 
expression was observed.
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Figure 6.78 - Dental pulp donor 1 cells 
(Passage 10) cultured in commercial 
chondrogenic media for 14 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and aggrecan antibody (red). Approximately 
70% of dental pulp cells exhibited positive 
aggrecan expression.
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Figure 6.79 - Dental pulp donor 1 cells 
(Passage 10) cultured in commercial 
chondrogenic media for 21 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and collagen 11 antibody (red). 
Approximately 90% of dental pulp cells 
exhibited positive collagen II expression.
Figure 6.80 - Dental pulp donor 3 cells 
(Passage 3) cultured in commercial 
chondrogenic media for 21 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and collagen X antibody (red). 
Approximately 30% of dental pulp cells 
exhibited positive collagen X expression.
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Figure 6.81 - Dental pulp donor 4 cells 
(Passage 15) cultured in commercially 
available chondrogenic differentiation media 
for 21 days.
Figure 6.82 - Dental pulp donor 4 cells 
(Passage 30) cultured in commercially 
available chondrogenic differentiation 
media for 21 days.
Figure 6.83 - Dental pulp donor 1 cells 
(Passage 10) cultured in commercial 
chondrogenic differentiation media for 28 
days stained with Alcian blue (Blue) and 
counterstained with Nuclear fast red (Pink). 
Approximately 60% of dental pulp cells 
exhibited positive Alcian blue staining.
Figure 6.84 - Dental pulp donor 1 cells 
(Passage 30) cultured in commercial 
chondrogenic differentiation media for 28 
days stained with Van Geison (Red) and 
counterstained with Celestine blue (Black). 
Approximately 90% of dental pulp cells 
exhibited positive Van Geison staining.
6.7.5 Chondrogenic Differentiation of Pulp-derived Cells using Chemically-
defined Media
In order to further findings describing the chondrogenic lineage potential of dental 
pulp populations, cells were cultured in chemically-defined chondrogenic media at a 
concentration of 3 x 103 cells per well of a 24 well plate. Cells again committed 
towards the progressive pathways of chondrogenesis observed using commercial 
media, though based upon aggrecan production, at an enhanced rate. Collagen I, 
previously expressed by approximately 90% of cells, ceased production following 3
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days of culture {Figure 6.85), which coincided with the production of aggrecan in 
approximately 75% of cells {Figure 6.86), a protein which was synthesised following 
14 days culture in commercial chondrogenic differentiation media.
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Figure 6.85 - Dental pulp donor 3 cells 
(Passage 3) cultured in chemically-defined 
chondrogenic media for 3 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and collagen I antibody (red). Approximately 
90% of dental pulp cells exhibited positive 
collagen I expression during the initial 3 days 
of chondrogenic culture, after which no 
expression was observed.
Figure 6.86 - Dental pulp donor 3 cells 
(Passage 20) cultured in chemically-defined 
chondrogenic media for 3 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and aggrecan antibody (red). Approximately 
75% of dental pulp cells exhibited positive 
aggrecan expression.
Following 21 days of culture collagen II production was identified within 
approximately 90% of cells, in addition to collagen X, which was expressed by 
approximately 30% of the population. Differentiating cells appeared morphologically 
similar to mature chondrocytes following 21 days culture {Figures 6.87 and 6.88), 
and glycosaminoglycan production in approximately 50% of cells was confirmed 
using Alcian blue staining {Figures 6.89 and 6.90), thereby suggesting that 
chondrogenesis in dental pulp-derived cells is more rapid when induced with 
chemically-defined media.
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Figure 6.87 - Dental pulp donor 2 cells 
(Passage 10) cultured in chemically-defined 
chondrogenic differentiation media for 21 
days.
Figure 6.89 - Dental pulp donor 4 cells 
(Passage 20) cultured in chemically-defined 
chondrogenic differentiation media for 21 
days stained with Alcian blue (Blue) and 
counterstained with Nuclear fast red (Pink). 
Approximately 50% of dental pulp cells 
exhibited positive Alcian blue staining.
Figure 6.88 - Dental pulp donor 3 cells 
(Passage 30) cultured in chemically-defined 
chondrogenic differentiation media for 21 
days.
Figure 6.90 - Dental pulp donor 4 cells 
(Passage 20) cultured in chemically-defined 
chondrogenic differentiation media for 21 
days stained with Alcian blue (Blue) and 
counterstained with Nuclear fast red (Pink). 
Approximately 50% of dental pulp cells 
exhibited positive Alcian blue staining.
However, whilst subpopulations of cells clearly demonstrated the ability to undertake 
chondrogenesis, the heterogeneous manner in which the population differentiated 
was clearly observed. Figures 6.87 and 6.88 illustrate the round morphology 
associated with chondrocytes, although morphologically dissimilar cells appear 
within the population. Whilst it could be argued that topographical stress impacts 
significantly on the morphology. Figures 6.89 and 6.90 clearly demonstrate that 
many cells were not generating glycosaminoglycans.
250
6.7.6 Osteogenic Differentiation of Pulp-derived Cells using Commercially
Available Media
To investigate the ability of dental pulp-derived cells to differentiate towards an 
osteogenic lineage, 3 x 101 cells per well of a 24 well plate were induced with 
commercially available osteogenic media. The adipogenic repressor/osteogenic 
inducer CHOP was initially observed following 7 days of induction within 
approximately 80% of the population {Figure 6.91), allowing the synthesis of nuclear 
localised CBFA-1 within approximately 80% of the population following 14 days of 
culture {Figure 6.92). CBFA-1 production co-localised with the synthesis of 
Osteocalcin. Interestingly, the hypertrophic cartilage associated protein Collagen X 
was observed within approximately 40% of cells following 21 days of culture. 
Finally, Von Kossa staining confirmed the calcification of the extracellular matrix, a 
key function of osteogenic cells, within approximately 75% of cells following 28 
days differentiation {Figure 6.93).
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Figure 6.91 - Dental pulp donor 1 cells 
(Passage 30) cultured in commercial 
osteogenic media for 7 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and CHOP antibody (red). Approximately 
80% of dental pulp cells exhibited positive 
CHOP expression.
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Figure 6.92 - Dental pulp donor 3 cells 
(Passage 10) cultured in commercial 
osteogenic media for 14 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and CBFA-1 antibody (red). Approximately 
80% of dental pulp cells exhibited positive 
CBFA-1 expression.
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Figure 6.93 - Dental pulp donor 1 cells (Passage 20) cultured in commercial osteogenic media 
for 28 days stained with Von Kossa (Dark brown) and counterstained with Harris’ 
Hematoxylin. Approximately 75% of dental pulp cells exhibited positive Von Kossa staining.
6.7.7 Osteogenic Differentiation of Pulp-derived Cells using Chemically-
defined Media
Following the demonstration of dental pulp-derived cells differentiating towards an 
osteogenic phenotype following commercially available chemical induction, cells 
were cultured in a chemically-defined osteogenic differentiation alternative. 
Osteogenic master regulator CHOP protein was expressed in approximately 90% ot 
the population following 7 days of culture {Figure 6.94), allowing the expression of 
CBFA-1 {Figure 6.95) and Osteocalcin {Figure 6.96) in approximately 80% of cells 
after 14 days. Collagen X was expressed in 50% of cells following 14 days of 
differentiation {Figure 6.97). Cells demonstrated morphological characteristics 
associated with osteoblasts {Figures 6.98 and 6.99), and calcification ot the 
extracellular matrix was observed in approximately 75% of cells following 21 days 
of culture.
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Figure 6.94 - Dental pulp donor 1 cells 
(Passage 28) cultured in chemically-defined 
osteogenic media for 7 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and CHOP antibody (red). Approximately 
90% of dental pulp cells exhibited positive 
CHOP expression.
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Figure 6.95 - Dental pulp donor 2 cells 
(Passage 10) cultured in chemically-defined 
osteogenic media for 14 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and CBFA-1 antibody (red). Approximately 
80% of dental pulp cells exhibited positive 
CBFA-1 expression.
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Figure 6.96 - Dental pulp donor 1 cells 
(Passage 3) cultured in chemically-defined 
osteogenic media for 14 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and osteocalcin antibody (red). 
Approximately 80% of dental pulp cells 
exhibited positive osteocalcin expression.
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Figure 6.97 - Dental pulp donor 1 cells 
(Passage 3) cultured in chemically-defined 
osteogenic media for 14 days stained with 
Hoechst 33258 (blue), Oregon green (green) 
and collagen X antibody (red). 
Approximately 50% of dental pulp cells 
exhibited positive collagen X expression.
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Figure 6.98 - Dental pulp donor 2 cells Figure 6.99 - Dental pulp donor 3 cells 
(Passage 10) cultured in chemically-defined (Passage 30) cultured in chemically-defined 
osteogenic differentiation media for 21 days. osteogenic differentiation media for 21 days.
6.7.8 Neural Differentiation of Pulp-derived Cells using Commercially
Available media
To establish the ability of cells within the dental pulp population to commit towards 
a neuronal lineage, 1% retinoic acid was added to basal culture media. 3 x 103 cells 
were cultured per well of a 24 well plate and exhibited morphological modifications 
towards the neuronal phenotype after 3 days. Phenotypically, approximately 80% of 
cells demonstrated production of beta-III-tubulin following 5 days of culture and 
maintained expression for the remainder of the 28 day culture period (Figure 6.100), 
whilst thick and thin axon regulatory protein neurofilament was expressed in the 
nucleus of approximately 90% of cells following 21 days of culture {Figure 6.101). 
NGF functions within the survival and proliferation of neurons whilst furthermore 
regulating the formation of neurite projections, and was expressed in approximately 
80% of the neuronally induced population post 7 days of culture {Figure 6.102). The 
NGF receptor p75 was expressed cytoplasmically within approximately 20% of the 
population following 21 days of culture {Figure 6.103), potentially regulating 
neuronal growth, migration, differentiation and apoptosis. However, whilst p75 is 
predominantly expressed by Schwann cells and neurons, this protein has also been 
detected in non-neuronal tissues, most notably within murine MSCs, and thus 
expression of this protein is not necessarily an indicator of the neuronal phenotype.
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Tachykinin neuropeptide substance P is hypothesised to function as a transmitter of 
pain signals to the CNS in vivo, although has also been proposed to play roles in 
cellular growth in vitro. It is interesting, therefore, that approximately 70% of 
neuronal ly differentiated cells exhibited substance P expression following 21 days of 
culture {Figure 6.104), maintaining this expression until day 28.
Synaptic vesicle protein 2, a membrane glycoprotein expressed within the secretory 
vesicles of neuronal and endocrine cells and proposed to function as a key regulator 
of complex signalling, was expressed in approximately 60% of cells following 21 
days of differentiation {Figure 6.105), further proposing a functional aspect of the 
differentiated population. Coinciding with synaptic vesicle 2 expression, 
synaptophysin, a synaptic vesicle protein present within almost all neurons in the 
brain, spinal cord and retina, was expressed within approximately 80% of the 
population following 21 days {Figure 6.106). Whilst the function of synaptophysin is 
not clearly understood, it is proposed to function through regulation of activity- 
dependent synapse formation. Of significant interest would now be to undertake dual 
staining with synaptophysin and synaptic vesicle protein 2 to ascertain whether such 
vesicles are in fact accommodating the neurotransmitter synaptophysin.
Interestingly, in addition to apparent neuronal differentiation, approximately 10% of 
cells demonstrated expression of the class III intermediate filament protein GFAP 
{Figure 6.107). GFAP is highly expressed in non-myelinating Schwann cells and 
functions to synthesise networks alleviating support and strength to neuronal cell 
axons.
Referring back to neuronal cells, morphological modifications observed following 14 
days of culture {Figures 6.108 to 6.109) also indicated that neuronal differentiation 
had occurred.
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Figure 6.100 - Dental pulp donor 3 cells 
(Passage 30) cultured in commercially 
available neural differentiation media for 21 
days stained with Hoechst 33258 (blue), 
Oregon green (green) and beta-Ill-tubulin 
antibody (red). Approximately 80% of dental 
pulp cells exhibited positive beta-III-tubulin 
expression.
Figure 6.101 - Dental pulp donor 3 cells 
(Passage 8) cultured in commercially 
available neural differentiation media for 21 
days stained with Hoechst 33258 (blue), 
Oregon green (green) and neurofilament 
antibody (red). Approximately 90% of 
dental pulp cells exhibited positive 
neurofilament expression.
Figure 6.102 - Dental pulp donor 3 cells 
(Passage 8) cultured in commercially 
available neural differentiation media for 7 
days stained with Hoechst 33258 (blue) and 
NGF antibody (green). Approximately 80% 
of dental pulp cells exhibited positive NGF 
expression.
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Figure 6.103 - Dental pulp donor 3 cells 
(Passage 8) cultured in commercially 
available neural differentiation media for 21 
days stained with Hoechst 33258 (blue), 
Oregon green (green) and p75 antibody 
(red). Approximately 20% of dental pulp 
cells exhibited positive p75 expression.
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Figure 6.104 - Dental pulp donor 1 cells 
(Passage 30) cultured in commercially 
available neural differentiation media for 21 
days stained with Hoechst 33258 (blue), 
Oregon green (green) and substance P 
antibody (red). Approximately 70% of dental 
pulp cells exhibited positive substance 
expression.
Figure 6.105 - Dental pulp donor 3 cells 
(Passage 3) cultured in commercially 
available neural differentiation media for 21 
days stained with Hoechst 33258 (blue), 
Oregon green (green) and synaptic vesicle 
protein 2 antibody (red). Approximately 60% 
of dental pulp cells exhibited positive synaptic 
vesicle 2 expression.
Figure 6.106 - Dental pulp donor 3 cells 
(Passage 8) cultured in commercially 
available neural differentiation media for 21 
days stained with Hoechst 33258 (blue) and 
synaptophysin antibody (green).
Approximately 80% of dental pulp cells 
exhibited positive synaptophysin expression.
Figure 6.107 - Dental pulp donor 3 cells 
(Passage 8) cultured in commercially 
available neural differentiation media for 21 
days stained with Hoechst 33258 (blue) and 
GFAP antibody (green). Approximately 10% 
of dental pulp cells exhibited positive GFAP 
expression.
257
Figure 6.108 - Dental pulp donor 3 cells 
(Passage 30) cultured in commercially 
available differentiation media for 14 days.
Figure 6.109 - Dental pulp donor 4 cells 
(Passage 30) cultured in commercially 
available differentiation media for 14 days.
6.7.9 Neural Differentiation of Pulp-derived Cells using Chemically-defined
Media
Given the capability of dental pulp-derived populations to undertake neuronal 
differentiation following exposure to retinoic acid, 3 x 101 cells from varying donor 
and passage were cultured in a chemically-defined, serum-free alternative. Neuronal 
developmental protein beta-III-tubulin was expressed in approximately 80% of the 
population following 5 days of neuronal culture and expression was maintained 
throughout the 28 day period {Figure 6.110), comparable with the nuclear-specific 
expression of axon development regulator neurofilament {Figure 6.111). Neuronal 
reparative protein NGF was expressed in approximately 70% of neuronally induced 
cells following 21 days {Figure 6.112), whilst it’s receptor p75 was expressed in 
approximately 20% of the {Figure 6.113).
Proposed pain transmission protein substance P was expressed in approximately 70% 
of the population following 21 days of culture {Figure 6.114) and was maintained 
until day 28. Functionality of the cells was further confirmed by the presence of 
synaptic vesicle 2 protein in approximately 60% of cells {Figure 6.115), with its 
hypothesised resident protein synaptophysin expressed by approximately 80% of the 
population {Figure 6.116).
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Consistent with commercially-induced neuronal differentiation, chemically-defined 
stimulus conferred subpopulations comprising approximately 10% of the total 
population to express the Schwann cell-associated protein GFAP {Figure 6.117) 
following 21 days of differentiation.
Referring to cells expressing neuronal-associated proteins, numerous subpopulations 
displayed morphological features associated with a neuronal phenotype, procuring an 
elongated morphology with axon-like projections {Figures 6.118 and 6.119).
Figure 6.110 - Dental pulp donor 3 cells 
(Passage 8) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and beta-III-tubulin antibody 
(red). Approximately 80% of dental pulp 
cells exhibited positive beta-III-tubulin 
expression.
Figure 6.111 - Dental pulp donor 2 cells 
(Passage 10) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and neurofilament antiobody 
(red). Approximately 80% of dental pulp 
cells exhibited positive neurofilament 
expression.
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■Figure 6.112 - Dental pulp donor 2 cells 
(Passage 8) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue) and NGF 
antibody (red). Approximately 70% of 
dental pulp cells exhibited positive NGF 
expression.
Figure 6.114 - Dental pulp donor 3 cells 
(Passage 30) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and substance P antibody (red). 
Approximately 70% of dental pulp cells 
exhibited positive substance P expression.
Figure 6.113 - Dental pulp donor 3 cells 
(Passage 8) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and p75 antibody (red). 
Approximately 20% of dental pulp cells 
exhibited positive p75 expression.
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Figure 6.115 - Dental pulp donor 4 cells 
(Passage 15) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and synaptic vesicle protein 2 
antibody (red). Approximately 60% of dental 
pulp cells exhibited positive synaptic vesicle 
protein 2 expression.
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Figure 6.116 - Dental pulp donor 3 cells 
(Passage 30) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and synaptophysin antibody 
(red). Approximately 80% of dental pulp 
cells exhibited positive synaptophysin 
expression.
Figure 6.118 - Dental pulp donor 2 cells 
(Passage 10) cultured in chemically-defined 
differentiation media for 14 days.
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Figure 6.117 - Dental pulp donor 1 cells 
(Passage 5) cultured in chemically-defined 
neural differentiation media for 21 days 
stained with Hoechst 33258 (blue) and GFAP 
antibody (red). Approximately 10% of dental 
pulp cells exhibited positive GFAP 
expression.
Figure 6.119 - Dental pulp donor 4 cells 
(Passage 23) cultured in chemically-defined 
differentiation media for 14 days.
6.7.10 Hepatic Differentiation of Pulp-derived Cells using Chemically-defined
Media
Whilst the ability to undertake neuronal differentiation after appropriate stimulation 
would suggest plasticity within the dental pulp population, the relative simplicity of 
neuronal lineage progression may in fact be due to the presence of neuronal 
progenitors predisposed to the niche following development of the neural crest. 
However, given the expression profiling of the population, in particular the
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expression of plasticity maintaining proteins such as Oct4 and Sox2, it was 
hypothesised that the dental pulp contained a primitive population capable of multi- 
if not pluri- potent differentiation. Therefore, to definitively demonstrate an ability to 
differentiate towards lineages not associated with the neural crest, pulp-derived 
populations were induced with chemically-defined hepatic differentiation media.
3 x 103 cells were cultured in hepatic chemically-defined differentiation media for 21 
days. In this instance, culture media removed at days 1, 3, 5, 7, 14 and 21 was 
retained for ELISA assaying. The major secretory product of hepatic cells in vivo is 
serum albumin, and cells cultured in hepatic differentiation media secreted increased 
levels of serum albumin into the culture media compared with basal cultures, whose 
aspirate were also assessed, over the 21 culture period. {Figure 6.120). Furthermore, 
expression of serum albumin in approximately 70% of hepatically induced cells was 
observed by immunohistochemistry following 21 days of culture (Figures 6.121 and 
6.122).
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Figure 6.120 - ELISA quantification of human serum albumin concentration in culture media 
aspirated from human dental pulp donor 1 cells (Passage 8; 0 x Freeze-thaw cycles) maintained 
in chemically-defined basal and hepatic conditions. Values represent mean concentrations (n = 
4) of serum albumin in each basal and hepatic cultures. Error bars correspond to Standard 
Deviations. Student Mest indicated that increased serum albmin concentrations observed in 
hepatic cultures were significant compared with basal cultures (*=p<0.001).
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Figure 6.121 - Dental pulp donor 1 cells 
(Passage 8) cultured in chemically-defined 
hepatic differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and serum albumin antibody 
(red). Approximately 70% of dental pulp 
cells exhibited positive serum albumin 
expression.
Figure 6.122 - Dental pulp donor 2 cells 
(Passage 20) cultured in chemically-defined 
hepatic differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and serum albumin antibody 
(red). Approximately 70% of dental pulp 
cells exhibited positive serum albumin 
expression.
Approximately 70% of hepatically induced dental pulp populations also expressed 
the fetal liver developmental-associated a-fetoprotein {Figure 6.123), which is 
hypothesised to function in a similar manner to serum albumin within the developing 
fetus. In vivo a-fetoprotein expression gradually reduces post-natally, although 
limited expression is maintained within the adult human.
In conclusion chemically-defined hepatic induction of dental pulp-derived 
populations infers a morphological {Figure 6.124) and functional hepatic phenotype 
in subpopulations of the culture. Furthermore, the expression of a-fetoprotein 
furthers the hypothesis that a subset of dental pulp-derived cells are of a primitive 
embryonic like nature.
20um
Figure 6.123 - Dental pulp donor 2 cells 
(Passage 20) cultured in chemically-defined 
hepatic differentiation media for 21 days 
stained with Hoechst 33258 (blue), Oregon 
green (green) and a-fetoprotein antibody 
(red). Approximately 70% of dental pulp 
cells exhibited positive a-fetoprotein 
expression.
Figure 6.124 - Dental pulp donor 2 cells 
(Passage 20) cultured in chemically-defined 
hepatic differentiation media for 21 days.
6.8 Antibody-based Purification of Dental Pulp Cells
6.8.1 Purification of Dental Pulp Subpopulations based on Surface Expression
Profiling using High Sneed Cell Sorting
Whilst dental pulp-derived cell populations demonstrated a maintained proliferative 
and differentiation capacity throughout prolonged in vitro culture, heterogeneity 
within the population was readily observed. Whilst many studies dismiss the 
influence of such heterogeneity in a clinical setting, many progenitor cells are pre­
committed towards a given lineage, and may therefore spontaneously undertake 
commitment towards terminal differentiation. Considering a stem cell orientated 
approach to repair following myocardial infarction, utilisation of cells containing 
osteogenic-committed cells may result in the formation of mature osteoblasts within 
regions of the heart, with potentially fatal repercussions given their calcified 
matrices. It is therefore imperative that isolated cells intended for clinical application 
are assessed upon a homogeneous subpopulation basis as opposed to global 
population analysis. Acknowledging the impact of such progenitor subsets, dental
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pulp-derived cells were sorted based on positive expression of surface antigens and 
phenotypically assessed post-sorting.
6.8.2 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Efflux of Hoechst 33342
Hoechst stained dental pulp populations from donors 1 and 3 were sorted at passages 
8, 15 and 25. Purification of the side population (SP), which is hypothesised to 
represent a hematopoietic subpopulation of cells, is facilitated by the two binding 
modes of Hoechst 33342 which subsequently result in different spectral properties, 
allowing resolution of multiple populations via simultaneous assessment of two 
respective wavelengths. The SP was discriminated by differential efflux of the 
Hoechst dye by ABCG2, a multi-drug-like transporter pump, and a property 
characteristic of HSCs. Cells exhibiting such behaviour, which represented 
approximately 0.1% of the dental pulp population, were sorted and these HoechstDu11 
populations sorted into a separate culture vessel.
HoechstDu11 sorted populations adhered to the TC plastic surface approximately 48 
hours post-sorting and spontaneously generated colonies in the absence of 
erythropoietin stimulation {Figure 6.125). Despite purification based on a functional 
aspect associated with HSCs, colonies exhibited a heterogeneous morphology, 
containing small rounded cells, endothelial and fibroblastic-like cells, and multi- 
nuclear cells, suggesting that a number of cells actively regulate a functional ABCG2 
pump. Nevertheless, following 12 days of culture independent colonies had 
proliferated and subsequently joined residing colonies to form a confluent monolayer 
of cells.
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Figure 6.125 - Pulp donor 1 (Passage 8) cells sorted of the basis of Hoechst0'1" efflux seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
Following confluence, HoechstDul1 sorted populations were assessed by flow 
cytometry using an array of surface antigens {Figure 6.126). Furthermore, purified 
cells were seeded within a platelet-poor plasma-derived gel in order to assess their 
capability to form microvasculature, a further characteristic phenomena of HSCs. 5.0 
x 10 3 HoechstDu11 cells suspended in commercial basal media were introduced onto 
the surface of the solidified gel and initiated the formation of microtubular-like 
structures following 5 days of culture {Figures 6.127 and 6.128). Following 14 days 
of culture, previously primitive structures were now densely formed microtubular­
like vessels {Figures 6.129 to 6.134), an apparent differentiation which did not occur 
when cells were cultured on tissue culture plastic.
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Figure 6.127 - Hoechst0"11 purified dental Figure 6.128 - HoechstDu11 purified dental
pulp donor 1 cells (Passage 8) cultured for 5 pulp donor 1 cells (Passage 8) cultured for 5
days on plasma derived gel. days on plasma derived gel.
Figure 6.129 - HoechstDuM purified dental Figure 6.130 - Hoechst0"11 purified dental
pulp donor 1 cells (Passage 8) cultured for 14 pulp donor 1 cells (Passage 8) cultured for
days on plasma derived gel. 14 days on plasma derived gel.
Figure 6.131 - Hoechst0"11 purified dental Figure 6.132 - Hoechst0"11 purified dental
pulp donor 3 cells (Passage 8) cultured for 14 pulp donor 3 cells (Passage 15) cultured for
days on plasma derived gel. 14 days on plasma derived gel.
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Figure 6.133 - HoechstDu" purified dental 
pulp donor 1 cells (Passage 8) cultured for 
14 days on plasma derived gel and stained 
with fluorescent cell tracking dye.
purified dentalFigure 6.134 - Hoechst
pulp donor 1 cells (Passage 8) cultured for 14 
days on plasma derived gel and stained with 
fluorescent cell tracking dye.
Surface phenotyping of the populations revealed reduced upregulation of MSC- 
associated antigens in HoechstDul1 purified cells but demonstrated an upregulation of 
endothelial-associated antigens CD31, CD62E, CD133 and VonWillebrand factor in 
both tissue culture plastic seeded and plasma-gel cultured populations. Both classes 
of CD34 demonstrated downregulation compared with the heterogeneous phenotype, 
suggesting that not all CD344 cells represent HSCs and, furthermore, that not all 
HSCs express class of CD34. Furthermore, approximately 99% of plasma gel- 
cultured HoechstDul1 cells cytoplasmically expressed VonWillebrand factor, as 
observed by immunohistochemistry (Figure 6.135), whilst this technique also 
revealed CD31 cytoplasmic and VE-Cadherin peripheral specific expression within 
approximately 90% of cells (Figure 6.136), thereby suggesting that this population ot 
purified cells had differentiated to a mature endothelial phenotype.
However, whilst HoechstDul1 purified populations demonstrated this phenotype 
immediately following cell sorting, cells cultured to a second passage post-sorting 
demonstrated a reversion to the heterogeneous phenotype associated with unsorted 
dental pulp cells. This reversion to a heterogeneous phenotype would suggest either 
that (i) Hoechst purification failed to adequately discriminate against varying 
subpopulations, allowing the culture of contaminate cell types not containing actively 
regulating ABCG2 pumps; (ii) Dental pulp-derived populations are incapable of 
homogeneous culture and subsequently re-establish the heterogeneic niche with 
which they reside in vivo. Whatever the reason, given the inability of the population 
to maintain phenotypic stability following sorting based upon Hoechst011'1
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discrimination, a small number of cells sorted on this basis were seeded onto TC 
plastic coverslips immediately post-sorting. Following culture in commercial basal 
media for 4 hours to allow adherence, cells were fixed and analysed using 
immunohistochemistry techniques to assess protein expression profiles of a majority 
subpopulation, thereby facilitating assessment of the HoechstDul1 subpopulation 
before heterogeneity is re-established. Following rapid post-sort 
immunohistochemistry of adherent HoechstDuli cells, results demonstrated that the 
majority of adherent populations expressed the stem cell proliferation protein 
nucleostemin within their nucleus, whilst also cytoplasmically expressing the 
plasticity regulating proteins Oct4 and Sox2. Interestingly, HoechstDul1 cells did not 
express the stem cell renewal protein Cripto-1; neither did they express the ES cell- 
associated protein Tra-1-81. RPE-lineage associated proteins MiTF and pax6 were 
not expressed within the population, nor were alternative neuronal lineage-associated 
proteins nestin, rest4 and TBR2. The adherent population also failed to express the 
MSC-associated protein STRO-1 {Table 6.2 - Page 295).
Figure 6.135 - HoechstDul1 dental pulp donor 1 
cells (Passage 8) cultured for 14 days on 
plasma derived gel and stained with Hoechst 
33342 (blue) and VonWillebrand factor 
antibody (green). Approximately 99% of 
dental pulp cells exhibited positive 
VonWillebrand expression.
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Figure 6.136 - HoechstDul1 dental pulp donor 1 
cells (Passage 8) cultured for 14 days on 
plasma derived gel and stained with CD31 
(red) and VE Cadherin antibody (green). 
Approximately 90% of dental pulp cells 
exhibited positive VE Cadherin and CD31 
dual expression.
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6.8,3 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD9
CD9 antigen expression has been reported on endothelial cells and ES cells amongst 
others. Dental pulp-derived cells exhibited approximately 10% - 20% positive CD9 
expression within the population, and were purified on this basis. Cells exhibiting 
low positive expression of CD9, termed CD9Du11, were purified and seeded in 
commercial basal media. Unlike HoechstDu11 derived cells, CD9Dul1 purified 
populations did not generate colonies on the TC plastic surface, exhibiting a 
heterogeneous morphology {Figure 6.137). Furthermore, upon confluence 10 days 
post-sorting, the population exhibited the heterogeneic phenotype associated with the 
unsorted pulp population. Purified cells seeded onto TC plastic coverslips were fixed 
following adherence and assessed using immunohistochemistry for their protein 
expressions. CD9DuI1 purified cells exhibited nuclear expression of stem cell renewal 
protein Cripto-1, with plasticity maintenance protein Sox2 also exhibiting nuclear 
expression. Stem cell proliferation protein nucleostemin was also expressed within 
the nucleus, although associated plasticity regulator Oct4 was expressed 
cytoplasmically. ES cell-associated protein Tra-1-81 was furthennore expressed 
within the cytoplasm of purified populations, indicating a primitive subpopulation. 
RPE-associated protein MiTF was expressed within the nucleus, whilst the more 
primitive RPE protein pax6 was expressed within the cytoplasm. Adherent cells 
expressed alternative neuronal-lineage associated proteins, rest4 and TBR2 expressed 
cytoplasmically. Interestingly though, cells did not express the neuronal progenitor- 
associated protein nestin. MSC-associated protein STRO-1 was also expressed 
cytoplasmically within the population {Table 6.2- Page 295).
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Figure 6.137 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD9l)ul1 expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected region.
CD9Light expressing cells demonstrated populations exhibiting increased levels of 
CD9. Purified populations exhibited a heterogeneous morphology on seeding onto 
TC plastic although they did not fonn distinct colonies {Figure 6.138). Furthermore, 
upon confluence 14 days post-sorting and subsequent analysis by flow cytometry, the 
population exhibited the heterogeneous phenotype associated with dental pulp. 
Following seeding on TC plastic coverslips, CD9Llght cells demonstrated the same 
protein expression profile as that observed with CD9Du11 cells {Table 6.2 - Page 295). 
In conclusion purification of dental pulp populations based upon CD9 failed to 
homogeneously purify populations, allowing contaminates which re-establish the 
heterogeneic phenotype.
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Figure 6.138 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD9l ,sht expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected region.
6.8.4 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD30
CD30 was expressed by approximately 25% - 40% of the population and represents a 
surface antigen predominantly expressed by embryonal carcinoma cells. CD30DuI1 
cells, representing those populations with low expression of CD30, were purified and 
seeded in basal media on TC plastic. Cells exhibited a heterogeneous morphology 
and demonstrated the fonnation of colonies on the TC plastic surface {Figure 6.139). 
Following confluence 17 days post-sorting, surface antigen profile analysis revealed 
the heterogeneous phenotype associated with dental pulp cells.
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Immunohistochemical phenotyping revealed that adherent cells 4 hours post-sorting 
demonstrated the nuclear expression of pluripotency regulators Oct4 and Sox2, with 
cells furthermore expressing Cripto-1 and Tra-1-81 within the cytoplasm. RPE 
progenitor protein pax6 was expressed within the cytoplasm of cells, whilst 
committed RPE progenitor protein MiTF was also cytoplasmically expressed. 
Alternative neuronal lineage-associated proteins rest4 and TBR2 were 
cytoplasmically expressed within the population, although nestin was not expressed. 
Cells exhibited nuclear expression of the stem cell proliferation protein 
nucleostemin, whilst furthermore exhibited cytoplasmic expression of the MSC- 
associated protein STRO-1 {Table 6.2 - Page 295).
Figure 6.139 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD301)ul1 expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
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CD30L,ght purified populations demonstrated distinct heterogeneity both 
morphologically {Figure 6.140) and phenotypically when observed using flow 
cytometry upon confluence 18 days post-sorting. Cells fixed following adherence 
demonstrated almost identical protein expression profiling compared with that 
observed within CD30DuI1 purified populations, the exception being the cytoplasmic 
expression of nestin within the population {Table 6.2 - Page 295).
Figure 6.140 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD301 IKl" expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected region.
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6.8.5 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD34 (Class III)
CD34 (Class III) represents an antigen largely associated with HSCs and was 
expressed by approximately 20% - 30% of dental pulp cells. CD34Du11 purified 
populations did not form colonies on TC plastic adherence, with the cells 
demonstrating a heterogeneous morphology {Figure 6.141). This heterogeneity was 
further highlighted when the population was assessed using flow cytometry upon 
confluency 14 days post-sorting, with cells displaying the heterogeneous phenotype 
previously identified for dental pulp cells. Immunohistochemistry 4 hours post­
sorting demonstrated that purified CD34Du11 populations did not express proteins 
associated with plasticity or primitive ES cells, although the population did exhibit 
nuclear expression of nucleostemin and cytoplasmic expression of STRO-1. 
Interestingly, neural progenitor protein rest4 was expressed within the cytoplasm of 
the cells, although no expression of nestin or TBR2 could be detected {Table 6.2 — 
Page 295).
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oFigure 6.141 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD34DuI1 expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected region.
CD34Llght purified populations generated numerous small heterogeneic colonies on 
adherence with the TC plastic substrate {Figure 6.142), although theyy demonstrated 
the heterogeneic phenotype associated with unsorted dental pulp cells when assessed 
using flow cytometry 14 days post-sorting. Immunohistochemical assessment 4 
hours post-sorting revealed a similar expression profile to that observed within 
CD34DuI1 purified populations, although CD34Llght populations exhibited nucleolar 
expression of the RPE protein MiTF and the cytoplasmic expression of the ES cell- 
associated protein Tra-1-81 {Table 6.2 - Page 295).
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Figure 6.142 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD341 l8ht expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
6.8.6 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD50
Leukocyte adhesion antigen CD50 was expressed by approximately 10% - 20% of 
dental pulp cells which were subsequently purified. CD50Du" populations generated 
distinct colonies on adherence to the TC plastic substrate, although the colonies 
demonstrated distinct heterogeneity {Figure 6.143), with further confirmed when the 
population was assessed using flow cytometry upon of confluence 11 days post­
sorting. Whilst cells displayed the heterogeneic phenotype associated with non- 
purified dental pulp cells, immunohistochemistry of adherent cells 4 hours post­
sorting demonstrated cytoplasmic expression of MiTF and pax6, indicating an RPE-
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associated cell type. Furthermore, neuronal proteins rest4 and TBR2 were 
cytoplasmically expressed, although nestin was not detected. Interestingly, whilst 
STRO-1 and nucleostemin were observed in the cytoplasm and nucleus respectively, 
plasticity regulatory proteins Cripto-1, Oct4 and Sox2 were not expressed (Table 6.2 
- Page 295).
Figure 6.143 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD50Du11 expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present
within the selected colony.
CD50Llght purified cells generated 3 distinct colonies following purification and 
demonstrated global heterogeneic morphology (Figure 6.144). However, on 
confluence 13 days post-sorting, flow cytometry revealed the heterogeneous 
phenotype associated with non-purified dental pulp cells. Immunohistochemistry of 
cells 4 hours post-sorting revealed a similar expression profile with that observed in 
CD50DuI1 purified populations, the exception being the nucleolar as opposed to 
cytoplasmic-specific expression of MiTF (Table 6.2 - Page 295).
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Figure 6.144 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD501 ,Kh, expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony/region.
6.8.7 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD56
Leukocyte-associated antigen CD56 was expressed by 20% - 40% of dental pulp- 
derived cells, and populations were subsequently sorted upon the basis of CD56DuI1 
and CD56Light expression. CD56Du" populations generated small heterogeneous 
colonies on adherence to the TC plastic substrate {Figure 6.145), and exhibited a 
heterogeneous dental pulp phenotype upon confluence 11 days post-sorting, as 
observed by flow cytometry. Cells fixed 4 hours post-sorting demonstrated 
cytoplasmic expression of plasticity regulation proteins Oct4 and Sox2, and although 
Cripto-1 expression was not observed, the ES cell-associated protein Tra-1-81 was
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also expressed within the cytoplasm. STRO-1 was also expressed within the 
cytoplasm of adherent cells, whilst stem cell proliferation protein nucleostemin was 
expressed in the nucleus. RPE-associated proteins pax6 and MiTF were expressed 
within the cytoplasm of adherent populations, whilst neuronal-associated proteins 
nestin, rest4 and TBR2 were expressed within the cytoplasm {Table 6.2 - Page 295).
Figure 6.145 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD56nul1 expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
CD56Llght purified populations did not generate colonies when interacting with the 
TC plastic surface, although did exhibit a heterogeneous morphology {Figure 6.146). 
However, upon confluence 13 days post-sorting, flow cytometry and 
immunohistochemistry revealed an identical protein expression profile to that 
observed within CD56DuI1 purified populations {Table 6.2 - Page 295).
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Figure 6.146 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD5611Kh* expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected region.
6.8.8 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD62E
Endothelial-associated antigen CD62E was expressed by approximately 5% - 20% of 
dental pulp cells, and thus CD62EDuI1 and CD62ELlght populations were isolated. 
CD62EDuI1 purified cells spontaneously generated colonies on the TC plastic surface 
{Figure 6.147). However, colonies were morphologically heterogeneous and, upon 
confluence 9 days post-sorting, flow cytometry further confirmed a heterogeneic 
pulp phenotype. Immunohistochemistry of adherent cells 4 hours following 
antibody-based purification revealed cytoplasmic expression of pax6 and MiTF, with 
alternative neuronal proteins rest4 and TBR2 also exhibiting cytoplasmic expression. 
Interestingly nestin was not expressed. Whilst cells exhibited cytoplasmic and
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nuclear expression of STRO-1 and nucleostemin, no Oct4, Sox2 or Cripto-1 
expression was detected (Table 6.2 - Page 295).
Figure 6.147 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD62EDl'M expression seeded 
in basal media and cultured for 48 hours post sorting. Images are representive of cells present 
within the selected colony.
CD62Llght purified populations also generated colonies when seeded onto TC plastic 
(Figure 6.148), and furthermore exhibited morphological and phenotypic 
heterogeneity, as observed by flow cytometric analysis of confluent cells confluence 
9 days post-sorting. Cells fixed 4 hours post-sorting demonstrated a similar 
expression profile to that observed in CD62DuI1 purified cells (Table 6.2 - Page 295).
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Figure 6.148 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD62E1 ,l:h, expression seeded 
in basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
6.8.9 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD73
MSC-associated antigen CD73 was expressed by 30% - 50% of dental pulp-derived 
populations and was purified on the basis of CD73DuI1 and CD73Llght expression. 
CD73DuI1 populations produced colony formation on TC plastic adherence, whilst 
CD73Llgln in fact did not form distinct colonies {Figure 6.149). However, 
heterogeneic morphology was observed within both populations, and phenotypic 
analysis of confluent purified populations 14 days post-sorting revealed a 
heterogeneic surface antigen profile. Regarding immunofluorescent staining of cells 
4 hours post-adherence, differently purified populations exhibited similar protein 
expression profiles as observed by immunohistochemistry. Both populations
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demonstrated cytoplasmic expression of pluripotent maintaining proteins Oct4, Sox2 
and Cripto-1, whilst Tra-1-81 was also expressed within the cytoplasm of cells. 
MiTF and Pax6 further exhibited cytoplasmic expression, as did alternative neuronal 
proteins nestin, rest4 and TBR2. Nucleostemin exhibited nuclear-specific expression 
within each population, whilst MSC-associated protein STRO-1 was cytoplasmically 
expressed {Table 6.2- Page 295).
Figure 6.149 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD73DuM and CD73Ll8h‘ 
expression seeded in basal media and cultured for 48 hours post-sorting.
6.8.10 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD81
Neural progenitor-associated antigen CD81 was expressed by approximately 5% of 
the dental pulp population and was subsequently purified based on this positive 
expression. CD81DuI1 purified cells generated one distinct colony on TC plastic 
adherence and displayed both morphological {Figure 6.150) and phenotypic 
heterogeneity, as observed by flow cytometry following attainment of confluence 20 
days post-sorting. Immunohistochemical assessment of adherent cells 4 hours post­
sorting demonstrated the cytoplasmic expression of plasticity maintaining proteins 
Cripto-1 and Sox2, whilst Oct4 was expressed within the nucleus of cells. ES-cell- 
associated protein Tra-1-81 was also expressed within the cytoplasm of cells. Whilst 
cells cytoplasmically expressed RPE progenitor-associated protein pax6, the
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committed progenitor protein MiTF was not detected within the culture. Neural- 
associated proteins nestin and TBR2 were also expressed cytoplasmically, whilst 
neuronal differentiation regulator rest4 exhibited nucleolar specific expression. Stem 
cell proliferation protein nucleostemin was expressed within the nucleus, whilst 
MSC-associated protein STRO-1 was expressed in the cytoplasm of purified cells 
(Table 6.2-Page 295).
Figure 6.150 - Pulp donor 1 (Passage 8) cells sorted of the basis of CDS 10ul1 expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony/region.
CD81Llght purified cells spontaneously generated colonies on the TC plastic surface, 
although cells exhibited both morphological (Figure 6.151) and phenotypic 
heterogeneity, as observed by flow cytometric analysis of confluent cells 24 days 
post-sorting. Immunohistochemistry of cells 4 hours post-sorting exhibited
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cytoplasmic expression of Oct4, Sox2 and Cripto-1, whilst also demonstrating 
nucleolar localised expression of Tra-1-81. Cells cytoplasmically expressed the RPE- 
associated protein pax6, whilst MiTF was also detected. Neural progenitor protein 
nestin was cytoplasmically expressed, as were associated proteins rest4 and TBR2. 
Nucleostemin was expressed within the nucleus of cells, and STRO-1 exhibited 
cytoplasmic-specific expression {Table 6.2 - Page 295).
Figure 6.151 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD811 ,sh< expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
6.8.11 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD90
MSC-associated antigen CD90 was expressed by approximately 25% - 30% of the 
dental pulp population, and CD90DuI1 purified cells generated one distinct colony
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when interacting with the TC plastic substrate {Figure 6.152). The global population 
displayed a morphological and, as demonstrated by flow cytometric analysis of 
confluent cells 17 days post-sorting, phenotypic heterogeneity as that observed in 
non-purified populations. Adherent populations assessed 4 hours post-sorting 
exhibited cytoplasmic expression of plasticity-maintainers Sox2 and Cripto-1, whilst 
furthennore exhibiting nuclear expression of Oct4. ES cell-associated protein Tra-1- 
81 also demonstrated cytoplasmic expression. RPE progenitor-associated protein 
pax6 was expressed within the nucleus of cells, whilst the RPE progression protein 
MiTF was cytoplasmically expressed. Neuronal proteins rest4 and TBR2 exhibited 
cytoplasmic expression, although nestin was not detected. Stem cell proliferation 
protein was detected within the nucleus of cells, whilst MSC-associated protein 
STRO-1 was expressed within the cytoplasm {Table 6.2- Page 295).
Figure 6.152 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD90n,in expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony/region.
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CD90Llght purified populations generated multiple colonies on adherence to TC 
plastic surface, although morphological {Figure 6.153) and phenotypic 
characteristics, as observed by flow cytometric studies of confluent cells 16 days 
post-sorting, were heterogeneous. Immunohistochemical analysis of adherent cells 
demonstrated nuclear expression of Oct4 and Sox2, whilst Cripto-1 exhibited 
nucleolar expression within cells. Furthennore, Tra-1-81 exhibited cytoplasmic 
expression. Pax6 exhibited nuclear expression, whilst associated protein MiTF was 
expressed within the cytoplasm. Whilst neural progenitor protein nestin was not 
detected, neuronal-associated proteins rest4 and TBR2 were expressed within the 
cytoplasm of cells. Nucleostemin was expressed within the nucleus, whilst STRO-1 
demonstrated cytoplasmic expression {Table 6.2 - Page 295).
Figure 6.153 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD901 iRht expression seeded in 
basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony. Images are representive of cells present w ithin the selected colony.
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6.8.12 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of CD 105
CD 105 is expressed by both endothelial cells and MSCs and was furthermore 
expressed by approximately 25% - 35% of dental pulp cells. CD105Duil purified cells 
demonstrated colony formation on adherence to the TC plastic surface, although they 
exhibited morphological {Figure 6.154) and phenotypic heterogeneity, as observed 
by flow cytmetric analysis of confluent cells 12 days post-sorting. Adherent cells 
analysed using immunohistochemistry 4 hours post-sorting demonstrated 
cytoplasmic expression of Oct4 and Sox2, although they did not express primitive- 
associated proteins Cripto-1 or Tra-1-81. Whilst RPE progenitor protein pax6 was 
expressed within the cytoplasm of cells, the progressive protein MiTF was not 
detected. Alternative neuronal proteins rest4 and TBR2 were cytoplasmically 
expressed within the population, although neural progenitor protein nestin was not 
expressed. Nucleostemin and STRO-1 were expressed within the nucleus and 
cytoplasm of cells respectively. Interestingly, CD105Llght purified populations did not 
generate colonies upon the surface of the TC plastic substrate; instead the 
heterogeneous cell population formed a monolayer population, becoming confluent 
10 days post-sorting. However, whilst not generating colonies, CD105Llght 
populations exhibited an identical phenotype compared with CD105Du11 populations, 
as observed by flow cytometry and iimnunohistochemistry {Table 6.2 — Page 295).
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Figure 6.154 - Pulp donor 1 (Passage 8) cells sorted of the basis of CD105Rul1 and CD105l ,,:h' 
expression seeded in basal media and cultured for 48 hours post-sorting.
6.8.13 Purification of Heterogeneous Dental Pulp Populations based upon
Differential Expression of STRO-1
STRO-1 was expressed by approximately 0.5% - 1% of heterogeneous dental pulp 
cells, and was subsequently purified to assess phenotypic capacity of the population. 
STRO-1Dul1 cells generated only one distinct colony on the surface of the TC plastic 
and became confluent 18 days post-sorting, with the population exhibiting 
morphological {Figure 6.155) and phenotypic characteristics associated with non- 
purified dental pulp populations. Immunohistochemistry of adherent populations 4 
hours post-sorting revealed cytoplasmic expression of the RPE-protein MiTF, 
although interestingly the primitive RPE protein pax6 was not expressed. Strikingly 
given the proposed cell phenotype STRO-1 is hypothesised to purify, no expression 
of Sox2 was detected within the population, although co-regulator Oct4 was detected 
within the nucleus of cells. Whilst embryonic-associated proteins Cripto-1 and Tra-1- 
81 were not expressed within the population, nucleostemin and STRO-1 were 
expressed within the nucleus and cytoplasm respectively. Interestingly, neural-
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associated proteins nestin, rest4 and TBR2 were expressed within the cytoplasm of 
the population {Table 6.2 - Page 295).
Figure 6.155 - Pulp donor 1 (Passage 8) cells sorted of the basis of STRO-lnul1 expression seeded 
in basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
STRO-lLlgln purified populations generated colonies upon adherence to the TC 
plastic, although demonstrated a similar morphological {Figure 6.166) and 
phenotypic heterogeneity, as observed by flow cytometric analysis of confluent cells 
22 days post-sorting, compared with STRO-lDu" positive cells. Furthermore, 
immunohistochemistry assaying of adherent cells 4 hours post-sorting demonstrated 
an identical expression to that observed in STRO-l0ul1 populations {Table 6.2 - Page 
295).
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Figure 6.156 - Pulp donor 1 (Passage 8) cells sorted of the basis of STRO-11 lfiht expression seeded 
in basal media and cultured for 48 hours post-sorting. Images are representive of cells present 
within the selected colony.
6.8.14 Antibody-based Techniques for the Purification of Heterogeneous Dental
Pulp populations
At present antibody-related techniques, and in particular the STRO-1 surface antigen, 
represent the most widely used method for the purification of homogeneous stem cell 
populations. However, attempted purification of dental pulp-derived populations 
using an array of surface antigens failed to ascertain a homogeneous subpopulation, 
with cells re-establishing a heterogeneic-associated phenotype upon confluence. 
Whilst Hoechst purified populations retain an alternative phenotype until second 
passage post-sort confluence, they too demonstrated a reversion to the heterogeneous 
dental pulp population at this point. This would suggest that by sorting on the basis
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of a functional cell aspect i.e. the presence of an ABCG2 transporter pump, cell 
populations of a greater purity than antibody related discrimination can be formed, 
but contaminates capable of re-establishing the heterogeneic phenotype still remain. 
And whilst adherent cells were assessed using immunohistochemistry 4 hours post­
sorting to allow probing of protein expression within each purified subpopulation 
{Table 6.2), their inability to maintain homogeneity subsequent to further 
proliferation is detrimental from a clinical perspective. It is therefore required that 
alternative techniques are devised capable of homogeneously discriminating against 
subpopulations of varying characteristics. However, whilst attaimnent of 
homogeneous subpopulations of cells from dental pulp would undoubtedy prove 
clinically significant, given the aforementioned results, it may be that this is not 
plausible; whilst we have initially attributed the re-establishment of heterogeneity to 
rogue progenitor impurities, it may be that the population as a whole in fact strives to 
remain in a heterogeneic state, maintaining standard numbers of each subpopulation 
that make up the niche. This is a plausible hypothesis given that purified populations 
exhibited increased cycling times compared with the heterogeneous, unpurified pulp 
populations, requiring greater culture time to obtain confluence. Given that that 
primitive cells exhibit a more quiescent state than committed cells, these results 
would therefore suggest that Hoechst and antigen purified populations were in fact 
stem or progenitor subsets. Further investigations are therefore required to establish 
whether this may be the case, a result with significant relevance for all future 
regenerative strategies.
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6.9 Conclusion
6.9.1 Dental Pulp as a Niche for the Isolation of Clinically Desirable Cells
Dental pulp represents an attractive niche from which to isolate cells for therapeutic 
strategies given the relative ease with which it can be obtained, especially with 
regards deciduous teeth from which cells could be isolated and cryopreserved 
following natural loss of the tooth. Isolation of cells from dental pulp was a relatively 
straightforward procedure, with isolated cells readily adhering and undertaking rapid 
proliferation. The maintenance of in vitro expression regardless of donor age or sex 
overcomes many therapeutic boundaries encountered with bone marrow, peripheral 
blood and umbilical cord-derived populations, and their ability to undertake 
multilineage differentiation further enhances their therapeutic value. Whilst dental 
pulp-derived populations were only induced towards adipogenic, chondrogenic, 
osteogenic, neuronal and hepatic lineages, their expression of plasticity regulating 
proteins Oct4 and Sox2 suggests a pluripotent capability comparable with that of ES 
cells, a hypothesis further enhanced by the expression of primitive proteins Cripto-1 
and Tra-1-81. The expression of pax6 and MiTF within the population suggests the 
presence of cells of an RPE committed lineage, thereby representing a potential 
source for regenerative approaches to macular degenerative diseases. However, given 
that pulp-derived cells display many characteristics associated with ES cells, it is 
required that they are assessed further for ES cell-associated traits such as karyotypic 
instability and spontaneous differentiation.
Assuming, however, that dental pulp-derived cells maintain a normal karyotype, it 
would be therapeutically beneficial if individual subpopulations were 
homogeneously isolated and assessed for their proliferative and differentiation 
capacity. However, Hoechst and antibody based purification strategies failed to 
homogeneously isolate differing subpopulations, with a heterogeneous phenotype 
maintained following culture. Whilst it is plausible that dental pulp cells 
diifferentiate to maintain the heterogeneity of the in vivo niche and, following 
purification, undergo numerous differentiations to re-establish this, it is also 
perceivable that current purification strategies fail to homogeneously exclude cell 
impurities which subsequently re-establish heterogeneity. Given that such an issue
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would have a significant impact on all regenerative strategies this is an issue which 
must be investigated.
In conclusion, dental pulp-derived populations heterogeneously expressed antigens 
associated with MSCs, HSCs and EPCs, and ES cells and alternative progenitors. It 
was of significant interest that this phenotype was maintained throughout prolonged 
in vitro culture, whilst this was also accompanied by consistant proliferation rates. 
Furthermore, following immunofluorescent probing of the population, stem and 
progenitor subpopulations became more apparent: the expression of Oct4, Sox2, 
Cripto-1 and Tra-1-81 indicated the presence of a highly immature, plastic 
population; rest4 and TBR2 suggested the presence of neuronal progenitors; and 
pax6 and MiTF those of the RPE lineage. The presence of large numbers of both 
hematopoietic and non-hematopoietic progenitors were demonstrated by CFU-GM 
and CFU-F assays, with such cells likely responsible for the observed adipogenic, 
chondrogenic, osteogenic, neuronal and hepatic differentiation. However, 
purification based upon differing Hoechst emission or variation in antigen expression 
failed to homogeneously isolate different subpopulations, although protein 
expression variance within initially adherent cells and the slow cycling times of 
sorted cells suggested that stem and progenitor subsets had been isolated. However, 
either through instated re-establishment of heterogeneity by the homogeneously 
sorted cells or inclusion of progenitor impurities post-purification, the population 
failed to maintain a homogeneous phenotype, an issue which needs to be addressed.
6.9.2 Response to Chapter Aims
Results presented within this chapter did address the aims detailed in 6.1.1, with cells 
isolated from the dental pulp of donors of varying age, sex and tooth condition being 
characterised. Flow cytometry analysis revealed similar phenotypic characteristics of 
isolated populations and this phenotype, along with proliferation rates, was 
maintained throughout in vitro culture and following freeze-thaw cycling. This was 
also the case with regards expression of plasticity regulating proteins, with Sox2, 
Oct4, Cripto-1 and Tra-1-81 expressed throughout in vitro culture. The maintained 
expression of rest4 and TBR2 suggested the presence of neuronal progenitors derived 
from the CNC, whilst cells expressing pax6 and MiTF were hypothesised to
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represent RPE progenitor cells. Isolated cells demonstrated a consistent ability to 
generate similar numbers of CFU-Fs and CFU-GMs and cells were successfully 
differentiated towards adipogenic, chondrogenic, osteogenic, neuronal and hepatic 
lineages at different passages as to demonstrate a maintained ability of populations to 
undertake multilineage differentiation. Given the phenotypic stability of the cells, 
telomere length studies were carried out and subsequently demonstrated that the 
rapid in vitro aging of cells, as observed in bone marrow-derived MSCs, had not 
taken place and is likely the reason for this stability. Finally, cells were purified 
using antibody-based methods and characterised as above. However, whether 
because of impurities following sorting or an inbuilt predisposition of cells to re­
establish heterogeneity, purified populations cultured to confluence re-established the 
heterogeneic phenotype.
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7. Stem Cell Conserved Domains as Novel Markers for Homogeneous
Isolation of Stem and Progenitor Subpomilations
7.1 Introduction
7.1.1 Requirement for the Development of Novel Methods to Isolate
Homogeneous Stem and Progenitor Subpopulations of High Purity from
Tissues
Investigations assessing the potential of cells derived from numerous adult tissues 
have yielded interesting results with respect to their ability to undertake lineage 
differentiation not associated with their residing niche or trophic germ layer. 
However, at present the majority of studies fail to identify subpopulations 
responsible for observed differentiation events, neglecting to distinguish whether a 
stem cell and/or more committed progenitor counterpart undertakes lineage 
commitment. Whilst partial homogeneity has been achieved through sorting on the 
basis of surface expression markers, and in particular STRO-1, such sorting 
techniques fail to purify cells of varying plasticity. This is particularly evident with 
regards data obtained from dental pulp studies both in heterogeneous and antigen- 
purified populations, in particular the incapacity of purified cells to maintain the 
homogeneously selected phenotype in vitro. Whilst this could conceivably be 
attributed to a phenomenon maintaining a pre-programmed global niche, it is also 
possible that surface antigen-based sorting techniques fail to homogeneously isolate 
individual subpopulations, subsequently resulting in single or multiple subpopulation 
impurities which, following in vitro culture, re-establish the global heterogeneous 
phenotype.
Whatever the reason, however, with which this heterogeneity is re-estbalished, it is 
likely that antigen-based purification fails to homogeneously select cells based on 
plasticity or lineage potential, and thus alternative methods based on the lineage 
capacity of the cell must be designed to allow purification. Should this be achieved, 
it may allow for investigations confirming the mechanisms responsible for re­
establishing the heterogeneic phenotype. Interestingly, many investigations have 
dismissed such issues of heterogeneity as inconsequential; suggesting that rogue
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progenitor subpopulations will exert minimum impact within a clinical setting. 
However, results of recent clinical studies have cast doubts on such theories, in 
particular with respect to clinical trials utilising bone marrow-derived stem cells for 
myocardial repair415. Following implantation many studies have reported the 
formation of calcified tissue within the myocardium, presumably resulting from 
subpopulations of osteogenic committed cells which have differentiated to a 
functional osteoblast. Such superfluous differentiation events could, in many clinical 
applications, prevent anticipated regeneration or prove potentially fatal. Thus, if 
tissue engineering approaches to medicine are to generate numerous clinical devices 
to accommodate a range of diseases, it is imperative that homogeneous cell 
populations are implanted. If it does, however, conspire that purified cells do in fact 
re-establish the heterogeneic niche with which they are associated, studies must be 
undertaken to assess the impact of progenitor subpopulations isolated from numerous 
tissues have within a clinical setting and, assuming a negative impact, to modify in 
vitro culture conditions to maintain the homogeneously selected phenotype.
7.1.2 Stem Cell Conserved Domains as Novel Markers for Homogeneous
Isolation of Stem and Progenitor Subpopulations
Initial understanding of DNA structure and its role within translational events 
depicted a scenario in which intron coding regions represent redundant bases, 
essentially serving as a buffering system to protect transcribed exons. Whilst in some 
senses this interpretation is correct in that introns are not transcribed per se, 
investigations over recent years have illustrated their fundamental role within the 
genome. In fact introns serve as regulators of exon, and therefore gene, transcription, 
acting as binding sites for transcriptional machinery to enable genes to be transcribed 
and subsequently translated. In addition to allowing binding of RNA polymerase II, 
intron promoter regions adjacent to genes allow binding of both general transcription 
factors (GTFs) such as TFILA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH, and 
consequently specific transcription factors such as those related to Oct and Sox 
transcription factor families. GTFs sequentially assemble on the core promoter 
thereby forming stable nucleoprotein complexes, which subsequently allows for the 
recruitment of RNA polymerase II to form the pre-initiation complex (PIC). Three 
divergent classes of DNA sequence elements direct RNA polymerase II transcription.
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The first includes DNA sequences within the core promoter; a pyrimidine-rich 
initiator motif and generally a TATA-box (consensus TATAAA) located 
approximately 25-35 base pair (bp) upstream of the transcription start site. Both of 
these DNA elements are recognised by the GTF machinery to initiate transcription. 
There are two other classes of m-regulatory elements: proximal-promoter and distal- 
promoter elements (enhancers). Specific transcription factors bind to these cis- 
regulatory elements, regulating transcription rates and expression patterns either by 
activating or inhibiting the recruitment and assembly of the PIC {Figure 7. /)416.
Promoter-proximal
elements
Figure 7.1 - Association of RNA polymerase II and GTFs to core promoter for transcription 
initiation. Core promoter elements shown are the TATA-box, promoter-proximal elements and 
promoter-distal elements (enhancers) (modified from B. Lewin, Genes IX).
Evolution strives to retain advantageous genetic modifications over increasing time, 
with many important developmental traits conserved throughout species 
development. Such genetic conservation can now be readily observed following the 
complete sequencing of numerous genomes within recent years, with the study of 
evolutionary conserved regions (ECRs) becoming an area of intensive research as a 
direct consequence. Conservation of genetic information implies a degree of 
importance towards the survival of the organism, with advantageous genes 
demonstrating high levels of conservation across species of increasing evolutionary 
stature. In addition to the conservation of advantageous coding regions, cis- 
regulatory elements responsible for transcriptional maintenance are also conserved. 
Many investigations have studied such ECRs and their residing polymorphisms and 
mutations and have suggested relationships with respect to various neurological 
disorders417, cocaine addiction418, and developmental progression376.
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Interestingly, identification of highly conserved genes fundamentally associated with 
maintenance of plasticity and control of differentiation revealed associated highly 
conserved c/s-regulatory flanking regions. Upon identification it was acknowledged 
that such areas could represent functional characteristics on which to base 
homogeneous cell purification strategies, and as such regions were interrogated for 
their residing transcription factor binding sites and subsequently tested for their 
specific activity within populations of varying plasticity and differentiation 
commitment. C/s-regulatory regions of high conservation and potential lineage 
identification were designated Stem Cell Conserved Domains (SCCDs).
SCCDs associated with desired phenotypic characteristics were selected and 
corresponding synthetically engineered sequences subsequently inserted into a 
pGL3p vector containing a Luciferase reporter gene with an SV40 minimal 
promoter. Constructs were transfected into both lineage induced and non-induced 
cells isolated from various tissues and assessed for their regulatory impacts via 
comparing fold increase or decrease of luciferase expression generated by SCCD 
containing reporters over the basal pGL3p vector expression. Whilst initial 
investigations detailed below have identified potential SCCDs for the isolation of 
varyingly plastic cells, pre-adipocytes and neuronal progenitor cells, bioinfonnatic 
studies have identified numerous SCCDs with potential for purifying numerous 
lineage committed progenitors {Table 7.7). Whilst initial investigations have 
attempted to generate proof of concept data regarding functions of selected SCCDs, 
domains signifying a regulatory function can subsequently be inserted into a vector 
containing a GFP reporter gene and thereby facilitate the homogeneous purification 
of cells based upon regulatory capacity associated with a given phenotype using high 
speed cell sorting {Figure 7.2).
Cell type
Pre-adipocyte 
Pr e- cardiomyo cyt e 
Pre-chondrocyte 
Pre-endothelial 
Pre-hematopoietic
Gene neighbouring a potential SCCD
Dlk-1, Fabp4, Fabp5, GATA2, GATA3, Irsl, Irs2, NDN
NPPA, TEAD1
CDH2, FGFR2, IGFL1, IGFL3, Sox9
CD34, CSF1, CSF2, CSF3, GATA1, IL7, IL7R
ANP32C, p-globin, CDX4, EPO, GYP A, Hoxb4, TNT
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Pre-hepatocyte
Pre-islets langerhan
Pre-metaneplnic
Pre-neuron
Pre-osteoblast
Pluripotent stem cell
Pre-RPE
Pre-skeletal muscle
CD24, CTLA4, Epha4, ITGB1, KRT8, NT5E, TCF1, 
Vcaml
CX3CL1, HAND-1, Hlxb-9, INSM1, MixLl, SLC2A2 
CALCRL, CDH6, DUSP6, Jagl, MMP10, MSX1, Pax2 
ASCL1, FGF8, FGFR2, MAP2, PROM1, REST, Sox2 
AAK1, CDH11, MEPE
BEST1, EOMES, FOXD3, HLA-DRA, Oct4, Sox2 
KRT7, RBP1, RBP2, RPE65 
DMD, Msxl, MYH13, Nkx2-5, Pax3
Table 7.1 - SCCDs neighbouring known regulatory genes fundamental to guidance/maintenance 
of given phenotypes: Potential regions for homogeneous purification of stem/progenitors 
subsets.
7.1.3 Aims of this Chapter
This investigation aims to provide proof of concept data for SCCDs flanking the (i) 
Sox2 gene to demonstrate a transcriptional role in regulating plasticity. Luciferase 
reporter constructs will be transfected into bone marrow-, dental pulp- and umbilical 
cord-derived cells cultured in basal conditions and adipogenic and neural 
differentiation media; (ii) NRSF gene to demonstrate a regulatory capacity with 
neurogenesis. Luciferase reporter constructs will be transfected into bone marrow- 
and dental pulp-derived cells cultured in basal and neuronal induction media; (iii) 
Dlk-1 gene to demonstrate a role within adipogenic lineage commitment. Luciferase 
reporter constructs will be transfected into bone marrow- and dental pulp-derived 
cells cultured in basal and adipogenic media. Obtained luciferase values will allow 
calculation of transcription factor binding, and therefore transcriptional regulatory 
capacity, of the selected SCCD. Should the selected regions prove to have a 
functional regulatory capacity, GFP reporter constructs containing the selected 
regions will be constructed to allow purification of cells displaying up-/down- 
regulations using high speed cell sorting.
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7.2 Sox2 SCCDs
7.2.1 Utilisation of Sox2 SCCDs for the Purification of Stem Cells Exhibiting
Varying Levels of Plasticity
Sox2 is highly expressed in ES cells and debatably within adult-derived cells, 
interacting with Oct4 and Nanog to facilitate downregulation of lineage specific 
transcription and thereby maintain the cell in an undifferentiated state, a fundamental 
property of the developing embryo93,96. The demonstration of Sox2 influence with 
regards maintenance of plasticity highlighted the region as a potential target for 
bioinformatics, and unsurprisingly the Sox2 gene is highly conserved throughout 
evolution, indicating that it may be fundamentally required to maintain plasticity 
during development. Further bioinfonnatic probing of regions surrounding the Sox2 
gene revealed a highly conserved m-regulatory SCCD approximately 3kb upstream 
of the Sox2 exon region, which contained binding sites for plasticity-associated 
transcription factors such as Oct4, HOXA4 and NF-kB, thereby suggesting a 
functional role for the SCCD. Synthetic sequences mimicking this SCCD were 
cloned into a pGL3p vector with an SV40 minimal promoter; Sox2a representing a 
short replicate and Sox2b a longer sequence. Plasmids containing these constructs 
were transfected into cells isolated from bone marrow, dental pulp and umbilical 
cord in both basal and induction media to assess the regulatory capacity of this 
SCCD.
7.2.2 Demonstration of a Regulatory Capacity of a Sox2 SCCD in Bone
Marrow-derived MSCs Cultured in Basal and Differentiation Media
To asses the regulatory capacity of the Sox2 SCCD, synthetically generated 
plasmids, Sox2a and Sox2b, were transfected into Lonza passage 5 bone marrow- 
derived MSCs using Qiagen Effectene technology. Cells cultured in commercially 
synthesised basal, adipogenic and neuronal media were transfected 48 hours prior to 
regulatory analysis. Sox2a {Figure 7.3) was upregulated between 6- and 11- fold in 
basal conditions over the 28 day culture period, indicating a fundamental regulatory 
role with within the population. Upon introduction into adipogenic and neuronal 
differentiation media, Sox2a demonstrated a reduced upregulation following 3 days
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of culture, with only a 1.82 fold upregulation in adipogenic media and a 1.55 fold 
upregulation in neuronal media. Following 7 days of differentiation, Sox2a was 
downregulated within the population, exhibiting a 0.31 fold decrease in adipogenic 
media and a 0.52 fold decrease in neuronal media. MSCs cultured in adipogenic 
media demonstrated further downregulation for the remainder of the culture period; 
exhibiting 0.54-, 0.65-, and 0.54- fold downregulations at 14, 21 and 28 days 
respectively. No regulatory data was obtained for MSCs cultured in neuronal media 
at 14 and 21 days, with infection of the culture preventing acquisition of data. 
However, the 0.8 fold downregulation following 28 days of neuronal culture would 
indicate that Sox2a remained downregulated for the duration of the culture. Sox2b 
{Figure 7.4) represented a sequence incorporating a greater length of the Sox2 SCCD 
sequence compared with Sox2a, although interestingly did not demonstrate as greater 
regulatory capacity. In basal conditions Sox2b exhibited a 1- to 2.5- fold 
upregulation over the 28 day culture period, indicating a reduced functional capacity 
compared with the Sox2a plasmid. Upon introduction into chemically-defined 
adipogenic media, cells exhibited a reduced 1.06 fold upregulation following 3 days 
of differentiation. Following further adipogenic differentiation, Sox2b was further 
downregulated; demonstrating 0.15-, 0.5-, 0.46-, and 0.47- fold downregulations at 
days 7, 14, 21 and 28 respectively. MSCs cultured in neural differentiation media 
demonstrated a similar regulatory capacity, exhibiting a reduced upregulation of 1.13 
fold following 3 days of differentiation, with 0.47- and 0.54- fold downregulation at 
days 7 and 28 respectively. No data was noted for days 14 and 21 due to infection of 
culture.
To assess the regulatory capacity of MSCs cultured for prolonged periods in vitro, 
passage 8 MSCs cultured in basal media were compared with passage 5 results 
obtained previously {Figure 7.5). Cells cultured for 7 days exhibited significant 
differences with regards Sox2a regulation, with passage 5 cells demonstrating a 9.58 
fold upregulation compared with 2.10 fold observed in passage 8 cells. Passage 8 
cells also demonstrated a reduced upregulation with regards Sox2b, generating a 1.04 
fold upregulation compared with 1.67 fold observed in passage 5 cells. This reduced 
upregulation is consistent with the labouring proliferative and differentiation 
capacities observed in vitro, suggesting that prolonged tissue culture either modifies 
transcriptional regulation responsible for maintenance of cellular plasticity, or
307
alternatively,
demonstrate
MSCs differentiate towards terminally 
downregulation of tire
differentiated cells which 
Sox2 SCCD.
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7.2.3 Demonstration of a Regulatory Capacity of a Sox2 SCCD in Dental pulp-
derived Populations Cultured in Basal and Differentiation Media
To assess the regulatory capacity of the Sox2 SCCD in dental pulp-derived 
populations, Sox2a and Sox2b were transfected into passage 5 pulp donor 3 cells 
cultured in chemically-defined basal, adipogenic and neuronal media. However, due 
to the reduced differentiation period required for lineage commitment of dental pulp 
cells in comparison with bone marrow-derived MSCs, as detailed in Chapter 6, cells 
were transfected at days 3, 7, 14 and 21, neglecting transfection at day 28.
Sox2a {Figure 7.6) transfected using Effectene transfection methods maintained a 
2.7- to 3.5- fold upregulation in basal conditions, demonstrating a regulatory role 
within the population. Following introduction into chemically-defined adipogenic 
media, the Sox2a SCCD was immediately downregulated; demonstrating 0.47-, 0.47, 
0.45- and 0.48- fold downregulation at days 3, 7, 14 and 21 respectively. Chemical 
induction towards a neuronal phenotype generated similar results, with the Sox2a 
SCCD downregulated 0.40-, 0.45-, 0.47- and 0.51- fold at days 3, 7, 14 and 21 
respectively. Sox2b {Figure 7.7) construct was transfected using Effectene 
methodologies. Cells cultured in basal media demonstrated a 1.5- to 2.0- fold 
upregulation of Sox2b over the 21 day culture, although this was downregulated after 
introduction of differentiation stimulation. Adipogenic differentiation resulted in 
0.44-, 0.50-, 0.44- and 0.46- fold downregulation at days 3, 7, 14 and 21 respectively. 
Conversely, neuronally induced cells demonstrated significantly reduced 
downregulation of Sox2b, with 0.19-, 0.08-, 0.19- and 0.0- fold downregulation at 
days 3, 7, 14 and 21 respectively. This apparently reduced downregulation following 
neuronal induction is interesting since the transfection efficiency was comparable 
with other transfections, suggesting that the results were an accurate reflection of 
regulatory function. It would therefore be interesting to probe cells exhibiting this 
partial downregulation to assess their phenotypic properties with regards neuronally 
associated markers, with homogenous characterisation potentially yielding highly 
proliferative neuronal progenitors.
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7.2.4 Demonstration of a Regulatory Capacity of a Sox2 SCCD in Whole
Umbilical Cord-derived Populations Cultured in Basal Media
Cells derived following enzymatic digestion of whole umbilical cord displayed many 
properties associated with bone marrow-derived populations, including similar 
phenotypic and proliferative characteristics. Passage 5 umbilical cords were therefore 
transfected with Sox2a and Sox2b reporter constructs to assess the regulatory impact 
of the Sox2 SCCD under basal conditions in comparison with the activity 
demonstrated in bone marrow-derived cells.
Sox2a and Sox2b reporter constructs were transfected using Effectene into cord 
cultured for 7 days in chemically-defined basal media {Figure 7.8). Sox2a 
demonstrated a 10.3 fold upregulation, marginally higher than the 9.58 fold 
upregulation observed in bone marrow-derived cells of the same passage. Sox2b 
generated a 2.59 fold upregulation in umbilical cord cells, again insignificantly 
higher than the 2.10 fold upregulation achieved in bone marrow-derived cells. Thus, 
whilst umbilical cord-derived cells exhibited slight increases with regards 
upregulation of the Sox2 SCCD, the insignificance of the regulatory differences are 
likely to be attributable to slightly varying numbers of alternatively transcribing 
progenitor cells or differing transfection efficiencies. It is therefore likely that both 
umbilical cord and bone marrow-derived heterogeneous populations globally 
regulate the Sox2 SCCD in a similar manner, and from further similarities observed 
with regards phenotypic and proliferative capacity, it could be suggested that 
populations derived from these two tissues contain subpopulations of stem, 
progenitor and terminally differentiated cells in similar quantities. Alternatively, 
however, the increased regulatory function of both Sox2 SCCDs exhibited by cord 
cells could be attrubuted to a small number of primitive cells derived from the 
developing embryo, populations which could represent highly plastic cells.
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7.2.5 Regulatory Capacity of Sox2 SCCD Represents Criteria on which to
Purify Homogenous Stem Cell Populations
Constructs designed to assess the regulatory capacity of the Sox2 SCCD 
demonstrated a key regulatory function in undifferentiated cells which is rapidly 
downregulated following differentiation. It is therefore suggested that the Sox2 
SCCD functions to maintain plasticity within cells, facilitating binding of 
transcription factors such as Oct4 which maintain cells in an undifferentiated state. 
Sox2a demonstrated a greater potential for assessing regulation in bone marrow, 
dental pulp and umbilical cord-derived cells, and therefore represents a potential 
target for the purification of multipotent stem cells cultured under basal conditions. 
With respect to the isolation of cells exhibiting varying levels of plasticity, cloning of 
the Sox2a SCCD into a GFP reporter construct can allow for the homogeneous 
isolation of cells based upon Sox2a upregulation, hypothesising that cells exhibiting 
greater upregulation of Sox2a represent a more potent phenotype with regards 
differentiation potential. This homogeneous characterisation of such multipotent 
subpopulations could finally allow assessment of differentiation capacity of adult 
stem cells and subsequently the development of regenerative techniques using 
homogeneous populations. Furthermore, cells exhibiting lesser upregulations could 
represent progenitors of varying lineage commitment, with their homogenous 
characterisation potentially allowing their application in numerous clinical 
applications.
Whilst homogeneous cell purification is the primary puipose of this novel 
technology, it could also represent a marker to allow tailoring of media to maintain 
isolated populations in an undifferentiated, homogeneous state for prolonged periods 
in vitro. Given the inability of antigen putified cells to maintain the homogeneous 
phenotype following proliferation, and furthermore the significantly reduced 
upregulation of Sox2a observed in passage 8 bone marrow cells compared with those 
cultured for only 5 passages, Sox2a can represent a marker on which to firstly purify 
subpopulations based upon a functional capacity and subsequently assess global 
cellular phenotype, providing investigators attempting to synthesise defined media to 
maintain cells for prolonged periods ex vivo with an invaluable tool to assess effects 
of the media with regards transcriptional regulation. Whilst antibody based
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phenotype profiling using flow cytometry allows investigators to assess maintenance 
of phenotype, it fails to identify whether desired stem or progenitor cell populations 
are being maintained. Media can therefore be tailored to generate maintained 
upregulation of Sox2a, potentially allowing for the culture of populations 
representing high levels of plasticity which can be proliferated for a prolonged period 
in vitro, generating large numbers of highly desirable cells for clinical application.
7.3 NRSF SCCDs
7.3.1 Utilisation of NRSF SCCDs for the Purification of Neural Progenitors
REST, also known as Neuronal Restrictive Silencer Factor (NRSF), is proposed to 
act as a key regulator of neuronal differentiation, essentially acting as a repressor of 
neuron-associated genes in non-neuronal tissue. Bioinformatic profiling of this 
region revealed high conservation of the NRSF gene and, from a perspective SCCD 
viewpoint, two highly conserved cis-regulatory regions upstream of the NRSF exon 
region. The first resides approximately 40kb upstream of the NRSF exon, and 
accommodates conserved binding sites for neurogenesis associated transcription 
factors Pax6 and Sox9. Short (NRSFla) and long (NRSFlb) sequences incorporating 
this SCCD region were cloned into a pGL3p vector. The second SCCD resides 
approximately 40kb upstream of the SPINK gene, and 11 Okb upstream of the NRSF 
exon. SPINK is a serine protease inhibitor and mutations of this region are 
hypothesised to be responsible for a loss of tyrosine inhibitor function419. However, 
due to the high conservation of the SCCD and the presence of a HOXA4 
transcription factor binding site, a transcription factor integral to neurogenesis, a 
sequence incorporating this region (NRSF2a) was cloned into a pGL3p vector. 
Plasmids containing NRSF-associated SCCDs were transfected into bone marrow 
and dental pulp-derived cells cultured in chemically-defined basal and neuronal 
media.
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7.3.2 Demonstration of Regulatory Capacity of a NRSF SCCD in Bone
Marrow-derived MSCs Cultured in Basal and Neuronal Differentiation
Media
Attempting to demonstrate regulatory capacity for one or both of the NRSF SCCDs 
in bone mannw-derived populations, NRSF constructs la, lb and 2a were 
transfected using Effectene into passage 5 bone marrow-derived MSCs cultured in 
chemically-defined basal and neuronal media at days 3,7, 14, 21 and 28.
NRSF la reporter construct representing a short version of the SCCD approximately 
40kb upstream of the NRSF exon, demonstrated upregulation of 5.3- to 8.5- fold in 
basal conditions, suggesting a functional role within non-neuronal differentiating 
cells {Figure 7.9). No data was obtained for day 21 transfections in basal conditions 
due to infection of the culture media. However, following exposure to neuronal 
induction, cells exhibited lessened upregulation of NRSFla, demonstrating 4.96-, 
2.51-, 1.83- and 1.08- fold upregulations at days 3, 7, 14 and 21 respectively. 
Following 28 days of neuronal differentiation, corresponding to a time point at which 
neural associated markers such as beta-III-tubulin and neurofilament are, from the 
literature, observed within the differentiating population; NRSFla demonstrated a 
0.56 fold downregulation within the population, suggesting that this downregulation 
was required for the expression of neuronal genes. It is therefore suggested that the 
NRSFla SCCD regulates NRSF gene expression, conversely acting as a regulator of 
neurogenesis by modifying transcription rates of NRSF. Under basal conditions the 
NRSF SCCD is highly upregulated, resulting in abundant production of the NRSF 
protein, which subsequently represses neuronal-associated genes under basal 
conditions. Upon detection of appropriate stimulation, in this case chemically 
synthesised neural differentiation media, the NRSF SCCD is downregulated, 
subsequently resulting in reduced levels of transcribed NRSF and thereby allowing 
expression of genes required for neuronal differentiation.
NRSFlb encompasses a greater proportion of the SCCD region and was transfected 
into passage 5 bone marrow-derived cells using Effectene. NRSFlb demonstrated a 
reduced upregulation in basal conditions compared with NRSFla, yielding 
upregulation of 1.8- to 2.3- fold over the 28 day culture period {Figure 7.10). No data
319
was obtained for day 21 transfections in basal conditions due to infection of the 
culture media. As with NRSFla, NRSFlb upregulation was reduced upon exposure 
to neural differentiation media, generating upregulation of 1.28-, 1.14-, L45-, 1.27- 
and 1.39- fold at days 3, 7, 14, 21 and 28 respectively. However, at no point during 
neurogenic differentiation was NRSFlb downregulated, perhaps indicating that the 
construct is less applicable for purification of neuronal progenitors.
In terms of genetic location, NRSF2a is more likely to be a regulator of the SPINK 
gene that NRSF. However, due its high conservation in comparison with that of the 
SPINK exon region, and furthermore the presence of a HOXA4 transcription factor 
binding site, NRSF2a was assessed for its regulatory activity in basal and neurogenic 
conditions. In basal conditions NRSF2a was upregulated 2.6- to 5.4- fold during the 
28 day culture period, suggesting a functional capacity within the MSC population. 
No data was obtained for day 21 transfections due to infection. Upon neuronal 
induction, NRSF2a demonstrated progressively reduced upregulations of 2.49-, 1.54- 
and 1.21- fold at days 3, 7 and 14 respectively. Following 21 days of culture NRSF2a 
was downregulated 0.08 fold, further downregulating to 0.17 fold following terminal 
differentiation. Whilst the downregulation at day 28 (and terminal differentiation) 
was less dramatic than encountered with NRSFla, the results nevertheless suggest a 
functional if less central role for the NRSF2a SCCD during neurogenesis {Figure 
7.11).
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7.3.3 Demonstration of Regulatory Capacity of a NRSF SCCD in Dental Pulp-
derived Cells Cultured in Basal and Neuronal Differentiation Media
Cells from pulp donor 3 cultured for 5 passages in vitro were assessed for the 
regulatory expression of the two NRSF SCCDs within the population. NRSF la was 
transfected into the cells using Effectene transfection techniques and, contrastingly to 
regulatory activity observed in bone marrow-derived cells, it was downregulated in 
basal conditions, with repressive activities comprising 0.2-, 0.09-, 0.34- and 0.07- 
fold downregulations observed at days 3, 7, 14 and 21 respectively {Figure 7.12). 
This consistent downregulation in basal conditions may initially cause concern, 
though when the hypothesised developmental origin of dental pulp-derived cells is 
considered, the downregulation is predictable, hi essence it is perceived that dental 
pulp represents a niche comprising numerous subpopulations, amongst them residing 
neural progenitor cells which are likely to express numerous neuronal associated 
genes, thus requiring a downregulation of NRSF gene expression, which it is 
suggested is regulated by the NRSF la SCCD. Upon introduction into neural 
differentiation media, NRSF la is further downregulated, yielding repression of 0.5 9-, 
0.58-, 0.58- and 0.67- fold at days 3, 7, 14 and 21 respectively. It is therefore 
hypothesised that NRSF la represents a candidate SCCD for the identification of 
neural progenitor subsets of varying commitment, with translation of the technology 
to a GFP based vector potentially circumventing the isolation of neural progenitors 
from induced and non-induced cell populations using high speed cell sorting post­
transfection.
NRSF lb, representing a longer version of NRSF la, was transfected in passage 5 
cells cultured in basal media and demonstrated downregulation of 0.04-, 0.29- and 
0.21- fold at days 3, 14 and 21 respectively {Figure 7.13). Unexpectedly, non- 
induced cells cultured for 7 days demonstrated a minimal upregulation encompassing 
a 1.09 fold increase, although this was attributed to a poor transfection efficiency 
achieved in one experimental repeat. Upon neuronal induction NRSF lb continued to 
be downregulated although did not appear to increase repression, generating 0.11-, 
0.14-, 0.29- and 0.21- fold decrease at days 3, 7, 14 and 21 respectively. Due to the 
reduced volatility in terms of regulatory repression, NRSFlb represents a less
324
suitable tool for the purification of neural progenitor cells from dental pulp in 
comparison to NRSFla.
The SPINK gene flanking SCCD NRSF2a also demonstrated downregulation when 
transfected into passage 5 dental pulp-derived cells, generated 0.23-, 0.19-, 0.35- and 
0.06 fold repressions at days 3, 7, 14 and 21 respectively {Figure 7.14). Post­
neuronal induction NRSF2a continued to be downregulated, yielding repression of 
0.39-, 0.37-, 0.34- and 0.49- fold at days 3, 7, 14 and 21 respectively. However, as 
with results obtained with NRSFlb, the limited variation with regards observed 
regulatory expression subsequently limits its capacity for the purification of 
homogenous subpopulations of neuronal precursors.
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7.3.4 Regulatory Capacity of NRSF SCCD Represents Criteria on which to
Purify Homogenous Neuronal Progenitor Populations
NRSF SCCDs and NRSFla in particular, demonstrated extensive functional capacity 
of regulatory activity in basal and neuronal conditions within bone marrow and 
dental pulp-derived populations. With regards bone marrow-derived cells, further 
investigations examining NRSFla regulation during days 21-28 of differentiation 
will elucidate days on which to transfect and subsequently isolate cells of a neuronal 
precursor phenotype, since cells differentiated for 21 days failed to downregulate 
NRSFla sufficiently to allow selection and at 28 days are likely to be terminally 
differentiated and of reduced clinical value. Considering NRSFla for purification of 
dental pulp cells, it is likely that it can be utilised to purify neuronal precursor cells 
from both induced and non-induced populations, potentially allowing for the 
selection of progressively more committed phenotypes depending on clinical 
requirement. Isolation of non-induced cells and cells exhibiting progressively more 
committed neuronal phenotypes can be homogeneously characterised and their 
ability to generate varying types of functional neuronal phenotype assessed. 
Furthermore, given that previously hypothesised purification of neuronal progenitor 
subsets based upon CD81+ and NGFR+ selection resulted in populations which 
demonstrated a heterogeneic phenotype following attaimnent of confluency, 
selection based upon this functional transcriptional capacity can homogeneously 
discriminate against potential progenitor impurities and thereby assess whether 
dental pulp-derived populations do in fact strive to remain within the heterogeneic 
niche, and subsequently re-establish heterogeneity through a series of specific 
differentiation events. If this is the case, further studies can assess the effects of 
heterogeneity from a clinical perspective and, should it prove to be detrimental, 
investigate in vitro conditions capable of programming cells to maintain a 
homogeneous phenotype.
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7.4 Dlk-1 SCCD
7.4.1 Utilisation of Dlk-1 SCCD for the Purification of Adipogenic Progenitors
Genetically based approaches using the 3T3-L1 pre-adipocyte cell line have 
facilitated the identification of key transcription factors key to the complex 
transcriptional cascade that is activated during adipogenesis. Such factors include 
PPAR gamma 2, C/EBP, and ADD1-sterol regulatory element binding protein 1c, 
whose combined sequential activation induce expression of adipocyte-specific genes, 
subsequently resulting in the activation of enzymes, structural proteins, hormone 
receptors, and a variety of secreted factors involved in the regulation of energy 
homeostasis420. Identification of these factors within differentiating stem and 
progenitor populations has illustrated their ability to differentiate to an adipogenic 
phenotype. However, the utilisation of cycling adipogenic precursors in vivo has 
been plagued by controversial phenomena detailing the dedifferentiation of 
preadipocytes to macrophages421. The phenomena has however, proved difficult to 
confirm given the heterogeneity of implanted cells. Furthermore, should the 
phenomena prove to be correct, evidence of its existence fails to generate a solution 
to the issue given that the mechanisms underlying their hypothesised 
dedifferentiation are vague. From both a scientific and clinical perspective therefore, 
the homogeneous implantation of adipogenic precursors would yield both conclusive 
scientific answers and consequently plausible clinical benefits. Understanding the 
homogeneous dedifferentiation, if indeed it does occur, would allow tailoring of the 
pre-implantation culture conditions to retain the pre-adipogenic phenotype. In fact 
the purification of pre-adipocytes alone may be sufficient to prevent 
dedifferentiation, removing the array of chemokines and growth factors present 
within the heterogeneous populations, factors which may have a significant role in 
pre-adipocyte dedifferentiation.
In an attempt to identify a functional SCCD associated with adipogenesis, 
bioinfonnatics were employed to assess genes and their surrounding regions 
associated with adipogenic differentiation. Following examination, Dlk-1, an in vitro 
inhibitor of adipogenesis422, was identified as having a highly conserved region 
approximately 18kb upstream of the exon region, furthermore containing a binding
330
site for the adipogenesis-associated transcription factor FREAC-2. Synthetic 
sequences mimicking this SCCD region were constructed and the resulting product 
cloned into a pGL3p vector.
7.4.2 Demonstration of a Dlk-1 SCCD Regulatory Capacity in Bone Marrow-
derived MSCs Cultured in Basal and Adiuogenic Differentiation
Media
In an attempt to demonstrate a regulatory function of the Dlk-1 SCCD during in vitro 
adipogenesis, passage 5 bone marrow-derived MSCs were transfected using 
Effectene methodologies. Cells cultured in basal media demonstrated upregulation of 
1,5- to 3.3- fold during the 28 day culture period {Figure 7.15). Upon initial 
introduction of chemically-defmed adipogenic stimulation, Dlk-1 remained 
upregulated within the cells, generating 2.77-, 2.48- and 1.40- fold increase at days 3, 
7, and 14 respectively. However, following 21 days of differentiation, Dlk-1 was 
downregulated 0.24 fold, and exhibited a further downregulation of 0.37-fold 
following 28 days and terminal differentiation of cells, as observed by Oil Red O 
staining.
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7.4.3 Demonstration of a Dlk-1 SCCD Regulatory Capacity in Dental Pulp-
derived MSCs Cultured in Basal and Adipogenic Differentiation
Media
The pGL3p-Dlk-l SCCD containing construct was transfected into passage 5 pulp 
donor 3 cells in order to assess its regulatory impact during in vitro adipogenesis 
within the population. Post-Effectene transfection, cells cultured in basal media 
displayed an upregulation of the Dlk-1 SCCD, as demonstrated by 4.74-, 3.77-, 3.08- 
and 2.91- fold upregulation at days 3, 7, 14 and 21 respectively (Figure 7.16). 
Following induction with chemically-defined adipogenic media, Dlk-1 remained 
upregulated during the initial 7 days of differentiation, generating upregulation of 
4.31- and 1.28- fold at days 3 and 7 respectively. However, after 14 days of 
adipogenic induction, Dlk-1 was downregulated 0.16 fold, with 0.54 fold repression 
after 21 days and terminal differentiation.
7.4.4 Regulatory Capacity of Dlk-1 SCCD Represents Criteria on which to
Purify Homogenous Adipogenic Progenitor Populations
Results obtained with bone marrow and dental pulp-derived cells suggest that the 
Dlk-1 SCCD functions as a key regulator of adipogenesis, inducing transcription of 
the Dlk-1 gene which subsequently represses genes required for adipogenesis. Upon 
appropriate adipogenic stimulation, the Dlk-1 SCCD is downregulated, 
consequentially reducing transcriptional levels at the Dlk-1 gene and allowing 
expression of genes required for adipogenesis. This functional capacity represents an 
attractive target for the isolation of adipogenic precursors, sorting Dlk-1-GFP 
transfected cells exhibiting downregulation of Dlk-1. Cells exhibiting varying levels 
of Dlk-1 downregulation can be subsequently purified and assessed for their 
phenotypic properties, thereby allowing homogeneous selection of pre-adipocytes 
demonstrating a stage of lineage commitment for implantation. Utilisation of such a 
homogeneous population pre-implantation will allow definitive assessment and 
subsequently further understanding of dedifferentiation mechanisms should this 
phenomena prove correct, although the elimination of undesirable cells and their 
accompanying chemokines and growth factors may prevent such dedifferentiation 
occurring. However, given that it is plausible that cells may in fact re-establish
333
heterogeneity following purification, it may be that, following proof of this theory 
and assessment of heterogeneic impact from a clinical setting, in vitro manipulation 
is required to maintain Dlk-1 SCCD purified cells in a homogeneous manner.
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7.5 Conclusion
7.5.1 Stem Cell Conserved Domains as Markers for the Purification of Stem
Cells and Progenitors of Varying Lineage
Current antibody-based methods for the purification of cells fail to homogeneously 
isolate stem and progenitor subpopulations based upon their functional 
characteristics. SCCDs flanking genes known to regulate a desired phenotype offer a 
novel marker on which to purify cells exhibiting desired proliferative or 
differentiation capacities. Thus far, regulatory activities for Sox2, NRSF and Dlk-1 
SCCDs have been demonstrated using luciferase-based reporter constructs with an 
SV40 minimal promoter. Cells were transfected using Effectene, providing a 
transfection efficiency of between 60-70%. Whilst Amaxa transfections yielded 
greater efficiencies, up to 90% in many cases, the number of cells required per 
transfection (5 x 105) was unfeasible when experiments were required to confirm a 
regulatory function. However, upon cloning a selected SCCD region into a GFP 
vector to allow homogeneous isolation of a desired subpopulation, Amaxa 
transfections may instead be utilised as screening larger numbers of cells to allow 
purification of a greater number of the desired subpopulation. Thus far, regulatory 
impacts observed for Sox2, NRSF and Dlk-1 SCCD using luciferase reporter 
constructs generate a global regulatory value, with phenotypically dissimilar cells 
producing different luciferase values for each construct. Thus, whilst many cells may 
demonstrate upregulation of the given construct, the value attained may be lower due 
to repression of the construct by alternative subpopulations {Figure 7.17). GFP 
assessment using flow cytometry circumvents this problem, allowing individual 
assessment of a cells regulatory capacity, facilitating its purification.
Sox2 Regulatory values:
= Stem cell (Upregulation +5)
= Progenitor cell (Upregulation +2) 
t0r = Terminally differentiated cells (Downregulation
Heterogeneous cell population: Global upregulation of luciferase (and therefore SCCD) - +11 
Figure 7.77- Global regulatory analysis of a given SCCD using luciferase reporter constructs.
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Cloning of given SCCDs into a GFP vector with a minimal promoter will provide an 
invaluable tool to facilitate the generation of homogeneous subpopulations for 
scientific assessment or clinical application. Further specificity of desired 
subpopulations can be attained by cloning SCCDs of varying properties into 
alternative reporter constructs. For example, dual transfection of a population with a 
Sox2a-GFP/NRSFla-YFP combination will allow purification of highly primitive 
neuronal progenitors.
In conclusion, evolution of these SCCDs into a GFP reporter construct will allow the 
homogeneous purification of desired stem and progenitor subsets based upon a 
functional transcriptional capacity. Definitive homogeneous isolation using this 
technology will allow the hypothesised phenomena describing the capability of 
purified cells to re-establishment heterogeneity to be assessed. Furthermore, if this 
hypothesis proves correct, further studies can assess the impacts of heterogeneity 
from a clinical perspective and, should it prove to be detrimental, studies attempting 
to modify in vitro conditions capable of reprogramming SCCD purified populations 
to maintain the homogeneously selected phenotype can be undertaken.
7.5.2 Response to Chapter Aims
Results detailed within this chapter largely addressed the aims set out in 7.1.2 by 
confirming the binding of transcription factors, and subsequently a regulatory 
function, at SCCDs flanking the Sox2, NRSF and Dlk-1 genes. Whilst some of the 
SCCDs tested failed to demonstrate a functional role, Sox2a, NRSF la and Dlk-1 
were of significant interest for the purification of multipotent stem/progenitor cells, 
neuronal progenitors, and adipogenic progenitor cells, respectively. However, whilst 
data obtained using a luciferase reporter construct allowed for the identification of 
functional SCCDs, it is now required that such regions are cloned into a GFP reporter 
construct in order to allow homogeneous purification using high speed cell sorting. 
Unfortunately, this task was not achieved within the timeframe of this project.
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8. Discussion and Conclusions
8.1 Discussion
8.1.1 Bone Marrow-, Peripheral Blood. Umbilical Cord- and Dental Pulp-
derived cells for use in Tissue Engineering
For many years both medical and public sectors have envisaged radical off-the-shelf 
therapies for a diverse range of debilitating illnesses, essentially allowing autologous 
replacement of compromised tissues or organs. Whilst at first such concepts 
appeared fanciful, progressive advances within the synonymous fields of tissue 
engineering and regenerative medicine throughout the previous half century have 
raised hopes that such therapies can become available. Conceptual understandings of 
developmental lineage commitments have allowed tailoring of in vitro culture 
conditions to essentially mimic those encountered in vivo, resulting in the isolation, 
limited ex vivo expansion and, in some cases, guided lineage differentiation of stem 
and progenitor subsets isolated from numerous tissues.
Whilst ES cells have generated much excitement with regards their pluripotent 
capability, their erratic behaviour concerning spontaneous differentiation and 
karyotype in stability raises key issues from a technical perspective, whilst the 
destruction of embryos required for their isolation raises a minefield of ethical 
dilemmas. Novel iPS cell technologies have attempted to overcome these issues, 
though much concern has been voiced regarding the oncogenicity of factors required 
to induce reprogramming and the potential for insertional mutagenesis as a 
consequence of integrating retroviral or lentiviral vectors. Furthermore, current iPS 
cell technologies induce only a limited number of cells within given populations to 
undertake reprogramming, and it is therefore plausible that cells which have 
maintained a limited capacity to undertake differentiation i.e. stem or progenitor 
cells, can be more readily induced to undertake complete reprogramming following 
appropriate stimulation. Therefore iPS cell technologies may benefit considerably 
from the utilisation of homogeneous stem or progenitor cells as a starting material, 
allowing investigators to comprehensively identify factors required to 
homogeneously reprogram given stem or progenitor subsets. The results detailed
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within this study may therefore be applicable to investigators attempting to optimise 
future iPS cell induction techniques, allowing selection of populations at an optimum 
passage or following SCCD-based purification to increase reprogramming efficiency.
In addition to furthering future iPS cell reprogramming attempts, results obtained 
within this investigation detail in vitro characteristics of isolated populations which 
must be considered when undertaking future biomaterial design. Current potential 
therapeutics at the forefront of research involves the combination of hypothesised 
multipotent cell populations with topographically or chemically modified 
biomaterials, potentially generating functional organ or tissue replacements. 
However, whilst the field of biomaterial development continues to progress at a rapid 
pace, it may be that materials currently being devised subsequently prove redundant 
given the cell types being seeded.
Bone marrow-derived cells currently represent the most utilised cell source with 
respect to seeding on varyious biomaterials, although the multipotentiality of cells 
seeded remains heterogeneous. Bone marrow-derived cells exhibit an inability to 
maintain an MSC-associated phenotype following a sixth in vitro passage, and whilst 
numerous antigens are questionable with regards their functional representation, the 
downregulation of chondrogenesis-requiring antigen CD 105 suggests that the 
population exhibited a reduced capacity to differentiate following increasing culture. 
This downregulation of MSC-associated antigens coincided with a dramatic 
reduction in proliferation, a considerable problem if these cells are to be utilised 
clinically. It is likely that this downregulation of MSC-associated antigens and 
proliferative capacity following in vitro culture can be attributed to rapid aging of the 
cells, a hypothesis substantiated by the fact that MSC populations exhibited 
significantly greater telomere length degradation in vitro compared with those 
observed in previous in vivo studies. Since tissue engineering applications are likely 
to require large numbers of cells, it is suggested that further studies are required to 
optimise in vitro culture conditions and thereby prevent such rapid aging, allowing 
cells to proliferate to Hayflicks limit of 70 passages395. However, until this is 
acieved, it is recommended that biomaterials are seeded with bone marrow-derived 
cells cultured for no more than 4 passages in vitro prior to seeding, thereby 
introducing to the materials populations exhibiting higher expression of MSC-
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associated antigens with a greater capacity for proliferation and almost certainly 
differentiation. However, whilst this may allow partial tailoring of biomaterials, the 
inability of current culture methods to yield large numbers of bone man'ow-derived 
cells which have not undertaken rapid aging, and subsequently phenotypic and 
proliferation demise, are likely to prevent incorporation of these cells into a tissue 
engineered construct.
Peripheral blood represents an attractive source for the isolation of clinically 
desirable cells given the non-invasive procedures required for attainment, an 
additional drawback of bone marrow-derived cells. Adherent populations isolated 
from peripheral blood of four donors using Histopaque and RosetteSep exhibited no 
morphological or phenotypic differences, with each population heterogeneously 
expressing antigens associated with MSCs, HSCs, EPCs and alternative progenitor 
subsets. CFU assays further indicated the presence of hematopoietic and non- 
hematopoietic progenitors within each population isolated, with each isolation 
method and donor generating similar numbers of CPUs. It was not surprising 
therefore that isolated populations were able to undertake adipogenic, chondrogenic 
and osteogenic differentiation. However, adherent populations displayed a severe 
limitation to undertake proliferation, with cells unable to sustain mitosis post initial 
confluence. This inability to undertake proliferation is obviously significant with 
regards the utilisation of such cells in a clinical application, and thus culture 
conditions must be addressed in order to facilitate continued cell division. However, 
given the similar phenotypic expression with bone marrow-derived populations, it 
may be that blood-derived cells display the same phenotypic instability restricting the 
clinical utilisation of then* bone marrow-derived counterparts.
The phenotypic instability of bone marrow and peripheral blood-derived populations 
represents a severe limitation with regards their prospective use in tissue engineering 
applications. It was therefore hoped that umbilical cords, given their functional 
capacity within development, may allow for the isolation of primitive cells capable 
of maintained proliferation and multilineage differentiation. Adherent cells obtained 
by plating of Wharton’s jelly and whole cord digestions yielded morphologically 
dissimilar cells describing fibroblastic- and smooth muscle- like morphologies 
respectively. However, both populations demonstrated a similar phenotypic
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expression profile to that observed in bone marrow-derived cells, and furthermore 
suffered the same phenotypic instability. Furthermore, umbilical cord-derived 
populations demonstrated a downregulation of MSC-associated surface antigens 
following cryopreservation, limiting their ability to be banked for future use. 
Following a fifth passage each isolated population also demonstrated a reduced 
capacity to undertake proliferation, a significant restriction with regards clinical 
potential. This reduced proliferation was also characterised by the ceasing of 
nucleostemin expression, which terminated following a sixth passage. And whilst it 
is of significant clinical potential that cord populations were able to neuronally 
differentiate, their inability to generate large cell numbers for clinical application 
require that corresponding issues required to evolve bone marrow-derived cell 
therapeutics are addressed.
Whilst bone marrow, peripheral blood and umbilical cord-derived populations 
displayed the ability to differentiate within subsets of the population, their inability to 
maintain stable in vitro phenotypes and coinciding reduction of proliferation cause 
significant reason for concern from a therapeutic viewpoint given that large numbers 
of cells, and thus prolonged in vitro culture, are likely to be required for clinical 
application, hi the instance of bone marrow-derived cells, the downregulation of 
MSC-associated antigens and coinciding reduction in proliferation appears to be due 
to the rapid in vitro aging of the population, a phenomena confirmed by their rapidly 
reducing telomeres in comparison with that observed in vivo. Thus it is imperative 
that culture conditions are modified to limit this aging of bone marrow, and 
presumably peripheral blood and umbilical cord cells, if they are to be utilised 
clinically.
However, whilst cells derived from bone marrow, peripheral blood and umbilical 
cord demonstrated severe limitations from a clinical perspective, dental pulp cells 
overcome many of these problems. Isolated dental pulp cells retained the ability to 
proliferate, a feat probably attributable to their maintained or in v/vo-like reducing 
telomere lengths. Furthennore, their ability to undertake adipogenic, chondrogenic, 
osteogenic, neuronal and hepatic lineages offers immense clinical value. This could, 
however, represent the tip of their differentiation iceberg given the high number of 
CFU-forming cells within the population and heterogeneous expression of proteins
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such as Oct4 and Sox2, indicating pluripotent capability comparable to ES cells. If 
through further study this proves to be the case, dental pulp could represent a highly 
valuable clinical source, overcoming many of the ethical and technical dilemmas 
associated with ES cells, although given their similar characteristics, it is essential 
that issues of karyotypic stability within the population are addressed.
Nevertheless, whilst overcoming numerous ES cell-related issues, the heterogeneity 
of dental pulp populations compared with ES cells is problematic. Despite 
purification based upon a number of surface antigens, the re-establishment of a 
heterogeneic phenotype suggests the presence of a highly proliferative subpopulation 
for which current antibodies are unable discriminate. Interestingly, upon purification 
based upon Hoechst dye emission, phenomena associated with a functional HSC- 
associated transporter pump, adherent populations maintained a stable phenotype 
until acquiring confluence and furthermore demonstrated the ability to form 
microtubule-like structures when cultured in a semi-solid matrix. Moreover, given 
that the population re-established a heterogeneic phenotype following a second 
passage post-purification, it would suggest that purification based upon functional 
aspects of a given cell phenotype yield populations of greater homogeneity, although 
Hoechst emission fails to completely exclude the highly proliferative impurity. 
However, whilst cell impurities would appear a likely explanation for this re­
establishment of heterogeneity, it could be that homogeneously purified progenitors, 
which were likely purified given the slower cycling times of sorted cells, strive to 
maintain the heterogeneic niche, with homogeneous stem cell populations 
undergoing differentiation in order to re-establish this post-sorting. This data 
complements previous studies describing the in vitro heterogeneity of clonal 
neurospheres423, and it may be that populations are capable of flexible and regulated 
tissue self-organisation based on cell-cell and cell-environment interactions424.
Further adding to the likelihood that stem and progenitor subsets were predominantly 
isolated following antibody-based purification, studies examining protein expression 
profiles of cells immediately post-sorting revealed expression of proteins associated 
with primitive cells including those of the RPE lineage, thereby highlighting dental 
pulp as possessing numerous subpopulations of diverse clinical potential. Thus, 
given that antibody-based purification strategies are acknowledged to incorporate
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impurities, it is essential that homogeneous subpopulations be attained as to ascertain 
whether this phenomena concerning re-establishment of heterogeneity is due to 
progenitor impurities or is a result of populations striving to re-establish the 
heterogeneic niche. As such, a novel SCCD-based cell purification strategy was 
devised.
SCCD technologies are based on the conservation of advantageous genetic 
modifications throughout species development, utilising such regions as criteria upon 
which to base cell purification. The Sox2 gene represents a key regulator within the 
maintenance of plasticity, and neighbouring SCCDs, in particular Sox2a, 
demonstrated an upregulation within bone marrow, dental pulp and umbilical cord 
populations under basal conditions. However, following chemical lineage induction 
the Sox2a SCCD was downregulated, and interestingly also exhibited reduced 
expression in eighth passage bone marrow populations compared with their passage 
5 counterparts. It is therefore suggested that Sox2 SCCD functions to maintain 
plasticity within cells, facilitating the binding of transcription factors fundamental for 
maintenance of a primitive phenotype. Sox2a thus represents a criterion upon which 
to purify cells exhibiting varying levels of upregulation and, therefore, plasticity. 
Progression of this current technology towards a GFP-based reporter construct can 
facilitate its use in the purification of stem and progenitor subsets exhibiting such 
regulatory differences, finally allowing for the homogeneous culture of cells 
exhibiting varying lineage potential. This would also answer questions of the 
capability of purified cells to re-establish heterogeneity, an issue which must be 
addressed if it conspires to be the case.
Translating to the field of iPS cell technologies, this technology can provide a base 
cell culture on which to optimise reprogramming strategies, with the hypothesis that 
cells which have not terminally differentiated proving more cooperative to 
subsequent re-establishment of plasticity.
Given the dowmegulation of MSC-associated antigens and coinciding reduced 
proliferation, likely due to the rapid in vitro aging of the population, the 
homogeneous isolation of a stem cell population can provide a base upon which to 
tailor culture conditions to prevent degradation. Given the hastily reducing telomere
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lengths in vitro compared with those observed within the bone marrow niche, it is 
apparent that culture conditions do not replicate those present in vivo. Utilising a 
homogeneous stem cell population as a starting culture will exclude superfluous 
progenitor and terminally differentiated cell types which, given their likely emission 
of numerous growth factors which could have unknown effects upon the stem cell 
subset, will allow greater optimisation of cultures.
From a biomaterial construction perspective, the purification of homogeneous stem 
cell populations will allow for the seeding of known cell populations and subsequent 
assessment of material success. At present, given the heterogeneity of populations 
being seeded, biomaterial design experts face an almost impossible task of 
generating chemical or topographically specific materials cable of guided lineage 
specific differentiation. Thus current blueprints for biomaterials are likely to prove 
redundant until homogeneous populations can be seeded. However, whilst 
purification based upon the Sox2 SCCD can yield undifferentiated populations for 
material seeding, it may prove prudent to utilise progenitor subsets, sorted upon the 
basis of SCCDs such as Dlk-1 or NRSF in the respective cases of adipogenic and 
neuronal precursors, as homogeneous seeding materials. If we consider that tissue 
engineering and regenerative approaches strive to regenerate a functional organ or 
tissue composed of terminally differentiated cells, it seems of little value seeding 
cells of a completely undifferentiated state only to direct them towards a given 
lineage, since this is likely to greatly increase intricacy of the biomaterial design. 
However, isolation of committed proliferative precursors will require far less 
manipulation from the material, and may therefore represent a more attractive cell 
type for tissue regeneration.
In conclusion, this technology represents a powerful tool within the field, allowing 
for the isolation of homogeneous stem and progenitor subsets of immense clinical 
potential. Whilst SCCD purified populations from bone marrow, peripheral blood 
and umbilical cord are likely to represent populations upon which further tailoring of 
culture conditions are required to prevent hypothesised in vitro aging, dental pulp 
purified populations, many of which appear to represent exciting progenitor subsets 
given their protein expression profiles and differentiation capacity, can represent a 
cell source upon which to base numerous SCCD purification and future regenerative
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strategies. Thus the simultaneous development of novel cell purification strategies 
based upon SCCDs is likely complement this interesting cell source, yielding stem 
and progenitor subsets of varying lineage, and therefore clinical, potential. Prior to 
this, however, we must establish whether SCCD purified cells are capable of 
maintaining this homogeneously selected phenotype following in vitro culture and, if 
it conspires that cells do in fact differentiate to recreate the heterogeneic niche, the 
issues of heterogeneity within clinical applications must be more rigourously studied. 
If following such assessment it is demonstrated that homogeneity is required to 
achieve tissue regeneration, in vitro culture conditions must be tailored in order to re­
program cells to maintain a homogeneous phenotype.
8.2 Conclusions
8.2.1 Concluding remarks of the investigation
Given the informative characterisation of each cell type gathered within this study, it 
is essential to compiled findings in a straightforward manner. Following the aims of 
the study detailed in section 1.5.1, the conclusive findings of this study are:-
1. Optimisation of techniques for the isolation of cells from various niches 
yielded adherent populations of similar phenotypic properties:
In the case of human peripheral blood, Histopaque and 
RosetteSep isolated, regardless of donor variation, 
adherent cells of similar morphological and phenotypic 
characteristics, likely incorporating MSC-like cells, HSC 
and EPCs, and progenitor subsets of different lineage 
potential.
Acquisition of adherent populations following the direct 
plating of umbilical cord-derived Wharton’s jelly yielded 
cells exhibiting a fibroblastic-like morphology. 
Conversely, however, cells isolated from whole cord 
digestion exhibited a smooth muscle-like morphology. 
Nonetheless, despite such apparent morphological 
differences, each population exhibited similar phenotypic
345
characteristics, likely incorporating MSC-like cells, HSCs 
and EPCs, and ES cell-like and progenitor subsets. 
Populations isolated following the mechanical and 
enzymatic digestions of human dental pulp exhibited a 
fibroblastic morphology, with adherent populations from 
different donors displaying similar morphological and 
phenotypic characteristics, likely incorporating 
hematopoietic and non-hematopoietic cells of primitive 
and more mature phenotypes.
2. Isolated populations were assessed for their phenotype and subsequent in 
vitro maintenance:
Bone marrow-derived populations purchased from Lonza 
exhibited expression of MSC-associated surface antigens 
throughout passages 3 and 4. However, subsequent 
passages exhibited downregulation of such antigens. 
Furthermore, this downregulation coincided with 
upregulation of antigens hypothesised to be associated 
with terminally differentiated cells such as endothelial 
cells, suggesting spontaneous terminal differentiation 
within the population.
Histopaque and RosetteSep purified cells exhibited similar 
phenotypic profiles regardless of donor. Primary passage 
adherent populations demonstrated, with the exception of 
CD 166, similar expression of MSC-associated antigens 
with that observed in bone marrow-derived populations. 
Isolated peripheral blood populations also exhibited 
expression of antigens associated with EPCs, HSCs and ES 
cells. However, given their significant lack of proliferative 
capacity, peripheral blood cell phenotypes could only be 
assessed for a primary passage.
Umbilical cord cells isolated via plating of Wharton’s jelly 
or whole cord digestion displayed, with the exception of 
antigens CD 166, HLA-ABC and HLA-DR, similar
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phenotypic profiles. Furthermore, phenotypic 
characteristics were similar to those observed within bone 
marrow-derived cells, including the inability to maintain 
this phenotype following progressive in vitro culture. 
Additionally, cryopreservation and subsequent thawing of 
each isolated cord population induced similar phenotypic 
modifications to those observed following prolonged in 
vitro culture.
Dental pulp-derived populations similar phenotypic 
profiles; exhibiting antigens associated with MSCs, HSCs, 
ES cells and alternative progenitor subsets, in particular 
those of the neuronal developmental lineage. Of particular 
interest was the ability of each dental pulp-derived 
population to maintain this phenotype throughout 
prolonged in vitro culture, in this case up to 40 passages, 
and also cryopreservation, with no apparent phenotypic 
modification.
3. Following investigation of phenotypic profiles, umbilical cord and dental 
pulp-derived populations were assessed for their protein expression:
Umbilical cord-derived cells exhibited nuclear-localised 
expression of the stem cell proliferation marker 
nucleostemin throughout passages 3-5, after which no 
expression was observed. Given the downregulation of 
MSC-associated antigens following similar periods of 
prolonged culture, it is suggested that cord populations 
differentiate to a phenotype incorporating significantly 
reduced plasticity and possible terminal differentiation. 
Dental pulp populations from each donor maintained 
protein expression, demonstrating expression of plasticity 
regulators Oct4 and Sox2. Further to the continued 
expression of STRO-1 and nucleostemin, dental pulp cells 
exhibited expression of embryonic development-associated 
proteins Cripto-1 and Tra-1-81. Given the developmental
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origin of this niche, the expression of neural progenitor- 
associated proteins within subsets of the population 
implies a potential for future neuronal regeneration 
strategies. Furthermore, the expression of RPE lineage- 
associated proteins pax6 and MiTF implies a potential for 
the regeneration of macular disease.
4. If isolated multipotent populations are to be utilised clinically, it is likely that 
large numbers of cells, and hence prolonged in vitro culture, are likely to be 
required:
Bone marrow-derived populations exhibited severe 
limitations regarding their ability to maintain proliferation, 
with cells post passage 5 demonstrating greatly reduced 
proliferative capacity, a property which further diminished 
following further culture, with passage 9 cells failing to 
proliferate to confluency.
Quantitative proliferation analysis of Histopaque and 
RosetteSep blood-derived cells was unable to be 
undertaken given their proliferative limitations. Extensive 
work is therefore required if blood-derived populations are 
to be utilised clinically, endeavouring to establish in vitro 
conditions capable of maintaining mitosis.
Umbilical cord populations exhibited similar proliferative 
limitations to those observed within bone marrow-derived 
cells, with increasing in vitro culture reducing their 
capacity to undertake mitosis.
- Dental pulp-derived populations, regardless of donor, 
exhibited exaggerated capacity to undertake proliferation 
compared with bone marrow and umbilical cord-derived 
populations. Furthermore, cells were able to maintain 
proliferation throughout prolonged in vitro culture and also 
following cryopreservation.
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5. CFU analysis represents an attractive assay for the quantification of 
progenitor subsets within a given isolated cell type, thereby indicating 
potential clinical value of isolated populations:
Histopaque and RosetteSep peripheral blood-derived 
populations from different donors displayed similar 
numbers of CFU-Fs and CFU-GMs within the population, 
generating approximately 70 colonies/106 cells for each 
assay.
Dental pulp-derived populations from each donor 
demonstrated CFU-fomiing capabilities, and furthermore 
retained this capability throughout prolonged in vitro 
culture, indicating a maintained presence of progenitor 
subpopulations. Concerning CFU-F assays, dental pulp- 
derived populations continually generated approximately 
25 CFU-Fs/0.5 x 104 cells, whilst furthermore forming 
approximately 8 CFU-GMs/0.5 x 104 seeded cells.
6. Given the phenotypic instability of bone marrow-derived populations 
following prolonged in vitro passage, attempts were undertaken to gain a 
mechanistic understanding of events responsible. Rapid aging of cells, as 
quantified by rapidly reducing telomeres, has been suggested as a possible 
underlying reason. Bone marrow populations were therefore compared with 
dental pulp-derived populations, which exhibited no surface antigen or 
proliferation failure:
- In vivo bone marrow cells exhibit a consistent telomere 
shortening of approximately 17 bases per annum. 
However, in vitro bone-marrow derived populations 
exhibited reductions of approximately 100-150 bases per 
passage, indicating rapid in vitro aging. This is likely to be 
responsible for reduced proliferation and dowmegulation 
of surface antigens, and thus culture conditions need to be 
addressed in order to prevent this pronounced aging 
process.
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- Dental pulp-derived populations displayed no surface 
antigen or proliferative modifications despite in vitro 
culture, and thus it was not surprising that they maintained 
a telomere length of approximately 1.3 x 104 bases in 
donor 1 isolated cells.
7. Guided lineage differentiation following exposure to appropriate stimulation 
is the basis of numerous regenerative applications. Early passage bone 
marrow-derived cells have previously demonstrated the capacity to undertake 
adipogenic, chondrogenic and osteogenic differentiation, although their 
ability to do this was compromised following increasing passage, likely due 
to rapid aging within the population. Populations isolated from differing 
niches were therefore assessed for their differentiation potential:
Following appropriate stimulation, blood-derived 
populations demonstrated the capacity to differentiate to 
adipogenic, chondrogenic and osteogenic phenotypes 
following appropriate commercially available stimulation. 
However, their inability to proliferate and attain significant 
cell numbers prior to differentiation is a restriction for their 
clinical utilisation.
Previous studies have demonstrated the ability of umbilical 
cord-derived populations to differentiate to adipogenic, 
chondrogenic and osteogenic lineages. After introduction 
into commercially available neural induction media, cells 
isolated from Wharton’s jelly and whole cord digestions 
heterogeneously demonstrated morphological and 
phenotypic characteristics associated with a neuronal 
phenotype, which could potentially prove therapeutically 
useful. However, given their phenotypic instability 
following prolonged in vitro culture, it is necessary that 
this issue be addressed prior to further investigations with 
this cell source.
Dental pulp-derived cells from each donor exhibited an 
innate ability to heterogeneously undertake adipogenic,
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chondrogenic, osteogenic, neuronal and hepatic lineages 
following stimulation with both commercially available 
and chemically-defined media. Furthermore, following the 
demonstration that subpopulations within the culture 
exhibited expression of plasticity-associated proteins Oct-4 
and Sox2, it may be that such cells are able to fiilfil further 
differentiation commitment following appropriate 
stimulation. Additionally, given their retained phenotype 
following in vitro culture, these cells could represent a 
clinically valuable cell source for numerous regenerative 
applications.
8. Despite the overwhelming ability demonstrated by dental pulp-derived 
populations, it is imperative that, if they are to be utilised within a clinical 
setting, each subpopulation is homogeneously isolated and characterised for 
their respective characteristics and potential:
Dental pulp-derived populations isolated upon the basis of 
surface antigen expression initially demonstrated differing 
protein expression profiles. However, when allowed to 
proliferate to confluence these populations resumed the 
heterogeneous phenotype associated with this population, 
suggesting that impurities not fulfilling the selection 
criteria had been incorporated within the culture. This was 
further substantiated when purification based upon 
emission of Hoechst 33342 dye, hypothesised to allow the 
homogeneous sorting of EPCs. Such cells retained a 
differing phenotype following initial confluence, although 
following a second passage re-established the 
heterogeneous phenotype, suggesting that purification 
upon the basis of a functional aspect within the population 
allows for greater purification. Hoechst-isolated 
populations seeded within a semi-solid matrix 
demonstrated the spontaneous formation of microtubular­
like structures which expressed VWF and CD31, proteins
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associated with EPCs. Such populations could therefore 
represent an attractive source for future myocardial 
engineering attempts. However, whilst progenitor 
impurities offer a plausible explanation for this re­
establishment of heterogeneity, it could be that purified 
stem and progenitor subsets strive to maintain the 
heterogeneic niche. And whilst it is acknowledged that 
impurities are ncorporated following antibody-based cell 
sorting, given the primitive protein expressions obseived 
within initially adherent cells and furthermore the slow 
cycling time of sorted populations, this explanation offers 
an alternative theory which must be addressed, although 
the homogeneous purification of cells based upon 
functional capacity will be required to assess this 
hypothesis.
Given the limitations of antigen-based cell sorting, novel 
SCCD purification strategies were developed. Initial 
investigations utilising a luciferase reporter construct 
enabled proof of concept studies to be undertake. Resulting 
data indicated the potential utilisation of the Sox2a SCCD 
for the purification of stem and progenitor cell subsets 
exhibiting varying levels of plasticity from heterogeneous 
populations. Furthermore, NRSF and Dlk-1 residing 
SCCDs and their associated transcription factor binding 
properties could represent attractive criteria for the 
isolation of neuronal and adipogenic progenitor subsets, 
both of which represent attractive cell types within the 
field of tissue engineering.
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8.3 Future work
8.3.1 Further Work Required to Advance Current Understandings towards a
Clinical Setting
Despite the findings of this study, further investigations on numerous fronts are 
required to progress the utilisation of respective cell types within this exciting and 
rapidly progressing field. It is envisaged that characterisation experiments 
undertaken within this study will not only shed light upon the cell types covered, but 
also represent a basis on which to undertake fixture cell characterisation. 
Furthermore, whilst initial proof of concept studies utilising SCCD purification 
strategies are interesting, research now must focus upon progressing this technology 
to a GFP based vector in order to facilitate homogeneous purification of desired 
subpopulations. It is therefore suggested that, in order to progress the field of tissue 
engineering towards a clinical endpoint, the following issues and corresponding 
investigations are addressed:
1. Given the phenotypic and proliferative instability of bone marrow and 
umbilical cord-derived populations of increasing passage, a detrimental issue 
from a clinical perspective given the likely requirement for large numbers of 
unmodified cells, tailoring of current in vitro culture conditions is obviously 
required to allow proliferation to Hayflicks limit. Furthermore, given that this 
instability is likely due to the rapid aging of cells in vitro, it is suggested that 
culture optimisations use telomere lengths as a guide to success.
2. Whilst quantitative assessment of phenotype and proliferation of blood- 
derived cells proved difficult given their severe proliferative incapacity, it is 
likely that such populations undergo in vitro aging similar to that observed 
within bone marrow-derived cells. However, given their non-invasive 
isolation and spontaneous in vivo regenerative capacity, combined with then- 
ability to undertake adipogenic, chondrogenic and osteogenic lineages, they 
represent an attractive cell source if culture conditions can be devised to 
allow their maintained growth.
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3. A fundamental prerequisite of regenerative approaches to medicine permits 
that cells, in particular those gathered from redundant tissues such as dental 
pulp of deciduous teeth and umbilical cords, are able to be cryopreserved 
until required for a given restorative strategy in later life. Whilst dental pulp- 
derived cells displayed no instability subsequent to freeze-thawing, umbilical 
cord-derived populations demonstrated a phenotype similar to that of late 
passage cells. Thus, if umbilical cord-derived cells are to be therapeutically 
viable, it is necessary that they can be stored for prolonged periods with no 
phenotypic modification, and thus current cryopreservation protocols need to 
be addressed.
4. Given the innate ability of dental pulp-derived cells to differentiate to 
adipogenic, chondrogenic, osteogenic, neuronal and hepatic lineages, and 
furthermore their heterogeneous expression of proteins responsible for 
regulation plasticity, it is of significant interest to observe alternative lineages 
they are able to differentiate into. Optimisation of stimulatory media and 
biomaterials will therefore be devised in order to further assess their 
differentiation potential.
5. Whilst it is of significant interest to ascertain the full capability of dental 
pulp-derived populations, their homogeneous isolation and characterisation 
prior to utilisation is essential. Progression of Sox2 SCCD technologies to a 
GFP-based reporter construct will facilitate the isolation of cells exhibiting 
varying levels of plasticity, whilst NRSF and Dlk-1 SCCDs can allow the 
homogeneous isolation of neuronal and adipogenic progenitors.
6. Following to the homogeneous isolation of stem and progenitor subsets based 
on SCCD selection criteria, numerous in vitro and in vivo characterisation 
studies will be undertaken. Initial studies must investigate the theory 
indicating the potential of purified stem and progenitor subpopulations to re­
establish heterogeneity, an issue which, if true, must be rigourously studied. 
Primarily the impact of such heterogeneity must be established on the clinical 
application and, should it prove to be inhibitory to regeneration, in vitro 
tailoring of conditions reprogramming cells to maintain homogeneity must be 
addressed. Following such investigations, of particular interest may be the in
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vivo implantation of adipogenic precursors which, given the homogeneity of 
the implanted population, will conclusively provide evidence concerning pre­
adipocyte dedifferentiation to macrophages. Furthermore, understanding the 
homogeneous dedifferentiation, if indeed it does occur, would allow tailoring 
of pre-implantation culture conditions to retain the pre-adipogenic phenotype. 
In fact the purification of pre-adipocytes alone may be sufficient to prevent 
dedifferentiation, removing the array of chemokines and growth factors 
present within the heterogeneous populations, factors which may have 
significant impact on pre-adipocyte dedifferentiation.
355
9. References
1. Meijer, G.J., de Bmijn, J.D., Koole, R. & van Blitterswijk, C.A. Cell-Based 
Bone Tissue Engineering. PLoS Med 4, e9 (2007).
2. Muschler, G.F., Nakamoto, C. & Griffith, L.G. Engineering principles of 
clinical cell-based tissue engineering. JBone Joint Surg Am 86-A, 1541-1558 
(2004).
3. Petit-Zeman, S. Regenerative medicine. Nat Biotechnol 19, 201-206 (2001).
4. Griffith, L.G. & Naughton, G. Tissue engineering—cuii'ent challenges and 
expanding opportunities. Science 295, 1009-1014 (2002).
5. Rice, M.A., Dodson, B.T., Arthur, J.A. & Anseth, K.S. Cell-based therapies 
and tissue engineering. Otolaryngol Clin North Am 38, 199-214, v (2005).
6. Smith, K.D. & Angus McGrouther, D. Strategies for cell engineering in tissue 
repair. Wound Repair Regen 5, 212 (1997).
7. Alsberg, E., Anderson, K.W., Albeiruti, A., Rowley, J.A. & Mooney, D.J. 
Engineering growing tissues, Proc Natl Acad Sci USA 99, 12025-12030 
(2002).
8. Zandstra, P.W. The opportunity of stem cell bioengineering. Biotechnol 
Bioeng 88, 263 (2004).
9. Zandstra, P.W. & Nagy, A. Stem cell bioengineering. Annu Rev Biomed Eng 
3, 275-305 (2001).
10. Cancedda, R., Dozin, B., Giamioni, P. & Quarto, R. Tissue engineering and 
cell therapy of cartilage and bone. Matrix Biol 22, 81-91 (2003).
11. Schek, R.M., Taboas, J.M., Hollister, S.J. & Krebsbach, P.H. Tissue 
engineering osteochondral implants for temporomandibular joint repair. 
Orthod Craniofac Res 8, 313-319 (2005).
12. Hart, D.A., Kydd, A.S., Frank, C.B. & Hildebrand, K.A. Tissue repair in 
rheumatoid arthritis: challenges and opportunities in the face of a systemic 
inflammatory disease. Best Pract Res Clin Rheumatol 18, 187-202 (2004).
13. Gu, Y., Yu, J., Lum, L.G. & Lee, R.J. Tissue engineering and stem cell 
therapy for myocardial repair. Front Biosci 12, 5157-5165 (2007).
14. Levenberg, S. Engineering blood vessels from stem cells: recent advances 
and applications. Curr Opin Biotechnol 16, 516-523 (2005).
15. Gomillion, C.T. & Burg, KJ. Stem cells and adipose tissue engineering. 
Biomaterials 27, 6052-6063 (2006).
16. Patrick, C.W., Jr. Tissue engineering strategies for adipose tissue repair. Anat 
Rec 263,361-366 (2001).
17. Patrick, C.W., Jr. Adipose tissue engineering: the future of breast and soft 
tissue reconstruction following tumor resection. Semin Surg Oncol 19, 302- 
311 (2000).
18. Andrade, C.F., Wong, A.P., Waddell, T.K., Keshavjee, S. & Liu, M. Cell- 
based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol 
Physiol 292, L510-518 (2007).
19. MacNeil, S. Progress and opportunities for tissue-engineered skin. Nature 
445, 874-880 (2007).
20. Kubota, A., et al. Transplantable retinal pigment epithelial cell sheets for 
tissue engineering. Biomaterials 27, 3639-3644 (2006).
356
21. Bartold, P.M., McCulloch, C.A., Narayanan, A.S. & Pitaru, S. Tissue 
engineering: a new paradigm for periodontal regeneration based on molecular 
and cell biology. Periodontal 2000 24, 253-269 (2000).
22. Nakashima, M. & Akamine, A. The application of tissue engineering to 
regeneration of pulp and dentin in endodontics. J Endod 31, 711-718 (2005).
23. Cross, W.R., Thomas, D.F. & Southgate, J. Tissue engineering and stem cell 
research in urology. BJUInt 92, 165-171 (2003).
24. Kingham, P.J., Terenghi, G. & Birchall, M.A. Tissue engineering strategies 
for reinnervation of the larynx. Clin Otolaryngol 31, 245 (2006).
25. Humes, H.D. Cell therapy and tissue engineering for renal replacement 
therapy. Am J Kidney Dis 32, xlii-xliv (1998).
26. Joraku, A., Sullivan, C.A., Yoo, JJ. & Atala, A. Tissue engineering of 
functional salivary gland tissue. Laryngoscope 115, 244-248 (2005).
27. Ding, D.C., Shyu, W.C., Lin, S.Z. & Li, H. Current concepts in adult stem 
cell therapy for stroke. CurrMed Chem 13, 3565-3574 (2006).
28. Wallace, V.A. Stem cells: a source for neuron repair in retinal disease. Can J 
Ophthalmol 42, 442-446 (2007).
29. Yannas, I.V. Facts and theories of induced organ regeneration. Adv Biochem 
Eng Biotechnol 93, 1-38 (2005).
30. Yannas, I.V. Similarities and differences between induced organ regeneration 
in adults and early foetal regeneration. JR Soc Interface 2, 403-417 (2005).
31. Yannas, I.V., Kwan, M.D. & Longaker, M.T. Early fetal healing as a model 
for adult organ regeneration. Tissue Eng 13, 1789-1798 (2007).
32. Goessler, U.R., Riedel, K., Hermann, K. & Riedel, F, Perspectives of gene 
therapy in stem cell tissue engineering. Cells Tissues Organs 183, 169-179 
(2006).
33. Daley, G.Q., Goodell, M.A. & Snyder, E.Y. Realistic prospects for stem cell 
therapeutics. Hematology Am Soc Hematol Educ Program, 398-418 (2003).
34. Stoltz, J.F., et al. Cell and tissue engineering and clinical applications: an 
overview. Biomed Mater Eng 16, S3-S18 (2006).
35. Myckatyn, T.M., Mackinnon, S.E. & McDonald, J.W. Stem cell 
transplantation and other novel techniques for promoting recovery from 
spinal cord injury. Transpl Immunol 12, 343-358 (2004).
36. Fodor, W.L. Tissue engineering and cell based therapies, from the bench to 
the clinic: the potential to replace, repair and regenerate. Reprod Biol 
Endoainol 1, 102 (2003).
37. Sanmartin, A., English, D. & Sanberg, P.R. Stem cells in cell transplantation. 
Stem Cells Dev 15, 963-966 (2006).
38. SanMaitin, A. & Borlongan, C.V. Cell transplantation: toward cell therapy. 
Cell Transplant 15, 665-673 (2006).
39. Koh, CJ. & Atala, A. Tissue engineering, stem cells, and cloning: 
opportunities for regenerative medicine. J Am Soc Nephrol 15, 1113-1125 
(2004).
40. Lutolf, M.P., et al Synthetic matrix metalloproteinase-sensitive hydrogels for 
the conduction of tissue regeneration: engineering cell-invasion 
characteristics. Proc Natl Acad Sci USA 100, 5413-5418 (2003).
41. Hattori, H., et al Bone formation using human adipose tissue-derived stromal 
cells and a biodegradable scaffold. J Biomed Mater Res B Appl Biomater 76, 
230-239 (2006).
357
42. Simpson, D., Liu, H., Fan, T.H., Nerem, R. & Dudley, S.C., Jr. A Tissue 
Engineering Approach to Progenitor Cell Delivery Results in Significant Cell 
Engraftment and Improved Myocardial Remodeling. Stem Cells (2007).
43. Fox, J.M., Chamberlain, G., Ashton, B.A. & Middleton, J. Recent advances 
into the understanding of mesenchymal stem cell trafficking. Br J Haematol 
137, 491-502 (2007).
44. Chen, S.L., et al. Improvement of cardiac function after transplantation of 
autologous bone marrow mesenchymal stem cells in patients with acute 
myocardial infarction. Chin Med J (Engl) 117, 1443-1448 (2004).
45. Miyahara, Y., et al. Monolayered mesenchymal stem cells repair scarred 
myocardium after myocardial infarction. Nat Med 12, 459-465 (2006).
46. Shiota, M., et al. Isolation and characterization of bone marrow-derived 
mesenchymal progenitor ceils with myogenic and neuronal properties. Exp 
Cell Res 313, 1008-1023 (2007).
47. Wiehe, J.M., et al. Labeling of adult stem cells for in vivo-application in the 
human heart. Histol Histopathol 20, 901-906 (2005).
48. Le Blanc, K., et al. Treatment of severe acute graft-versus-host disease with 
third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441 
(2004).
49. Fang, B., Song, Y., Zhao, R.C., Han, Q. & Lin, Q. Using human adipose 
tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft- 
versus-host disease resembling acute hepatitis. Transplant Proc 39, 1710- 
1713 (2007).
50. Fang, B., Song, Y.P., Liao, L.M., Han, Q. & Zhao, R.C. Treatment of severe 
therapy-resistant acute graft-versus-host disease with human adipose tissue- 
derived mesenchymal stem cells. Bone Marrow Transplant 38, 389-390 
(2006).
51. Audet, J. Stem cell bioengineering for regenerative medicine. Expert Opin 
Biol Ther 4, 631-644 (2004).
52. Raghunath, J., Salacinski, H.J., Sales, K.M., Butler, P.E. & Seifalian, A.M. 
Advancing cartilage tissue engineering: the application of stem cell 
technology. Carr Opin Bioteclmol 16, 503-509 (2005).
53. Mauney, J.R., Volloch, V. & Kaplan, D.L. Matrix-mediated retention of 
adipogenic differentiation potential by human adult bone marrow-derived 
mesenchymal stem cells during ex vivo expansion. Biomaterials 26, 6167- 
6175 (2005).
54. Yoshimoto, H., Shin, Y.M., Terai, H. & Vacanti, J.P. A biodegradable 
nano fiber scaffold by electrospinning and its potential for bone tissue 
engineering. Biomaterials 24, 2077-2082 (2003).
55. PP, B.M., et al. Chitosan particles agglomerated scaffolds for cartilage and 
osteochondral tissue engineering approaches with adipose tissue derived stem 
cells. J Mater Sci Mater Med 16, 1077-1085 (2005).
56. Lechner, S. & Huss, R. Bone engineering: combining smart biomaterials and 
the application of stem cells. Artif Organs 30, 770-774 (2006).
57. Mao, J.J., et al. Craniofacial tissue engineering by stem cells. J Dent Res 85, 
966-979 (2006).
58. Blau, H.M., Brazelton, T.R. & Weimann, J.M. The evolving concept of a 
stem cell: entity or function? Cell 105, 829-841 (2001).
59. Alison, M.R., Poulsom, R., Forbes, S. & Wright, N.A. An introduction to 
stem cells. J Pathol 197, 419-423 (2002).
358
60. Crick, F. Central dogma of molecular biology. Nature 227, 561-563 (1970).
61. Lakshmipathy, U. & Verfaillie, C. Stem cell plasticity. Blood Rev 19, 29-38 
(2005).
62. Horwitz, E.M. Stem cell plasticity: a new image of the bone marrow stem 
cell. Curr Opin Pediatr 15, 32-37 (2003).
63. Kohyama, J., et al Brain from bone: efficient "meta-differentiation" of 
marrow stroma-derived mature osteoblasts to neurons with Noggin or a 
demethylating agent. Differentiation 68, 235-244 (2001).
64. Frisen, J. Stem cell plasticity? Neuron 35, 415-418 (2002).
65. Wulf, G.G., Jackson, K.A. & Goodell, M.A. Somatic stem cell plasticity: 
current evidence and emerging concepts. Exp Hematol 29, 1361-1370 (2001).
66. Forbes, S.J., Vig, P., Poulsom, R., Wright, N.A. & Alison, M.R. Adult stem 
cell plasticity: new pathways of tissue regeneration become visible. Clin Sci 
(Bond) 103, 355-369 (2002).
67. Almeida-Porada, G., Porada, C. & Zanjani, E.D. Adult stem cell plasticity 
and methods of detection. Rev Clin Exp Hematol 5, 26-41 (2001).
68. Alsberg, E., von Recum, H.A. & Mahoney, M.J. Environmental cues to guide 
stem cell fate decision for tissue engineering applications. Expert Opin Biol 
Ther 6, 847-866 (2006).
69. Benayahu, D., Akavia, U.D. & Shur, I. Differentiation of bone marrow 
stroma-derived mesenchymal cells. Curr Med Chem 14, 173-179 (2007).
70. Mertelsmann, R. Plasticity of bone marrow-derived stem cells. J Hematother 
Stem Cell Res 9, 957-960 (2000).
71. Colter, D.C., Class, R., DiGirolamo, C.M. & Prockop, D.J. Rapid expansion 
of recycling stem cells in cultures of plastic-adherent cells from human bone 
marrow. Proc Natl Acad Sci USA 97, 3213-3218 (2000).
72. Martin-Rendon, E. & Watt, S.M. Exploitation of stem cell plasticity. Transfus 
Med 13, 325-349 (2003).
73. Poulsom, R., Alison, M.R., Forbes, SJ. & Wright, N.A. Adult stem cell 
plasticity. J Pathol 197, 441-456 (2002),
74. Goodell, M. A., et al Stem cell plasticity in muscle and bone marrow. Ann N 
Y Acad Sci 938, 208-218; discussion 218-220 (2001).
75. Pittenger, M.F., et al Multilineage potential of adult human mesenchymal 
stem cells. Science 284, 143-147 (1999).
76. Planat-Benard, V., et al Plasticity of human adipose lineage cells toward 
endothelial cells: physiological and therapeutic perspectives. Circulation 109, 
656-663 (2004).
77. Wislet-Gendebien, S., et al Plasticity of cultured mesenchymal stem cells: 
switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 
23, 392-402 (2005).
78. Zuk, P.A., et al Multilineage cells from human adipose tissue: implications 
for cell-based therapies. Tissue Eng 7, 211-228 (2001).
79. Makino, S., et al Cardiomyocytes can be generated from marrow stromal 
cells in vitro. J Clin Invest 103, 697-705 (1999).
80. Sanchez-Ramos, J.R. Neural cells derived from adult bone marrow and 
umbilical cord blood. JNeurosci Res 69, 880-893 (2002).
81. Harris, J.R., et al Bone marrow-derived cells home to and regenerate retinal 
pigment epithelium after injury. Invest Ophthalmol Vis Sci 47, 2108-2113 
(2006).
359
82. Strem, B.M., et al Multipotential differentiation of adipose tissue-derived 
stem cells. Keio JMed 54, 132-141 (2005).
83. Jiang, Y„ et al Pluripotency of mesenchymal stem cells derived from adult 
marrow. Nature 447, 880-881 (2007).
84. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from 
mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 
663-676 (2006).
85. Gurdon, J.B. From nuclear transfer to nuclear reprogramming: The reversal 
of cell differentiation. Annual Review Of Cell And Developmental Biology 22, 
1-22 (2006).
86. Gurdon, J.B. Nuclear transplantation in eggs and oocytes. J Cell Sci Suppl 4, 
287-318 (1986).
87. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N. & Tada, T. Nuclear 
reprogramming of somatic cells by in vitro hybridization with ES cells. Curr 
Biolll, 1553-1558 (2001).
88. Perry, A.C. Induced pluripotency and cellular alchemy. Nat Biotechnol 24, 
1363-1364 (2006).
89. Hochedlinger, K. & Jaenisch, R. Nuclear reprogramming and pluripotency. 
Nature 441, 1061-1067 (2006).
90. Hansis, C., Barreto, G., Maltry, N. & Niehrs, C. Nuclear reprogramming of 
human somatic cells by xenopus egg extract requires BRG1. Curr Biol 14, 
1475-1480 (2004).
91. Kikyo, N., Wade, P.A., Guschin, D., Ge, H. & Wolffe, A.P. Active 
remodeling of somatic nuclei in egg cytoplasm by the nucleosomal ATPase 
ISWI. Science 289, 2360-2362 (2000).
92. Campbell, P.A., Perez-Iratxeta, C., Andrade-Navarro, M.A. & Rudnicki, 
M.A. Oct4 targets regulatory nodes to modulate stem cell function. PLoS 
ONE 2, e553 (2007).
93. Masui, S„ et al. Pluripotency governed by Sox2 via regulation of Oct3/4 
expression in mouse embryonic stem cells. Nat Cell Biol 9, 625-635 (2007).
94. Wang, J., et al. A protein interaction network for pluripotency of embryonic 
stem cells. Nature 444, 364-368 (2006).
95. Hatano, S.Y., et al Pluripotential competence of cells associated with Nanog 
activity. Mech Dev 122, 67-79 (2005).
96. Wang, Z.X.. et al Oct4 and sox2 directly regulate expression of another 
pluripotency transcription factor, Zfp206, in embryonic stem cells. Journal 
Of Biological Chemistry 282, 12822-12830 (2007).
97. Loh, Y.H., et al The Oct4 and Nanog transcription network regulates 
pluripotency in mouse embryonic stem cells. Nat Genet 38, 431-440 (2006).
98. Kaji, K., et al The NuRD component Mbd3 is required for pluripotency of 
embryonic stem cells. Nat Cell Biol 8, 285-292 (2006).
99. Byrne, J.A., Simonsson, S., Western, P.S. & Gurdon, J.B. Nuclei of adult 
mammalian somatic cells are directly reprogrammed to oct-4 stem cell gene 
expression by amphibian oocytes. Curr Biol 13, 1206-1213 (2003).
100. Mitsui, K., et al The homeoprotein Nanog is required for maintenance of 
pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003).
101. Chambers, I„ et al. Functional expression cloning of Nanog, a pluripotency 
sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003).
102. Pan, G. & Thomson, J.A. Nanog and transcriptional networks in embryonic 
stem cell pluripotency. Cell Res 17, 42-49 (2007).
360
103. Nichols, JM et al. Formation of pluripotent stem cells in the mammalian 
embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 
(1998).
104. Avilion, A.A., et al. Multipotent cell lineages in early mouse development 
depend on SOX2 function. Genes Dev 17, 126-140 (2003).
105. Solter, D. From teratocarcinomas to embryonic stem cells and beyond: a 
history of embryonic stem cell research. Nat Rev Genet 7, 319-327 (2006).
106. Lavine, M., Roberts, L. & Smith, O. If I Only Had a. Science 295, 995-
(2002).
107. Ding, S. & Schultz, P.G. A role for chemistry in stem cell biology. Nat 
Biotech?2ol 22, 833-840 (2004).
108. Thomson, J.A., et al Embryonic stem cell lines derived from human 
blastocysts. Science 282, 1145-1147 (1998).
109. Choong, C. & Rao, M.S. Human embryonic stem cells. Neurosurg Clin NAm 
18, 1-14, vii (2007).
110. Geijsen, N., et al. Derivation of embryonic germ cells and male gametes from 
embryonic stem cells. Nature 427, 148-154 (2004).
111. Hubner, K., et al. Derivation of oocytes from mouse embryonic stem cells. 
Science 300, 1251-1256 (2003).
112. Toyooka, Y., Tsunekawa, N., Akasu, R. & Noce, T. Embryonic stem cells 
can form germ cells in vitro. Proc Natl Acad Sci USA 100, 11457-11462 
(2003).
113. Fischbach, G.D. & Fischbach, R.L. Stem cells: science, policy, and ethics. J 
Clin Invest 114, 1364-1370 (2004).
114. Costa, F.F., Le Blanc, K. & Brodin, B. Concise review: cancer/testis antigens, 
stem cells, and cancer. Stem Cells 25, 707-711 (2007).
115. Bobrow, J.C. The ethics and politics of stem cell research. Trans Am 
Ophthalmol Soc 103, 138-141; discussion 141-132 (2005).
116. Balint, J.A. Ethical issues in stem cell research. Albany Law Rev 65, 729-742
(2002).
117. Brace, A. The search for truth and freedom: ethical issues surrounding human 
cloning and stem cell research. J Law Med 9, 323-335 (2002).
118. Childress, J.F. Human stem cell research: some controversies in bioethics and 
public policy. Blood Cells Mol Dis 32, 100-105 (2004).
119. Chin, J.J. Ethical issues in stem cell research. Med J Malaysia 58 Suppl A, 
111-118 (2003).
120. Cohen, C.B. Ethical issues in embryonic stem cell research. Jama 285, 1439; 
author reply 1440 (2001).
121. de, S.C.N.M. Research ethics, science policy, and four contexts for the stem 
cell debate. JInvestig Med 54, 38-42 (2006).
122. de Wert, G. The use of human embryonic stem cells for research: an ethical 
evaluation. Prog Brain Res 138, 465-470 (2002).
123. Vicini, A. Ethical issues and approaches in stem cell research: from 
international insights to a proposal. J Soc Christ Ethics 23, 71-98 (2003).
124. Wainwright, S.P., Williams, C., Michael, M., Farsides, B. & Cribb, A. Ethical 
boundary-work in the embryonic stem cell laboratory. Social Health Illn 28, 
732-748 (2006).
125. Welin, S. Ethical issues in human embryonic stem cell research. Acta Obstet 
Gynecol Scand 81, 377-382 (2002).
361
126. Wertz, D.C. Embryo and stem cell research in the United States: history and 
politics. Ge?ie Ther 9, 674-678 (2002).
127. Solter, D. & Knowles, B.B. Immunosurgery of mouse blastocyst. Proc Natl 
Acad Sci US All, 5099-5102 (1975).
128. Balbach, S.T., et al Chromosome stability differs in cloned mouse embryos 
and derivative ES cells. Dev Biol 308, 309-321 (2007).
129. Matveeva, N.M., et al. Unequal segregation of parental chromosomes in 
embryonic stem cell hybrids. MolReprod Dev 71, 305-314 (2005).
130. Ljubuncic, P. & Reznick, A.Z. The evolutionary theories of aging revisited—a 
mini-review. Gerontology 55, 205-216 (2009).
131. Shamblott, M.J., et al. Derivation of pluripotent stem cells from cultured 
human primordial germ cells. Proc Natl Acad Sci USA 95, 13726-13731 
(1998).
132. Gurdon, J.B., Laskey, R.A. & Reeves, O.R. The developmental capacity of 
nuclei transplanted from keratinized skin cells of adult frogs. JEmbiyol Exp 
Morphol 34, 93-112 (1975).
133. Gurdon, J.B. Nuclear transplantation and the analysis of gene activity in early 
amphibian development. Adv Exp Med Biol 62, 35-44 (1975).
134. Quinlivan, T.D., Martin, C.A., Taylor, W.B. & Cairney, I.M. Estimates of 
pre- and perinatal mortality in the New Zealand Romney Marsh ewe. I, Pre- 
and perinatal mortality in those ewes that conceived to one service. J Reprod 
Fertil 11, 379-390 (1966).
135. Nash, M.L., Hungerford, L.L., Nash, T.G. & Zinn, G.M. Risk factors for 
perinatal and postnatal mortality in lambs. Vet Rec 139, 64-67 (1996).
136. Wilmut, I, Schnieke, A.E., McWliir, J., Kind, AJ. & Campbell, K.H. Viable 
offspring derived from fetal and adult mammalian cells. Cloning Stem Cells 
9, 3-7 (2007).
137. Ready, T. Scientists resign over stem-cell study. Nat Med 8, 200 (2002).
138. Wilmut, I. Are there any normal cloned mammals? Nat Med 8, 215-216
(2002).
139. Tamashiro, K.L., et al. Cloned mice have an obese phenotype not transmitted 
to their offspring. Nat Med 8, 262-267 (2002).
140. Maherali, N., et al Directly reprogrammed fibroblasts show global epigenetic 
remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70 
(2007).
141. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent 
induced pluripotent stem cells. Nature 448, 313-317 (2007).
142. Liu, H., et al. Generation of induced pluripotent stem cells from adult rhesus 
monkey fibroblasts. Cell Stem Cell 3, 587-590 (2008).
143. Yu, J., et al. Induced pluripotent stem cell lines derived from human somatic 
cells. Science 318, 1917-1920 (2007).
144. Muller, L.U., Daley, G.Q. & Williams, D.A. Upping the Ante: Recent 
Advances in Direct Reprogramming. Mol Ther (2009).
145. Nakagawa, M., et al. Generation of induced pluripotent stem cells without 
Myc from mouse and human fibroblasts. Nat Bioteclmol 26, 101-106 (2008).
146. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. 
Generation of mouse induced pluripotent stem cells without viral vectors. 
Science 322, 949-953 (2008).
362
147. Stadtfeld, M., Nagaya, M., Utikal, J.5 Weir, G. & Hochedlinger, K. Induced 
pluripotent stem cells generated without viral integration. Science 322, 945- 
949 (2008).
148. Huangfu, D., et al Induction of pluripotent stem cells by defined factors is 
greatly improved by small-molecule compounds. Nat Biotechnol 26, 795-797 
(2008).
149. Kim, J.B., et al Oct4-induced pluripotency in adult neural stem cells. Cell 
136,411-419(2009).
150. Park, I.H., et al Reprogramming of human somatic cells to pluripotency with 
defined factors. Nature 451, 141-146 (2008).
151. Takahashi, K., et al Induction of pluripotent stem cells from adult human 
fibroblasts by defined factors. Cell 131, 861-872 (2007).
152. Alison, M.R., et al Recipes for adult stem cell plasticity: fusion cuisine or 
readymade? J Clin Pathol 57, 113-120 (2004).
153. Brzoska, M., Geiger, H., Gauer, S. & Baer, P. Epithelial differentiation of 
human adipose tissue-derived adult stem cells. Biochem Biophys Res 
Commun 330, 142-150 (2005).
154. Chen, Y., Teng, F.Y. & Tang, B.L. Coaxing bone marrow stromal 
mesenchymal stem cells towards neuronal differentiation: progress and 
uncertainties. Cell Mol Life Sci 63, 1649-1657 (2006).
155. Gimble, J. & Guilak, F. Adipose-derived adult stem cells: isolation, 
characterization, and differentiation potential. Cytotherapy 5, 362-369 (2003).
156. Grove, J.E., Brascia, E. & Krause, D.S. Plasticity of bone marmw-derived 
stem cells. Stem Cells 22, 487-500 (2004).
157. Kim, S., et al Neural differentiation potential of peripheral blood- and bone- 
maiTow-derived precursor cells. Brain Res 1123, 27-33 (2006).
158. Quesenberry, P J., et al Stem cell plasticity: an overview. Blood Cells Mol 
Dis 32, 1-4 (2004).
159. Sekiya, I., Larson, B.L., Vuoristo, J.T., Cui, J.G. & Prockop, D.J. Adipogenic 
differentiation of human adult stem cells from bone marrow stroma (MSCs).
J Bone Miner Res 19, 256-264 (2004).
160. Spyridonidis, A., Zeiser, R., Folio, M., Metaxas, Y. & Finke, J. Stem cell 
plasticity: the debate begins to clarify. Stem Cell Rev 1, 37-43 (2005).
161. Verfaillie, C.M. Adult stem cells: assessing the case for pluripotency. Trends 
Cell Biol 12, 502-508 (2002).
162. Yang, X., et al Plasticity of epidermal adult stem cells derived from adult 
goat ear skin. Mol Reprod Dev 74, 386-396 (2007),
163. Young, H.E. & Black, A.C., Jr. Adult stem cells. Anat Rec A Discov Mol Cell 
EvolBiol 276, 75-102 (2004).
164. Hong, L., Peptan, LA., Colpan, A. & Daw, J.L. Adipose tissue engineering by 
human adipose-derived stromal cells. Cells Tissues Organs 183, 133-140 
(2006).
165. Binder, S.P. & Fox, B.S. Tissue engineering of bone. Cell based strategies. 
Clin Orthop Relat Res, S68-83 (1999).
166. Marcacci, M., et al New cell-based technologies in bone and cartilage tissue 
engineering. II. Cartilage regeneration. Chir Organi Mov 88, 42-47 (2003).
167. Lietz, M., Dreesmann, L., Hoss, M., Oberhoffner, S. & Schlosshauer, B. 
Neuro tissue engineering of glial nerve guides and the impact of different cell 
types. Biomaterials 27, 1425-1436 (2006).
363
168. Yen, A.H. & Sharpe, P.T. Stem cells and tooth tissue engineering. Cell Tissue 
Res 331, 359-372 (2008).
169. Dieterlen-Lievre, F. On the origin of haemopoietic stem cells in the avian 
embryo: an experimental approach. JEmbryol Exp Morphol 33, 607-619 
(1975).
170. Turpen, J.B., Knudson, C.M. & Hoefen, P.S. The early ontogeny of 
hematopoietic cells studied by grafting cytogenetically labeled tissue anlagen: 
localization of a prospective stem cell compartment. Dev Biol 85, 99-112 
(1981).
171. Ciau-Uitz, A., Walmsley, M. & Patient, R. Distinct origins of adult and 
embryonic blood in Xenopus. Cell 102, 787-796 (2000).
172. Moore, M.A. & Metcalf, D. Ontogeny of the haemopoietic system: yolk sac 
origin of in vivo and in vitro colony forming cells in the developing mouse 
embryo. Br J Haematol 18, 279-296 (1970).
173. Muller, A.M., Medvinsky, A., Strouboulis, J., Grosveld, F. & Dzierzak, E. 
Development of hematopoietic stem cell activity in the mouse embryo. 
Immunity 1, 291-301 (1994).
174. Medvinsky, A. & Dzierzak, E. Definitive hematopoiesis is autonomously 
initiated by the AGM region. Cell 86, 897-906 (1996).
175. de Bruijn, M.F., Speck, N.A., Peeters, M.C. & Dzierzak, E. Definitive 
hematopoietic stem cells first develop within the major arterial regions of the 
mouse embryo. EMBO J19, 2465-2474 (2000).
176. Dzierzak, E, The emergence of definitive hematopoietic stem cells in the 
mammal. Curr Opin Hematol 12, 197-202 (2005).
177. Flake, A.W., Hanison, M.R., Adzick, N.S. & Zanjani, E.D. Transplantation 
of fetal hematopoietic stem cells in utero: the creation of hematopoietic 
chimeras. Science 233, 776-778 (1986).
178. Kondo, M., et al Biology of hematopoietic stem cells and progenitors: 
implications for clinical application. Annu Rev Immunol 21, 759-806 (2003).
179. Giebel, B., et al Primitive human hematopoietic cells give rise to 
differentially specified daughter cells upon their initial cell division. Blood 
107,2146-2152 (2006).
180. Barzilay, R., et al Induction of human mesenchymal stem cells into 
dopamine-producing cells with different differentiation protocols. Stem Cells 
Dev 17, 547-554 (2008).
181. Sheng, H„ et al. A critical role of IFNgamma in priming MSC-mediated 
suppression of T cell proliferation through up-regulation of B7-H1. Cell Res 
18, 846-857 (2008).
182. Keating, A. How do mesenchymal stromal cells suppress T cells? Cell Stem 
Cell 2,106-108 (2008).
183. Baal, N„ et al Expression of transcription factor Oct-4 and other embryonic 
genes in CD 133 positive cells from human umbilical cord blood. Thi'omb 
Haemost 92, 767-775 (2004).
184. Voelkel, T., et al Highly efficient neural differentiation of peripheral blood 
human hematopoietic stem cells. EASES J. 22, 30- (2008).
185. Ebihara, Y., et al Hematopoietic origins of fibroblasts: II. In vitro studies of 
fibroblasts, CFU-F, and fibrocytes. Exp Hematol 34, 219-229 (2006).
186. Chen, N., et al Human umbilical cord blood progenitors: the potential of 
these hematopoietic cells to become neural. Stem Cells 23, 1560-1570 (2005).
364
187. Gomez-Ochoa, PM et al. Isolation and development of haematopoietic 
progenitor cells from peripheral blood of adult and newborn pigs. Acta Vet 
Hung 55, 171-180(2007).
188. Shizum, J.A., Negrin, R.S. & Weissman, LL. Hematopoietic stem and 
progenitor cells: clinical and preclinic al regeneration of the hematolymphoid 
system. Annu Rev Med 56, 509-538 (2005).
189. Antin, J.H. Graft-versus-leukemia: no longer an epiphenomenon. Blood 82, 
2273-2277 (1993).
190. Ferrara, J.L., Levy, R. & Chao, N.J. Pathophysiologic mechanisms of acute 
graft-vs.-host disease. Biol Blood Marrow Transplant 5, 347-356 (1999).
191. Friedenstein, A.J., Chailakhjan, R.K. & Lalykina, K.S. The development of 
fibroblast colonies in monolayer cultures of guinea-pig bone marrow and 
spleen cells. Cell Tissue Kinet 3, 393-403 (1970).
192. Alhadlaq, A. & Mao, J.J. Tissue-engineered neogenesis of human-shaped 
mandibular condyle from rat mesenchymal stem cells. JDent Res 82, 951- 
956 (2003).
193. Thomson, B.M., et al. Preliminary characterization of porcine bone marrow 
stromal cells: skeletogenic potential, colony-forming activity, and response to 
dexamethasone, transforming growth factor beta, and basic fibroblast growth 
idiQXov. J Bone Miner Res 8, 1173-1183 (1993).
194. Meirelles Lda, S. & Nardi, N.B. Murine marrow-derived mesenchymal stem 
cell: isolation, in vitro expansion, and characterization. BrJHaematol 123, 
702-711 (2003).
195. Jiang, Y.} et al Pluripotency of mesenchymal stem cells derived from adult 
marrow. Nature 418, 41-49 (2002).
196. Alhadlaq, A., et al Adult stem cell driven genesis of human-shaped articular 
condyle. Ann Biomed Eng 32, 911-923 (2004).
197. Wakitani, S., et al Mesenchymal cell-based repair of large, full-thickness 
defects of articular cartilage. J Bone Joint SurgAm 76, 579-592 (1994).
198. Kadiyala, S., Young, R.G., Thiede, M.A. & Bruder, S.P. Culture expanded 
canine mesenchymal stem cells possess osteochondrogenic potential in vivo 
and in vitro. Cell Transplant 6, 125-134 (1997).
199. Shang, Q., et al Tissue-engineered bone repair of sheep cranial defects with 
autologous bone marrow stromal cells. J Craniofac Surg 12, 586-593; 
discussion 594-585 (2001).
200. Ringe, J„ et al Porcine mesenchymal stem cells. Induction of distinct 
mesenchymal cell lineages. Cell Tissue Res 307, 321-327 (2002).
201. Worster, A.A., Nixon, A.J., Brower-Toland, B.D. & Williams, J. Effect of 
transforming growth factor beta 1 on chondrogenic differentiation of cultured 
equine mesenchymal stem cells. Am J Vet Res 61, 1003-1010 (2000).
202. Niku, M., Ilmonen, L., Pessa-Morikawa, T. & livanainen, A. Limited 
contribution of circulating cells to the development and maintenance of 
nonhematopoietic bovine tissues. Stem Cells 22, 12-20 (2004).
203. Simmons, P.J. & Torok-Storb, B. Identification of stromal cell precursors in 
human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 
55-62 (1991).
204. Seshi, B., Kumar, S. & Sellers, D. Human bone marrow stromal cell: 
coexpression of markers specific for multiple mesenchymal cell lineages. 
Blood Cells Mol Dis 26, 234-246 (2000).
365
205. Haynesworth, S.E., Baber, M.A. & Caplan, A.I. Cell surface antigens on 
human marrow-derived mesenchymal cells are detected by monoclonal 
antibodies. Bone 13, 69-80 (1992).
206. Modderman, W.E., Vrijheid-Lammers, T., Lowik, C.W. & Nijweide, P.J. 
Removal of hematopoietic cells and macrophages from mouse bone marrow 
cultures: isolation of fibroblastlike stromal cells. Exp Hematol 22, 194-201 
(1994).
207. Van Vlasselaer, P., Falla, N., Snoeck, H. & Mathieu, E. Characterization and 
purification of osteogenic cells from murine bone marrow by two-color cell 
sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin. 
Blood 753-763 (1994).
208. Rickard, D.J., et al Isolation and characterization of osteoblast precursor 
cells from human bone marrow. JBone Miner Res 11, 312-324 (1996).
209. Gronthos, S., Simmons, P.J., Graves, S.E. & Robey, P.G. Integrin-mediated 
interactions between human bone marrow stromal precursor cells and the 
extracellular matrix. Bone 28,174-181 (2001).
210. Gronthos, S., et al Molecular and cellular characterisation of highly purified 
stromal stem cells derived from human bone marrow. J Cell Sci 116, 1827- 
1835 (2003).
211. Hinds, K.A., et al. Highly efficient endosomal labeling of progenitor and 
stem cells with large magnetic particles allows magnetic resonance imaging 
of single cells. Blood 102, 867-872 (2003).
212. Alison, M.R., Brittan, M., Lovell, M.J. & Wright, N.A. Markers of adult 
tissue-based stem cells. Handb Exp Pharmacol, 185-227 (2006).
213. Tseng, P.Y., Chen, C.J., Sheu, C.C., Yu, C.W. & Huang, Y.S. Spontaneous 
differentiation of adult rat marrow stromal cells in a long-term culture. J Vet 
Med Sci 69, 95-102 (2007).
214. Zannettino, A.C., et al. Human mulipotential mesenchymal/stromal stem cells 
are derived from a discrete subpopulation of STRO-lbright/CD34 /CD45(- 
)/glycophorin-A-bone marrow cells. Haematologica 92, 1707-1708 (2007).
215. Gronthos, S. & Zannettino, A.C. A method to isolate and purify human bone 
marrow stromal stem cells. Methods Mol Biol 449, 45-57 (2008).
216. Tsai, R.Y. & McKay, R.D. A nucleolar mechanism controlling cell 
proliferation in stem cells and cancer cells. Genes Dev 16, 2991-3003 (2002).
217. Baddoo, M., et al Characterization of mesenchymal stem cells isolated from 
murine bone marrow by negative selection. J Cell Biochem 89, 1235-1249 
(2003).
218. Lengner, C.J., Welstead, G.G. & Jaenisch, R. The pluripotency regulator 
Oct4: a role in somatic stem cells? Cell Cycle 7, 725-728 (2008).
219. Liedtke, S., Stephan, M. & Kogler, G. Oct4 expression revisited: potential 
pitfalls for data misinterpretation in stem cell research. Biol Chem 389, 845- 
850 (2008).
220. Zuk, P.A. The intracellular distribution of the ES cell totipotent markers 
OCT4 and Sox2 in adult stem cells differs dramatically according to 
commercial antibody used. J Cell Biochem 106, 867-877 (2009).
221. Lengner, C.J., et al Oct4 expression is not required for mouse somatic stem 
cell self-renewal. Cell Stem Cell 1, 403-415 (2007).
222. Greco, S.J., Liu, K. & Rameshwar, P. Functional similarities among genes 
regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem 
Cells 25, 3143-3154 (2007).
366
223. Izadpanah, R., et al Characterization of multipotent mesenchymal stem cells 
from the bone marrow of rhesus macaques. Stem Cells Dev 14, 440-451 
(2005).
224. Ulloa-Montoya, F., et al Comparative transcriptome analysis of embryonic 
and adult stem cells with extended and limited differentiation capacity. 
Genome Biol 8, R163 (2007).
225. Prockop, D.J. Marrow stromal cells as stem cells for nonhematopoietic 
tissues. Science 276, 71-74 (1997).
226. Mets, T. & Verdonk, G. In vitro aging of human bone marrow derived 
stromal cells. Mech Ageing Dev 16, 81-89 (1981).
227. D'Ippolito, G., Schiller, P.C., Ricordi, C., Roos, B.A. & Howard, G.A. Age- 
related osteogenic potential of mesenchymal stromal stem cells from human 
vertebral bone marrow. JBone Miner Res 14, 1115-1122 (1999).
228. Binder, S.P., Jaiswal, N. & Haynesworth, S.E. Growth kinetics, self-renewal, 
and the osteogenic potential of purified human mesenchymal stem cells 
during extensive subcultivation and following cryopreservation. J Cell 
Biochem 64, 278-294 (1997).
229. Digirolamo, C.M., et al. Propagation and senescence of human marrow 
stromal cells in culture: a simple colony-forming assay identifies samples 
with the greatest potential to propagate and differentiate. Br J Haematol 107, 
275-281 (1999).
230. Banfi, A., et al Proliferation kinetics and differentiation potential of ex vivo 
expanded human bone marrow stromal cells: Implications for their use in cell 
therapy. Exp Hematol 28, 707-715 (2000).
231. Stendemp, K., Justesen, J., Clausen, C. & Kassem, M. Aging is associated 
with decreased maximal life span and accelerated senescence of bone marrow 
stromal cells. Bone 33, 919-926 (2003).
232. Rombouts, W.J. & Ploemacher, R.E. Primary murine MSC show highly 
efficient homing to the bone marrow but lose homing ability following 
culture. Leukemia 17, 160-170 (2003).
233. Baxter, M.A., et al Study of telomere length reveals rapid aging of human 
marrow stromal cells following in vitro expansion. Stem Cells 22, 675-682 
(2004).
234. Raposio, E., et al Characterization of multipotent cells from human adult hair 
follicles. Toxicol In Vitro 21, 320-323 (2007).
235. Gage, F.H. Mammalian neural stem cells. Science 287, 1433-1438 (2000).
236. Jiao, J. & Chen, D.F. Induction of neurogenesis in nonconventional 
neurogenic regions of the adult central nervous system by niche astrocyte- 
produced signals. Stem Cells 26, 1221-1230 (2008).
237. Bentley, A.J., et al Characterization of human corneal stem cells by 
synchrotron infrared micro-spectroscopy. Mol Vis 13, 237-242 (2007).
238. German, M.J., et al Characterization of putative stem cell populations in the 
cornea using synchrotron infrared microspectroscopy. Invest Ophthalmol Vis 
Sci 47, 2417-2421 (2006).
239. Kim, H.S., et al Phenotypic characterization of human corneal epithelial cells 
expanded ex vivo from limbal explant and single cell cultures. Exp Eye Res 
79, 41-49 (2004).
240. Revoltella, R.P., Papini, S., Rosellini, A. & Michelini, M. Epithelial stem 
cells of the eye surface. Cell Prolif40, 445-461 (2007).
367
241. Alunad, L, Das, A.V., James, J., Bhattacharya, S. & Zhao, X. Neural stem 
cells in the mammalian eye: types and regulation. Semin Cell Dev Biol 15, 
53-62 (2004).
242. Ahmad, I., Tang, L. & Pham, H. Identification of neural progenitors in the 
adult mammalian eye. Biochem Biophys Res Commun 270, 517-521 (2000).
243. Amato, M.A., Arnault, E. & Perron, M. Retinal stem cells in vertebrates: 
parallels and divergences. IntJDev Biol 48, 993-1001 (2004).
244. Sun, G., Asami, M., Ohta, H., Kosaka, J. & Kosaka, M. Retinal 
stem/progenitor properties of iris pigment epithelial cells. Dev Biol 289, 243- 
252 (2006).
245. Arthur, A., Ryclikov, G., Shi, S., Koblar, S.A. & Gronthos, S. Adult human 
dental pulp stem cells differentiate toward functionally active neurons under 
appropriate environmental cues. Stem Cells 26,1787-1795 (2008).
246. Jo, Y.Y., et al. Isolation and characterization of postnatal stem cells from 
human dental tissues. Tissue Eng 13, 767-773 (2007).
247. Liu, X., Driskell, R.R. & Engelhardt, J.F. Stem cells in the lung. Methods 
Enzymol 419, 285-321 (2006).
248. Abuljadayel, IS., et al SCID repopulating cells derived from umnobilised 
adult human peripheral blood. Curr Med Res Opin 20, 87-100 (2004).
249. Kuwana, M., et al Human circulating CD 14+ monocytes as a source of 
progenitors that exhibit mesenchymal cell differentiation. JLeukoc Biol 74, 
833-845 (2003).
250. Roufosse, C.A., Direkze, N.C., Otto, W.R. & Wright, N.A. Circulating 
mesenchymal stem cells. IntJBiochem Cell Biol 36, 585-597 (2004).
251. Zhao, Y., et al A unique human blood-derived cell population displays high 
potential for producing insulin. Biochem Biophys Res Commun 360, 205-211 
(2007).
252. Barile, L., Messina, E., Giacomello, A. & Marban, E. Endogenous Cardiac 
Stem Cells. Prog Cardiovasc Dis 50, 31-48 (2007).
253. Booth, C., O'Shea, J.A. & Potten, C.S. Maintenance of functional stem cells 
in isolated and cultured adult intestinal epithelium. Exp Cell Res 249, 359- 
366(1999).
254. Potten, C.S. Stem cells in gastrointestinal epithelium: numbers, 
characteristics and death. Philos Trans R Soc Lond B Biol Sci 353, 821-830 
(1998).
255. Stappenbeck, T.S., Mills, J.C. & Gordon, J.I. Molecular features of adult 
mouse small intestinal epithelial progenitors. Proc Natl Acad Sci USA 100, 
1004-1009 (2003).
256. Wong, M.H. Regulation of intestinal stem cells. J Investig Dermatol Symp 
Proc 9, 224-228 (2004).
257. Banas, A., et al Adipose tissue-derived mesenchymal stem cells as a source 
of human hepatocytes. Hepatology 46, 219-228 (2007).
258. Boquest, A.C., Shahdadfar, A., Brinchmann, J.E. & Collas, P. Isolation of 
stromal stem cells from human adipose tissue. Methods Mol Biol 325, 35-46 
(2006).
259. Casteilla, L. & Dani, C. Adipose tissue-derived cells: from physiology to 
regenerative medicine. Diabetes Metab 32, 393-401 (2006).
260. Casteilla, L., et al Plasticity of adipose tissue: a promising therapeutic 
avenue in the treatment of cardiovascular and blood diseases? Arch Mai 
Coeur Vaiss 98, 922-926 (2005).
368
261. Choi, Y.S., et al Adipogenic differentiation of adipose tissue derived adult 
stem cells in nude mouse. Biochem Biophys Res Commun 345, 631-637 
(2006).
262. Dicker, A., et al Functional studies of mesenchymal stem cells derived from 
adult human adipose tissue. Exp Cell Res 308, 283-290 (2005).
263. Gimble, J.M., Katz, A.J. & Bunnell, B.A. Adipose-derived stem cells for 
regenerative medicine. Circ Res 100, 1249-1260 (2007).
264. Hausman, GJ. & Hausman, D.B. Search for the preadipocyte progenitor cell. 
J Clin Invest 116, 3103-3106 (2006).
265. Deasy, B.M., Jankowski, RJ. & Huard, J. Muscle-derived stem cells: 
characterization and potential for cell-mediated therapy. Blood Cells Mol Dis 
27, 924-933 (2001).
266. O'Brien, K., Muskiewicz, K. & Gussoni, E. Recent advances in and 
therapeutic potential of muscle-derived stem cells. J Cell Biochem Suppl 38, 
80-87 (2002).
267. Tajbakhsh, S. Skeletal muscle stem and progenitor cells: reconciling genetics 
and lineage. Exp Cell Res 306, 364-372 (2005).
268. Vourc'h, P., et al Isolation and characterization of cells with neurogenic 
potential from adult skeletal muscle. Biochem Biophys Res Commun 317, 
893-901 (2004).
269. Belicchi, M., et al Human skin-derived stem cells migrate throughout 
forebrain and differentiate into astrocytes after injection into adult mouse 
brain. JNeurosci Res 77, 475-486 (2004).
270. Cotsarelis, G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol 
126, 1459-1468 (2006).
271. Kawase, Y., Yanagi, Y., Takato, T., Fujimoto, M. & Okochi, H. 
Characterization of multipotent adult stem cells from the skin: transforming 
growth factor-beta (TGF-beta) facilitates cell growth. Exp Cell Res 295, 194- 
203 (2004).
272. Meindl, S., Schmidt, U., Vaculik, C. & Elbe-Burger, A. Characterization, 
isolation, and differentiation of murine skin cells expressing hematopoietic 
stem cell markers. JLeukoc Biol 80, 816-826 (2006).
273. Watt, F.M. Epidermal stem cells: markers, patterning and the control of stem 
cell fate. Philos Trans R Soc Bond B Biol Sci 353, 831-837 (1998).
274. Gimble, J.M. & Guilak, F. Differentiation potential of adipose derived adult 
stem (ADAS) cells. Curr Top Dev Biol 58, 137-160 (2003).
275. Corti, S., et al Identification of a primitive brain-derived neural stem cell 
population based on aldehyde dehydrogenase activity. Stem Cells 24, 975-985 
(2006).
276. Sosnova, M., Bradl, M. & Forrester, J.V. CD34+ corneal stromal cells are 
bone marrow-derived and express hemopoietic stem cell markers. Stem Cells 
23, 507-515 (2005).
277. Kerkis, I., et al Isolation and characterization of a population of immature 
dental pulp stem cells expressing OCT-4 and other embryonic stem cell 
markers. Cells Tissues Organs 184, 105-116 (2006).
278. Nowak, J.A., Polak, L., Pasolli, H.A. & Fuchs, E. Hair follicle stem cells are 
specified and function in early skin morphogenesis. Cell Stem Cell 3, 33-43 
(2008).
279. Montgomery, R.K. & Breault, D.T. Small intestinal stem cell markers. JAnat 
213, 52-58 (2008).
369
280. Kim, C.F. Paving the road for lung stem cell biology: bronchioalveolar stem 
cells and other putative distal lung stem cells. Am JPhysiol Lung Cell Mol 
Physiol 293, L1092-1098 (2007).
281. Porat, Y., et al Isolation of an adult blood-derived progenitor cell population 
capable of differentiation into angiogenic, myocardial and neural lineages. Br 
J Haematol 135, 703-714 (2006).
282. Delo, D.M., De Coppi, P., Bartsch, G., Jr. & Atala, A. Amniotic fluid and 
placental stem cells. Methods Enzymol 419, 426-438 (2006).
283. Fauza, D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet 
Gynaecol 18, 877-891 (2004).
284. Kaviani, A., et al The placenta as a cell source in fetal tissue engineering. J 
Pediatr Snrg 37, 995-999; discussion 995-999 (2002).
285. Matikainen, T. & Laine, J. Placenta-an alternative source of stem cells. 
Toxicol Appl Pharmacol 207, 544-549 (2005).
286. Coles, B.L., et al. Facile isolation and the characterization of human retinal 
stem cells. Proc Natl Acad Sci USA 101, 15772-15777 (2004).
287. Engelhardt, M., Bogdahn, U. & Aigner, L. Adult retinal pigment epithelium 
cells express neural progenitor properties and the neuronal precursor protein 
doublecortin. Brain Res 1040, 98-111 (2005).
288. Toma, J.G., et al Isolation of multipotent adult stem cells from the dermis of 
mammalian skin. Nat Cell Biol 3, 778-784 (2001).
289. Carlin, R., Davis, D., Weiss, ML, Schultz, B. & Troyer, D. Expression of early 
transcription factors Oct4, Sox2 and Nanog by porcine umbilical cord (PUC) 
matrix cells. Reprod Biol Endocrinol 4, 8 (2006).
290. Wang, H.S., et al Mesenchymal stem cells in the Wharton's jelly of the 
human umbilical cord. Stem Cells 22, 1330-1337 (2004).
291. Alvarado-Moreno, A., Chavez-Gonzalez, A., Cerbulo, A., Arriaga, L. & 
Mayani, H. Cell cycle differences in vitro between primitive hematopoietic 
cell populations from adult and umbilical cord blood. Stem Cells Dev 16, 
223-230 (2007).
292. Aoki, M., Yasutake, M. & Murohara, T. Derivation of functional endothelial 
progenitor cells from human umbilical cord blood mononuclear cells isolated 
by a novel cell filtration device. Stem Cells 22, 994-1002 (2004).
293. Cicuttini, F.M., Welch, K. & Boyd, A.W. Characterization of CD34+HLA- 
DR-CD38+ and CD34+HLA-DR-CD38- progenitor cells from human 
umbilical cord blood. Growth Factors 10,127-134 (1994).
294. Oka, M., et al CD9 is associated with leukemia inhibitory factor-mediated 
maintenance of embryonic stem cells. Mol Biol Cell 13, 1274-1281 (2002).
295. Viriyakosol, S., Mathison, J.C., Tobias, P.S. & Kirkland, T.N. Structure- 
function analysis of CD 14 as a soluble receptor for lipopolysaccharide. J Biol 
Chem 275, 3144-3149 (2000).
296. Gadhoum, S.Z. & Sackstein, R. CD 15 expression in human myeloid cell 
differentiation is regulated by sialidase activity. Nat Chem Biol 4, 751-757 
(2008).
297. Jimenez-Marin, A., et al Molecular cloning and characterization of the pig 
homologue to human CD29, the integrin betal subunit. Transplantation 70, 
649-655 (2000).
298. Herszfeld, D., et al CD30 is a survival factor and a biomarker for 
transformed human pluripotent stem cells. Nat Biotechnol 24, 351-357 
(2006).
370
299. DeLisser, H.M., et al. Involvement of endothelial PECAM-1/CD31 in 
angiogenesis. Am J Pathol 151, 671-677 (1997).
300. Steen, R., Tjonnfjord, G.E., Groseth, L.A. & Egeland, T. Characteristics of 
haemopoietic progenitor cells related to CD34 epitope class expression. EurJ 
Haematol 64, 245-251 (2000).
301. Bourguignon, L.Y., Peyrollier, K., Xia, W. & Gilad, E. Hyaluronan-CD44 
interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene 
expression, and ankyrin-regulated multidrug efflux in breast and ovarian 
tumor cells. J Biol Chem 283, 17635-17651 (2008).
302. Hermiston, ML., Xu, Z. & Weiss, A. CD45: a critical regulator of signaling 
thresholds in immune cells. Anna Rev Immunol 21, 107-137 (2003).
303. Kos, F.J. & Chin, C.S. Costimulation of T cell receptor-triggered IL-2 
production by Jurkat T cells via fibroblast growth factor receptor 1 upon its 
engagement by CD56. Immunol Cell Biol 80, 364-369 (2002).
304. Barry, F., Boynton, R., Murphy, M, Haynesworth, S. & Zaia, J. The SH-3 
and SH-4 antibodies recognize distinct epitopes on CD73 from human 
mesenchymal stem cells. Biochem Biophys Res Commun 289, 519-524 
(2001).
305. Airas, L., Niemela, J. & Jalkanen, S. CD73 engagement promotes 
lymphocyte binding to endothelial cells via a lymphocyte function-associated 
antigen-1-dependent mechanism. J Immunol 165, 5411-5417 (2000).
306. Klassen, H., Schwartz, M.R., Bailey, A.H. & Young, M.J. Surface markers 
expressed by multipotent human and mouse neural progenitor cells include 
tetraspanins and non-protein epitopes. Neurosci Lett 312,180-182 (2001).
307. Nakamura, Y.3 et al. Expression of CD90 on keratinocyte stem/progenitor 
cells. Br J Dermatol 154, 1062-1070 (2006).
308. Cho, S.K., Bourdeau, A., Letarte, M. & Zuniga-Pflucker, J.C. Expression and 
function of CD105 during the onset of hematopoiesis from Flkl(+) 
precursors. Blood 98, 3635-3642 (2001).
309. Fu, X., et al Migration of bone marrow-derived mesenchymal stem cells 
induced by tumor necrosis factor-alpha and its possible role in wound 
healing. Wound Repair Regen 17, 185-191 (2009).
310. Monsef, N., Seller, M., Isaksson, M., Abrahamsson, P.A. & Panagopoulos, I. 
The expression of pluripotency marker Oct 3/4 in prostate cancer and benign 
prostate hyperplasia. Prostate (2009).
311. Peh, G.S., Lang, R.J., Pera, M.F. & Hawes, S.M. CD 133 expression by neural 
progenitors derived from human embryonic stem cells and its use for their 
prospective isolation. Stem Cells Dev 18, 269-282 (2009).
312. Sorrentino, A., et al. Isolation and characterization of CD146+ multipotent 
mesenchymal stromal cells. Exp Hematol 36, 1035-1046 (2008).
313. Varma, M.J., et al. Phenotypical and functional characterization of freshly 
isolated adipose tissue-derived stem cells. Stem Cells Dev 16, 91-104 (2007).
314. Kim, J., et al. Ex vivo characteristics of human amniotic membrane-derived 
stem cells. Cloning Stem Cells 9, 581-594 (2007).
315. De Meyer, S.F., Deckmyn, H. & Vanhoorelbeke, K. Von Willebrand factor to 
the rescue. Blood (2009).
316. Kumar, S., Coenen, M.J., Scherer, P.E. & Balm, R.S. Evidence for enhanced 
adipogenesis in the orbits of patients with Graves' ophthalmopathy. J Clin 
EndocrinolMetab 89, 930-935 (2004).
371
317. Rodriguez, A.M., et aL Adipocyte differentiation of multipotent cells 
established from human adipose tissue. Biochem Biophys Res Commun 315, 
255-263 (2004).
318. Ryden, M„ et al Functional characterization of human mesenchymal stem 
cell-derived adipocytes. Biochem Biophys Res Commun 311, 391-397 (2003).
319. Zvonic, S., et al. Secretome of primary cultures of human adipose-derived 
stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics 6, 
18-28 (2007).
320. David, J.J., Tullu, M.S., Rathi, P., Sawalakhe, N. & Ghildiyal, R.G. Neonatal 
presentation of a rare metabolic liver disease. Trop Gastroenterol 29, 229- 
231 (2008).
321. Jelliffe-Pawlowski, L.L., Walton-Haynes, L. & Currier, RJ. Identification of 
second trimester screen positive pregnancies at increased risk for congenital 
heart defects. Prenat Diagn (2009).
322. Kaibori, M., Matsui, K., Saito, T. & Kamiyama, Y. Risk factors for early 
death due to recuiTence after resection of large hepatocellular carcinomas. 
Hepatogastroenterology 55, 2151-2156 (2008).
323. Warren, M. & Karen, T.S. Two cases of primary yolk sac tumor of the liver 
in childhood; case reports and literature review. Pediatr Dev Pathol, 1 
(2009).
324. Wu, F.X., et al Identifying serological biomarkers of hepatocellular 
carcinoma using surface-enhanced laser desorption/ionization-time-of-flight 
mass spectroscopy. Cancer Lett (2009).
325. Cai, Y.F., Chen, J.S., Su, S.Y., Zhen, ZJ. & Chen, H.W. Passage of bone- 
marrow-derived liver stem cells in a proliferating culture system. World J 
Gastroenterol 15, 1630-1635 (2009).
326. Barry, F,, Boynton, R.E., Liu, B. & Murphy, J.M. Chondrogenic 
differentiation of mesenchymal stem cells from bone marrow: differentiation- 
dependent gene expression of matrix components. Exp Cell Res 268, 189-200 
(2001).
327. Chen, J.R., et al Transplanted bone marrow stromal cells migrate, 
differentiate and improve motor function in rats with experimentally induced 
cerebral stroke. JAnat 213, 249-258 (2008).
328. Yu, L.M., Wosnick, J.H. & Shoichet, M.S. Miniaturized system of 
neurotrophin patterning for guided regeneration. JNeurosci Methods 171, 
253-263 (2008).
329. Joe, P.A., Banerjee, A. & Luduena, R.F. The roles of cysl24 and ser239 in 
the functional properties of human betalll tubulin. Cell Motil Cytoskeleton 
65, 476-486 (2008).
330. Draberova, E., et al Class III beta-tubulin is constitutively coexpressed with 
glial fibrillary acidic protein and nestin in midgestational human fetal 
astrocytes: implications for phenotypic identity. JNeuropathol Exp Neurol 
67, 341-354 (2008).
331. Bostrom, M„ et al Neural network and "ganglion" formations in vitro: a 
video microscopy and scanning electron microscopy study on adult cultured 
spiral ganglion cells. Otol Neurotol 28,1109-1119 (2007).
332. Ning, H., et al Insulin growth factor signaling mediates neuron-like 
differentiation of adipose-tissue-derived stem cells. Differentiation 76, 488- 
494 (2008).
372
333. Curran, J.M., Chen, R. & Hunt, J.A. Controlling the phenotype and function 
of mesenchymal stem cells in vitro by adhesion to silane-modified clean glass 
surfaces. Biomaterials 26, 7057-7067 (2005).
334. Phillips, J.E., Guldberg, R.E. & Garcia, AJ. Dermal Fibroblasts Genetically 
Modified to Express Runx2/Cbfal as a Mineralizing Cell Source for Bone 
Tissue Engineering. Tissue Eng (2007).
335. Schutze, N., Noth, U., Schneidereit, J., Hendrich, C. & Jakob, F. Differential 
expression of CCN-family members in primary human bone marrow-derived 
mesenchymal stem cells during osteogenic, chondrogenic and adipogenic 
differentiation. Cell Commun Signal 3, 5 (2005).
336. Isenmami, S,, Cakouros, D., Zannettino, A., Shi, S. & Gronthos, S. hTERT 
transcription is repressed by Cbfal in human mesenchymal stem cell 
populations. J Bone Miner Res 22, 897-906 (2007).
337. Pereira, R.C., Stadmeyer, L., Marciniak, S.J., Ron, D. & Canalis, E. C/EBP 
homologous protein is necessary for normal osteoblastic function. J Cell 
Biochem 97, 633-640 (2006).
338. Heckmann, L., et al Human mesenchymal progenitor cell responses to a 
novel textured poly(L-lactide) scaffold for ligament tissue engineering. J 
Biomed Mater Res B Appl Biomater 81, 82-90 (2007).
339. Wei, Y., Hu, Y., Lv, R. & Li, D. Regulation of adipose-derived adult stem 
cells differentiating into chondrocytes with the use of rhBMP-2. Cytotherapy 
8, 570-579 (2006).
340. Lee, J.W., Kim, Y.H., Kim, S.H., Han, S.H. & Hahn, S.B. Chondrogenic 
differentiation of mesenchymal stem cells and its clinical applications. Yonsei 
Med J 45 Suppl, 41-47 (2004).
341. Raghunath, J„ et al. Chondrogenic potential of blood-acquired mesenchymal 
progenitor cells. J Blast Reconstr Aesthet Surg (2009).
342. Shoulders, M.D. & Raines, R.T. Collagen Structure and Stability. Anna Rev 
Biochem (2009).
343. Li, J., et al. A minimal common osteochondrocytic differentiation media for 
the osteogenic and chondrogenic differentiation of bone marrow stromal cells 
in the construction of osteochondral graft. Tissue Eng Part A (2009).
344. Strizzi, L., Bianco, C., Normanno, N. & Salomon, D. Cripto-1: a 
multifunctional modulator during embryogenesis and oncogenesis. Oncogene 
24, 5731-5741 (2005).
345. Guo, G., et al Klf4 reverts developmentally programmed restriction of 
ground state pluripotency. Development 136, 1063-1069 (2009).
346. Park, I.H. & Daley, G.Q. Human iPS cell derivation/reprogramming. Curr 
Protoc Stem Cell Biol Chapter 4, Unit 4A 1 (2009).
347. Levin, B.E. Synergy of nature and nurture in the development of childhood 
obesity. IntJ Obes (Lond) 33 Suppl 1, S53-56 (2009).
348. Ziylan, Y.Z., Baltaci, A.K. & Mogulkoc, R. Leptin transport in the central 
nervous system. Cell Biochem Fund 27, 63-70 (2009).
349. Villanueva, E.C. & Myers, M.G., Jr. Leptin receptor signaling and the 
regulation of mammalian physiology. IntJ Obes (Lond) 32 Suppl 7, S8-12 
(2008).
350. Fantuzzi, G. Three questions about leptin and immunity. Brain Behav Immun 
23, 405-410(2009).
351. Park, H.Y. & Gilchrest, B.A. More on MITF. J Invest Dermatol 119, 1218- 
1219(2002).
373
352. Tsukiji, N., et al. Mitf functions as an in ovo regulator for cell differentiation 
and proliferation during development of the chick RPE. Dev Biol 326, 335- 
346 (2009).
353. Covaceuszach, S.; et al. Development of a non invasive NGF-based therapy 
for Alzheimer's disease. Curr Alzheimer Res 6, 158-170 (2009).
354. Nomura, J., et al Differential Requirement for Nucleostemin in Embryonic 
Stem Cell and Neural Stem Cell Viability. Stem Cells 27, 1066-1076 (2009).
355. Ma, H. & Pederson, T. Nucleostemin: a multiplex regulator of cell-cycle 
progression. Trends Cell Biol 18, 575-579 (2008).
356. Ma, PI. & Pederson, T. Depletion of the nucleolar protein nucleostemin 
causes G1 cell cycle arrest via the p53 pathway. Mol Biol Cell 18, 2630-2635 
(2007).
357. Prusa, A.R., Marton, E., Rosner, M., Bemaschek, G. & Hengstschlager, M. 
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell 
research? HumReprod 18, 1489-1493 (2003),
358. Lee, N.K., et al Endocrine regulation of energy metabolism by the skeleton. 
Cell 130, 456-469 (2007).
359. Fumno, T. & Nakanishi, M. Neurotrophic factors increase tumor necrosis 
factor-alpha-induced nuclear translocation of NF-kappaB in rat PC 12 cells. 
Neurosci Lett 392, 240-244 (2006).
360. Burke, M.A. & Bothwell, M. p75 neurotrophin receptor mediates 
neurotrophin activation of NF-kappa B and induction of iNOS expression in 
P19 neurons. JNeurobiol 55, 191-203 (2003).
361. Hamanoue, M., et al p75-mediated NF-kappaB activation enhances the 
survival response of developing sensory neurons to nerve growth factor. Mol 
Cell Neurosci 14, 28-40 (1999).
362. Cragnolini, A.B., Huang, Y., Gokina, P. & Friedman, WJ. Nerve growth 
factor attenuates proliferation of astrocytes via the p75 neurotrophin receptor. 
Glia (2009).
363. Cvekl, A. & Duncan, M.K. Genetic and epigenetic mechanisms of gene 
regulation during lens development. Prog Retin Eye Res 26, 555-597 (2007).
364. Liu, W., Lagutin, O.V., Mende, M., Streit, A. & Oliver, G. Six3 activation of 
Pax6 expression is essential for mammalian lens induction and specification. 
EMBOJ25, 5383-5395 (2006).
365. Brasaemle, D.L., et al Perilipin A increases triacylglycerol storage by 
decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 275, 38486- 
38493 (2000).
366. Bruce, A.W., et al Genome-wide analysis of repressor element 1 silencing 
transcription factor/neuron-restrictive silencing factor (REST/NRSF) target 
genes. Proc Natl Acad Sci USA 101, 10458-10463 (2004).
367. Pimioji, R.C., et al Repressor element-1 silencing transcription 
factor/neuronal restrictive silencer factor (REST/NRSF) can regulate HSV-1 
immediate-early transcription via histone modification. Virol J 4, 56 (2007).
368. Tabuchi, A., et al REST4-mediated modulation of REST/NRSF-silencing 
function during BDNF gene promoter activation. Biochem Biophys Res 
Commun 290, 415-420 (2002).
369. Caddick, J., Kingham, P.J., Gardiner, N.J., Wiberg, M. & Terenghi, G. 
Phenotypic and functional characteristics of mesenchymal stem cells 
differentiated along a Schwann cell lineage. Glia 54, 840-849 (2006).
374
370. Hachem, S., et al. Spatial and temporal expression of S100B in cells of 
oligodendrocyte lineage. Glia 51, 81-97 (2005).
371. Zimmer, D.B., Cornwall, E.H., Landar, A. & Song, W. The S100 protein 
family: history, function, and expression. Brain Res Bull 37, 417-429 (1995).
372. Katoh, Y. & Katoh, M. Comparative genomics on SOX2 orthologs. Oncol 
Rep 14, 797-800 (2005).
373. Rodda, D.J., et al Transcriptional regulation of nanog by OCT4 and SOX2. J 
Biol Chem 280, 24731-24737 (2005).
374. Stadtfeld, M., Brennand, K. & Hochedlinger, K. Reprogramming of 
pancreatic beta cells into induced pluripotent stem cells. CurrBiol 18, 890- 
894 (2008).
375. Stadtfeld, M, Maherali, N., Breault, D.T. & Hochedlinger, K. Defining 
molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. 
Cell Stem Cell 2, 230-240 (2008).
376. Uchikawa, M., Ishida, Y., Takemoto, T., Kamachi, Y. & Kondoh, H. 
Functional analysis of chicken Sox2 enhancers highlights an array of diverse 
regulatory elements that are conserved in mammals. Dev Cell 4, 509-519 
(2003).
377. Gronthos, S., et al Differential cell surface expression of the STRO-1 and 
alkaline phosphatase antigens on discrete developmental stages in primary 
cultures of human bone cells. J Bone Miner Res 14, 47-56 (1999).
378. Tuli, R., et al Characterization of multipotential mesenchymal progenitor 
cells derived from human trabecular bone. Stem Cells 21, 681-693 (2003).
379. Brown, S.M., Lamberts, D.W., Reid, T.W., Nishida, T. & Murphy, C.J. 
Neurotrophic and anhidrotic keratopathy treated with substance P and 
insulinlike growth factor 1. Arch Ophthalmol 115, 926-927 (1997).
380. Reid, T.W., Murphy, CJ., Iwahashi, C.K., Foster, B.A. & Mannis, M.J. 
Stimulation of epithelial cell growth by the neuropeptide substance P. J Cell 
Biochem 52, 476-485 (1993).
381. Cho, K.J., et al Neurons derived from human mesenchymal stem cells show 
synaptic transmission and can be induced to produce the neurotransmitter 
substance P by interleukin-1 alpha. Stem Cells 23, 383-391 (2005).
382. Millward-Sadler, S J., et al Tachykinin expression in cartilage and function 
in human articular chondrocyte mechanotransduction. Arthritis Rheum 48, 
146-156 (2003).
383. Tarsa, L. & Goda, Y. Synaptophysin regulates activity-dependent synapse 
formation in cultured hippocampal neurons. Proc Natl Acad Sci USA 99, 
1012-1016(2002).
384. Hodge, R.D., et al Intermediate progenitors in adult hippocampal 
neurogenesis: Tbr2 expression and coordinate regulation of neuronal output. 
JNeurosci 28, 3707-3717 (2008).
385. Bach, T.L., Barsigian, C., Yaen, C.H. & Martinez, J. Endothelial cell VE- 
cadherin functions as a receptor for the betal5-42 sequence of fibrin. JBiol 
Chem 273, 30719-30728 (1998).
386. Ali, F.R., Haddley, K. & Quimi, J.P. Assessing the impact of genetic 
variation on transcriptional regulation in vitro. Methods Mol Biol 628, 195- 
214.
387. Alhadlaq, A. & Mao, J.J. Mesenchymal stem cells: isolation and therapeutics. 
Stem Cells Dev 13, 436-448 (2004).
375
388. Arthur, A., Zannettino, A. & Gronthos, S. The therapeutic applications of 
multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell 
Physiol (2008).
389. Barry, F.P. & Murphy, J.M. Mesenchymal stem cells: clinical applications 
and biological characterization. Int JBiochem Cell Biol 36, 568-584 (2004).
390. Grayson, W.L., Zhao, F., Izadpanah, R., Bunnell, B. & Ma, T. Effects of 
hypoxia on human mesenchymal stem cell expansion and plasticity in 3D 
constructs. J Cell Physiol 207, 331-339 (2006).
391. Neuhuber, B., Swanger, S.A., Howard, L., Mackay, A. & Fischer, I. Effects 
of plating density and culture time on bone marrow stromal cell 
characteristics. Exp Hematol 36, 1176-1185 (2008).
392. Bensidhoum, M., et al Homing of in vitro expanded Stro-1- or Stro-l+ 
human mesenchymal stem cells into the NOD/SCID mouse and their role in 
supporting human CD34 cell engraftment. Vol. 103 3313-3319 (2004).
393. Beyer Nardi, N. & da Silva Meirelles, L. Mesenchymal stem cells: isolation, 
in vitro expansion and characterization. Handb Exp Pharmacol, 249-282 
(2006).
394. Rhodes, N.P., Shortland, A.P., Rattray, A. & Williams, D.F. Platelet reactions 
to modified surfaces under dynamic conditions. J Mater Sci Mater Med 9, 
767-772 (1998).
395. Hayflick, L. The Limited in Vitro Lifetime of Human Diploid Cell Strains. 
Exp Cell Res 37, 614-636 (1965).
396. Asahara, T., et al Isolation of putative progenitor endothelial cells for 
angiogenesis. Science 275, 964-967 (1997).
397. Kalka, C., et al Transplantation of ex vivo expanded endothelial progenitor 
cells for therapeutic neovascularization. Proc Natl Acad Sci US A 97, 3422- 
3427 (2000).
398. Kawamoto, A„ et al Intramyocardial transplantation of autologous 
endothelial progenitor cells for therapeutic neovascularization of myocardial 
ischemia. Circulation 107, 461-468 (2003).
399. Harraz, M,, Jiao, C,, Hanlon, H.D., Hartley, R.S. & Schatteman, G.C. CD34- 
blood-derived human endothelial cell progenitors. Stem Cells 19, 304-312 
(2001).
400. Nakul-Aquaronne, D., Bayle, J. & Frelin, C. Coexpression of endothelial 
markers and CD 14 by cytokine mobilized CD34+ cells under angiogenic 
stimulation. Cardiovasc Res 57, 816-823 (2003).
401. Lin, Y., Weisdorf, D.J., Solovey, A. & Hebbel, R.P. Origins of circulating 
endothelial cells and endothelial outgrowth from blood. J Clin Invest 105, 71- 
77 (2000).
402. Gulati, R., et al Diverse origin and function of cells with endothelial 
phenotype obtained from adult human blood. Circ Res 93, 1023-1025 (2003).
403. Zhang, S.J., et al Adult endothelial progenitor cells from human peripheral 
blood maintain monocyte/macrophage function throughout in vitro culture. 
Cell Res 16, 577-584 (2006).
404. Cesselli, D., et al Multipotent progenitor cells are present in human 
peripheral blood. Circ Res 104, 1225-1234 (2009).
405. Kliman, H J. The placenta revealed. Am J Pathol 143, 332-336 (1993).
406. Kobayashi, K., Kubota, T. & Aso, T. Study on myofibroblast differentiation 
in the stromal cells of Wharton's jelly: expression and localization of alpha- 
smooth muscle actin. Early Hum Dev 51, 223-233 (1998).
376
407. Schroder, J. Fetal cells in the blood of pregnant mothers. J Med Genet 18, 
321-322 (1981).
408. Kang, X.Q., et al. Differentiating characterization of human umbilical cord 
blood-derived mesenchymal stem cells in vitro. Cell Biol Int 30, 569-575 
(2006).
409. Kern, S., Eichler, H., Stoeve, J., Kluter, H. & Bieback, K. Comparative 
analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, 
or adipose tissue. Stem Cells 24, 1294-1301 (2006).
410. Romanov, Y.A., Svintsitskaya, V.A. & Smirnov, V.N. Searching for 
alternative sources of postnatal human mesenchymal stem cells; candidate 
MSC-like cells from umbilical cord. Stem Cells 21, 105-110 (2003).
411. Weiss, MX. & Troyer, D.L. Stem cells in the umbilical cord. Stem Cell Rev 
2,155-162 (2006).
412. Cho, S.W., et al Lineage of non-cranial neural crest cell in the dental 
mesenchyme: using a lacZ reporter gene during early tooth development. J 
Electron Microsc (Tolcyo) 52, 567-571 (2003).
413. Chai, Y., et al. Fate of the mammalian cranial neural crest during tooth and 
mandibular morphogenesis. Development 127, 1671-1679 (2000).
414. Miletich, I. & Sharpe, P.T. Neural crest contribution to mammalian tooth 
formation. Birth Defects Res C Embryo Today 72, 200-212 (2004).
415. Yoon, Y.S., Park, J.S., Tkebuchava, T., Luedeman, C. & Losordo, D.W. 
Unexpected severe calcification after transplantation of bone marrow cells in 
acute myocardial infarction. Circulation 109, 3154-3157 (2004).
416. Orphanides, G., Lagrange, T. & Reinberg, D. The general transcription 
factors of RNA polymerase 11. Genes Dev 10, 2657-2683 (1996).
417. MacKenzie, A. & Quinn, J.P. Post-genomic approaches to exploring 
neuropeptide gene mis-expression in disease. Neuropeptides 38, 1-15 (2004).
418. Guindalini, C., et al A dopamine transporter gene functional variant 
associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci U S 
A 103, 4552-4557 (2006).
419. Gomez-Lira, M., et al Mutations in the SPINK1 gene in idiopathic 
pancreatitis Italian patients. EurJHum Genet 11, 543-546 (2003).
420. Atiar Rahman, M„ et al Proteome analysis for 3T3-L1 adipocyte 
differentiation. J Microbiol Biotechnol 18, 1895-1902 (2008).
421. Charriere, G., et al Preadipocyte conversion to macrophage. Evidence of 
plasticity. J Biol Chem 278, 9850-9855 (2003).
422. Moon, Y.S., et al Mice lacking paternally expressed Pref-1/Dlkl display 
growth retardation and accelerated adiposity. Mol Cell Biol 22, 5585-5592 
(2002).
423. Suslov, O.N., Kukekov, V.G., Ignatova, T.N. & Steindler, D.A. Neural stem 
cell heterogeneity demonstrated by molecular phenotyping of clonal 
neurospheres. Proc Natl Acad Sci USA 99, 14506-14511 (2002).
424. Loeffler, M. & Roeder, I. Tissue stem cells: definition, plasticity, 
heterogeneity, self-organization and models—a conceptual approach. Cells 
Tissues Organs 171, 8-26 (2002).
377
